Chapter 296-62 WAC

Last Update: 1/3/17

GENERAL OCCUPATIONAL HEALTH STANDARDS

WAC Sections

PART AGENERAL
PART BACCESS TO RECORDS
Note:
Access to records has been moved to chapter 296-802 WAC.
PART B-1
TRADE SECRETS
Note:
Chapter 296-62 WAC General occupational health standards Part B-1 Trade secrets (WAC 296-62-05301 through 296-62-05325) has been repealed. Please refer to WAC 296-901-14018 Trade secrets.
296-62-005Occupational health and environmental control—Foreword.
296-62-010Purpose and scope.
296-62-020Definitions applicable to all sections of this chapter.
296-62-040Unconstitutionality clause.
296-62-050Application for waiver or variances.
PART C-1
RETAIN DEPARTMENT OF TRANSPORTATION LABELING
296-62-055Retain labeling required by the department of transportation.
296-62-05510Scope.
296-62-05520Retain readily visible DOT labeling.
PART DCONTROLS AND DEFINITIONS
296-62-060Control requirements in addition to those specified.
PART ERESPIRATORY PROTECTION
Note:
The respiratory protection rules for general industry have been moved to chapter 296-842 WAC. The respiratory protection rules for the agriculture industry have been moved to chapter 296-307 WAC, part Y-5.
PART FCARCINOGENS
296-62-073Carcinogens—Scope and application.
296-62-07302Communication of hazards.
296-62-07304Definitions.
296-62-07306Requirements for areas containing carcinogens listed in WAC 296-62-07302.
296-62-07308General regulated area requirements.
296-62-07310Signs, information and training.
296-62-07312Reports.
296-62-07314Medical surveillance.
296-62-07316Premixed solutions.
PART GCARCINOGENS (SPECIFIC)
296-62-07329Vinyl chloride.
296-62-07336Acrylonitrile.
296-62-07337Appendix A—Substance safety data sheet for acrylonitrile.
296-62-07338Appendix B—Substance technical guidelines for acrylonitrile.
296-62-07339Appendix C—Medical surveillance guidelines for acrylonitrile.
296-62-07340Appendix D—Sampling and analytical methods for acrylonitrile.
296-62-073421,2-Dibromo-3-chloropropane.
296-62-07343Appendix A—Substance safety data sheet for DBCP.
296-62-07344Appendix B—Substance technical guidelines for DBCP.
296-62-07346Appendix C—Medical surveillance guidelines for DBCP.
296-62-07355Ethylene oxide.
296-62-07357Definitions.
296-62-07359Permissible exposure limits (PEL).
296-62-07361Exposure monitoring.
296-62-07363Regulated areas.
296-62-07365Methods of compliance.
296-62-07367Respiratory protection and personal protective equipment.
296-62-07369Emergency situations.
296-62-07371Medical surveillance.
296-62-07373Communication of EtO hazards.
296-62-07375Recordkeeping.
296-62-07377Observation of monitoring.
296-62-07381Appendices.
296-62-07383Appendix A—Substance safety data sheet for ethylene oxide (nonmandatory).
296-62-07385Appendix B—Substance technical guidelines for ethylene oxide (nonmandatory).
296-62-07387Appendix C—Medical surveillance guidelines for ethylene oxide (nonmandatory).
296-62-07389Appendix D—Sampling and analytical methods for ethylene oxide (nonmandatory).
296-62-074Cadmium.
296-62-07401Scope.
296-62-07403Definitions.
296-62-07405Permissible exposure limit (PEL).
296-62-07407Exposure monitoring.
296-62-07409Regulated areas.
296-62-07411Methods of compliance.
296-62-07413Respirator protection.
296-62-07415Emergency situations.
296-62-07417Protective work clothing and equipment.
296-62-07419Hygiene areas and practices.
296-62-07421Housekeeping.
296-62-07423Medical surveillance.
296-62-07425Communication of cadmium hazards.
296-62-07427Recordkeeping.
296-62-07429Observation of monitoring.
296-62-07433Appendices.
296-62-07441Appendix A, substance safety data sheet—Cadmium.
296-62-07443Appendix B—Substance technical guidelines for cadmium.
296-62-07447Appendix D—Occupational health history interview with reference to cadmium exposure directions.
296-62-07449Appendix E—Cadmium in workplace atmospheres.
296-62-07451A short description of Appendix F to 29 C.F.R. 1910.1027—Nonmandatory protocol for biological monitoring.
296-62-074601,3-Butadiene.
296-62-07470Methylene chloride.
296-62-07473Appendix A.
296-62-07475Appendix B.
296-62-07477Appendix C.
PART HAIR CONTAMINANTS
Note:
The air contaminant rules for general industry have been moved to chapter 296-841 WAC. The air contaminant rules for the agriculture industry have been moved to chapter 296-307 WAC, part Y-6.
PART IAIR CONTAMINANTS (SPECIFIC)
296-62-07517Reserved.
296-62-07519Thiram.
296-62-07521Lead.
296-62-07531Appendix D sampling and analytical methods for benzene monitoring and measurement procedures.
296-62-07540Formaldehyde.
296-62-07542Appendix A—Substance technical guideline for formalin.
296-62-07544Appendix B—Sampling strategy and analytical methods for formaldehyde.
296-62-07546Appendix C medical surveillance—Formaldehyde.
296-62-07548Appendix D—Nonmandatory medical disease questionnaire.
296-62-076Methylenedianiline.
296-62-07601Scope and application.
296-62-07603Definitions.
296-62-07605Permissible exposure limits (PEL).
296-62-07607Emergency situations.
296-62-07609Exposure monitoring.
296-62-07611Regulated areas.
296-62-07613Methods of compliance.
296-62-07615Respiratory protection.
296-62-07617Protective work clothing and equipment.
296-62-07619Hygiene facilities and practices.
296-62-07621Communication of hazards.
296-62-07623Housekeeping.
296-62-07625Medical surveillance.
296-62-07627Medical removal—Temporary medical removal of an employee.
296-62-07629Medical removal protection benefits.
296-62-07631Recordkeeping.
296-62-07633Observation of monitoring.
296-62-07637Appendices.
296-62-07654Appendix A to WAC 296-62-076—Substance data sheet, for 4,4'-methylenedianiline.
296-62-07656Appendix B to WAC 296-62-076—Substance technical guidelines, MDA.
296-62-07658Appendix C to WAC 296-62-076—Medical surveillance guidelines for MDA.
296-62-07660Appendix D to WAC 296-62-076—Sampling and analytical methods for MDA monitoring and measurement procedures.
PART I1—ASBESTOS, TREMOLITE, ANTHOPHYLLITE, AND ACTINOLITE
296-62-077Asbestos, tremolite, anthophyllite, and actinolite.
296-62-07701Scope and application.
296-62-07703Definitions.
296-62-07705Permissible exposure limits (PEL).
296-62-07706Multiemployer worksites.
296-62-07709Exposure assessment and monitoring.
296-62-07711Regulated areas.
296-62-07712Requirements for asbestos activities in construction and shipyard work.
296-62-07713Methods of compliance for asbestos activities in general industry.
296-62-07715Respiratory protection.
296-62-07717Protective work clothing and equipment.
296-62-07719Hygiene facilities and practices.
296-62-07721Communication of hazards.
296-62-07722Employee information and training.
296-62-07723Housekeeping.
296-62-07725Medical surveillance.
296-62-07727Recordkeeping.
296-62-07728Competent person.
296-62-07733Appendices.
296-62-07735Appendix A—WISHA reference method—Mandatory.
296-62-07737Appendix B—Detailed procedure for asbestos sampling and analysis—Nonmandatory.
296-62-07741Appendix D—Medical questionnaires—Mandatory.
296-62-07743Appendix E—Interpretation and classification of chest roentgenograms—Mandatory.
296-62-07745Appendix F—Work practices and engineering controls for automotive brake and clutch inspection, disassembly, repair and assembly—Mandatory.
296-62-07747Appendix G—Substance technical information for asbestos—Nonmandatory.
296-62-07749Appendix H—Medical surveillance guidelines for asbestos—Nonmandatory.
296-62-07751Appendix I—Work practices and engineering controls for Class I asbestos operations—Nonmandatory.
296-62-07753Appendix J—Polarized light microscopy of asbestos—Nonmandatory.
296-62-07755Appendix K—Smoking cessation program information for asbestos, tremolite, anthophyllite, and actinolite—Nonmandatory.
PART I2—HEXAVALENT CHROMIUM
296-62-08003Hexavalent chromium.
296-62-08005Definitions.
296-62-08007Permissible exposure limit (PEL).
296-62-08009Exposure determination.
296-62-08011Regulated areas.
296-62-08013Methods of compliance.
296-62-08015Respiratory protection.
296-62-08017Protective work clothing and equipment.
296-62-08019Hygiene areas and practices.
296-62-08021Housekeeping.
296-62-08023Medical surveillance.
296-62-08025Communication of chromium (VI) hazards.
296-62-08027Recordkeeping.
296-62-08029Dates.
PART JBIOLOGICAL AGENTS
Note:
The bloodborne pathogen rules for general industry have been moved to chapter 296-823 WAC.
PART J1—PHYSICAL AGENTS
296-62-090Physical agents.
296-62-09001Definitions.
296-62-09004Ionizing radiation.
296-62-09005Nonionizing radiation.
296-62-09007Pressure.
296-62-09009Vibration.
296-62-09013Temperature, radiant heat, or temperature-humidity combinations.
296-62-095Outdoor heat exposure.
296-62-09510Scope and purpose.
296-62-09520Definitions.
296-62-09530Employer and employee responsibility.
296-62-09540Drinking water.
296-62-09550Responding to signs and symptoms of heat-related illness.
296-62-09560Information and training.
PART KHEARING CONSERVATION
Note:
The hearing conservation rules for general industry have been moved to chapter 296-817 WAC. The hearing conservation rules for the agriculture industry have been moved to chapter 296-307 WAC, part Y-7.
PART LATMOSPHERES AND VENTILATION
296-62-11015Abrasive blasting.
296-62-11019Spray-finishing operations.
296-62-135Oxygen deficient atmospheres.
296-62-136Ventilation.
296-62-13605Definition.
296-62-13610Ventilation guide.
296-62-13615Adequate system.
296-62-13620Exhaust.
296-62-13625Make-up air quantity.
296-62-13630Design and operation.
296-62-13635Compatibility of systems.
PART MCONFINED SPACES
Note:
The confined spaces rules for general industry have been moved to chapter 296-809 WAC. The confined spaces rules for the agriculture industry have been moved to chapter 296-307 WAC, part Y-8.
PART NCOTTON DUST
296-62-14533Cotton dust.
296-62-14535Appendix A—Air sampling and analytical procedures for determining concentrations of cotton dust.
296-62-14537Appendix B-I through B-III—Respiratory questionnaire.
296-62-14539Appendix C—Spirometry prediction tables for normal males and females.
296-62-14541Appendix D—Pulmonary function standards for cotton dust standard.
296-62-14543Appendix E—Vertical elutriator equivalency protocol.
PART OCOKE OVENS
296-62-200Coke oven emissions.
296-62-20001Definitions.
296-62-20003Permissible exposure limit.
296-62-20005Regulated areas.
296-62-20007Exposure monitoring and measurement.
296-62-20009Methods of compliance.
296-62-20011Respiratory protection.
296-62-20013Protective clothing and equipment.
296-62-20015Hygiene facilities and practices.
296-62-20017Medical surveillance.
296-62-20019Employee information and training.
296-62-20021Communication of hazards.
296-62-20023Recordkeeping.
296-62-20025Observation of monitoring.
296-62-20027Appendix A—Coke oven emissions substance information sheet.
296-62-20029Appendix B—Industrial hygiene and medical surveillance guidelines.
PART PHAZARDOUS WASTE OPERATIONS AND TREATMENT, STORAGE, AND DISPOSAL FACILITIES
Note:
The hazardous waste rules for general industry have been moved to chapter 296-843 WAC.
PART QHAZARDOUS CHEMICALS IN LABORATORIES
Note:
The hazardous chemicals in laboratories rules for general industry have been moved to chapter 296-828 WAC.
PART RHAZARDOUS DRUGS
296-62-500Hazardous drugs.
296-62-50005Scope.
296-62-50010Definitions.
296-62-50015Hazardous drugs control program.
296-62-50020Hazard assessment.
296-62-50025Engineering controls.
296-62-50030Personal protective equipment (PPE).
296-62-50035Safe handling practices.
296-62-50040Cleaning and housekeeping.
296-62-50045Spill control.
296-62-50050Training.
296-62-50055Implementation plan.
DISPOSITION OF SECTIONS FORMERLY CODIFIED IN THIS TITLE
296-62-030Revisions. [Order 70-8, § 296-62-030, filed 7/31/70, effective 9/1/70; Rule 3.010, effective 8/1/63.] Repealed by Order 73-3, filed 5/7/73.
296-62-051Ergonomics. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-051, filed 5/26/00, effective 7/1/02.] Repealed by WSR 07-03-163, filed 1/24/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-05101What is the purpose of this rule? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05101, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05103Which employers are covered by this rule? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05103, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05105What is a "caution zone job"? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05105, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05110When do employers' existing ergonomics activities comply with this rule? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05110, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05120Which employees must receive ergonomics awareness education and when? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05120, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05122What must be included in ergonomics awareness education? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05122, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05130What options do employers have for analyzing and reducing WMSD hazards? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05130, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05140How must employees be kept involved and informed? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-23-060, § 296-62-05140, filed 11/20/01, effective 7/1/02; WSR 00-12-024, § 296-62-05140, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05150How are terms and phrases used in this rule? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05150, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05160When must employers comply with this rule? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05160, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05172Appendix A: Illustrations of physical risk factors. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05172, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05174Appendix B: Criteria for analyzing and reducing WMSD hazards for employers who choose the specific performance approach. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05174, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-05176Appendix C: Standard industry classification (SIC) codes. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-12-024, § 296-62-05176, filed 5/26/00, effective 7/1/02.] Repealed by Initiative 841, approved 11/4/03, effective 12/4/03.
296-62-052Access to employee exposure and medical records. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-052, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-052, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05201Purpose. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05201, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05201, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05203Scope and application. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05203, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05203, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05205Definitions. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05205, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05205, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05207Preservation of records. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05207, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05207, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05207, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05209Access to records. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-17-033, § 296-62-05209, filed 8/8/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05209, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-05209, filed 11/30/83. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05209, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05211Trade secrets. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05211, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05211, filed 8/27/81.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05213Employee information. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05213, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05213, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05215Transfer of records. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05215, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05215, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05217Appendices. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05217, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05217, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05219Effective date. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05219, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05219, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05221Appendix A—Sample authorization letter for the release of employee medical record information to a designated representative. [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05221, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05221, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05223Appendix B—Availability of NIOSH Registry of Toxic Effects of Chemical Substances (RTECS). [Statutory Authority: Chapter 49.17 RCW. WSR 89-11-035 (Order 89-03), § 296-62-05223, filed 5/15/89, effective 6/30/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-05223, filed 8/27/81.] Repealed by WSR 04-10-026, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-802 WAC.
296-62-05301Definitions. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05301, filed 5/9/01, effective 9/1/01.] Repealed by WSR 17-02-066, filed 1/3/17, effective 2/3/17. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-05305Meet certain conditions if you withhold trade secret information. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-14-026, § 296-62-05305, filed 6/29/04, effective 9/1/04. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05305, filed 5/9/01, effective 9/1/01.] Repealed by WSR 17-02-066, filed 1/3/17, effective 2/3/17. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-05310Reveal trade secret information when it is needed in order to treat a medical or first-aid emergency. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05310, filed 5/9/01, effective 9/1/01.] Repealed by WSR 17-02-066, filed 1/3/17, effective 2/3/17. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-05315Reveal trade secret information in nonemergency situations when requested by a health professional, employee, or designated representative. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05315, filed 5/9/01, effective 9/1/01.] Repealed by WSR 17-02-066, filed 1/3/17, effective 2/3/17. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-05320Deny a written request for disclosure of a specific chemical identity in the manner specified in this rule. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05320, filed 5/9/01, effective 9/1/01.] Repealed by WSR 17-02-066, filed 1/3/17, effective 2/3/17. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-05325Understand what is a trade secret. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05325, filed 5/9/01, effective 9/1/01.] Repealed by WSR 17-02-066, filed 1/3/17, effective 2/3/17. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-054Manufacturers, importers and distributors—Hazard communication. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-01-096, § 296-62-054, filed 12/17/02, effective 6/1/03. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-054, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 88-14-108 (Order 88-11), § 296-62-054, filed 7/6/88. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 84-22-012 (Order 84-22), § 296-62-054, filed 10/30/84; WSR 84-13-001 (Order 84-14), § 296-62-054, filed 6/7/84.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-560 through 296-307-56050.
296-62-05402Determine whether the chemicals you produce in your workplace or import are hazardous. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05402, filed 5/9/01, effective 9/1/01.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-560 through 296-307-56050.
296-62-05403Scope and application. [Statutory Authority: RCW 49.17.010, [49.17].050 and [49.17].060. WSR 95-22-015, § 296-62-05403, filed 10/20/95, effective 1/16/96. Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05403, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05403, filed 7/6/88; WSR 87-24-051 (Order 87-24), § 296-62-05403, filed 11/30/87. Statutory Authority: RCW 49.17.230, 49.70.180, 49.17.040, 49.17.050 and 49.17.240. WSR 86-12-004 (Order 86-22), § 296-62-05403, filed 5/22/86. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 85-10-004 (Order 85-09), § 296-62-05403, filed 4/19/85; WSR 84-22-012 (Order 84-22), § 296-62-05403, filed 10/30/84; WSR 84-13-001 (Order 84-14), § 296-62-05403, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05404Use these criteria in making hazard determinations. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05404, filed 5/9/01, effective 9/1/01.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-560 through 296-307-56050.
296-62-05405Definitions applicable to this part. [Statutory Authority: RCW 49.17.010, [49.17].050 and [49.17].060. WSR 95-22-015, § 296-62-05405, filed 10/20/95, effective 1/16/96. Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05405, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05405, filed 7/6/88; WSR 87-24-051 (Order 87-24), § 296-62-05405, filed 11/30/87. Statutory Authority: RCW 49.17.050(2) and 49.17.040. WSR 87-10-008 (Order 87-06), § 296-62-05405, filed 4/27/87. Statutory Authority: RCW 49.17.230, 49.70.180, 49.17.040, 49.17.050 and 49.17.240. WSR 86-12-004 (Order 86-22), § 296-62-05405, filed 5/22/86. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 85-10-004 (Order 85-09), § 296-62-05405, filed 4/19/85; WSR 84-22-012 (Order 84-22), § 296-62-05405, filed 10/30/84; WSR 84-13-001 (Order 84-14), § 296-62-05405, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05406Determine whether the chemicals you produce or import are health hazards. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05406, filed 5/9/01, effective 9/1/01.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-560 through 296-307-56050.
296-62-05407Hazard determination. [Statutory Authority: RCW 49.17.010, [49.17].050 and [49.17].060. WSR 95-22-015, § 296-62-05407, filed 10/20/95, effective 1/16/96. Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05407, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05407, filed 7/6/88. Statutory Authority: RCW 49.17.230, 49.70.180, 49.17.040, 49.17.050 and 49.17.240. WSR 86-12-004 (Order 86-22), § 296-62-05407, filed 5/22/86. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 84-13-001 (Order 84-14), § 296-62-05407, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05408Obtain or develop a material safety data sheet for each hazardous chemical you produce or import. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05408, filed 5/9/01, effective 9/1/01.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-560 through 296-307-56050.
296-62-05409Written hazard communication program. [Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05409, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05409, filed 7/6/88. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 84-13-001 (Order 84-14), § 296-62-05409, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05410Label clearly each container of hazardous chemicals that leaves your workplace. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05410, filed 5/9/01, effective 9/1/01.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-560 through 296-307-56050.
296-62-05411Labels and other forms of warning. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-006, § 296-62-05411, filed 1/18/95, effective 3/10/95; WSR 94-16-145, § 296-62-05411, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05411, filed 7/6/88. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 85-10-004 (Order 85-09), § 296-62-05411, filed 4/19/85; WSR 84-13-001 (Order 84-14), § 296-62-05411, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05412Provide material safety data sheets. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-05412, filed 5/9/01, effective 9/1/01.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-560 through 296-307-56050.
296-62-05413Material safety data sheets. [Statutory Authority: RCW 49.17.040, [49.17.]050 and [49.17.]060. WSR 97-11-055, § 296-62-05413, filed 5/20/97, effective 8/1/97. Statutory Authority: RCW 49.17.010, [49.17].050 and [49.17].060. WSR 95-22-015, § 296-62-05413, filed 10/20/95, effective 1/16/96. Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05413, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05413, filed 7/6/88. Statutory Authority: RCW 49.17.230, 49.70.180, 49.17.040, 49.17.050 and 49.17.240. WSR 86-12-004 (Order 86-22), § 296-62-05413, filed 5/22/86. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 85-10-004 (Order 85-09), § 296-62-05413, filed 4/19/85; WSR 84-22-012 (Order 84-22), § 296-62-05413, filed 10/30/84; WSR 84-13-001 (Order 84-14), § 296-62-05413, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05415Employee information and training. [Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05415, filed 8/3/94, effective 9/12/94. Statutory Authority: RCW 49.17.230, 49.70.180, 49.17.040, 49.17.050 and 49.17.240. WSR 86-12-004 (Order 86-22), § 296-62-05415, filed 5/22/86. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 84-13-001 (Order 84-14), § 296-62-05415, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05417Trade secrets. [Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05417, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05417, filed 7/6/88. Statutory Authority: RCW 49.17.230, 49.70.180, 49.17.040, 49.17.050 and 49.17.240. WSR 86-12-004 (Order 86-22), § 296-62-05417, filed 5/22/86. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 84-22-012 (Order 84-22), § 296-62-05417, filed 10/30/84; WSR 84-13-001 (Order 84-14), § 296-62-05417, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05419Effective dates. [Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05419, filed 8/3/94, effective 9/12/94. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 84-13-001 (Order 84-14), § 296-62-05419, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05421Appendix A—Health hazard definitions (mandatory). [Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05421, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05421, filed 7/6/88. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 85-10-004 (Order 85-09), § 296-62-05421, filed 4/19/85; WSR 84-22-012 (Order 84-22), § 296-62-05421, filed 10/30/84; WSR 84-13-001 (Order 84-14), § 296-62-05421, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05423Appendix B—Hazard determination (mandatory). [Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05423, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05423, filed 7/6/88. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 84-13-001 (Order 84-14), § 296-62-05423, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05425Appendix C—Information sources (advisory). [Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05425, filed 8/3/94, effective 9/12/94; WSR 88-14-108 (Order 88-11), § 296-62-05425, filed 7/6/88. Statutory Authority: RCW 49.17.230, 49.70.180, 49.17.040, 49.17.050 and 49.17.240. WSR 86-12-004 (Order 86-22), § 296-62-05425, filed 5/22/86. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 85-10-004 (Order 85-09), § 296-62-05425, filed 4/19/85; WSR 84-13-001 (Order 84-14), § 296-62-05425, filed 6/7/84.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05427Appendix D. [Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05427, filed 8/3/94, effective 9/12/94. Statutory Authority: RCW 49.17.050(2) and 49.17.040. WSR 87-10-008 (Order 87-06), § 296-62-05427, filed 4/27/87. Statutory Authority: RCW 49.17.230, 49.70.180, 49.17.040, 49.17.050 and 49.17.240. WSR 86-12-004 (Order 86-22), § 296-62-05427, filed 5/22/86.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-05429Appendix E—Guidelines for employer compliance (advisory). [Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-05429, filed 8/3/94, effective 9/12/94.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-070Chemical agents (airborne or contact). [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 02-16-047, § 296-62-070, filed 8/1/02, effective 10/1/02; Order 70-8, § 296-62-070, filed 7/31/70, effective 9/1/70; Section VII, effective 8/1/63.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-009.
296-62-07001Definitions (airborne chemical agents). [Order 73-3, § 296-62-07001, filed 5/7/73.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-009.
296-62-07003Definitions (contact chemical agents). [Order 73-3, § 296-62-07003, filed 5/7/73.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-009.
296-62-07005Control of chemical agents. [Order 73-3, § 296-62-07005, filed 5/7/73.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-018.
296-62-07007Labeling of chemical agents. [Order 73-3, § 296-62-07007, filed 5/7/73.] Repealed by WSR 90-09-026 (Order 90-01), filed 4/10/90, effective 5/25/90. Statutory Authority: Chapter 49.17 RCW.
296-62-071Respiratory protection. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-20-114, § 296-62-071, filed 10/1/03, effective 1/1/04. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-071, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07101To whom does chapter 296-62 WAC, Part E apply? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07101, filed 5/9/01, effective 9/1/01; WSR 99-10-071, § 296-62-07101, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-08-026 (Order 82-10), § 296-62-07101, filed 3/30/82. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07101, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07102When are you allowed to rely on respirators to protect employees from breathing contaminated air? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07102, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07103What are your responsibilities as an employer? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07103, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07103, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07105Definitions. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-21-100, § 296-62-07105, filed 10/18/00, effective 1/1/01; WSR 99-10-071, § 296-62-07105, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-07105, filed 1/18/95, effective 3/1/95; WSR 94-15-096 (Order 94-07), § 296-62-07105, filed 7/20/94, effective 9/20/94; WSR 93-19-142 (Order 93-04), § 296-62-07105, filed 9/22/93, effective 11/1/93; WSR 91-24-017 (Order 91-07), § 296-62-07105, filed 11/22/91, effective 12/24/91. RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07105, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07107When is a respiratory protection program required? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07107, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 90-09-026 (Order 90-01), § 296-62-07107, filed 4/10/90, effective 5/25/90. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-03-023 (Order 82-1), § 296-62-07107, filed 1/15/82. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07107, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07109When must you update your written respiratory protection program? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07109, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-13-045 (Order 82-22), § 296-62-07109, filed 6/11/82; WSR 82-03-023 (Order 82-1), § 296-62-07109, filed 1/15/82. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07109, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07111What must be included in your written respiratory protection program? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07111, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07111, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07113What are the requirements for a program administrator? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07113, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.040, [49.17.]050 and [49.17.]060. WSR 97-19-014, § 296-62-07113, filed 9/5/97, effective 11/5/97. Statutory Authority: Chapter 49.17 RCW. WSR 91-24-017 (Order 91-07), § 296-62-07113, filed 11/22/91, effective 12/24/91; WSR 88-14-108 (Order 88-11), § 296-62-07113, filed 7/6/88. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07113, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07115Who pays for the respirators, training, medical evaluations, and fit testing? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07115, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 88-14-108 (Order 88-11), § 296-62-07115, filed 7/6/88. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-07115, filed 11/30/83; WSR 82-08-026 (Order 82-10), § 296-62-07115, filed 3/30/82. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07115, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07117What must you do when employees choose to wear respirators when respirators are not required? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-21-100, § 296-62-07117, filed 10/18/00, effective 1/1/01; WSR 99-10-071, § 296-62-07117, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07117, filed 7/27/81.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07119Identification of air-purifying respirator canisters. [Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07119, filed 7/27/81.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07121Effective date. [Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-07121, filed 7/27/81.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07130What must be considered when selecting any respirator? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07130, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07131What else must you consider when selecting a respirator for use in atmospheres that are not IDLH? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-21-100, § 296-62-07131, filed 10/18/00, effective 1/1/01; WSR 99-10-071, § 296-62-07131, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07132What else must you consider when selecting a respirator for use in IDLH atmospheres? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07132, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07133What else must you consider when selecting a respirator for emergency and rescue use? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07133, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07150What are the general requirements for medical evaluations? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-21-100, § 296-62-07150, filed 10/18/00, effective 1/1/01; WSR 99-10-071, § 296-62-07150, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07151Who must perform medical evaluations? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07151, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07152What information must you provide to the PLHCP in addition to the questionnaire? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07152, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07153How must the medical evaluations and the questionnaire be administered? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07153, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07154Who must review the questionnaire and determine what, if any, follow-up evaluations are needed? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07154, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07155What must be included in the PLHCP's written recommendation? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-21-100, § 296-62-07155, filed 10/18/00, effective 1/1/01; WSR 99-10-071, § 296-62-07155, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07156When are future medical evaluations required? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-21-100, § 296-62-07156, filed 10/18/00, effective 1/1/01; WSR 99-10-071, § 296-62-07156, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07160When is fit testing required? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07160, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07161What is required when an employee finds the respirator's fit unacceptable? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07161, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07162How must fit testing be done? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-21-100, § 296-62-07162, filed 10/18/00, effective 1/1/01; WSR 99-10-071, § 296-62-07162, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07170How must you prevent problems with the seal on tight-fitting facepieces? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07170, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07171How do you monitor continuing effectiveness of your employees' respirators? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07171, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07172What are the standby procedures when respirators are used in IDLH situations? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07172, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07175How must respirators be cleaned and disinfected? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07175, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07176How must respirators be stored? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07176, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07177When must respirators be inspected? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07177, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07178How must respirators be inspected and maintained? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07178, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07179How must respirators be repaired and adjusted? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07179, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07182What are the breathing gas requirements for atmosphere-supplying respirators? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07182, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07184How must filters, cartridges and canisters be labeled? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07184, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07186What are the general training requirements? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07186, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07188How do you know if you adequately trained your employees? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07188, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07190When must your employees be trained? [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-21-100, § 296-62-07190, filed 10/18/00, effective 1/1/01; WSR 99-10-071, § 296-62-07190, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07192How must you evaluate the effectiveness of your respiratory protection program? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07192, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07194What are the recordkeeping requirements? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07194, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07201Appendix A-1: General fit testing requirements for respiratory protection—Mandatory. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07201, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07202What are the general requirements for fit testing? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07202, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07203What are the fit test exercise requirements? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07203, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07205Appendix A-2: Qualitative fit testing (QLFT) protocols for respiratory protection—Mandatory. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07205, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07206What are the general qualitative fit testing (QLFT) protocols? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07206, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07208Isoamyl acetate protocol (a QLFT). [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07208, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07209What are the odor threshold screening procedures for isoamyl acetate (QLFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07209, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07210What are the isoamyl acetate fit testing procedures (QLFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07210, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07212Saccharin solution aerosol protocol (QLFT). [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07212, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07213What are the taste threshold screening procedures for saccharin (QLFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07213, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07214What is the saccharin solution aerosol fit testing procedure (QLFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07214, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07217 BitrexTM (denatonium benzoate) solution aerosol qualitative fit testing (QLFT) protocol. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07217, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07218What is the taste threshold screening procedure for BitrexTM (QLFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07218, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07219What is the BitrexTM solution aerosol fit testing procedure (QLFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07219, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07222Irritant smoke (stannic chloride) protocol (QLFT). [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07222, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07223What are the general requirements and precautions for irritant smoke fit testing (QLFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07223, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07224What is the sensitivity screening check protocol for irritant smoke (QLFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07224, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07225What is the irritant smoke fit testing procedure (QLFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07225, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07230Appendix A-3: Quantitative fit testing (QNFT) protocols for respiratory protection—Mandatory. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07230, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07231What are the general requirements for quantitative fit testing (QNFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07231, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07233Generated aerosol quantitative fit testing protocol (QNFT). [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07233, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07234What equipment is required for generated aerosol fit testing (QNFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07234, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07235What are the procedures for generated aerosol quantitative fit testing (QNFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07235, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07236How are fit factors calculated (QNFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07236, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07238Ambient aerosol condensation nuclei counter (CNC) quantitative fit testing protocol. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07238, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07239General information about ambient aerosol condensation nuclei counter (CNC) protocol (QNFT). [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07239, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07240What are the general requirements for ambient aerosol condensation nuclei counter (CNC) protocol (QNFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07240, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07242What are the Portacount fit testing procedures? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07242, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07243How is the Portacount test instrument used? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07243, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07245Controlled negative pressure (CNP) quantitative fit testing protocol (QNFT). [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07245, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07246How does controlled negative pressure (CNP) fit testing work (QNFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07246, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07247What are the controlled negative pressure (CNP) fit testing requirements and procedures (QNFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07247, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07248What test exercises are required for controlled negative pressure (CNP) fit testing (QNFT)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07248, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07251Appendix B-1: User seal check procedures—Mandatory. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07251, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07253Appendix B-2: Respirator cleaning procedures—Mandatory. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07253, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07255Appendix C: WISHA respirator medical evaluation questionnaire—Mandatory. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 00-21-100, § 296-62-07255, filed 10/18/00, effective 1/1/01; WSR 99-10-071, § 296-62-07255, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07257Appendix D: Health care provider respirator recommendation form—Nonmandatory. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07257, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07260Appendix E: Additional information regarding respirator selection—Nonmandatory. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07260, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07261How do you classify respiratory hazards? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07261, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07263What are oxygen deficient respiratory hazards? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07263, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07265What needs to be considered when combinations of contaminants occur in the workplace? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07265, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07267What are the two major types of respirators? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07267, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07269What are air-purifying respirators (APRs)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07269, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07271What are the general limitations for air-purifying respirators (APRs)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07271, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07273What are particulate-removing respirators? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07273, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07275What are vapor- and gas-removing respirators? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07275, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07277What are combination particulate- and vapor- and gas-removing respirators? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07277, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07279What types of filters, canisters and cartridges are available for air-purifying respirators (APRs)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07279, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07281How do atmosphere-supplying respirators work? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07281, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07283What are the capabilities and limitations of atmosphere-supplying respirators? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07283, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07285What is a supplied-air respirator? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07285, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07287What are the general capabilities and limitations of supplied-air respirators? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07287, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07289What are combination supplied-air and air-purifying respirators? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07289, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07291What are combination supplied-air respirators with auxiliary self-contained air supply? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07291, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07293What is a self-contained breathing apparatus respirator (SCBA)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07293, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07295What are the limitations for self-contained breathing apparatus respirators (SCBA)? [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07295, filed 5/4/99, effective 9/1/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-073014-Nitrobiphenyl. [Order 74-35, § 296-62-07301, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-07303Alpha-Naphthylamine. [Order 74-35, § 296-62-07303, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-073054,4'-Methylene bis (2-chloroaniline). [Order 74-35, § 296-62-07305, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-07307Methyl chloromethyl ether. [Order 74-35, § 296-62-07307, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-073093,3'-Dichlorobenzidine (and its salts). [Order 74-35, § 296-62-07309, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-07311Bis-Chloromethyl ether. [Order 74-35, § 296-62-07311, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-07313Beta-Naphthylamine. [Order 74-35, § 296-62-07313, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-07315Benzidine. [Order 74-35, § 296-62-07315, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-073174-Aminodiphenyl. [Order 74-35, § 296-62-07317, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-07319Ethyleneimine. [Order 76-6, § 296-62-07319, filed 3/1/76.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-07321Beta-Propiolactone. [Order 74-35, § 296-62-07321, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-073232-Acetylaminofluorene. [Order 74-35, § 296-62-07323, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-073254-Dimethylaminoazobenzene. [Order 74-35, § 296-62-07325, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-07327N-Nitrosodimethylamine—Carcinogen standard report form. [Order 74-35, § 296-62-07327 and Carcinogen Standard Report Form, filed 9/20/74.] Repealed by WSR 80-17-014 (Order 80-20), filed 11/13/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW.
296-62-07335Benzene. [Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30, and 43.22 RCW. WSR 78-09-092 (Order 78-16), § 296-62-07335, filed 8/31/78.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.
296-62-07341Acrylonitrile. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 86-16-009 (Order 86-28), § 296-62-07341, filed 7/25/86. Statutory Authority: RCW 49.17.040, 49.17.050, and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-07341, filed 8/27/81; WSR 81-16-015 (Order 81-20), § 296-62-07341, filed 7/27/81; WSR 80-11-010 (Order 80-14), § 296-62-07341, filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30, and 43.22 RCW. WSR 78-07-052 (Order 78-10), § 296-62-07341, filed 6/28/78.] Repealed by WSR 88-11-021 (Order 88-04), filed 5/11/88. Statutory Authority: Chapter 49.17 RCW.
296-62-073451,2-Dibromo-3-chloropropane. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 86-16-009 (Order 86-28), § 296-62-07345, filed 7/25/86. Statutory Authority: RCW 49.17.040, 49.17.050, and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-07345, filed 8/27/81; WSR 81-16-015 (Order 81-20), § 296-62-07345, filed 7/27/81; WSR 80-11-010 (Order 80-14), § 296-62-07345, filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050, and 49.17.240, chapters 42.30, and 43.22 RCW. WSR 78-07-052 (Order 78-10), § 296-62-07345, filed 6/28/78.] Repealed by WSR 88-11-021 (Order 88-04), filed 5/11/88. Statutory Authority: Chapter 49.17 RCW.
296-62-07347Inorganic arsenic. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-18-090, § 296-62-07347, filed 9/2/03, effective 11/1/03. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07347, filed 5/9/01, effective 9/1/01; WSR 99-17-094, § 296-62-07347, filed 8/17/99, effective 12/1/99; WSR 99-10-071, § 296-62-07347, filed 5/4/99, effective 9/1/99; WSR 98-02-030, § 296-62-07347, filed 12/31/97, effective 1/31/98. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-07347, filed 7/20/94, effective 9/20/94. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-07347, filed 8/27/81; WSR 81-16-015 (Order 81-20), § 296-62-07347, filed 7/27/81; WSR 79-08-115 (Order 79-9), § 296-62-07347, filed 7/31/79; WSR 79-02-037 (Order 79-1), § 296-62-07347, filed 1/23/79.] Repealed by WSR 05-01-173, filed 12/21/04, effective 5/1/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07349Lead. [Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-07349, filed 8/27/81; WSR 81-16-015 (Order 81-20), § 296-62-07349, filed 7/27/81; WSR 80-11-009 (Order 80-16), § 296-62-07349, filed 8/8/80.] Decodified by WSR 82-13-045 (Order 82-22), filed 6/11/82. Statutory Authority: RCW 49.17.040 and 49.17.050. Later promulgation, see WAC 296-62-07521.
296-62-07353Ethylene oxide. [Statutory Authority: RCW 49.17.050(2) and 49.14.040 [49.17.040]. WSR 87-07-022 (Order 87-01), § 296-62-07353, filed 3/12/87. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 86-16-009 (Order 86-28), § 296-62-07353, filed 7/25/86; WSR 85-10-004 (Order 85-09), § 296-62-07353, filed 4/19/85; WSR 85-01-022 (Order 84-24), § 296-62-07353, filed 12/11/84.] Repealed by WSR 87-24-051 (Order 87-24), filed 11/30/87. Statutory Authority: Chapter 49.17 RCW.
296-62-07354Appendices—Inorganic arsenic. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-17-094, § 296-62-07354, filed 8/17/99, effective 12/1/99; WSR 98-02-030, § 296-62-07354, filed 12/31/97, effective 1/31/98. Statutory Authority: Chapter 49.17 RCW. WSR 90-20-091 (Order 90-14), § 296-62-07354, filed 10/1/90, effective 11/15/90.] Repealed by WSR 07-03-153, filed 1/23/07, effective 6/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07379Dates. [Statutory Authority: Chapter 49.17 RCW. WSR 88-23-054 (Order 88-25), § 296-62-07379, filed 11/14/88; WSR 87-24-051 (Order 87-24), § 296-62-07379, filed 11/30/87.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07431Dates. [Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07431, filed 3/13/93, effective 4/27/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07445Appendix C—Qualitative and quantitative fit testing procedures—(Fit test protocols). [Statutory Authority: Chapter 49.17 RCW. WSR 96-09-030, § 296-62-07445, filed 4/10/96, effective 6/1/96; WSR 93-21-075 (Order 93-06), § 296-62-07445, filed 10/20/93, effective 12/1/93; WSR 93-07-044 (Order 93-01), § 296-62-07445, filed 3/13/93, effective 4/27/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-075Air contaminants. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-20-115, § 296-62-075, filed 10/1/03, effective 1/1/04. Statutory Authority: RCW 49.17.040, [49.17.]050 and [49.17.]060. WSR 97-19-014, § 296-62-075, filed 9/5/97, effective 11/5/97. Statutory Authority: Chapter 49.17 RCW. WSR 89-15-002 (Order 89-06), § 296-62-075, filed 7/6/89, effective 8/7/89; Order 73-3, § 296-62-075, filed 5/7/73.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07501Airborne contaminants. [Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-07501, filed 6/5/02, effective 8/1/02. Statutory Authority: RCW 49.17.040, [49.17.]050 and [49.17.]060. WSR 97-19-014, § 296-62-07501, filed 9/5/97, effective 11/5/97. Statutory Authority: Chapter 49.17 RCW. WSR 89-15-002 (Order 89-06), § 296-62-07501, filed 7/6/89, effective 8/7/89. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-03-023 (Order 82-1), § 296-62-07501, filed 1/15/82. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-015 (Order 81-20), § 296-62-07501, filed 7/27/81; WSR 80-11-010 (Order 80-14), § 296-62-07501, filed 8/8/80; Order 73-3, § 296-62-07501, filed 5/7/73.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07503Ceiling vs. time-weighted average limits. [Statutory Authority: Chapter 49.17 RCW. WSR 89-15-002 (Order 89-06), § 296-62-07503, filed 7/6/89, effective 8/7/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 80-11-010 (Order 80-14), § 296-62-07503, filed 8/8/80; Order 73-3, § 296-62-07503, filed 5/7/73.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07505"Skin" notation. [Statutory Authority: Chapter 49.17 RCW. WSR 89-15-002 (Order 89-06), § 296-62-07505, filed 7/6/89, effective 8/7/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 80-11-010 (Order 80-14), § 296-62-07505, filed 8/8/80; Order 73-3, § 296-62-07505, filed 5/7/73.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07507Mixtures. [Statutory Authority: Chapter 49.17 RCW. WSR 90-03-029 (Order 89-20), § 296-62-07507, filed 1/11/90, effective 2/26/90; WSR 89-15-002 (Order 89-06), § 296-62-07507, filed 7/6/89, effective 8/7/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 80-11-010 (Order 80-14), § 296-62-07507, filed 8/8/80; Order 73-3, § 296-62-07507, filed 5/7/73.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07509Nuisance dusts. [Statutory Authority: Chapter 49.17 RCW. WSR 93-01-067 (Order 92-15), § 296-62-07509, filed 12/11/92, effective 1/15/93. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 80-11-010 (Order 80-14), § 296-62-07509, filed 8/8/80; Order 73-3, § 296-62-07509, filed 5/7/73.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07510Total particulate. [Statutory Authority: RCW 49.17.040, [49.17.]050 and [49.17.]060. WSR 97-19-014, § 296-62-07510, filed 9/5/97, effective 11/5/97. Statutory Authority: Chapter 49.17 RCW. WSR 89-15-002 (Order 89-06), § 296-62-07510, filed 7/6/89, effective 8/7/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 80-11-010 (Order 80-14), § 296-62-07510, filed 8/8/80.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07511Simple asphyxiants. [Statutory Authority: Chapter 49.17 RCW. WSR 89-15-002 (Order 89-06), § 296-62-07511, filed 7/6/89, effective 8/7/89. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 80-11-010 (Order 80-14), § 296-62-07511, filed 8/8/80; Order 73-3, § 296-62-07511, filed 5/7/73.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07513Physical factors. [Statutory Authority: RCW 49.17.040, 49.17.050, and 49.17.240. WSR 80-11-010 (Order 80-14), § 296-62-07513, filed 8/8/80; Order 73-3, § 296-62-07513, filed 5/7/73.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07515Control of chemical agents. [Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050, and 49.26.130. WSR 00-06-075, § 296-62-07515, filed 3/1/00, effective 4/10/00. Statutory Authority: RCW 49.17.040, [49.17].050 and [49.17].060. WSR 98-10-029, § 296-62-07515, filed 4/24/98, effective 7/24/98; WSR 97-19-014, § 296-62-07515, filed 9/5/97, effective 11/5/97. Statutory Authority: Chapter 49.17 RCW. WSR 96-17-056, § 296-62-07515, filed 8/20/96, effective 10/15/96; WSR 93-01-067 (Order 92-15), § 296-62-07515, filed 12/11/92, effective 1/15/93; WSR 91-11-070 (Order 91-01), § 296-62-07515, filed 5/20/91, effective 6/20/91; WSR 90-03-029 (Order 89-20), § 296-62-07515, filed 1/11/90, effective 2/26/90; WSR 89-15-002 (Order 89-06), § 296-62-07515, filed 7/6/89, effective 8/7/89; WSR 88-14-108 (Order 88-11), § 296-62-07515, filed 7/6/88; WSR 87-24-051 (Order 87-24), § 296-62-07515, filed 11/30/87. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 86-16-009 (Order 86-28), § 296-62-07515, filed 7/25/86; WSR 85-01-022 (Order 84-24), § 296-62-07515, filed 12/11/84; WSR 82-13-045 (Order 82-22), § 296-62-07515, filed 6/11/82. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-015 (Order 81-20), § 296-62-07515, filed 7/27/81; WSR 80-11-010 (Order 80-14), § 296-62-07515, filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.150 and 49.17.240. WSR 79-08-115 (Order 79-9), § 296-62-07515, filed 7/31/79; Order 73-3, § 296-62-07515, filed 5/7/73.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07523Benzene. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 05-01-172, § 296-62-07523, filed 12/21/04, effective 3/1/05. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07523, filed 5/9/01, effective 9/1/01; WSR 99-10-071, § 296-62-07523, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 88-21-002 (Order 88-23), § 296-62-07523, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-13-152, filed 6/21/05, effective 8/1/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07525Appendix A substance safety data sheet—Benzene. [Statutory Authority: Chapter 49.17 RCW. WSR 88-21-002 (Order 88-23), § 296-62-07525, filed 10/6/88, effective 11/7/88.] Repealed by WSR 07-03-153, filed 1/23/07, effective 6/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07527Appendix B substance technical guidelines—Benzene. [Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-07527, filed 6/5/02, effective 8/1/02. Statutory Authority: Chapter 49.17 RCW. WSR 88-21-002 (Order 88-23), § 296-62-07527, filed 10/6/88, effective 11/7/88.] Repealed by WSR 07-03-153, filed 1/23/07, effective 6/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07529Appendix C medical surveillance guidelines for benzene. [Statutory Authority: Chapter 49.17 RCW. WSR 88-21-002 (Order 88-23), § 296-62-07529, filed 10/6/88, effective 11/7/88.] Repealed by WSR 07-03-153, filed 1/23/07, effective 6/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-07533Appendix E qualitative and quantitative fit testing procedures. [Statutory Authority: Chapter 49.17 RCW. WSR 96-09-030, § 296-62-07533, filed 4/10/96, effective 6/1/96; WSR 94-15-096 (Order 94-07), § 296-62-07533, filed 7/20/94, effective 9/20/94; WSR 88-21-002 (Order 88-23), § 296-62-07533, filed 10/6/88, effective 11/7/88.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07550Appendix E—Qualitative and quantitative fit testing procedures. [Statutory Authority: Chapter 49.17 RCW. WSR 96-09-030, § 296-62-07550, filed 4/10/96, effective 6/1/96; WSR 88-21-002 (Order 88-23), § 296-62-07550, filed 10/6/88, effective 11/7/88.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07635Effective date. [Statutory Authority: Chapter 49.17 RCW. WSR 93-04-111 (Order 92-15), § 296-62-07635, filed 2/3/93, effective 3/15/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07639Start up dates. [Statutory Authority: Chapter 49.17 RCW. WSR 93-04-111 (Order 92-15), § 296-62-07639, filed 2/3/93, effective 3/15/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07662Appendix E to WAC 296-62-076—Qualitative and quantitative fit testing procedures. [Statutory Authority: Chapter 49.17 RCW. WSR 93-04-111 (Order 92-15), § 296-62-07662, filed 2/3/93, effective 3/15/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07664Appendix E-1—Qualitative fit test protocols. [Statutory Authority: Chapter 49.17 RCW. WSR 93-04-111 (Order 92-15), § 296-62-07664, filed 2/3/93, effective 3/15/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07666Appendix E-1-a—Isoamyl acetate (banana oil) protocol. [Statutory Authority: Chapter 49.17 RCW. WSR 93-04-111 (Order 92-15), § 296-62-07666, filed 2/3/93, effective 3/15/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07668Appendix E-1-b—Saccharin solution aerosol protocol. [Statutory Authority: Chapter 49.17 RCW. WSR 96-09-030, § 296-62-07668, filed 4/10/96, effective 6/1/96; WSR 93-04-111 (Order 92-15), § 296-62-07668, filed 2/3/93, effective 3/15/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07670Appendix E-1-c—Irritant fume protocol. [Statutory Authority: Chapter 49.17 RCW. WSR 93-04-111 (Order 92-15), § 296-62-07670, filed 2/3/93, effective 3/15/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07672Appendix E-2—Quantitative fit test procedures. [Statutory Authority: Chapter 49.17 RCW. WSR 93-04-111 (Order 92-15), § 296-62-07672, filed 2/3/93, effective 3/15/93.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07707Identification. [Statutory Authority: Chapter 49.17 RCW. WSR 89-21-018 (Order 89-10), § 296-62-07707, filed 10/10/89, effective 11/24/89; WSR 87-24-051 (Order 87-24), § 296-62-07707, filed 11/30/87. Statutory Authority: RCW 49.17.050(2) and 49.17.040. WSR 87-10-008 (Order 87-06), § 296-62-07707, filed 4/27/87.] Repealed by WSR 97-01-079, filed 12/17/96, effective 3/1/97. Statutory Authority: RCW 49.17.040, [49.17.]050 and [49.17.]060.
296-62-07729Observation of monitoring. [Statutory Authority: RCW 49.17.050(2) and 49.17.040. WSR 87-10-008 (Order 87-06), § 296-62-07729, filed 4/27/87.] Repealed by WSR 87-24-051 (Order 87-24), filed 11/30/87. Statutory Authority: Chapter 49.17 RCW.
296-62-07731Dates. [Statutory Authority: Chapter 49.17 RCW. WSR 91-03-044 (Order 90-18), § 296-62-07731, filed 1/10/91, effective 2/12/91; WSR 89-11-035 (Order 89-03), § 296-62-07731, filed 5/15/89, effective 6/30/89; WSR 87-24-051 (Order 87-24), § 296-62-07731, filed 11/30/87. Statutory Authority: RCW 49.17.050(2) and 49.17.040. WSR 87-10-008 (Order 87-06), § 296-62-07731, filed 4/27/87.] Repealed by WSR 97-01-079, filed 12/17/96, effective 3/1/97. Statutory Authority: RCW 49.17.040, [49.17.]050 and [49.17.]060.
296-62-07739Appendix C—Qualitative and quantitative fit testing procedures—Mandatory. [Statutory Authority: Chapter 49.17 RCW. WSR 96-09-030, § 296-62-07739, filed 4/10/96, effective 6/1/96; WSR 87-24-051 (Order 87-24), § 296-62-07739, filed 11/30/87. Statutory Authority: RCW 49.17.050(2) and 49.17.040. WSR 87-10-008 (Order 87-06), § 296-62-07739, filed 4/27/87.] Repealed by WSR 99-10-071, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-07761Nonasbestiform tremolite, anthophyllite, and actinolite. [Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-07761, filed 11/30/87.] Repealed by WSR 97-19-014, filed 9/5/97, effective 11/5/97. Statutory Authority: RCW 49.17.040, [49.17.]050 and [49.17.]060.
296-62-080Biological agents. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 02-16-047, § 296-62-080, filed 8/1/02, effective 10/1/02; Order 73-3, § 296-62-080, filed 5/7/73; Order 70-8, § 296-62-080, filed 7/31/70, effective 9/1/70; Rule 8.010, effective 8/1/63.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see WAC 296-307-018.
296-62-08001Bloodborne pathogens. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-09-110, § 296-62-08001, filed 4/22/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-13-078, § 296-62-08001, filed 6/19/01, effective 8/6/01. Statutory Authority: Chapter 49.17 RCW. WSR 93-01-067 (Order 92-15), § 296-62-08001, filed 12/11/92, effective 1/15/93; WSR 92-08-100 (Order 92-01), § 296-62-08001, filed 4/1/92, effective 5/5/92.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-08050Appendix A—Hepatitis B vaccine declination—Mandatory. [Statutory Authority: Chapter 49.17 RCW. WSR 92-08-100 (Order 92-01), § 296-62-08050, filed 4/1/92, effective 5/5/92.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09003Lighting and illumination. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09003, filed 11/30/83; WSR 82-13-045 (Order 82-22), § 296-62-09003, filed 6/11/82; Order 76-6, § 296-62-09003, filed 3/1/76; Order 73-3, § 296-62-09003, filed 5/7/73.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-09011Occupational noise exposure. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-03-023 (Order 82-1), § 296-62-09011, filed 1/15/82. Statutory Authority: RCW 49.17.040, 49.17.050, and 49.17.240. WSR 81-16-016 (Order 81-19), § 296-62-09011, filed 7/27/81; WSR 80-11-010 (Order 80-14), § 296-62-09011, filed 8/8/80; Order 73-3, § 296-62-09011, filed 5/7/73.] Repealed by WSR 83-24-013 (Order 83-34), filed 11/30/83. Statutory Authority: RCW 49.17.040 and 49.17.050.
296-62-09015Hearing conservation. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-11-060, § 296-62-09015, filed 5/19/03, effective 8/1/03. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09015, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09015, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09017Definitions. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09017, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09017, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09019Monitoring. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09019, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09019, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09021Method of noise measurement. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09021, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09021, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09023Calibration of monitoring equipment. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09023, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09023, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09024Employee notification. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09024, filed 11/30/83.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09025Observation of monitoring. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-03-023 (Order 82-1), § 296-62-09025, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09026Noise control. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09026, filed 11/30/83.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09027Audiometric testing program. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09027, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09027, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09029Audiometric test requirements. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09029, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09029, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09031Hearing protectors. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09031, filed 11/30/83; WSR 82-13-045 (Order 82-22), § 296-62-09031, filed 6/11/82; WSR 82-03-023 (Order 82-1), § 296-62-09031, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09033Hearing protector attenuation. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09033, filed 11/30/83; WSR 82-13-045 (Order 82-22), § 296-62-09033, filed 6/11/82; WSR 82-03-023 (Order 82-1), § 296-62-09033, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09035Training program. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09035, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09035, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09037Access to information and training materials. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-03-023 (Order 82-1), § 296-62-09037, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09039Warning signs. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09039, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09039, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09041Recordkeeping. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-10-026, § 296-62-09041, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09041, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09041, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09043Appendices. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09043, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09043, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09045Effective dates. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-03-023 (Order 82-1), § 296-62-09045, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09047Appendix A—Audiometric measuring instruments. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09047, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09047, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09049Appendix B—Audiometric test rooms. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-03-023 (Order 82-1), § 296-62-09049, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09051Appendix C—Acoustic calibration of audiometers. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09051, filed 11/30/83; WSR 82-13-045 (Order 82-22), § 296-62-09051, filed 6/11/82; WSR 82-03-023 (Order 82-1), § 296-62-09051, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09053Appendix D—Methods for estimating the adequacy of hearing protector attenuation. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09053, filed 11/30/83; WSR 82-03-023 (Order 82-1), § 296-62-09053, filed 1/15/82.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-09055Appendix E—Noise exposure computation. [Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-09055, filed 11/30/83.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-100Oxygen deficient atmospheres. [Statutory Authority: Chapter 49.17 RCW. WSR 91-24-017 (Order 91-07), § 296-62-100, filed 11/22/91, effective 12/24/91. RCW 49.17.040, 49.17.050, and 49.17.240. WSR 81-16-015 (Order 81-20), § 296-62-100, filed 7/27/81; Order 73-3, § 296-62-100, filed 5/7/73; Order 70-8, § 296-62-100, filed 7/31/70, effective 9/1/70; Rule 10.010, effective 8/1/63.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. Later promulgation, see WAC 296-62-135.
296-62-110Ventilation. [Order 73-3, § 296-62-110, filed 5/7/73; Order 70-8, § 296-62-110, filed 7/31/70, effective 9/1/70; Rules 11.010-11.030, effective 8/1/63.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. Later promulgation, see WAC 296-62-136.
296-62-11001Definition. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-11001, filed 1/18/95, effective 3/1/95. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-11001, filed 11/13/80; Order 73-3, § 296-62-11001, filed 5/7/73.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-11003Ventilation guide. [Order 73-3, § 296-62-11003, filed 5/7/73.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-11005Adequate system. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 07-03-163, § 296-62-11005, filed 1/24/07, effective 4/1/07; Order 73-3, § 296-62-11005, filed 5/7/73.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-11007Exhaust. [Order 73-3, § 296-62-11007, filed 5/7/73.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-11009Make-up air quantity. [Order 73-3, § 296-62-11009, filed 5/7/73.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-11011Design and operation. [Statutory Authority: Chapter 49.17 RCW. WSR 91-11-070 (Order 91-01), § 296-62-11011, filed 5/20/91, effective 6/20/91; Order 73-3, § 296-62-11011, filed 5/7/73.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-11013Compatibility of systems. [Order 73-3, § 296-62-11013, filed 5/7/73.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-11017Grinding, polishing, and buffing operations. [Order 73-3, § 296-62-11017 and diagrams, filed 5/7/73.] Repealed by WSR 07-05-062, filed 2/20/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-11021Open surface tanks. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 02-15-102, § 296-62-11021, filed 7/17/02, effective 10/1/02; WSR 01-11-038, § 296-62-11021, filed 5/9/01, effective 9/1/01; WSR 99-10-071, § 296-62-11021, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 91-24-017 (Order 91-07), § 296-62-11021, filed 11/22/91, effective 12/24/91. RCW 49.17.040, 49.17.050, and 49.17.240. WSR 81-16-015 (Order 81-20), § 296-62-11021, filed 7/27/81; WSR 80-11-010 (Order 80-14), § 296-62-11021, filed 8/8/80; Order 73-3, § 296-62-11021, filed 5/7/73.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-307 WAC, Part U-3.
296-62-120Respiratory protection. [Order 70-8, § 296-62-120 filed 7/31/70, effective 9/1/70; Rule 12.010, effective 8/1/63.] Repealed by Order 73-3, filed 5/7/73.
296-62-12000Environmental tobacco smoke in office work environments—Scope and application. [Statutory Authority: Chapter 49.17 RCW. WSR 94-07-086 (Order 93-18), § 296-62-12000, filed 3/16/94, effective 9/1/94.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-12003Definitions. [Statutory Authority: Chapter 49.17 RCW. WSR 94-07-086 (Order 93-18), § 296-62-12003, filed 3/16/94, effective 9/1/94.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-12005Controls for environmental tobacco smoke. [Statutory Authority: Chapter 49.17 RCW. WSR 94-07-086 (Order 93-18), § 296-62-12005, filed 3/16/94, effective 9/1/94.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-12007Effective date. [Statutory Authority: Chapter 49.17 RCW. WSR 94-07-086 (Order 93-18), § 296-62-12007, filed 3/16/94, effective 9/1/94.] Repealed by WSR 06-12-074, filed 6/6/06, effective 9/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-12009Appendix—Smoking cessation program information—Nonmandatory. [Statutory Authority: Chapter 49.17 RCW. WSR 94-07-086 (Order 93-18), § 296-62-12009, filed 3/16/94, effective 9/1/94.] Repealed by WSR 01-11-038, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050.
296-62-130Emergency washing facilities. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 02-16-047, § 296-62-130, filed 8/1/02, effective 10/1/02. Statutory Authority: RCW 49.17.040. WSR 99-07-063, § 296-62-130, filed 3/17/99, effective 6/17/99. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 85-10-004 (Order 85-09), § 296-62-130, filed 4/19/85; Order 73-3, § 296-62-130, filed 5/7/73; Order 70-8, § 296-62-130, filed 7/31/70, effective 9/1/70; Rule 13.010, effective 8/1/63.] Repealed by WSR 03-10-068, filed 5/6/03, effective 8/1/03. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. Later promulgation, see chapter 296-307 WAC, Part B.
296-62-140Industrial sanitation. [Order 70-8, § 296-62-140, filed 7/31/70, effective 9/1/70; Rule 14.010, effective 8/1/63.] Repealed by Order 73-3, filed 5/7/73.
296-62-141Permit-required confined spaces. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-03-081, § 296-62-141, filed 1/20/04, effective 5/1/04. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-141, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14100Scope and application. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14100, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14105Definitions. [Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-14105, filed 6/5/02, effective 8/1/02; WSR 99-22-046, § 296-62-14105, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14110General requirements. [Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-14110, filed 6/5/02, effective 8/1/02; WSR 99-22-046, § 296-62-14110, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14115Permit-required confined space program (permit space program). [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14115, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14120Permit system. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14120, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14125Required entry permit information. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14125, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14130Training. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14130, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14135Duties of authorized entrants. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14135, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14140Duties of attendants. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14140, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14145Duties of entry supervisors. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14145, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14150Rescue and emergency services. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14150, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14155Employee participation. [Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-14155, filed 6/5/02, effective 8/1/02; WSR 99-22-046, § 296-62-14155, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14170Appendices to WAC 296-62-141—Permit-required confined spaces. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14170, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14171Appendix A—Permit-required confined space decision flow chart. [Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-14171, filed 6/5/02, effective 8/1/02; WSR 99-22-046, § 296-62-14171, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14172Appendix B—Procedures for atmospheric testing. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14172, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14173Appendix C—Examples of permit-required confined space programs. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14173, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14174Appendix D—Sample permits. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14174, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14175Appendix E—Sewer system entry. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14175, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-14176Appendix F—Rescue team or rescue service evaluation criteria. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-22-046, § 296-62-14176, filed 10/29/99, effective 2/1/00.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-145Permit-required confined spaces. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-145, filed 1/18/95, effective 3/1/95; Order 73-3, § 296-62-145 reference section, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14500Scope and application. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14500, filed 1/18/95, effective 3/1/95.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14501Definitions. [Statutory Authority: RCW 49.17.040, [49.17].050 and [49.17].060. WSR 95-17-036, § 296-62-14501, filed 8/9/95, effective 9/25/95. Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14501, filed 1/18/95, effective 3/1/95; WSR 91-24-017 (Order 91-07), § 296-62-14501, filed 11/22/91, effective 12/24/91. RCW 49.17.040, 49.17.050, and 49.17.240. WSR 80-11-010 (Order 80-14), § 296-62-14501, filed 8/8/80; Order 73-3, § 296-62-14501, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14503General requirements. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14503, filed 1/18/95, effective 3/1/95; WSR 91-11-070 (Order 91-01), § 296-62-14503, filed 5/20/91, effective 6/20/91; Order 73-3, § 296-62-14503, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14505Permit-required confined space program (permit space program). [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14505, filed 1/18/95, effective 3/1/95; Order 73-3, § 296-62-14505, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14507Permit system. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14507, filed 1/18/95, effective 3/1/95. Statutory Authority: RCW 49.17.040, 49.17.050, and 49.17.240. WSR 81-16-015 (Order 81-20), § 296-62-14507, filed 7/27/81; WSR 80-11-010 (Order 80-14), § 296-62-14507, filed 8/8/80; Order 73-3, § 296-62-14507, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14509Entry permit. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14509, filed 1/18/95, effective 3/1/95; Order 73-3, § 296-62-14509, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14511Training. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14511, filed 1/18/95, effective 3/1/95; WSR 91-24-017 (Order 91-07), § 296-62-14511, filed 11/22/91, effective 12/24/91; Order 73-3, § 296-62-14511, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14513Duties of authorized entrants. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14513, filed 1/18/95, effective 3/1/95; Order 73-3, § 296-62-14513, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14515Duties of attendants. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14515, filed 1/18/95, effective 3/1/95; WSR 91-24-017 (Order 91-07), § 296-62-14515, filed 11/22/91, effective 12/24/91. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-15-017 (Order 83-19), § 296-62-14515, filed 7/13/83, effective 9/12/83; WSR 82-13-045 (Order 82-22), § 296-62-14515, filed 6/11/82; Order 73-3, § 296-62-14515, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14517Duties of entry supervisors. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14517, filed 1/18/95, effective 3/1/95; Order 73-3, § 296-62-14517, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14519Rescue and emergency services. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14519, filed 1/18/95, effective 3/1/95; WSR 91-24-017 (Order 91-07), § 296-62-14519, filed 11/22/91, effective 12/24/91; Order 73-3, § 296-62-14519, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14520Appendices to WAC 296-62-145—Permit-required confined spaces. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14520, filed 1/18/95, effective 3/1/95.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14521Appendix A—Permit-required confined space decision flow chart. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14521, filed 1/18/95, effective 3/1/95; Order 73-3, § 296-62-14521, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14523Appendix B—Procedures for atmospheric testing. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14523, filed 1/18/95, effective 3/1/95; Order 73-3, § 296-62-14523, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14525Appendix C—Examples of permit-required confined space programs. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14525, filed 1/18/95, effective 3/1/95; WSR 91-24-017 (Order 91-07), § 296-62-14525, filed 11/22/91, effective 12/24/91. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 82-03-023 (Order 82-1), § 296-62-14525, filed 1/15/82; Order 73-3, § 296-62-14525, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14527Appendix D—Sample permits. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14527, filed 1/18/95, effective 3/1/95; Order 73-3, § 296-62-14527, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14529Appendix E—Sewer system entry. [Statutory Authority: RCW 49.17.040, [49.17].050 and [49.17].060. WSR 95-17-036, § 296-62-14529, filed 8/9/95, effective 9/25/95. Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-14529, filed 1/18/95, effective 3/1/95; Order 73-3, § 296-62-14529, filed 5/7/73.] Repealed by WSR 99-22-046, filed 10/29/99, effective 2/1/00. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050.
296-62-14531Exposure to cotton dust in cotton gins. [Statutory Authority: RCW 49.17.040, 49.17.050, and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-14531, filed 8/27/81; WSR 81-16-015 (Order 81-20), § 296-62-14531, filed 7/27/81; WSR 80-11-010 (Order 80-14), § 296-62-14531, filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.150 and 49.17.240. WSR 79-02-037 (Order 79-1), § 296-62-14531, filed 1/23/79.] Repealed by WSR 87-24-051 (Order 87-24), filed 11/30/87. Statutory Authority: Chapter 49.17 RCW.
296-62-146Appendices. [Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-146, filed 8/27/81.] Repealed by WSR 87-24-051 (Order 87-24), filed 11/30/87. Statutory Authority: Chapter 49.17 RCW.
296-62-14601Appendix A—Requirements for classification and respiratory use of workers exposed to cotton dust in gins. [Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-14601, filed 8/27/81.] Repealed by WSR 88-23-054 (Order 88-25), filed 11/14/88. Statutory Authority: Chapter 49.17 RCW.
296-62-14603Appendix B-1—Respiratory questionnaire. [Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-14603, filed 8/27/81.] Repealed by WSR 87-24-051 (Order 87-24), filed 11/30/87. Statutory Authority: Chapter 49.17 RCW.
296-62-14605Appendix C—Spirometry prediction tables for normal males and females. [Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-14605, filed 8/27/81.] Repealed by WSR 88-23-054 (Order 88-25), filed 11/14/88. Statutory Authority: Chapter 49.17 RCW.
296-62-14607Appendix D—Pulmonary function standards for cotton dust standard. [Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-14607, filed 8/27/81.] Repealed by WSR 88-23-054 (Order 88-25), filed 11/14/88. Statutory Authority: Chapter 49.17 RCW.
296-62-150Appendix I—Threshold limit values for 1969. [Order 70-8, § 296-62-150, filed 7/31/70, effective 9/1/70; Rules (part), effective 12/1/63.] Repealed by Order 73-3, filed 5/7/73.
296-62-155Appendix I—Adopted values. [Order 70-8, § 296-62-155, filed 7/31/70, effective 9/1/70; Rules (part), effective 12/1/63.] Repealed by Order 73-3, filed 5/7/73.
296-62-157Threshold limit values of physical agents for 1969. [Order 70-8, § 296-62-157, filed 7/31/70, effective 9/1/70.] Repealed by Order 73-3, filed 5/7/73.
296-62-160Appendix II—Levels of illumination currents. [Appendix II, effective 12/1/63.] Repealed by Order 70-8, filed 7/31/70, effective 9/1/70. Also repealed by Order 73-3, filed 5/7/73.
296-62-165Appendix III—Nonionizing radiation. [Order 70-8, § 296-62-165, filed 7/31/70, effective 9/1/70; Appendix III, effective 8/1/63.] Repealed by Order 73-3, filed 5/7/73.
296-62-170Appendix IV—Temperature, radiant heat, humidity, or air velocity combinations. [Order 70-8, § 296-62-170, filed 7/31/70, effective 9/1/70; Appendix IV, effective 8/1/63.] Repealed by Order 73-3, filed 5/7/73.
296-62-175References. [Order 70-8, § 296-62-175, filed 7/31/70, effective 9/1/70.] Repealed by Order 73-3, filed 5/7/73.
296-62-180Appendix V—Use and care of respiratory protective equipment, compressed air supply for respirators. [Order 70-8, § 296-62-180, filed 7/31/70, effective 9/1/70.] Repealed by Order 73-3, filed 5/7/73.
296-62-185References. [Order 70-8, § 296-62-185, filed 7/31/70, effective 9/1/70.] Repealed by Order 73-3, filed 5/7/73.
296-62-300Hazardous waste operations and treatment, storage, and disposal facilities. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-02-053, § 296-62-300, filed 1/5/04, effective 5/1/04. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-300, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-300, filed 7/20/94, effective 9/20/94; WSR 91-24-017 (Order 91-07), § 296-62-300, filed 11/22/91, effective 12/24/91; WSR 90-20-091 (Order 90-14), § 296-62-300, filed 10/1/90, effective 11/15/90; WSR 89-21-018 (Order 89-10), § 296-62-300, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-300, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30001Scope and application. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-30001, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30001, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30003Definitions. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30003, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3010Overview of a written safety and health program. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3010, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-3010, filed 1/18/95, effective 3/1/95; WSR 89-21-018 (Order 89-10), § 296-62-3010, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3010, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30105Elements of a safety and health program. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30105, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30110Safety considerations during the initial site excavation. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30110, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30115Notifying contractors and subcontractors of procedures and hazards. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30115, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30120Availability of the safety and health program. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30120, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30125Organizational structure of the site safety and health program. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30125, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30130Comprehensive workplan of the site program. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30130, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30135Overview of a site-specific safety and health plan. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30135, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30140Preentry briefing of the site-specific safety and health plan. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30140, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30145Effectiveness of site safety and health plan. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30145, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3020Site characterization and analysis. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3020, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-3020, filed 8/3/94, effective 9/12/94; WSR 90-20-091 (Order 90-14), § 296-62-3020, filed 10/1/90, effective 11/15/90; WSR 89-21-018 (Order 89-10), § 296-62-3020, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3020, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30205Preliminary evaluation. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30205, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30210Hazard identification. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30210, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30215Required information. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30215, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30220Personal protective equipment. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30220, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30225Monitoring. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30225, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30230Risk identification. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-30230, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30230, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30235Employee notification. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-30235, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30235, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3030Site control. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3030, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 89-21-018 (Order 89-10), § 296-62-3030, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3030, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30305Site control program. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30305, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30310Elements of the site control program. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30310, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30315Site work zones. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30315, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3040General training requirements and the employees covered. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3040, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 95-04-007, § 296-62-3040, filed 1/18/95, effective 3/1/95; WSR 91-24-017 (Order 91-07), § 296-62-3040, filed 11/22/91, effective 12/24/91; WSR 90-20-091 (Order 90-14), § 296-62-3040, filed 10/1/90, effective 11/15/90; WSR 89-21-018 (Order 89-10), § 296-62-3040, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3040, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30405Elements covered in training. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30405, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30410Initial training. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30410, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30415Management and supervisor training. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30415, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30420Law enforcement at illicit drug labs. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30420, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30425Training course content for 40 and 80 hour hazardous waste cleanup courses. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-30425, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30425, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30430Training content for 24-hour hazardous waste cleanup course. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30430, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3043516-hour supplemental training for hazardous waste sites. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-30435, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30435, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30440Additional 8 hours of training for supervisors and managers. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30440, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30445Qualifications for trainers. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30445, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30450Training certification. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30450, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30455Training requirements for emergency response. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30455, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30460Refresher training. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30460, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30465Equivalent training. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30465, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3050Medical surveillance. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3050, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 91-11-070 (Order 91-01), § 296-62-3050, filed 5/20/91, effective 6/20/91; WSR 90-20-091 (Order 90-14), § 296-62-3050, filed 10/1/90, effective 11/15/90; WSR 89-21-018, § 296-62-3050, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3050, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30505Employees covered. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30505, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30510Frequency of medical examinations and consultations. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30510, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30515Content of medical examinations and consultations. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30515, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30520Examination by a physician and costs. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30520, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30525Information provided to the physician. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30525, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30530Physician's written opinion. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30530, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30535Recordkeeping of medical surveillance activities. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30535, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3060Engineering controls, work practices, and personal protective equipment for employee protection. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 05-03-093, § 296-62-3060, filed 1/18/05, effective 3/1/05. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3060, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-3060, filed 7/20/94, effective 9/20/94; WSR 90-20-091 (Order 90-14), § 296-62-3060, filed 10/1/90, effective 11/15/90; WSR 89-21-018, § 296-62-3060, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3060, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30605Personal protective equipment selection. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-30605, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30605, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30610Totally encapsulating chemical protective suits. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30610, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30615Personal protective equipment (PPE) program. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30615, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3070Monitoring concentrations of hazardous substances. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3070, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 90-20-091 (Order 90-14), § 296-62-3070, filed 10/1/90, effective 11/15/90; WSR 89-21-018, § 296-62-3070, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3070, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30705Monitoring during initial entry. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30705, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30710Periodic monitoring. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30710, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30715Monitoring of high-risk employees. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30715, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3080Informational programs. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3080, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 89-21-018, § 296-62-3080, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3080, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3090General requirements for handling drums and containers. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-3090, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3090, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 93-19-142 (Order 93-04), § 296-62-3090, filed 9/22/93, effective 11/1/93; WSR 91-11-070 (Order 91-01), § 296-62-3090, filed 5/20/91, effective 6/20/91; WSR 89-21-018, § 296-62-3090, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3090, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30905Opening drums and containers. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30905, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30910Material handling equipment. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30910, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30915Radioactive wastes. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30915, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30920Shock-sensitive wastes. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30920, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30925Laboratory waste packs. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30925, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30930Sampling of drum and container contents. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30930, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30935Shipping and transport of drums. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30935, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-30940Tanks and vaults procedures. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-30940, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3100Decontamination procedures. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3100, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 89-21-018, § 296-62-3100, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3100, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31005Location of decontamination areas. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31005, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31010Decontamination of equipment and solvents. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31010, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31015Decontamination of personal protective clothing and equipment. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31015, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31020Showers and change rooms used for decontamination. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-18-090, § 296-62-31020, filed 9/2/03, effective 11/1/03. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31020, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3110Emergency response plan for employees at uncontrolled hazardous waste sites. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3110, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 90-20-091 (Order 90-14), § 296-62-3110, filed 10/1/90, effective 11/15/90; WSR 90-09-026 (Order 90-01), § 296-62-3110, filed 4/10/90, effective 5/25/90; WSR 89-21-018 (Order 89-10), § 296-62-3110, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3110, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31105Elements of an emergency response plan at uncontrolled hazardous waste sites. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31105, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31110Procedures for handling emergency incidents at uncontrolled hazardous waste sites. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31110, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3112Emergency response to hazardous substance releases. [Statutory Authority: Chapter 49.17 RCW. WSR 90-20-091 (Order 90-14), § 296-62-3112, filed 10/1/90, effective 11/15/90; WSR 89-21-018, § 296-62-3112, filed 10/10/89, effective 11/24/89.] Repealed by WSR 99-07-097, filed 3/23/99, effective 6/23/99. Statutory Authority: RCW 49.17.040.
296-62-3120Illumination. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3120, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-3120, filed 7/20/94, effective 9/20/94; WSR 89-21-018, § 296-62-3120, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3120, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3130Sanitation at temporary workplaces. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3130, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 89-21-018, § 296-62-3130, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3130, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31305Potable water. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31305, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31310Nonpotable water. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31310, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31315Toilet facilities. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31315, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31320Food handling. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31320, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31325Temporary sleeping quarters. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31325, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31330Washing facilities. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31330, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31335Showers and change rooms. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-18-090, § 296-62-31335, filed 9/2/03, effective 11/1/03. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-17-033, § 296-62-31335, filed 8/8/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31335, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3138New technology programs. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3138, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 89-21-018, § 296-62-3138, filed 10/10/89, effective 11/24/89.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3140Certain operations conducted under the Resource Conservation and Recovery Act of 1976 (RCRA). [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3140, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 94-16-145, § 296-62-3140, filed 8/3/94, effective 9/12/94; WSR 91-24-017 (Order 91-07), § 296-62-3140, filed 11/22/91, effective 12/24/91; WSR 90-20-091 (Order 90-14), § 296-62-3140, filed 10/1/90, effective 11/15/90; WSR 89-21-018, § 296-62-3140, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3140, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31405Safety and health program under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31405, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31410Hazard communication program requirements under RCRA. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-31410, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31410, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31415Medical surveillance program requirements under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31415, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31420Decontamination program requirements under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31420, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31425New technology programs requirements under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31425, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31430Material handling program requirements under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31430, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31435Training program for new employees under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31435, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31440Training program for current employees. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31440, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31445RCRA requirements for trainers. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31445, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31450Emergency response program requirements under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31450, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31455Emergency response plan under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31455, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31460Elements of an emergency response plan under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31460, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31465Training requirements for emergency response under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31465, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-31470Procedures for handling emergency incidents under RCRA. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-31470, filed 3/23/99, effective 6/23/99.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3150Start up dates. [Statutory Authority: Chapter 49.17 RCW. WSR 88-21-002 (Order 88-23), § 296-62-3150, filed 10/6/88, effective 11/7/88.] Repealed by WSR 89-21-018 (Order 89-10), filed 10/10/89, effective 11/24/89. Statutory Authority: Chapter 49.17 RCW.
296-62-3152Appendices to Part P—Hazardous waste operations and TSD facilities. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3152, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 89-21-018, § 296-62-3152, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3152, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3160Appendix A—Personal protective equipment test methods. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3160, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 91-24-017 (Order 91-07), § 296-62-3160, filed 11/22/91, effective 12/24/91; WSR 90-20-091 (Order 90-14), § 296-62-3160, filed 10/1/90, effective 11/15/90; WSR 89-21-018, § 296-62-3160, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3160, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3170Appendix B—General description and discussion of the levels of protection and protective gear. [Statutory Authority: Chapter 49.17 RCW. WSR 95-04-006, § 296-62-3170, filed 1/18/95, effective 3/10/95; WSR 90-20-091 (Order 90-14), § 296-62-3170, filed 10/1/90, effective 11/15/90; WSR 89-21-018, § 296-62-3170, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3170, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3180Appendix C—Compliance guidelines. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3180, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 90-20-091 (Order 90-14), § 296-62-3180, filed 10/1/90, effective 11/15/90; WSR 89-21-018 (Order 89-10), § 296-62-3180, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3180, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3190Appendix D—References. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3190, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 90-20-091 (Order 90-14), § 296-62-3190, filed 10/1/90, effective 11/15/90; WSR 89-21-018 (Order 89-10), § 296-62-3190, filed 10/10/89, effective 11/24/89; WSR 88-21-002 (Order 88-23), § 296-62-3190, filed 10/6/88, effective 11/7/88.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-3195Appendix E—Training curriculum guidelines. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 05-03-093, § 296-62-3195, filed 1/18/05, effective 3/1/05. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-3195, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-3195, filed 3/23/99, effective 6/23/99. Statutory Authority: Chapter 49.17 RCW. WSR 95-04-006, § 296-62-3195, filed 1/18/95, effective 3/10/95.] Repealed by WSR 05-01-166, filed 12/21/04, effective 4/2/05. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060.
296-62-400Occupational exposure to hazardous chemicals in laboratories. [Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-400, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40001Scope and application. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 05-03-093, § 296-62-40001, filed 1/18/05, effective 3/1/05. Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40001, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40003Definitions applicable to all sections of this chapter. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-40003, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40003, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40005Permissible exposure limits. [Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40005, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40007Employee exposure determination. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 05-03-093, § 296-62-40007, filed 1/18/05, effective 3/1/05. Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40007, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40009Chemical hygiene plan—General. [Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40009, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40011Employee information and training. [Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40011, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40013Medical consultation and medical examinations. [Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40013, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40015Hazard identification. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-40015, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-40015, filed 7/20/94, effective 9/20/94; WSR 90-17-051 (Order 90-10), § 296-62-40015, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40017Use of respirators. [Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40017, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40019Recordkeeping. [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-10-026, § 296-62-40019, filed 4/27/04, effective 8/1/04. Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40019, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40021Start up date. [Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40021, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40023Appendices. [Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40023, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40025Appendix A—National Research Council recommendations concerning chemical hygiene in laboratories (nonmandatory). [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-17-033, § 296-62-40025, filed 8/8/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-40025, filed 7/20/94, effective 9/20/94; WSR 90-17-051 (Order 90-10), § 296-62-40025, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-40027Appendix B—References (nonmandatory). [Statutory Authority: Chapter 49.17 RCW. WSR 90-17-051 (Order 90-10), § 296-62-40027, filed 8/13/90, effective 9/24/90.] Repealed by WSR 06-02-060, filed 1/3/06, effective 4/1/06. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060.
296-62-410Emergency response to hazardous substance release. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-410, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41001Scope and application. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41001, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41003Definitions. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41003, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41010Emergency response. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41010, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41011Emergency response plan. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41011, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41013Elements of an emergency response plan. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41013, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41015Procedures for handling emergency response. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41015, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41017Skilled support personnel. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41017, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41019Specialist employees. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41019, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41020Training. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41020, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41021Training before participation. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41021, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41023Trainers. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41023, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41025Refresher training. [Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-17-094, § 296-62-41025, filed 8/17/99, effective 12/1/99. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41025, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41030Employee personal protective equipment. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41030, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41031Personal protective equipment selection. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-41031, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41031, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41033Totally encapsulating chemical protective suits. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41033, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41035Personal protective equipment (PPE) program. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41035, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41040Medical surveillance and consultation for emergency response. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41040, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41041Employees covered. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41041, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41042Frequency of medical examinations and consultations. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41042, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41043Content of medical examinations and consultations. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41043, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41044Examination by a physician and costs. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41044, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41045Information provided to the physician. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41045, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41046Physician's written opinion. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41046, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41047Recordkeeping of medical surveillance activities. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41047, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41060Post emergency response operations. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41060, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41061Removal of hazardous substances. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41061, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41063Employees training and protective equipment. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41063, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41080Appendices to Part R—Emergency response. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41080, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41081Appendix A—Personal protective equipment test methods. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41081, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41082Appendix B—General description and discussion of the levels of protection and protective gear. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41082, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41084Appendix C—Compliance guidelines. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41084, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41085Appendix D—References. [Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41085, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-41086Appendix E—Training curriculum guidelines. [Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-41086, filed 5/9/01, effective 9/1/01. Statutory Authority: RCW 49.17.040. WSR 99-07-097, § 296-62-41086, filed 3/23/99, effective 6/23/99.] Repealed by WSR 02-11-141, filed 5/22/02, effective 10/1/02. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. Later promulgation, see chapter 296-824 WAC.
296-62-900Note on application of appendices A through H. [Order 73-3, Note (codified as WAC 296-62-900), filed 5/7/73.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.
296-62-901Appendix A. [Order 73-3, Appendix A (codified as WAC 296-62-901), filed 5/7/73.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.
296-62-902Appendix B. [Order 73-3, Appendix B (codified as WAC 296-62-902), filed 5/7/73.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.
296-62-903Appendix C—Threshold limit values for mixtures. [Order 73-3, Appendix C (codified as WAC 296-62-903), filed 5/7/73.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.
296-62-904Appendix D—Permissible excursions for time-weighted average (TWA) limits. [Order 73-3, Appendix D (codified as WAC 296-62-904), filed 5/7/73.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.
296-62-905Appendix E—Some nuisance particulates (see note q). [Order 73-3, Appendix E (codified as WAC 296-62-905), filed 5/7/73.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.
296-62-906Appendix F. [Order 73-3, Appendix F (codified as WAC 296-62-906), filed 5/7/73.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.
296-62-907Appendix G—Notice of intended changes (for 1972). [Order 73-3, Appendix G (codified as WAC 296-62-907), filed 5/7/73.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.
296-62-908Appendix H—Notice of intent to change the TLV for lasers-1972. [Order 73-3, Appendix H (codified as WAC 296-62-908), filed 5/7/73.] Repealed by WSR 80-11-010 (Order 80-14), filed 8/8/80. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240.


296-62-005
Occupational health and environmental control—Foreword.

(1) Foreword.
(a) Modern industry is changing at an ever-increasing pace. New inventions, discoveries and developments cause changes in every facet of the industrial process. In keeping with this changing technology is the necessity to provide an adequate guide for the protection of working men and women. This chapter is for the guidance of both labor and management and to call particular attention to the way in which modernization and updating of the standards can be accomplished.
(b) This chapter is intended to cover as fully as is practical the environment in which work is performed. In addition to the suggestions made herein, the services of modern occupational medicine must also be considered. Occupational medicine with its specialized techniques for examination, diagnosis, and treatment adds another protection for the worker as he encounters newly-developed materials and methods.
(c) With the full realization that close cooperation between government and industry, labor and management, and all the health sciences, is essential, this chapter is promulgated for the health of all the workmen coming under the jurisdiction of the department of labor and industries.
(d) This chapter is promulgated in accordance with the applicable requirements as outlined in the Washington State Administrative Procedure Act (chapter 34.04 RCW) and other applicable statutes.
[Order 73-3, § 296-62-005, filed 5/7/73; Order 70-8, § 296-62-005, filed 7/31/70, effective 9/1/70.]



296-62-010
Purpose and scope.

The rules in this chapter are designed to protect the health of employees and help to create a healthy work place by establishing requirements to control health hazards. Requirements for chemical hazard communication programs, workplace lighting levels and exposure records are in chapter 296-800 WAC, the safety and health core rules.
[Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-010, filed 5/9/01, effective 9/1/01; Order 73-3, § 296-62-010, filed 5/7/73; Order 70-8, § 296-62-010, filed 7/31/70, effective 9/1/70; Section I, effective 8/1/63.]



296-62-020
Definitions applicable to all sections of this chapter.

Unless the context indicates otherwise, words used in this chapter shall have the meaning given in this section.
(1) "Adequate" or "effective" means compliance with terms and intent of these standards.
(2) "Appendix" means references or recommendations to be used as guides in applying the provisions of this chapter.
(3) "Approved" means approved by the director of the department of labor and industries or his authorized representative, or by an organization that is specifically named in a rule, such as Underwriters' Laboratories (UL), Mine Safety and Health Administration (MSHA), or the National Institute for Occupational Safety and Health (NIOSH).
(4) "Authorized person" means a person approved or assigned by the employer to perform a specific type of duty or duties or to be at a specific location or locations at the job site.
(5) "Coal tar pitch volatiles" as used in WAC 296-62-07515, Table I, include the fused polycyclic hydrocarbons which volatilize from the distillation residues of coal, petroleum, (excluding asphalt), wood, and other organic matter. Asphalt (CAS 8052-42-4, and CAS 64742-93-4) is not covered under the "coal tar pitch volatiles" standard.
(6) "Competent person" means one who is capable of identifying existing and predictable hazards in the surroundings or working conditions which are unsanitary, hazardous, or dangerous to employees, and who has authorization to take prompt corrective action to eliminate them.
(7) "Department" means the department of labor and industries.
(8) "Director" means the director of the department of labor and industries, or his designated representative.
(9) "Employer" means any person, firm, corporation, partnership, business trust, legal representative, or other business entity which engages in any business, industry, profession, or activity in this state and employs one or more employees or who contracts with one or more persons, the essence of which is the personal labor of such person or persons and includes the state, counties, cities, and all municipal corporations, public corporations, political subdivisions of the state, and charitable organizations: Provided, That any persons, partnership, or business entity not having employees, and who is covered by the industrial insurance act shall be considered both an employer and an employee.
(10) "Hazard" means that condition, potential or inherent, which can cause injury, death, or occupational disease.
(11) "Occupational disease" means such disease or infection as arises naturally and proximately out of employment.
(12) "Qualified" means one who, by possession of a recognized degree, certificate, or professional standing, or who by extensive knowledge, training, and experience, has successfully demonstrated ability to solve or resolve problems relating to the subject matter, the work, or the project.
(13) "Shall" or "must" means mandatory.
(14) "Should" or "may" means recommended.
(15) "Suitable" means that which fits, or has the qualities or qualifications to meet a given purpose, occasion, condition, function, or circumstance.
(16) "Worker," "personnel," "person," "employee," and other terms of like meaning, unless the context of the provision containing such term indicates otherwise, mean an employee of an employer who is employed in the business of their employer whether by way of manual labor or otherwise and every person in this state who is engaged in the employment of or who is working under an independent contract the essence of which is their personal labor for an employer whether by manual labor or otherwise.
(17) "Work place" means any plant, yard, premises, room, or other place where an employee or employees are employed for the performance of labor or service over which the employer has the right of access or control. This includes, but is not limited to, all work places covered by industrial insurance under Title 51 RCW, as now or hereafter amended.
(18) Abbreviations used in this chapter:
(a) "ANSI" means American National Standards Institute.
(b) "ASHRE" means American Society of Heating and Refrigeration Engineers.
(c) "BTU" means British thermal unit.
(d) "BTUH" means British thermal unit per hour.
(e) "CFM" means cubic feet per minute.
(f) "C.F.R." means Code of Federal Register.
(g) "CGA" means Compressed Gas Association.
(h) "ID" means inside diameter.
(i) "MCA" means Manufacturing Chemist Association or Chemical Manufacturer Association (CMA).
(j) "NEMA" means National Electrical Manufacturing Association.
(k) "NFPA" means National Fire Protection Association.
(l) "OD" means outside diameter.
(m) "WAC" means Washington Administrative Code.
(n) "WISHA" means Washington Industrial Safety and Health Act (chapter 80, Laws of 1973).
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 07-03-163, § 296-62-020, filed 1/24/07, effective 4/1/07. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-020, filed 7/20/94, effective 9/20/94. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-020, filed 11/30/83. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 43.22 and 42.30 RCW. WSR 80-17-015 (Order 80-21), § 296-62-020, filed 11/13/80; Order 73-3, § 296-62-020, filed 5/7/73; Order 70-8, § 296-62-020, filed 7/31/70, effective 9/1/70; Section II, effective 8/1/63.]



296-62-040
Unconstitutionality clause.

In the event that any section, paragraph, sentence, clause, phrase or work of this chapter is declared unconstitutional or invalid for any reason the remainder of said standard or this chapter shall not be affected thereby.
[Order 73-3, § 296-62-040, filed 5/7/73; Order 70-8, § 296-62-040, filed 7/31/70, effective 9/1/70; Rule 4.010, effective 8/1/63.]



296-62-050
Application for waiver or variances.

See WAC 296-900-11005, Applying for a variance.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 07-03-163, § 296-62-050, filed 1/24/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-050, filed 5/9/01, effective 9/1/01; Order 73-3, § 296-62-050, filed 5/7/73; Order 70-8, § 296-62-050, filed 7/31/70, effective 9/1/70; Rule 5.010, effective 8/1/63.]



296-62-055
Retain labeling required by the department of transportation.

Your responsibility:
To make sure DOT-required labeling on packages and containers in your workplace is retained to alert employees of potentially hazardous contents.
Note:
Terms used in this rule are defined by the USDOT in Title 49 of the Code of Federal Regulations (C.F.R.) Part 171. To access the C.F.R. visit: http://www.dot.gov
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-01-096, § 296-62-055, filed 12/17/02, effective 6/1/03.]



296-62-05510
Scope.

This chapter applies to packages, freight containers, rail freight cars, motor vehicles, and transport vehicles required to be marked, placarded, or labeled by the U.S. Department of Transportation in Title 49 of the C.F.R., Parts 171-180.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-01-096, § 296-62-05510, filed 12/17/02, effective 6/1/03.]



296-62-05520
Retain readily visible DOT labeling.

You must:
• Retain readily visible DOT labeling as specified in Table 1.
Table 1
Specifications for Retaining DOT Labeling
If you receive
Retain DOT markings, placards and labels UNTIL:
• Packages of hazardous materials
• Hazardous materials are sufficiently removed
– Packaging must be
■ cleaned of residue
■ purged of vapors
• Freight containers
• Rail freight cars
• Motor vehicles
• Transport vehicles
• Hazardous materials are sufficiently removed
• Nonbulk packages that will not be reshipped
• You replace the DOT labeling with labeling that complies with WAC 296-901-140, Hazard communication
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-62-05520, filed 3/18/14, effective 5/1/14. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-01-096, § 296-62-05520, filed 12/17/02, effective 6/1/03.]



296-62-060
Control requirements in addition to those specified.

Note:
The requirements in this section apply only to agriculture. The requirements for general industry relating to control requirements have been moved to chapter 296-800 WAC, Safety and health core rules.
(1) In those cases where no acceptable standards have been derived for the control of hazardous conditions, every reasonable precaution shall be taken to safeguard the health of the worker whether provided herein or not.
(2) Preservation of records.
(a) Scope and application. This section applies to each employer who makes, maintains or has access to employee exposure records or employee medical records.
(b) Definitions.
(i) "Employee exposure record" - A record of monitoring or measuring which contains qualitative or quantitative information indicative of employee exposure to toxic materials or harmful physical agents. This includes both individual exposure records and general research or statistical studies based on information collected from exposure records.
(ii) "Employee medical record" - A record which contains information concerning the health status of an employee or employees exposed or potentially exposed to toxic materials or harmful physical agents. These records may include, but are not limited to:
(A) The results of medical examinations and tests;
(B) Any opinions or recommendations of a physician or other health professional concerning the health of an employee or employees; and
(C) Any employee medical complaints relating to workplace exposure. Employee medical records include both individual medical records and general research or statistical studies based on information collected from medical records.
(c) Preservation of records. Each employer who makes, maintains, or has access to employee exposure records or employee medical records shall preserve these records.
(d) Availability of records. The employer shall make available, upon request, to the director, department of labor and industries, or his designee, all employee exposure records and employee medical records for examination and copying.
(e) Effective date. This standard shall become effective thirty days after filing with the code reviser.
(3) Monitoring of employees. The department shall use industrial hygiene sampling methods and techniques including but not limited to personal monitoring devices and equipment approved by the director or his designee for the purpose of establishing compliance with chapter 296-62 WAC.
(a) The employer shall permit the director or his designee to monitor and evaluate any workplace or employee in accordance with all provisions of this subsection.
(b) The employer shall not prevent or discourage an employee from cooperating with the department by restricting or inhibiting his/her participation in the use of personal monitoring devices and equipment in accordance with all provisions of this subsection.
[Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 02-16-047, § 296-62-060, filed 8/1/02, effective 10/1/02. Statutory Authority: RCW 49.17.040, 49.17.050, and 49.17.240. WSR 80-11-010 (Order 80-14), § 296-62-060, filed 8/8/80; Order 73-3, § 296-62-060, filed 5/7/73; Order 70-8, § 296-62-060, filed 7/31/70, effective 9/1/70; Rule 6.010, effective 8/1/63.]



296-62-073
Carcinogens—Scope and application.

(1) All sections of this chapter which include WAC 296-62-073 in the section number apply to the manufacturing, processing, repackaging, releasing, handling or storing of carcinogens.
(2) This section shall not apply to solid or liquid mixtures containing less than 0.1 percent by weight or volume of the carcinogens listed in WAC 296-62-07302.
[Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-073, filed 11/30/87. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-073, filed 11/13/80; Order 76-6, § 296-62-073, filed 3/1/76; Order 74-35, § 296-62-073, filed 9/20/74.]



296-62-07302
Communication of hazards.

(1) Hazard communication.
(a) Chemical manufacturers, importers, distributors, and employers shall comply with all requirements of the Hazard Communication Standard (HCS), WAC 296-901-140 for each carcinogen listed in subsection (2) of this section.
(b) In classifying the hazards of carcinogens listed in subsection (2) of this section, at least the hazards listed in subsection (2) of this section are to be addressed.
(c) Employers shall include the carcinogens listed in subsection (2) of this section in the hazard communication program established to comply with the HCS, WAC 296-901-140. Employers shall ensure that each employee has access to labels on containers of the carcinogens listed in subsection (2) of this section and to safety data sheets, and is trained in accordance with the requirements of HCS and subsection (2) of this section.
(2) List of carcinogens:
(a) 4-Nitrobiphenyl: Cancer (CAS 92-93-3).
(b) Alpha-Naphthylamine: Cancer; skin irritation; and acute toxicity effects (CAS 134-32-7).
(c) Methyl chloromethyl ether: Cancer; skin, eye and respiratory effects; acute toxicity effects; and flammability (CAS 107-30-2).
(d) 3,3'-Dichlorobenzidine (and its salts): Cancer and skin sensitization (CAS 91-94-1).
(e) Bis-Chloromethyl ether: Cancer; skin, eye, and respiratory tract effects; acute toxicity effects; and flammability (CAS 542-88-1).
(f) Beta-Naphthylamine: Cancer and acute toxicity effects (CAS 91-59-8).
(g) Benzidine: Cancer and acute toxicity effects (CAS 92-87-5).
(h) 4-Aminodiphenyl: Cancer (CAS 92-67-1).
(i) Ethyleneimine: Cancer; mutagenicity; skin and eye effects; liver effects; kidney effects; acute toxicity effects; and flammability (CAS 151-56-4).
(j) Beta-Propiolactone: Cancer; skin irritation; eye effects; and acute toxicity effects (CAS 57-57-8).
(k) 2-Acetylaminofluorene: Cancer (CAS 53-96-3).
(l) 4-Dimethylaminoazo-benzene: Cancer, skin effects; and respiratory tract irritation (CAS 60-11-7).
(m) N-Nitrosodimethylamine: Cancer; liver effects; and acute toxicity effects (CAS 62-75-9).
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-62-07302, filed 3/18/14, effective 5/1/14. Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-07302, filed 6/5/02, effective 8/1/02. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-07302, filed 7/20/94, effective 9/20/94. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 85-10-004 (Order 85-09), § 296-62-07302, filed 4/19/85; WSR 82-13-045 (Order 82-22), § 296-62-07302, filed 6/11/82; WSR 81-07-048 (Order 81-4), § 296-62-07302, filed 3/17/81. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-07302, filed 11/13/80.]



296-62-07304
Definitions.

The definitions set forth in this section apply throughout WAC 296-62-073 through 296-62-07316.
(1) Absolute filter - Is one capable of retaining 99.97 percent of a mono disperse aerosol of 0.3 micron size particles.
(2) Authorized employee - An employee whose duties require him to be in the regulated area and who has been specifically assigned to those duties by the employer.
(3) Clean change room - A room where employees put on clean clothing and/or protective equipment in an environment free of carcinogens listed in WAC 296-62-07302. The clean change room shall be contiguous to and have an entry from a shower room, when the shower room facilities are otherwise required in this section.
(4) Closed system - An operation involving carcinogens listed in WAC 296-62-07302 where containment prevents the release of carcinogens.
(5) Decontamination - The inactivation of a carcinogen listed in WAC 296-62-07302 or its safe disposal.
(6) Disposal - The safe removal of a carcinogen listed in WAC 296-62-07302 from the work environment.
(7) Emergency - An unforeseen circumstance or set of circumstances resulting in the release of a carcinogen which may result in exposure to or contact with any carcinogen listed in WAC 296-62-07302.
(8) External environment - Any environment external to regulated and nonregulated areas.
(9) Isolated system - A fully enclosed structure other than the vessel of containment of a listed carcinogen which is impervious to the passage of listed carcinogens and which would prevent the entry of carcinogens into regulated areas, nonregulated areas, or the external environment, should leakage or spillage from the vessel of containment occur.
(10) Laboratory-type hood - A device enclosed on three sides and the top and bottom, designed and maintained so as to draw air inward at an average linear face velocity of 150 feet per minute with a minimum of 125 feet per minute, designed, constructed and maintained such that an operation involving a listed carcinogen within the hood does not require the insertion of any portion of any employees' body other than his hands and arms.
(11) Nonregulated area - Any area under the control of the employer where entry and exit is neither restricted nor controlled.
(12) Open-vessel system - An operation involving listed carcinogens in an open vessel, which is not in an isolated system, a laboratory-type hood, nor in any other system affording equivalent protection against the entry of carcinogens into regulated areas, nonregulated areas, or the external environment.
(13) Protective clothing - Clothing designed to protect an employee against contact with or exposure to listed carcinogens.
(14) Regulated area - An area where entry and exit is restricted and controlled.
[Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-07304, filed 6/5/02, effective 8/1/02. Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-07304, filed 11/30/87. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 81-07-048 (Order 81-4), § 296-62-07304, filed 3/17/81. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-07304, filed 11/13/80.]



296-62-07306
Requirements for areas containing carcinogens listed in WAC 296-62-07302.

(1) A regulated area shall be established by an employer where listed carcinogens are manufactured, processed, used, repackaged, released, handled or stored.
(2) All such areas shall be controlled in accordance with the requirements for the following category or categories describing the operation involved:
(a) Isolated systems. Employees working with carcinogens within an isolated system such as a "glove box" shall wash their hands and arms upon completion of the assigned task and before engaging in other activities not associated with the isolated system.
(b) Closed system operation. Within regulated areas where carcinogens are stored in sealed containers, or contained in a closed system including piping systems with any sample ports or openings closed while carcinogens are contained within:
(i) Access shall be restricted to authorized employees only;
(ii) Employees shall be required to wash hands, forearms, face and neck upon each exit from the regulated areas, close to the point of exit and before engaging in other activities.
(c) Open vessel system operations. Open vessel system operations as defined in WAC 296-62-07304(12) are prohibited.
(d) Transfer from a closed system. Charging or discharging point operations, or otherwise opening a closed system. In operations involving "laboratory-type hoods," or in locations where a carcinogen is contained in an otherwise "closed system," but is transferred, charged, or discharged into other normally closed containers, the provisions of this section shall apply.
(i) Access shall be restricted to authorized employees only;
(ii) Each operation shall be provided with continuous local exhaust ventilation so that air movement is always from ordinary work areas to the operation. Exhaust air shall not be discharged to regulated areas, nonregulated areas or the external environment unless decontaminated. Clean makeup air shall be introduced in sufficient volume to maintain the correct operation of the local exhaust system.
(iii) Employees shall be provided with, and required to wear, clean, full body protective clothing (smocks, coveralls, or long-sleeved shirt and pants), shoe covers and gloves prior to entering the regulated area.
(iv) Each employee engaged in handling operations involving the following carcinogens must be provided with and required to wear and use a NIOSH-certified self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode, or any supplied air respirator that has a full facepiece and is operated in a pressure-demand or other positive pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus as required in chapter 296-842 WAC. A respirator affording higher levels of protection than this respirator may be substituted.
Methyl Chloromethyl Ether;
 
bis-Chloromethyl Ether;
 
Ethylenemine;
 
beta-Propiolactone;
 
4-Amino Diphenyl.
 
(v) Each employee engaged in handling operations involving the following carcinogens must be provided with, and required to wear and use, NIOSH-certified air-purifying, half-mask respirator with particulate filters as required in chapter 296-842 WAC. A respirator affording higher levels of protection than this respirator may be substituted.
4-Nitrobiphenyl;
 
alpha-Naphthylamine;
 
4-4'Methylene bis(2-Chloroaniline);
 
3-3'Dichlorobenzidine (and its salts);
 
beta-Naphthylamine;
 
Benzidine;
 
2-acetylamino fluroene;
 
4-imethylaminoazobenzene;
 
n-nitrosodimethylamine.
 
must be provided with, and required to wear and use, a half-face, filter-type respirator certified for solid or liquid particulates with minimum efficiency rating of 95% as required in chapter 296-842 WAC. A respirator affording higher levels of protection than this respirator may be substituted.
(vi) Prior to each exit from a regulated area, employees shall be required to remove and leave protective clothing and equipment at the point of exit and at the last exit of the day, to place used clothing and equipment in impervious containers at the point of exit for purposes of decontamination or disposal. The contents of such impervious containers shall be identified, as required under WAC 296-62-07302.
(vii) Employees shall be required to wash hands, forearms, face and neck on each exit from the regulated area, close to the point of exit, and before engaging in other activities.
(viii) Employees shall be required to shower after the last exit of the day.
(ix) Drinking fountains are prohibited in the regulated area.
(e) Maintenance and decontamination activities. In clean up of leaks or spills, maintenance or repair operations on contaminated systems or equipment, or any operations involving work in an area where direct contact with carcinogens could result, each authorized employee entering the area shall:
(i) Be provided with and required to wear, clean, impervious garments, including gloves, boots and continuous-air supplied hood in accordance with WAC 296-800-160, and respiratory protective equipment required by this chapter 296-842 WAC;
(ii) Be decontaminated before removing the protective garments and hood;
(iii) Be required to shower upon removing the protective garments and hood.
(f) Laboratory activities. The requirements of this subdivision shall apply to research and quality control activities involving the use of carcinogens listed in WAC 296-62-07302.
(i) Mechanical pipetting aids shall be used for all pipetting procedures.
(ii) Experiments, procedures and equipment which could produce aerosols shall be confined to laboratory-type hoods or glove boxes.
(iii) Surfaces on which carcinogens are handled shall be protected from contamination.
(iv) Contaminated wastes and animal carcasses shall be collected in impervious containers which are closed and decontaminated prior to removal from the work area. Such wastes and carcasses shall be incinerated in such a manner that no carcinogenic products are released.
(v) All other forms of listed carcinogens shall be inactivated prior to disposal.
(vi) Laboratory vacuum systems shall be protected with high efficiency scrubbers or with disposable absolute filters.
(vii) Employees engaged in animal support activities shall be:
(A) Provided with, and required to wear, a complete protective clothing change, clean each day, including coveralls or pants and shirt, foot covers, head covers, gloves, and appropriate respiratory protective equipment or devices; and
(B) Prior to each exit from a regulated area, employees shall be required to remove and leave protective clothing and equipment at the point of exit and at the last exit of the day, to place used clothing and equipment in impervious containers at the point of exit for purposes of decontamination or disposal. The contents of such impervious containers shall be identified as required under WAC 296-62-07310 (2), (3) and (4).
(C) Required to wash hands, forearms, face and neck upon each exit from the regulated area close to the point of exit, and before engaging in other activities; and
(D) Required to shower after the last exit of the day.
(viii) Employees, other than those engaged only in animal support activities, each day shall be:
(A) Provided with and required to wear a clean change of appropriate laboratory clothing, such as a solid front gown, surgical scrub suit, or fully buttoned laboratory coat.
(B) Prior to each exit from a regulated area, employees shall be required to remove and leave protective clothing and equipment at the point of exit and at the last exit of the day, to place used clothing and equipment in impervious containers at the point of exit for purposes of decontamination or disposal. The contents of such impervious containers shall be identified as required under WAC 296-62-07310 (2), (3) and (4).
(C) Required to wash hands, forearms, face and neck upon each exit from the regulated area close to the point of exit, and before engaging in other activities.
(ix) Air pressure in laboratory areas and animal rooms where carcinogens are handled and bioassay studies are performed shall be negative in relation to the pressure in surrounding areas. Exhaust air shall not be discharged to regulated areas, nonregulated areas or the external environment unless decontaminated.
(x) There shall be no connection between regulated areas and any other areas through the ventilation system.
(xi) A current inventory of the carcinogens shall be maintained.
(xii) Ventilated apparatus such as laboratory-type hoods, shall be tested at least semi-annually or immediately after ventilation modification or maintenance operations, by personnel fully qualified to certify correct containment and operation.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-62-07306, filed 3/18/14, effective 5/1/14. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and chapter 49.17 RCW. WSR 12-24-071, § 296-62-07306, filed 12/4/12, effective 1/4/13. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 09-15-145, § 296-62-07306, filed 7/21/09, effective 9/1/09; WSR 05-03-093, § 296-62-07306, filed 1/18/05, effective 3/1/05. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07306, filed 5/9/01, effective 9/1/01; WSR 99-10-071, § 296-62-07306, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 96-09-030, § 296-62-07306, filed 4/10/96, effective 6/1/96. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 86-16-009 (Order 86-28), § 296-62-07306, filed 7/25/86; WSR 85-10-004 (Order 85-09), § 296-62-07306, filed 4/19/85. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-16-015 (Order 81-20), § 296-62-07306, filed 7/27/81. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-07306, filed 11/13/80.]



296-62-07308
General regulated area requirements.

(1) Respirator program. The employer must implement a respiratory protection program as required in chapter 296-62 WAC, Part E (except WAC 296-62-07130 (1) and (5) and 296-62-07131), which covers each employee required by this chapter to use a respirator.
(2) Emergencies. In an emergency, immediate measures including, but not limited to, the requirements of (a), (b), (c), (d) and (e) of this subsection shall be implemented.
(a) The potentially affected area shall be evacuated as soon as the emergency has been determined.
(b) Hazardous conditions created by the emergency shall be eliminated and the potentially affected area shall be decontaminated prior to the resumption of normal operations.
(c) Special medical surveillance by a physician shall be instituted within twenty-four hours for employees present in the potentially affected area at the time of the emergency. A report of the medical surveillance and any treatment shall be included in the incident report, in accordance with WAC 296-62-07312(2).
(d) Where an employee has a known contact with a listed carcinogen, such employee shall be required to shower as soon as possible, unless contraindicated by physical injuries.
(e) An incident report on the emergency shall be reported as provided in WAC 296-62-07312(2).
(3) Hygiene facilities and practices.
(a) Storage or consumption of food, storage or use of containers of beverages, storage or application of cosmetics, smoking, storage of smoking materials, tobacco products or other products for chewing, or the chewing of such products, are prohibited in regulated areas.
(b) Where employees are required by this section to wash, washing facilities shall be provided in accordance with WAC 296-800-230.
(c) Where employees are required by this section to shower, shower facilities shall be provided.
(i) One shower shall be provided for each ten employees of each sex, or numerical fraction thereof, who are required to shower during the same shift.
(ii) Body soap or other appropriate cleansing agents convenient to the showers shall be provided as specified in WAC 296-800-230, of the safety and health core rules.
(iii) Showers shall be provided with hot and cold water feeding a common discharge line.
(iv) Employees who use showers shall be provided with individual clean towels.
(d) Where employees wear protective clothing and equipment, clean change rooms shall be provided and shall be equipped with storage facilities for street clothes and separate storage facilities for the protective clothing for the number of such employees required to change clothes.
(e) Where toilets are in regulated areas, such toilets shall be in a separate room.
(4) Contamination control.
(a) Regulated areas, except for outdoor systems, shall be maintained under pressure negative with respect to nonregulated areas. Local exhaust ventilation may be used to satisfy this requirement. Clean makeup air in equal volume shall replace air removed.
(b) Any equipment, material, or other item taken into or removed from a regulated area shall be done so in a manner that does not cause contamination in nonregulated areas or the external environment.
(c) Decontamination procedures shall be established and implemented to remove carcinogens from the surfaces of materials, equipment and the decontamination facility.
(d) Dry sweeping and dry mopping are prohibited.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 09-15-145, § 296-62-07308, filed 7/21/09, effective 9/1/09; WSR 03-18-090, § 296-62-07308, filed 9/2/03, effective 11/1/03. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07308, filed 5/9/01, effective 9/1/01; WSR 99-10-071, § 296-62-07308, filed 5/4/99, effective 9/1/99. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-24-013 (Order 83-34), § 296-62-07308, filed 11/30/83. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-07308, filed 11/13/80.]



296-62-07310
Signs, information and training.

(1) Signs.
(a) The employer shall post entrances to regulated areas with signs bearing the legend:
danger
(chemical identification)
may cause cancer
authorized personnel only
(b) The employer shall post signs at entrances to regulated areas containing operations covered in WAC 296-62-07306 (2)(e). The signs shall bear the legend:
danger
(chemical identification)
may cause cancer
wear air-supplied hoods, impervious suits, and protective equipment in this area
authorized personnel only
(c) Prior to June 1, 2016, employers may use the following legend in lieu of that specified in (a) of this subsection:
cancer-suspect agent
authorized personnel only
(d) Prior to June 1, 2016, employers may use the following legend in lieu of that specified in (b) of this subsection:
cancer-suspect agent exposed in this area
IMPERVIOUS SUIT INCLUDING GLOVES, BOOTS, AND AIR-SUPPLIED HOOD
REQUIRED AT ALL TIMES
authorized personnel only
(e) Appropriate signs and instructions shall be posted at the entrance to, and exit from, regulated areas, informing employees of the procedures that must be followed in entering and leaving a regulated area.
(2) Prohibited statements. No statements shall appear on or near any required sign, label, or instruction that contradicts or detracts from the effect of any required warning, information or instruction.
(3) Training and indoctrination.
(a) Each employee prior to being authorized to enter a regulated area, shall receive a training and indoctrination program including, but not necessarily limited to:
(i) The nature of the carcinogenic hazards of listed carcinogens, including local and systemic toxicity;
(ii) The specific nature of the operation involving carcinogens which could result in exposure;
(iii) The purpose for and application of the medical surveillance program, including, as appropriate, methods of self-examination;
(iv) The purpose for and application of decontamination practices and purposes;
(v) The purpose for and significance of emergency practices and procedures;
(vi) The employee's specific role in emergency procedures;
(vii) Specific information to aid the employee in recognition and evaluation of conditions and situations which may result in the release of listed carcinogens;
(viii) The purpose for and application of specific first-aid procedures and practices;
(ix) A review of this section at the employee's first training and indoctrination program and annually thereafter.
(b) Specific emergency procedures shall be prescribed, and posted, and employees, shall be familiarized with their terms, and rehearsed in their application.
(c) All materials relating to the program shall be provided upon request to the director.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-62-07310, filed 3/18/14, effective 5/1/14. Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-07310, filed 11/30/87. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 81-07-048 (Order 81-4), § 296-62-07310, filed 3/17/81. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-07310, filed 11/13/80.]



296-62-07312
Reports.

(1) Operations. Not later than October 30, 1974, the information required in WAC 296-62-07312 (1)(a), (b), (c) and (d) of this section must be reported in writing to the Department of Labor and Industries, WISHA Services Division, Policy and Technical Services, P.O. Box 44610, Olympia, WA 98504-4610. Any changes in the information must also be reported in writing within 15 calendar days of the change.
(a) A brief description and in plant location of the area(s) regulated and the address of each regulated area;
(b) The name(s) and other identifying information as to the presence of listed carcinogens in each regulated area;
(c) The number of employees in each regulated area, during normal operations including maintenance activities; and
(d) The manner in which a carcinogen is present in each regulated area; e.g., whether it is manufactured, processed, used, repackaged, released, stored, or otherwise handled.
(2) Incidents. Incidents which result in the release of a listed carcinogen into any area where employees may be potentially exposed shall be reported in accordance with this subsection.
(a) The occurrence of the incident, including any facts obtainable at that time, as well as a report on any medical treatment of affected employees, must be reported within 24 hours to the Department of Labor and Industries, WISHA Services Division, Policy and Technical Services, P.O. Box 44610, Olympia, WA 98504-4610.
(b) A written report must be filed with the Department of Labor and Industries, WISHA Services Division, Policy and Technical Services, P.O. Box 44610, Olympia, WA 98504-4610, within 15 calendar days after the incident occurs, and must include:
(i) A specification of the amount of material released, the amount of time involved, and an explanation of the procedure used in determining this figure;
(ii) A description of the area involved, and the extent of known and possible employee exposure and area contamination;
(iii) A report of any medical treatment of affected employees, and any medical surveillance program implemented; and
(iv) An analysis of the circumstances of the incident, and measures taken or to be taken, with specific completion dates, to avoid further similar releases.
carcinogen standard report
Company: . . . . . . . . .
Plant Address: . . . . . .
Date: . . . . . . . . . . . . .
Prepared By: . . . . . . . . . .
Title: . . . . . . . . . . . . . . . .
Compound and
Other
Identifying
Information
Description of
Inplant
Location of
Regulated Area*
Number of
Employees
in Each
Regulated Area*
Normally
Maintenance
Manner** In
Which
Compound is
Present in
Each Regulated
Area*
 
*
See WAC 296-62-07308 for definition of "regulated area."
**
Indicated whether manufactured, processed, used, repackaged, released, stored, or if otherwise handled (describe).
[Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-07312, filed 6/5/02, effective 8/1/02. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 81-07-048 (Order 81-4), § 296-62-07312, filed 3/17/81. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-07312, filed 11/13/80.]



296-62-07314
Medical surveillance.

(1) At no cost to the employee, a program of medical surveillance must be established and implemented for employees considered for assignment to enter regulated areas, and for authorized employees.
(2) Examinations.
(a) Before an employee is assigned to enter a regulated area, a preassignment physical examination by a physician must be provided and must include a personal history of the employee and/or his/her family and occupational background, including genetic and environmental factors.
(i) Taking of employees' medical history and background history must be considered to be a routine part of standard medical practice.
(ii) This provision does not require "genetic testing" of any employee.
(iii) This provision does not require the exclusion of otherwise qualified employees from jobs on the basis of genetic factors.
(b) Authorized employees must be provided periodic physical examination, not less often than annually, following the preassignment examination.
(c) In all physical examinations, the examining physician must be requested to consider whether there exist conditions of increased risk, including reduced immunological competence, pregnancy, cigarette smoking, and those undergoing treatment with steroids or cytotoxic agents.
(3) Records.
(a) Employers of employees examined pursuant to this subdivision must maintain complete and accurate records of all such medical examinations. Records must be maintained for the duration of the employee's employment. The employer shall ensure that medical records are maintained and made available in accordance with chapter 296-802 WAC, Employee medical and exposure records.
(b) Records required by this section must be provided upon request to employees, designated representatives, and the director in accordance with chapter 296-802 WAC.
(c) Any employer who requests a physical examination of an employee or prospective employee as required by this section must obtain from the physician a statement of the employee's suitability for employment in the specific exposure.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and chapter 49.17 RCW. WSR 12-24-071, § 296-62-07314, filed 12/4/12, effective 1/4/13. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-10-026, § 296-62-07314, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-07314, filed 6/5/02, effective 8/1/02. Statutory Authority: Chapter 49.17 RCW. WSR 91-03-044 (Order 90-18), § 296-62-07314, filed 1/10/91, effective 2/12/91; WSR 90-03-029 (Order 89-20), § 296-62-07314, filed 1/11/90, effective 2/26/90. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 83-15-017 (Order 83-19), § 296-62-07314, filed 7/13/83, effective 9/12/83. Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-07314, filed 11/13/80.]



296-62-07316
Premixed solutions.

(1) Where 4,4'—Methylene bis (2—chloroaniline) is present only in a single solution at a temperature not exceeding 220°F. the establishment of a regulated area is not required; however,
(a) Only authorized employees shall be permitted to handle such materials.
(b) Each day employees shall be provided with and required to wear a clean change of protective clothing (smocks, coveralls, or long-sleeved shirts and pants), gloves and other protective garments and equipment necessary to prevent contact with the solution in the process used.
(c) Employees shall be required to remove and leave protective clothing and equipment when leaving the work area at the end of the work day, or at any time solution is spilled on such clothing or equipment. Used clothing and equipment shall be placed in impervious containers for purposes of decontamination or disposal. The contents of such impervious containers shall be identified, as required under WAC 296-62-07310 (2), (3) and (4).
(d) Employees shall be required to wash hands and face after removing such clothing and equipment and before engaging in other activities.
(e) Employees assigned to work covered by this section shall be deemed to be working in regulated areas for the purposes of WAC 296-62-07308 (1), (2)(a) and (b), and (3)(c) and (d), 296-62-07310, 296-62-07312 and 296-62-07314.
(f) Work areas where solution may be spilled shall be:
(i) Covered daily or after any spill with a clean covering; or
(ii) Clean thoroughly, daily and after any spill.
[Statutory Authority: RCW 49.17.040, 49.17.050, 49.17.240, chapters 42.30 and 43.22 RCW. WSR 80-17-014 (Order 80-20), § 296-62-07316, filed 11/13/80.]



296-62-07329
Vinyl chloride.

(1) Scope and application.
(a) This section includes requirements for the control of employee exposure to vinyl chloride (chloroethene), Chemical Abstracts Service Registry No. 75014.
(b) This section applies to the manufacture, reaction, packaging, repackaging, storage, handling or use of vinyl chloride or polyvinyl chloride, but does not apply to the handling or use of fabricated products made of polyvinyl chloride.
(c) This section applies to the transportation of vinyl chloride or polyvinyl chloride except to the extent that the department of transportation may regulate the hazards covered by this section.
(2) Definitions.
(a) "Action level" means a concentration of vinyl chloride of 0.5 ppm averaged over an eight-hour work day.
(b) "Authorized person" means any person specifically authorized by the employer whose duties require him/her to enter a regulated area or any person entering such an area as a designated representative of employees for the purpose of exercising an opportunity to observe monitoring and measuring procedures.
(c) "Director" means the director of department of labor and industries or his/her designated representative.
(d) "Emergency" means any occurrence such as, but not limited to, equipment failure, or operation of a relief device which is likely to, or does, result in massive release of vinyl chloride.
(e) "Fabricated product" means a product made wholly or partly from polyvinyl chloride, and which does not require further processing at temperatures, and for times, sufficient to cause mass melting of the polyvinyl chloride resulting in the release of vinyl chloride.
(f) "Hazardous operation" means any operation, procedure, or activity where a release of either vinyl chloride liquid or gas might be expected as a consequence of the operation or because of an accident in the operation, which would result in an employee exposure in excess of the permissible exposure limit.
(g) "Polyvinyl chloride" means polyvinyl chloride homopolymer or copolymer before such is converted to a fabricated product.
(h) "Vinyl chloride" means vinyl chloride monomer.
(3) Permissible exposure limit.
(a) No employee may be exposed to vinyl chloride at concentrations greater than 1 ppm averaged over any 8-hour period, and
(b) No employee may be exposed to vinyl chloride at concentrations greater than 5 ppm averaged over any period not exceeding 15 minutes.
(c) No employee may be exposed to vinyl chloride by direct contact with liquid vinyl chloride.
(4) Monitoring.
(a) A program of initial monitoring and measurement shall be undertaken in each establishment to determine if there is any employee exposed, without regard to the use of respirators, in excess of the action level.
(b) Where a determination conducted under subdivision (a) of this subsection shows any employee exposures without regard to the use of respirators, in excess of the action level, a program for determining exposures for each such employee shall be established. Such a program:
(i) Shall be repeated at least monthly where any employee is exposed, without regard to the use of respirators, in excess of the permissible exposure limit.
(ii) Shall be repeated not less than quarterly where any employee is exposed, without regard to the use of respirators, in excess of the action level.
(iii) May be discontinued for any employee only when at least two consecutive monitoring determinations, made not less than five working days apart, show exposures for that employee at or below the action level.
(c) Whenever there has been a production, process or control change which may result in an increase in the release of vinyl chloride, or the employer has any other reason to suspect that any employee may be exposed in excess of the action level, a determination of employee exposure under subdivision (a) of this subsection shall be performed.
(d) The method of monitoring and measurement shall have an accuracy (with a confidence level of 95 percent) of not less than plus or minus fifty percent from 0.25 through 0.5 ppm, plus or minus thirty-five percent from over 0.5 ppm through 1.0 ppm, plus or minus twenty-five percent over 1.0 ppm, (methods meeting these accuracy requirements are available from the director).
(e) Employees or their designated representatives shall be afforded reasonable opportunity to observe the monitoring and measuring required by this subsection.
(5) Regulated area.
(a) A regulated area shall be established where:
(i) Vinyl chloride or polyvinyl chloride is manufactured, reacted, repackaged, stored, handled or used; and
(ii) Vinyl chloride concentrations are in excess of the permissible exposure limit.
(b) Access to regulated areas shall be limited to authorized persons.
(6) Methods of compliance. Employee exposures to vinyl chloride shall be controlled to at or below the permissible exposure limit provided in subsection (3) of this section by engineering, work practice, and personal protective controls as follows:
(a) Feasible engineering and work practice controls shall immediately be used to reduce exposures to at or below the permissible exposure limit.
(b) Wherever feasible engineering and work practice controls which can be instituted immediately are not sufficient to reduce exposures to at or below the permissible exposure limit, they shall nonetheless be used to reduce exposures to the lowest practicable level, and shall be supplemented by respiratory protection in accordance with subsection (7) of this section. A program shall be established and implemented to reduce exposures to at or below the permissible exposure limit, or to the greatest extent feasible, solely by means of engineering and work practice controls, as soon as feasible.
(c) Written plans for such a program shall be developed and furnished upon request for examination and copying to the director. Such plans shall be updated at least every six months.
(7) Respiratory protection.
(a) General. For employees who use respirators required by this section, the employer must provide each employee an appropriate respirator that complies with the requirements of this section.
(b) Respirator program. The employer must develop, implement, and maintain a respiratory protection program as required in chapter 296-842 WAC, Respirators, which covers each employee required by this chapter to use a respirator. Exception: The requirements in WAC 296-842-13005 that address change out of vapor or gas respirator cartridges or canisters.
(c) Respirator selection. The employer must:
(i) Select and provide to employees appropriate respirators as specified in this section and WAC 296-842-13005 in the respirator rule.
(ii) Provide organic vapor cartridges that have a service life of at least one hour when employees use air-purifying respirators in vinyl chloride concentrations up to 10 parts per million (ppm).
(iii) Make sure the following respirators, when selected, are equipped with a canister with a service life of at least four hours when used in vinyl chloride concentrations up to 25 ppm:
(A) Helmet, hood, or full-facepiece PAPRs
OR
(B) Gas masks with a front- or back-mounted canister.
(d) Where air-purifying respirators are used:
(i) Air-purifying canisters or cartridges must be replaced prior to the expiration of their service life or the end of the shift in which they are first used, whichever occurs first, and
(ii) A continuous monitoring and alarm system must be provided when concentrations of vinyl chloride could reasonably exceed the allowable concentrations for the devices in use. Such system shall be used to alert employees when vinyl chloride concentrations exceed the allowable concentrations for the devices in use, and
(iii) Respirators specified for higher concentrations may be used for lower concentration.
(8) Hazardous operations.
(a) Employees engaged in hazardous operations, including entry of vessels to clean polyvinyl chloride residue from vessel walls, shall be provided and required to wear and use;
(i) Respiratory protection in accordance with subsections (3) and (7) of this section; and
(ii) Protective garments to prevent skin contact with liquid vinyl chloride or with polyvinyl chloride residue from vessel walls. The protective garments shall be selected for the operation and its possible exposure conditions.
(b) Protective garments shall be provided clean and dry for each use.
(c) Emergency situations. A written operational plan for emergency situations shall be developed for each facility storing, handling, or otherwise using vinyl chloride as a liquid or compressed gas. Appropriate portions of the plan shall be implemented in the event of an emergency. The plan shall specifically provide that:
(i) Employees engaged in hazardous operations or correcting situations of existing hazardous releases shall be equipped as required in (a) and (b) of this subsection;
(ii) Other employees not so equipped shall evacuate the area and not return until conditions are controlled by the methods required in subsection (6) of this section and the emergency is abated.
(9) Training. Each employee engaged in vinyl chloride or polyvinyl chloride operations shall be provided training in a program relating to the hazards of vinyl chloride and precautions for its safe use.
(a) The program shall include:
(i) The nature of the health hazard from chronic exposure to vinyl chloride including specifically the carcinogenic hazard;
(ii) The specific nature of operations which could result in exposure to vinyl chloride in excess of the permissible limit and necessary protective steps;
(iii) The purpose for, proper use, and limitations of respiratory protective devices;
(iv) The fire hazard and acute toxicity of vinyl chloride, and the necessary protective steps;
(v) The purpose for and a description of the monitoring program;
(vi) The purpose for and a description of, the medical surveillance program;
(vii) Emergency procedures:
(A) Specific information to aid the employee in recognition of conditions which may result in the release of vinyl chloride; and
(B) A review of this standard at the employee's first training and indoctrination program, and annually thereafter.
(b) All materials relating to the program shall be provided upon request to the director.
(10) Medical surveillance. A program of medical surveillance shall be instituted for each employee exposed, without regard to the use of respirators, to vinyl chloride in excess of the action level. The program shall provide each such employee with an opportunity for examinations and tests in accordance with this subsection. All medical examinations and procedures shall be performed by or under the supervision of a licensed physician and shall be provided without cost to the employee.
(a) At the time of initial assignment, or upon institution of medical surveillance;
(i) A general physical examination shall be performed with specific attention to detecting enlargement of liver, spleen or kidneys, or dysfunction in these organs, and for abnormalities in skin, connective tissues and the pulmonary system (see Appendix A).
(ii) A medical history shall be taken, including the following topics:
(A) Alcohol intake,
(B) Past history of hepatitis,
(C) Work history and past exposure to potential hepatotoxic agents, including drugs and chemicals,
(D) Past history of blood transfusions, and
(E) Past history of hospitalizations.
(iii) A serum specimen shall be obtained and determinations made of:
(A) Total bilirubin,
(B) Alkaline phosphatase,
(C) Serum glutamic oxalacetic transaminase (SGOT),
(D) Serum glutamic pyruvic transaminase (SGPT), and
(E) Gamma glustamyl transpeptidase.
(b) Examinations provided in accordance with this subdivision shall be performed at least:
(i) Every six months for each employee who has been employed in vinyl chloride or polyvinyl chloride manufacturing for ten years or longer; and
(ii) Annually for all other employees.
(c) Each employee exposed to an emergency shall be afforded appropriate medical surveillance.
(d) A statement of each employee's suitability for continued exposure to vinyl chloride including use of protective equipment and respirators, shall be obtained from the examining physician promptly after any examination. A copy of the physician's statement shall be provided each employee.
(e) If any employee's health would be materially impaired by continued exposure, such employee shall be withdrawn from possible contact with vinyl chloride.
(f) Laboratory analyses for all biological specimens included in medical examinations shall be performed in laboratories licensed under 42 C.F.R. Part 74.
(g) If the examining physician determines that alternative medical examinations to those required by (a) of this subsection will provide at least equal assurance of detecting medical conditions pertinent to the exposure to vinyl chloride, the employer may accept such alternative examinations as meeting the requirements of (a) of this subsection, if the employer obtains a statement from the examining physician setting forth the alternative examinations and the rationale for substitution. This statement shall be available upon request for examination and copying to authorized representatives of the director.
(11) Communication of hazards.
(a) Hazard communication – General.
(b) Chemical manufacturers, importers, distributors and employers shall comply with all requirements of the Hazard Communication Standard (HCS), WAC 296-901-140 for vinyl chloride and polyvinyl chloride.
(c) In classifying the hazards of vinyl chloride at least the following hazards are to be addressed: Cancer; central nervous system effects; liver effects; blood effects; and flammability.
(d) Employers shall include vinyl chloride in the hazard communication program established to comply with the HCS, WAC 296-901-140. Employers shall ensure that each employee has access to labels on containers of vinyl chloride and to safety data sheets, and is trained in accordance with the requirements of HCS and subsection (9) of this section.
(12) Signs.
(a) The employers shall post entrances to regulated areas with legible signs bearing the legend:
DANGER
VINYL CHLORIDE
MAY CAUSE CANCER
AUTHORIZED PERSONNEL ONLY
(b) The employer shall post signs at areas containing hazardous operations or where emergencies currently exist. The signs shall be legible and bear the legend:
DANGER
VINYL CHLORIDE
MAY CAUSE CANCER
WEAR RESPIRATORY PROTECTION AND PROTECTIVE CLOTHING IN THIS AREA
AUTHORIZED PERSONNEL ONLY
(c) Prior to June 1, 2016, employers may use the following legend in lieu of that specified in (a) of this subsection:
CANCER-SUSPECT AGENT IN THIS AREA PROTECTIVE EQUIPMENT REQUIRED AUTHORIZED PERSONNEL ONLY
(d) Prior to June 1, 2016, employers may use the following legend in lieu of that specified in (b) of this subsection:
CANCER-SUSPECT AGENT IN THIS AREA
PROTECTIVE EQUIPMENT REQUIRED
AUTHORIZED PERSONNEL ONLY
(13) Labels.
(a) In addition to the other requirements in this section, the employer shall ensure that labels for containers of polyvinyl chloride resin waste from reactors or other waste contaminated with vinyl chloride are legible and include the following information:
CONTAMINATED WITH VINYL CHLORIDE MAY CAUSE CANCER
(b) Prior to June 1, 2015, employers may include the following information on labels of containers of polyvinyl chloride resin waste from reactors or other waste contaminated with vinyl chloride in lieu of the labeling requirements in (a) of this subsection:
CONTAMINATED WITH VINYL CHLORIDE
CANCER-SUSPECT AGENT
(c) Prior to June 1, 2015, employers may include the following information for containers of polyvinyl chloride in lieu of the labeling requirements in subsection (11)(b) of this section:
POLYVINYL CHLORIDE (OR TRADE NAME) CONTAINS VINYL CHLORIDE VINYL CHLORIDE IS A CANCER-SUSPECT AGENT
(d) Containers of vinyl chloride shall be legibly labeled either:
(i) Prior to June 1, 2015, employers may include either the following information in either subsection (13)(d)(i) or (ii) of this section on containers of vinyl chloride in lieu of the labeling requirements in subsection (11)(b) of this section:
VINYL CHLORIDE EXTREMELY FLAMMABLE GAS UNDER PRESSURE CANCER-SUSPECT AGENT
(or)
(ii) In accordance with 49 C.F.R. Parts 170-189, with the additional legend applied near the label or placard:
CANCER-SUSPECT AGENT
(e) No statement shall appear on or near any required sign, label, or instruction which contradicts or detracts from the effect of any required warning, information, or instruction.
(14) Records.
(a) All records maintained in accordance with this section shall include the name and Social Security number of each employee where relevant.
(b) Records of required monitoring and measuring and medical records shall be provided upon request to employees, designated representatives, and the director in accordance with chapter 296-802 WAC. These records shall be provided upon request to the director. Authorized personnel rosters shall also be provided upon request to the director.
(i) Monitoring and measuring records shall:
(A) State the date of such monitoring and measuring and the concentrations determined and identify the instruments and methods used;
(B) Include any additional information necessary to determine individual employee exposures where such exposures are determined by means other than individual monitoring of employees; and
(C) Be maintained for not less than 30 years.
(ii) Medical records shall be maintained for the duration of the employment of each employee plus 20 years, or 30 years, whichever is longer.
(c) The employer shall comply with any additional requirements set forth in chapter 296-802 WAC.
(d) Employees or their designated representatives shall be provided access to examine and copy records of required monitoring and measuring.
(e) Former employees shall be provided access to examine and copy required monitoring and measuring records reflecting their own exposures.
(f) Upon written request of any employee, a copy of the medical record of that employee shall be furnished to any physician designated by the employee.
(15) Reports.
(a) Not later than 1 month after the establishment of a regulated area, the following information shall be reported to the director. Any changes to such information shall be reported within fifteen days.
(i) The address and location of each establishment which has one or more regulated areas; and
(ii) The number of employees in each regulated area during normal operations, including maintenance.
(b) Emergencies and the facts obtainable at that time, shall be reported within twenty-four hours to the director. Upon request of the director, the employer shall submit additional information in writing relevant to the nature and extent of employee exposures and measures taken to prevent future emergencies of similar nature.
(c) Within ten working days following any monitoring and measuring which discloses that any employee has been exposed, without regard to the use of respirators, in excess of the permissible exposure limit, each such employee shall be notified in writing of the results of the exposure measurement and the steps being taken to reduce the exposure to within the permissible exposure limit.
(16) Appendix A supplementary medical information.
When required tests under subsection (10)(a) of this section show abnormalities, the tests should be repeated as soon as practicable, preferably within three to four weeks. If tests remain abnormal, consideration should be given to withdrawal of the employee from contact with vinyl chloride, while a more comprehensive examination is made.
Additional tests which may be useful:
(a) For kidney dysfunction: Urine examination for albumin, red blood cells, and exfoliative abnormal cells.
(b) Pulmonary system: Forced vital capacity, forced expiratory volume at one second, and chest roentgenogram (posterior-anterior, 14 x 17 inches).
(c) Additional serum tests: Lactic acid dehydrogenase, lactic acid dehydrogenase isoenzyme, protein determination, and protein electrophoresis.
(d) For a more comprehensive examination on repeated abnormal serum tests: Hepatitis B antigen, and liver scanning.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-62-07329, filed 3/18/14, effective 5/1/14. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and chapter 49.17 RCW. WSR 12-24-071, § 296-62-07329, filed 12/4/12, effective 1/4/13. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 09-15-145, § 296-62-07329, filed 7/21/09, effective 9/1/09; WSR 07-05-072, § 296-62-07329, filed 2/20/07, effective 4/1/07; WSR 05-03-093, § 296-62-07329, filed 1/18/05, effective 3/1/05; WSR 04-10-026, § 296-62-07329, filed 4/27/04, effective 8/1/04. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07329, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-07329, filed 7/20/94, effective 9/20/94; WSR 91-03-044 (Order 90-18), § 296-62-07329, filed 1/10/91, effective 2/12/91. Statutory Authority: RCW 49.17.040 and 49.17.050. WSR 86-16-009 (Order 86-28), § 296-62-07329, filed 7/25/86; WSR 82-13-045 (Order 82-22), § 296-62-07329, filed 6/11/82. Statutory Authority: RCW 49.17.040, 49.17.050 and 49.17.240. WSR 81-18-029 (Order 81-21), § 296-62-07329, filed 8/27/81; WSR 81-16-015 (Order 81-20), § 296-62-07329, filed 7/27/81; Order 75-41, § 296-62-07329, filed 12/19/75.]



296-62-07336
Acrylonitrile.

(1) Scope and application.
(a) This section applies to all occupational exposure to acrylonitrile (AN), Chemical Abstracts Service Registry No. 000107131, except as provided in (b) and (c) of this subsection.
(b) This section does not apply to exposures which result solely from the processing, use, and handling of the following materials:
(i) ABS resins, SAN resins, nitrile barrier resins, solid nitrile elastomers, and acrylic and modacrylic fibers, when these listed materials are in the form of finished polymers, and products fabricated from such finished polymers;
(ii) Materials made from and/or containing AN for which objective data is reasonably relied upon to demonstrate that the material is not capable of releasing AN in airborne concentrations in excess of 1 ppm as an eight-hour time-weighted average, under the expected conditions of processing, use, and handling which will cause the greatest possible release; and
(iii) Solid materials made from and/or containing AN which will not be heated above 170°F during handling, use, or processing.
(c) An employer relying upon exemption under (1)(b)(ii) shall maintain records of the objective data supporting that exemption, and of the basis of the employer's reliance on the data as provided in subsection (17) of this section.
(2) Definitions, as applicable to this section:
(a) "Acrylonitrile" or "AN" - Acrylonitrile monomer, chemical formula CH2=CHCN.
(b) "Action level" - A concentration of AN of 1 ppm as an eight-hour time-weighted average.
(c) "Authorized person" - Any person specifically authorized by the employer whose duties require the person to enter a regulated area, or any person entering such an area as a designated representative of employees for the purpose of exercising the opportunity to observe monitoring procedures under subsection (18) of this section.
(d) "Decontamination" means treatment of materials and surfaces by water washdown, ventilation, or other means, to assure that the materials will not expose employees to airborne concentrations of AN above 1 ppm as an eight-hour time-weighted average.
(e) "Director" - The director of labor and industries, or his authorized representative.
(f) "Emergency" - Any occurrence such as, but not limited to, equipment failure, rupture of containers, or failure of control equipment, which is likely to, or does, result in unexpected exposure to AN in excess of the ceiling limit.
(g) "Liquid AN" means AN monomer in liquid form, and liquid or semiliquid polymer intermediates, including slurries, suspensions, emulsions, and solutions, produced during the polymerization of AN.
(h) "Polyacrylonitrile" or "PAN" - Polyacrylonitrile homopolymers or copolymers, except for materials as exempted under subsection (1)(b) of this section.
(3) Permissible exposure limits.
(a) Inhalation.
(i) Time-weighted average limit (TWA). The employer shall assure that no employee is exposed to an airborne concentration of acrylonitrile in excess of two parts acrylonitrile per million parts of air (2 ppm), as an eight-hour time-weighted average.
(ii) Ceiling limit. The employer shall assure that no employee is exposed to an airborne concentration of acrylonitrile in excess of 10 ppm as averaged over any fifteen-minute period during the working day.
(b) Dermal and eye exposure. The employer shall assure that no employee is exposed to skin contact or eye contact with liquid AN or PAN.
(4) Notification of use and emergencies.
(a) Use. Within ten days of the effective date of this standard, or within fifteen days following the introduction of AN into the workplace, every employer shall report, unless he has done so pursuant to the emergency temporary standard, the following information to the director for each such workplace:
(i) The address and location of each workplace in which AN is present;
(ii) A brief description of each process of operation which may result in employee exposure to AN;
(iii) The number of employees engaged in each process or operation who may be exposed to AN and an estimate of the frequency and degree of exposure that occurs; and
(iv) A brief description of the employer's safety and health program as it relates to limitation of employee exposure to AN. Whenever there has been a significant change in the information required by this subsection, the employer shall promptly amend such information previously provided to the director.
(b) Emergencies and remedial action. Emergencies, and the facts obtainable at that time, shall be reported within twenty-four hours of the initial occurrence to the director. Upon request of the director, the employer shall submit additional information in writing relevant to the nature and extent of employee exposures and measures taken to prevent future emergencies of a similar nature.
(5) Exposure monitoring.
(a) General.
(i) Determinations of airborne exposure levels shall be made from air samples that are representative of each employee's exposure to AN over an eight-hour period.
(ii) For the purposes of this section, employee exposure is that which would occur if the employee were not using a respirator.
(b) Initial monitoring. Each employer who has a place of employment in which AN is present shall monitor each such workplace and work operation to accurately determine the airborne concentrations of AN to which employees may be exposed. Such monitoring may be done on a representative basis, provided that the employer can demonstrate that the determinations are representative of employee exposures.
(c) Frequency.
(i) If the monitoring required by this section reveals employee exposure to be below the action level, the employer may discontinue monitoring for that employee. The employer shall continue these quarterly measurements until at least two consecutive measurements taken at least seven days apart, are below the action level, and thereafter the employer may discontinue monitoring for that employee.
(ii) If the monitoring required by this section reveals employee exposure to be at or above the action level but below the permissible exposure limits, the employer shall repeat such monitoring for each such employee at least quarterly.
(iii) If the monitoring required by this section reveals employee exposure to be in excess of the permissible exposure limits, the employer shall repeat these determinations for each such employee at least monthly. The employer shall continue these monthly measurements until at least two consecutive measurements, taken at least seven days apart, are below the permissible exposure limits, and thereafter the employer shall monitor at least quarterly.
(d) Additional monitoring. Whenever there has been a production, process, control or personnel change which may result in new or additional exposure to AN, or whenever the employer has any other reason to suspect a change which may result in new or additional exposures to AN, additional monitoring which complies with this subsection shall be conducted.
(e) Employee notification.
(i) Within five working days after the receipt of monitoring results, the employer shall notify each employee in writing of the results which represent that employee's exposure.
(ii) Whenever the results indicate that the representative employee exposure exceeds the permissible exposure limits, the employer shall include in the written notice a statement that the permissible exposure limits were exceeded and a description of the corrective action being taken to reduce exposure to or below the permissible exposure limits.
(f) Accuracy of measurement. The method of measurement of employee exposures shall be accurate, to a confidence level of ninety-five percent, to within plus or minus twenty-five percent for concentrations of AN at or above the permissible exposure limits, and plus or minus thirty-five percent for concentrations of AN between the action level and the permissible exposure limits.
(g) Weekly survey of operations involving liquid AN. In addition to monitoring of employee exposures to AN as otherwise required by this subsection, the employer shall survey areas of operations involving liquid AN at least weekly to detect points where AN liquid or vapor are being released into the workplace. The survey shall employ an infra-red gas analyzer calibrated for AN, a multipoint gas chromatographic monitor, or comparable system for detection of AN. A listing of levels detected and areas of AN release, as determined from the survey, shall be posted prominently in the workplace, and shall remain posted until the next survey is completed.
(6) Regulated areas.
(a) The employer shall establish regulated areas where AN concentrations are in excess of the permissible exposure limits.
(b) Regulated areas shall be demarcated and segregated from the rest of the workplace, in any manner that minimizes the number of persons who will be exposed to AN.
(c) Access to regulated areas shall be limited to authorized persons or to persons otherwise authorized by the act or regulations issued pursuant thereto.
(d) The employer shall assure that in the regulated area, food or beverages are not present or consumed, smoking products are not present or used, and cosmetics are not applied, (except that these activities may be conducted in the lunchrooms, change rooms and showers required under subsection (13)(a) through (c) of this section.
(7) Methods of compliance.
(a) Engineering and work practice controls.
(i) The employer shall institute engineering or work practice controls to reduce and maintain employee exposures to AN, to or below the permissible exposure limits, except to the extent that the employer establishes that such controls are not feasible.
(ii) Wherever the engineering and work practice controls which can be instituted are not sufficient to reduce employee exposures to or below the permissible exposure limits, the employer shall nonetheless use them to reduce exposures to the lowest levels achievable by these controls and shall supplement them by the use of respiratory protection which complies with the requirements of subsection (8) of this section.
(b) Compliance program.
(i) The employer shall establish and implement a written program to reduce employee exposures to or below the permissible exposure limits solely by means of engineering and work practice controls, as required by subsection (7)(a) of this section.
(ii) Written plans for these compliance programs shall include at least the following:
(A) A description of each operation or process resulting in employee exposure to AN above the permissible exposure limits;
(B) Engineering plans and other studies used to determine the controls for each process;
(C) A report of the technology considered in meeting the permissible exposure limits;
(D) A detailed schedule for the implementation of engineering or work practice controls; and
(E) Other relevant information.
(iii) The employer shall complete the steps set forth in the compliance program by the dates in the schedule.
(iv) Written plans for such a program shall be submitted upon request to the director, and shall be available at the worksite for examination and copying by the director, or any affected employee or representative.
(v) The plans required by this subsection shall be revised and updated at least every six months to reflect the current status of the program.
(8) Respiratory protection.
(a) General. For employees who use respirators required by this section, the employer must provide each employee an appropriate respirator that complies with the requirements of this subsection. Respirators must be used during:
(i) Periods necessary to install or implement feasible engineering and work-practice controls;
(ii) Work operations, such as maintenance and repair activities or reactor cleaning, for which the employer establishes that engineering and work-practice controls are not feasible;
(iii) Work operations for which feasible engineering and work-practice controls are not yet sufficient to reduce employee exposure to or below the permissible exposure limits;
(iv) In emergencies.
(b) Respirator program.
Employers must develop, implement and maintain a respiratory protection program in accordance with chapter 296-842 WAC, Respirators, which covers each employee required by this chapter to use a respirator.
(c) Respirator selection. The employer must:
(i) Select and provide to employees appropriate respirators by following the requirements in this section and WAC 296-842-13005 in the respirator rule.
(ii) Provide to employees, for escape, any organic vapor, air-purifying respirator or any self-contained breathing apparatus (SCBA) that meets the selection requirements of WAC 296-842-13005 in the respirator rule.
(9) Emergency situations.
(a) Written plans.
(i) A written plan for emergency situations shall be developed for each workplace where AN is present. Appropriate portions of the plan shall be implemented in the event of an emergency.
(ii) The plan shall specifically provide that employees engaged in correcting emergency conditions shall be equipped as required in subsection (8) of this section until the emergency is abated.
(b) Alerting employees.
(i) Where there is the possibility of employee exposure to AN in excess of the ceiling limit due to the occurrence of an emergency, a general alarm shall be installed and maintained to promptly alert employees of such occurrences.
(ii) Employees not engaged in correcting the emergency shall be evacuated from the area and shall not be permitted to return until the emergency is abated.
(10) Protective clothing and equipment.
(a) Provision and use. Where eye or skin contact with liquid AN or PAN may occur, the employer shall provide at no cost to the employee, and assure that employees wear, appropriate protective clothing or other equipment in accordance with WAC 296-800-160 to protect any area of the body which may come in contact with liquid AN or PAN.
(b) Cleaning and replacement.
(i) The employer shall clean, launder, maintain, or replace protective clothing and equipment required by this subsection, as needed to maintain their effectiveness. In addition, the employer shall provide clean protective clothing and equipment at least weekly to each affected employee.
(ii) The employer shall assure that impermeable protective clothing which contacts or is likely to have contacted liquid AN shall be decontaminated before being removed by the employee.
(iii) The employer shall assure that AN- or PAN-contaminated protective clothing and equipment is placed and stored in closable containers which prevent dispersion of the AN or PAN outside the container.
(iv) The employer shall assure that an employee whose nonimpermeable clothing becomes wetted with liquid AN shall immediately remove that clothing and proceed to shower. The clothing shall be decontaminated before it is removed from the regulated area.
(v) The employer shall assure that no employee removes AN- or PAN-contaminated protective equipment or clothing from the change room, except for those employees authorized to do so for the purpose of laundering, maintenance, or disposal.
(vi) The employer shall inform any person who launders or cleans AN- or PAN-contaminated protective clothing or equipment of the potentially harmful effects of exposure to AN.
(vii) The employer shall assure that containers of contaminated protective clothing and equipment which are to be removed from the workplace for any reason are labeled in accordance with subsection (16)(c)(ii) of this section, and that such labels remain affixed when such containers leave the employer's workplace.
(11) Housekeeping.
(a) All surfaces shall be maintained free of accumulations of liquid AN and of PAN.
(b) For operations involving liquid AN, the employer shall institute a program for detecting leaks and spills of liquid AN, including regular visual inspections.
(c) Where spills of liquid AN are detected, the employer shall assure that surfaces contacted by the liquid AN are decontaminated. Employees not engaged in decontamination activities shall leave the area of the spill, and shall not be permitted in the area until decontamination is completed.
(d) Liquids. Where AN is present in a liquid form, or as a resultant vapor, all containers or vessels containing AN shall be enclosed to the maximum extent feasible and tightly covered when not in use, with adequate provision made to avoid any resulting potential explosion hazard.
(e) Surfaces.
(i) Dry sweeping and the use of compressed air for the cleaning of floors and other surfaces where AN and PAN are found is prohibited.
(ii) Where vacuuming methods are selected, either portable units or a permanent system may be used.
(A) If a portable unit is selected, the exhaust shall be attached to the general workplace exhaust ventilation system or collected within the vacuum unit, equipped with high efficiency filters or other appropriate means of contaminant removal, so that AN is not reintroduced into the workplace air; and
(B) Portable vacuum units used to collect AN may not be used for other cleaning purposes and shall be labeled as prescribed by subsection (16)(c)(ii) of this section.
(iii) Cleaning of floors and other contaminated surfaces may not be performed by washing down with a hose, unless a fine spray has first been laid down.
(12) Waste disposal. AN and PAN waste, scrap, debris, bags, containers or equipment, shall be disposed of in sealed bags or other closed containers which prevent dispersion of AN outside the container, and labeled as prescribed in subsection (16)(c)(ii) of this section.
(13) Hygiene facilities and practices. Where employees are exposed to airborne concentrations of AN above the permissible exposure limits, or where employees are required to wear protective clothing or equipment pursuant to subsection (11) of this section, or where otherwise found to be appropriate, the facilities required by WAC 296-800-230 shall be provided by the employer for the use of those employees, and the employer shall assure that the employees use the facilities provided. In addition, the following facilities or requirements are mandated.
(a) Change rooms. The employer shall provide clean change rooms in accordance with WAC 296-800-230.
(b) Showers.
(i) The employer shall provide shower facilities in accordance with WAC 296-800-230.
(ii) In addition, the employer shall also assure that employees exposed to liquid AN and PAN shower at the end of the work shift.
(iii) The employer shall assure that, in the event of skin or eye exposure to liquid AN, the affected employee shall shower immediately to minimize the danger of skin absorption.
(c) Lunchrooms.
(i) Whenever food or beverages are consumed in the workplace, the employer shall provide lunchroom facilities which have a temperature controlled, positive pressure, filtered air supply, and which are readily accessible to employees exposed to AN above the permissible exposure limits.
(ii) In addition, the employer shall also assure that employees exposed to AN above the permissible exposure limits wash their hands and face prior to eating.
(14) Medical surveillance.
(a) General.
(i) The employer shall institute a program of medical surveillance for each employee who is or will be exposed to AN above the action level. The employer shall provide each such employee with an opportunity for medical examinations and tests in accordance with this subsection.
(ii) The employer shall assure that all medical examinations and procedures are performed by or under the supervision of a licensed physician, and shall be provided without cost to the employee.
(b) Initial examinations. At the time of initial assignment, or upon institution of the medical surveillance program, the employer shall provide each affected employee an opportunity for a medical examination, including at least the following elements:
(i) A work history and medical history with special attention to skin, respiratory, and gastrointestinal systems, and those nonspecific symptoms, such as headache, nausea, vomiting, dizziness, weakness, or other central nervous system dysfunctions that may be associated with acute or chronic exposure to AN.
(ii) A physical examination giving particular attention to central nervous system, gastrointestinal system, respiratory system, skin and thyroid.
(iii) A 14" x 17" posteroanterior chest X-ray.
(iv) Further tests of the intestinal tract, including fecal occult blood screening, and proctosigmoidoscopy, for all workers forty years of age or older, and for any other affected employees for whom, in the opinion of the physician, such testing is appropriate.
(c) Periodic examinations.
(i) The employer shall provide examinations specified in this subsection at least annually for all employees specified in subsection (14)(a) of this section.
(ii) If an employee has not had the examinations prescribed in subsection (14)(b) of this section within six months of termination of employment, the employer shall make such examination available to the employee upon such termination.
(d) Additional examinations. If the employee for any reason develops signs or symptoms commonly associated with exposure to AN, the employer shall provide appropriate examination and emergency medical treatment.
(e) Information provided to the physician. The employer shall provide the following information to the examining physician:
(i) A copy of this standard and its appendices;
(ii) A description of the affected employee's duties as they relate to the employee's exposure;
(iii) The employee's representative exposure level;
(iv) The employee's anticipated or estimated exposure level (for preplacement examinations or in cases of exposure due to an emergency);
(v) A description of any personal protective equipment used or to be used; and
(vi) Information from previous medical examinations of the affected employee, which is not otherwise available to the examining physician.
(f) Physician's written opinion.
(i) The employer shall obtain a written opinion from the examining physician which shall include:
(A) The results of the medical examination and test performed;
(B) The physician's opinion as to whether the employee has any detected medical condition which would place the employee at an increased risk of material impairment of the employee's health from exposure to AN;
(C) Any recommended limitations upon the employee's exposure to AN or upon the use of protective clothing and equipment such as respirators; and
(D) A statement that the employee has been informed by the physician of the results of the medical examination and any medical conditions which require further examination or treatment.
(ii) The employer shall instruct the physician not to reveal in the written opinion specific findings or diagnoses unrelated to occupational exposure to AN.
(iii) The employer shall provide a copy of the written opinion to the affected employee.
(15) Employee information and training.
(a) Training program.
(i) The employer shall train each employee exposed to AN above the action level, each employee whose exposures are maintained below the action level by engineering and work practice controls, and each employee subject to potential skin or eye contact with liquid AN in accordance with the requirements of this section. The employer shall institute a training program and ensure employee participation in the training program.
(ii) The training program shall be provided at the time of initial assignment, or upon institution of the training program, and at least annually thereafter, and the employer shall assure that each employee is informed of the following:
(A) The information contained in Appendices A, B and C;
(B) The quantity, location, manner of use, release or storage of AN and the specific nature of operations which could result in exposure to AN, as well as any necessary protective steps;
(C) The purpose, proper use, and limitations of respirators and protective clothing;
(D) The purpose and a description of the medical surveillance program required by subsection (14) of this section;
(E) The emergency procedures developed, as required by subsection (9) of this section; and
(F) The engineering and work practice controls, their function and the employee's relationship thereto; and
(G) A review of this standard.
(b) Access to training materials.
(i) The employer shall make a copy of this standard and its appendices readily available to all affected employees.
(ii) The employer shall provide, upon request, all materials relating to the employee information and training program to the director.
(16) Communication of hazards.
(a) Hazard communication - General.
(i) Chemical manufacturers, importers, distributors and employers shall comply with all requirements of the Hazard Communication Standard (HCS), WAC 296-901-140 for AN and AN-based materials not exempted under subsection (1)(b) of this section.
(ii) In classifying the hazards of AN and AN-based materials at least the following hazards are to be addressed: Cancer; central nervous system effects; liver effects; skin sensitization; skin, respiratory, and eye irritation; acute toxicity effects; and flammability.
(iii) Employers shall include AN and AN-based materials in the hazard communication program established to comply with the HCS, WAC 296-901-140. Employers shall ensure that each employee has access to labels on containers of AN and AN-based materials and to safety data sheets, and is trained in accordance with the requirements of HCS and subsection (15) of this section.
(iv) The employer may use labels or signs required by other statutes, regulations, or ordinances in addition to, or in combination with, signs and labels required by this subsection.
(v) The employer shall ensure that no statement appears on or near any sign or label, required by this subsection, that contradicts or detracts from the required sign or label.
(b) Signs.
(i) The employer shall post signs to clearly indicate all workplaces where AN concentrations exceed the permissible exposure limits. The signs shall bear the following legend:
DANGER
ACRYLONITRILE (AN)
MAY CAUSE CANCER
RESPIRATORY PROTECTION MAY BE REQUIRED IN THIS AREA
AUTHORIZED PERSONNEL ONLY
(ii) The employer shall ensure that signs required by (b) of this subsection are illuminated and cleaned as necessary so that the legend is readily visible.
(iii) Prior to June 1, 2016, employers may use the following legend in lieu of that specified in (b)(i) of this subsection:
DANGER
ACRYLONITRILE (AN)
CANCER HAZARD
AUTHORIZED PERSONNEL ONLY
RESPIRATORS MAY BE REQUIRED
(c) Labels.
(i) The employer shall ensure that precautionary labels are in compliance with (a)(i) of this subsection and are affixed to all containers of liquid AN and AN-based materials not exempted under subsection (1)(b) of this section. The employer shall ensure that the labels remain affixed when the materials are sold, distributed or otherwise leave the employer's workplace.
(ii) Prior to June 1, 2015, employers may include the following information on precautionary labels required by this subsection in lieu of the labeling requirements in (b)(i) of this subsection:
DANGER
CONTAINS ACRYLONITRILE (AN)
CANCER HAZARD
(iii) The employer shall ensure that the precautionary labels required by (c) of this subsection are readily visible and legible.
(17) Recordkeeping.
(a) Objective data for exempted operations.
(i) Where the processing, use, and handling of products fabricated from PAN are exempted pursuant to subsection (1)(b) of this section, the employer shall establish and maintain an accurate record of objective data reasonably relied upon in support of the exemption.
(ii) This record shall include the following information:
(A) The relevant condition in subsection (1)(b) upon which exemption is based;
(B) The source of the objective data;
(C) The testing protocol, results of testing, and/or analysis of the material for the release of AN;
(D) A description of the operation exempted and how the data supports the exemption; and
(E) Other data relevant to the operations, materials, and processing covered by the exemption.
(iii) The employer shall maintain this record for the duration of the employer's reliance upon such objective data.
(b) Exposure monitoring.
(i) The employer shall establish and maintain an accurate record of all monitoring required by subsection (5) of this section.
(ii) This record shall include:
(A) The dates, number, duration, and results of each of the samples taken, including a description of the sampling procedure used to determine representative employee exposure;
(B) A description of the sampling and analytical methods used and the data relied upon to establish that the methods used meet the accuracy and precision requirements of subsection (5)(f) of this section;
(C) Type of respiratory protective devices worn, if any; and
(D) Name, Social Security number and job classification of the employee monitored and of all other employees whose exposure the measurement is intended to represent.
(iii) The employer shall maintain this record for at least 40 years or the duration of employment plus 20 years, whichever is longer.
(c) Medical surveillance.
(i) The employer shall establish and maintain an accurate record for each employee subject to medical surveillance as required by subsection (14) of this section.
(ii) This record shall include:
(A) A copy of the physicians' written opinions;
(B) Any employee medical complaints related to exposure to AN;
(C) A copy of the information provided to the physician as required by subsection (14)(f) of this section; and
(D) A copy of the employee's medical and work history.
(iii) The employer shall assure that this record be maintained for at least forty years or for the duration of employment plus twenty years, whichever is longer.
(d) Availability.
(i) The employer shall assure that all records required to be maintained by this section be made available upon request to the director for examination and copying.
(ii) Records required by (a) through (c) of this subsection shall be provided upon request to employees, designated representatives, and the assistant director in accordance with chapter 296-802 WAC. Records required by (a) of this subsection shall be provided in the same manner as exposure monitoring records.
(iii) The employer shall assure that employee medical records required to be maintained by this section, be made available, upon request, for examination and copying, to the affected employee or former employee, or to a physician designated by the affected employee, former employee, or designated representative.
(e) Transfer of records.
(i) Whenever the employer ceases to do business, the successor employer shall receive and retain all records required to be maintained by this section.
(ii) The employer shall also comply with any additional requirements involving transfer of records set forth in WAC 296-802-60005.
(18) Observation of monitoring.
(a) Employee observation. The employer shall provide affected employees, or their designated representatives, an opportunity to observe any monitoring of employee exposure to AN conducted pursuant to subsection (5) of this section.
(b) Observation procedures.
(i) Whenever observation of the monitoring of employee exposure to AN requires entry into an area where the use of protective clothing or equipment is required, the employer shall provide the observer with personal protective clothing or equipment required to be worn by employees working in the area, assure the use of such clothing and equipment, and require the observer to comply with all other applicable safety and health procedures.
(ii) Without interfering with the monitoring, observers shall be entitled:
(A) To receive an explanation of the measurement procedures;
(B) To observe all steps related to the measurement of airborne concentrations of AN performed at the place of exposure; and
(C) To record the results obtained.
(19) Appendices. The information contained in the appendices is not intended, by itself, to create any additional obligation not otherwise imposed, or to detract from any obligation.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-62-07336, filed 3/18/14, effective 5/1/14. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and chapter 49.17 RCW. WSR 12-24-071, § 296-62-07336, filed 12/4/12, effective 1/4/13. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 09-15-145, § 296-62-07336, filed 7/21/09, effective 9/1/09; WSR 07-05-072, § 296-62-07336, filed 2/20/07, effective 4/1/07; WSR 05-03-093, § 296-62-07336, filed 1/18/05, effective 3/1/05; WSR 04-10-026, § 296-62-07336, filed 4/27/04, effective 8/1/04; WSR 03-18-090, § 296-62-07336, filed 9/2/03, effective 11/1/03. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07336, filed 5/9/01, effective 9/1/01; WSR 99-10-071, § 296-62-07336, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 88-11-021 (Order 88-04), § 296-62-07336, filed 5/11/88.]



296-62-07337
Appendix A—Substance safety data sheet for acrylonitrile.

(1) Substance identification.
(a) Substance: Acrylonitrile (CH2 CHCN).
(b) Synonyms: Propenenitrile; vinyl cyanide; cyanoethylene; AN; VCN; acylon; carbacryl; fumigrian; ventox.
(c) Acrylonitrile can be found as a liquid or vapor, and can also be found in polymer resins, rubbers, plastics, polyols, and other polymers having acrylonitrile as a raw or intermediate material.
(d) AN is used in the manufacture of acrylic and modiacrylic fibers, acrylic plastics and resins, speciality polymers, nitrile rubbers, and other organic chemicals. It has also been used as a fumigant.
(e) Appearance and odor: Colorless to pale yellow liquid with a pungent odor which can only be detected at concentrations above the permissible exposure level, in a range of 13-19 parts AN per million parts of air (13-19 ppm).
(f) Permissible exposure: Exposure may not exceed either:
(i) Two parts AN per million parts of air (2 ppm) averaged over the eight-hour workday; or
(ii) Ten parts AN per million parts of air (10 ppm) averaged over any fifteen-minute period in the workday.
(iii) In addition, skin and eye contact with liquid AN is prohibited.
(2) Health hazard data.
(a) Acrylonitrile can affect your body if you inhale the vapor (breathing), if it comes in contact with your eyes or skin, or if you swallow it. It may enter your body through your skin.
(b) Effects of overexposure:
(i) Short-term exposure: Acrylonitrile can cause eye irritation, nausea, vomiting, headache, sneezing, weakness, and light-headedness. At high concentrations, the effects of exposure may go on to loss of consciousness and death. When acrylonitrile is held in contact with the skin after being absorbed into shoe leather or clothing, it may produce blisters following several hours of no apparent effect. Unless the shoes or clothing are removed immediately and the area washed, blistering will occur. Usually there is no pain or inflammation associated with blister formation.
(ii) Long-term exposure: Acrylonitrile has been shown to cause cancer in laboratory animals and has been associated with higher incidences of cancer in humans. Repeated or prolonged exposure of the skin to acrylonitrile may produce irritation and dermatitis.
(iii) Reporting signs and symptoms: You should inform your employer if you develop any signs or symptoms and suspect they are caused by exposure to acrylonitrile.
(3) Emergency first-aid procedures.
(a) Eye exposure: If acrylonitrile gets into your eyes, wash your eyes immediately with large amounts of water, lifting the lower and upper lids occasionally. Get medical attention immediately. Contact lenses should not be worn when working with this chemical.
(b) Skin exposure: If acrylonitrile gets on your skin, immediately wash the contaminated skin with water. If acrylonitrile soaks through your clothing, especially your shoes, remove the clothing immediately and wash the skin with water. If symptoms occur after washing, get medical attention immediately. Thoroughly wash the clothing before reusing. Contaminated leather shoes or other leather articles should be discarded.
(c) Inhalation: If you or any other person breathes in large amounts of acrylonitrile, move the exposed person to fresh air at once. If breathing has stopped, perform artificial respiration. Keep the affected person warm and at rest. Get medical attention as soon as possible.
(d) Swallowing: When acrylonitrile has been swallowed, give the person large quantities of water immediately. After the water has been swallowed, try to get the person to vomit by having him touch the back of his throat with his finger. Do not make an unconscious person vomit. Get medical attention immediately.
(e) Rescue: Move the affected person from the hazardous exposure. If the exposed person has been overcome, notify someone else and put into effect the established emergency procedures. Do not become a casualty yourself. Understand your emergency rescue procedures and know the location of the emergency equipment before the need arises.
(f) Special first-aid procedures: First-aid kits containing an adequate supply (at least two dozen) of amyl nitrite pearls, each containing 0.3 ml, should be maintained at each site where acrylonitrile is used. When a person is suspected of receiving an overexposure to acrylonitrile, immediately remove that person from the contaminated area using established rescue procedures. Contaminated clothing must be removed and the acrylonitrile washed from the skin immediately. Artificial respiration should be started at once if breathing has stopped. If the person is unconscious, amyl nitrite may be used as an antidote by a properly trained individual in accordance with established emergency procedures. Medical aid should be obtained immediately.
(4) Respirators and protective clothing.
(a) Respirators: You may be required to wear a respirator for nonroutine activities, in emergencies, while your employer is in the process of reducing acrylonitrile exposures through engineering controls, and in areas where engineering controls are not feasible. If respirators are worn, they must have a label issued by the National Institute for Occupational Safety and Health under the provisions of 42 C.F.R. part 84 stating that the respirators have been certified for use with organic vapors. For effective protection, respirators must fit your face and head snugly. Respirators should not be loosened or removed in work situations where their use is required.
(b) Supplied-air suits: In some work situations, the wearing of supplied-air suits may be necessary. Your employer must instruct you in their proper use and operation.
(c) Protective clothing:
(i) You must wear impervious clothing, gloves, face shield, or other appropriate protective clothing to prevent skin contact with liquid acrylonitrile. Where protective clothing is required, your employer is required to provide clean garments to you as necessary to assume that the clothing protects you adequately.
(ii) Replace or repair impervious clothing that has developed leaks.
(iii) Acrylonitrile should never be allowed to remain on the skin. Clothing and shoes which are not impervious to acrylonitrile should not be allowed to become contaminated with acrylonitrile, and if they do the clothing and shoes should be promptly removed and decontaminated. The clothing should be laundered or discarded after the AN is removed. Once acrylonitrile penetrates shoes or other leather articles, they should not be worn again.
(d) Eye protection: You must wear splashproof safety goggles in areas where liquid acrylonitrile may contact your eyes. In addition, contact lenses should not be worn in areas where eye contact with acrylonitrile can occur.
(5) Precautions for safe use, handling, and storage.
(a) Acrylonitrile is a flammable liquid, and its vapors can easily form explosive mixtures in air.
(b) Acrylonitrile must be stored in tightly closed containers in a cool, well-ventilated area, away from heat, sparks, flames, strong oxidizers (especially bromine), strong bases, copper, copper alloys, ammonia, and amines.
(c) Sources of ignition such as smoking and open flames are prohibited wherever acrylonitrile is handled, used, or stored in a manner that could create a potential fire or explosion hazard.
(d) You should use nonsparking tools when opening or closing metal containers of acrylonitrile, and containers must be bonded and grounded when pouring or transferring liquid acrylonitrile.
(e) You must immediately remove any nonimpervious clothing that becomes wetted with acrylonitrile, and this clothing must not be reworn until the acrylonitrile is removed from the clothing.
(f) Impervious clothing wet with liquid acrylonitrile can be easily ignited. This clothing must be washed down with water before you remove it.
(g) If your skin becomes wet with liquid acrylonitrile, you must promptly and thoroughly wash or shower with soap or mild detergent to remove any acrylonitrile from your skin.
(h) You must not keep food, beverages, or smoking materials, nor are you permitted to eat or smoke in regulated areas where acrylonitrile concentrations are above the permissible exposure limits.
(i) If you contact liquid acrylonitrile, you must wash your hands thoroughly with soap or mild detergent and water before eating, smoking, or using toilet facilities.
(j) Fire extinguishers and quick drenching facilities must be readily available, and you should know where they are and how to operate them.
(k) Ask your supervisor where acrylonitrile is used in your work area and for any additional plant safety and health rules.
(6) Access to information.
(a) Each year, your employer is required to inform you of the information contained in this Substance Safety Data Sheet for acrylonitrile. In addition, your employer must instruct you in the proper work practices for using acrylonitrile, emergency procedures, and the correct use of protective equipment.
(b) Your employer is required to determine whether you are being exposed to acrylonitrile. You or your representative has the right to observe employee measurements and to record the results obtained. Your employer is required to inform you of your exposure. If your employer determines that you are being overexposed, he or she is required to inform you of the actions which are being taken to reduce your exposure to within permissible exposure limits.
(c) Your employer is required to keep records of your exposures and medical examinations. These records must be kept by the employer for at least forty years or for the period of your employment plus twenty years, whichever is longer.
(d) Your employer is required to release your exposure and medical records to you or your representative upon your request.
[Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07337, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-07337, filed 7/20/94, effective 9/20/94; WSR 88-11-021 (Order 88-04), § 296-62-07337, filed 5/11/88.]



296-62-07338
Appendix B—Substance technical guidelines for acrylonitrile.

(1) Physical and chemical data.
(a) Substance identification:
(i) Synonyms: AN; VCN; vinyl cyanide; propenenitrile; cyanoethylene; Acrylon; Carbacryl; Fumigrain; Ventox.
(ii) Formula: CH2=CHCN.
(iii) Molecular weight: 53.1.
(b) Physical data:
(i) Boiling point (760 mm Hg): 77.3°C (171°F);
(ii) Specific gravity (water = 1): 0.81 (at 20°C or 68°F);
(iii) Vapor density (air = 1 at boiling point of acrylonitrile): 1.83;
(iv) Melting point: -83°C (-117°F);
(v) Vapor pressure (@20°F): 83 mm Hg;
(vi) Solubility in water, percent by weight @20°C (68°F): 7.35;
(vii) Evaporation rate (Butyl Acetate = 1): 4.54; and
(viii) Appearance and odor: Colorless to pale yellow liquid with a pungent odor at concentrations above the permissible exposure level. Any detectable odor of acrylonitrile may indicate overexposure.
(2) Fire, explosion, and reactivity hazard data.
(a) Fire:
(i) Flash point: -1°C (30°F) (closed cup).
(ii) Autoignition temperature: 481°C (898°F).
(iii) Flammable limits air, percent by volume: Lower: 3, Upper: 17.
(iv) Extinguishing media: Alcohol foam, carbon dioxide, and dry chemical.
(v) Special firefighting procedures: Do not use a solid stream of water, since the stream will scatter and spread the fire. Use water to cool containers exposed to a fire.
(vi) Unusual fire and explosion hazards: Acrylonitrile is a flammable liquid. Its vapors can easily form explosive mixtures with air. All ignition sources must be controlled where acrylonitrile is handled, used, or stored in a manner that could create a potential fire or explosion hazard. Acrylonitrile vapors are heavier than air and may travel along the ground and be ignited by open flames or sparks at locations remote from the site at which acrylonitrile is being handled.
(vii) For purposes of compliance with the requirements of WAC 296-800-300, acrylonitrile is classified as a class IB flammable liquid. For example, 7,500 ppm, approximately one-fourth of the lower flammable limit, would be considered to pose a potential fire and explosion hazard.
(viii) For purposes of compliance with WAC 296-24-59207, acrylonitrile is classified as a Class B fire hazard.
(ix) For purpose of compliance with WAC 296-24-95613, locations classified as hazardous due to the presence of acrylonitrile shall be Class I, Group D.
(b) Reactivity:
(i) Conditions contributing to instability: Acrylonitrile will polymerize when hot, and the additional heat liberated by the polymerization may cause containers to explode. Pure AN may self-polymerize, with a rapid build-up of pressure, resulting in an explosion hazard. Inhibitors are added to the commercial product to prevent self-polymerization.
(ii) Incompatibilities: Contact with strong oxidizers (especially bromine) and strong bases may cause fires and explosions. Contact with copper, copper alloys, ammonia, and amines may start serious decomposition.
(iii) Hazardous decomposition products: Toxic gases and vapors (such as hydrogen cyanide, oxides of nitrogen, and carbon monoxide) may be released in a fire involving acrylonitrile and certain polymers made from acrylonitrile.
(iv) Special precautions: Liquid acrylonitrile will attack some forms of plastics, rubbers, and coatings.
(3) Spill, leak, and disposal procedures.
(a) If acrylonitrile is spilled or leaked, the following steps should be taken:
(i) Remove all ignition sources.
(ii) The area should be evacuated at once and reentered only after the area has been thoroughly ventilated and washed down with water.
(iii) If liquid acrylonitrile or polymer intermediate, collect for reclamation or absorb in paper, vermiculite, dry sand, earth, or similar material, or wash down with water into process sewer system.
(b) Persons not wearing protective equipment should be restricted from areas of spills or leaks until clean-up has been completed.
(c) Waste disposal methods: Waste materials shall be disposed of in a manner that is not hazardous to employees or to the general population. Spills of acrylonitrile and flushing of such spills shall be channeled for appropriate treatment or collection for disposal. They shall not be channeled directly into the sanitary sewer system. In selecting the method of waste disposal, applicable local, state, and federal regulations should be consulted.
(4) Monitoring and measurement procedures.
(a) Exposure above the permissible exposure limit:
(i) Eight-hour exposure evaluation: Measurements taken for the purpose of determining employee exposure under this section are best taken so that the average eight-hour exposure may be determined from a single eight-hour sample or two four-hour samples. Air samples should be taken in the employee's breathing zone (air that would most nearly represent that inhaled by the employee).
(ii) Ceiling evaluation: Measurements taken for the purpose of determining employee exposure under this section must be taken during periods of maximum expected airborne concentrations of acrylonitrile in the employee's breathing zone. A minimum of three measurements should be taken on one work shift. The average of all measurements taken is an estimate of the employee's ceiling exposure.
(iii) Monitoring techniques: The sampling and analysis under this section may be performed by collecting the acrylonitrile vapor on charcoal adsorption tubes or other composition adsorption tubes, with subsequent chemical analysis. Sampling and analysis may also be performed by instruments such as real-time continuous monitoring systems, portable direct-reading instruments, or passive dosimeters. Analysis of resultant samples should be by gas chromatograph.
(iv) Appendix D lists methods of sampling and analysis which have been tested by NIOSH and OSHA for use with acrylonitrile. NIOSH and OSHA have validated modifications of NIOSH Method S-156 (see Appendix D) under laboratory conditions for concentrations below 1 ppm. The employer has the obligation of selecting a monitoring method which meets the accuracy and precision requirements of the standard under his/her unique field conditions. The standard requires that methods of monitoring must be accurate, to a 95-percent confidence level, to ±35-percent for concentrations of AN at or above 2 ppm, and to ±50-percent for concentrations below 2 ppm. In addition to the methods described in Appendix D, there are numerous other methods available for monitoring for AN in the workplace. Details on these other methods have been submitted by various companies to the rulemaking record, and are available at the OSHA Docket Office.
(b) Since many of the duties relating to employee exposure are dependent on the results of monitoring and measuring procedures, employers shall assure that the evaluation of employee exposures is performed by a competent industrial hygienist or other technically qualified person.
(5) Protective clothing.
(a) Employees shall be provided with and required to wear appropriate protective clothing to prevent any possibility of skin contact with liquid AN. Because acrylonitrile is absorbed through the skin, it is important to prevent skin contact with liquid AN. Protective clothing shall include impermeable coveralls or similar full-body work clothing, gloves, head-coverings, as appropriate to protect areas of the body which may come in contact with liquid AN.
(b) Employers should ascertain that the protective garments are impermeable to acrylonitrile. Nonimpermeable clothing and shoes should not be allowed to become contaminated with liquid AN. If permeable clothing does become contaminated, it should be promptly removed, placed in a regulated area for removal of the AN, and not worn again until the AN is removed. If leather footwear or other leather garments become wet from acrylonitrile, they should be replaced and not worn again, due to the ability of leather to absorb acrylonitrile and hold it against the skin. Since there is no pain associated with the blistering which may result from skin contact with liquid AN, it is essential that the employee be informed of this hazard so that he or she can be protected.
(c) Any protective clothing which has developed leaks or is otherwise found to be defective shall be repaired or replaced. Clean protective clothing shall be provided to the employee as necessary to assure its protectiveness. Whenever impervious clothing becomes wet with liquid AN, it shall be washed down with water before being removed by the employee. Employees are also required to wear splash-proof safety goggles where there is any possibility of acrylonitrile contacting the eyes.
(6) Housekeeping and hygiene facilities. For purposes of complying with WAC 296-24-120, 296-800-220 and 296-800-230, the following items should be emphasized:
(a) The workplace should be kept clean, orderly, and in a sanitary condition. The employer is required to institute a leak and spill detection program for operations involving liquid AN in order to detect sources of fugitive AN emissions.
(b) Dry sweeping and the use of compressed air is unsafe for the cleaning of floors and other surfaces where liquid AN may be found.
(c) Adequate washing facilities with hot and cold water are to be provided, and maintained in a sanitary condition. Suitable cleansing agents are also to be provided to assure the effective removal of acrylonitrile from the skin.
(d) Change or dressing rooms with individual clothes storage facilities must be provided to prevent the contamination of street clothes with acrylonitrile. Because of the hazardous nature of acrylonitrile, contaminated protective clothing should be placed in a regulated area designated by the employer for removal of the AN before the clothing is laundered or disposed of.
(7) Miscellaneous precautions.
(a) Store acrylonitrile in tightly-closed containers in a cool, well-ventilated area and take necessary precautions to avoid any explosion hazard.
(b) High exposures to acrylonitrile can occur when transferring the liquid from one container to another.
(c) Nonsparking tools must be used to open and close metal acrylonitrile containers. These containers must be effectively grounded and bonded prior to pouring.
(d) Never store uninhibited acrylonitrile.
(e) Acrylonitrile vapors are not inhibited.
They may form polymers and clog vents of storage tanks.
(f) Use of supplied-air suits or other impervious coverings may be necessary to prevent skin contact with and provide respiratory protection from acrylonitrile where the concentration of acrylonitrile is unknown or is above the ceiling limit. Supplied-air suits should be selected, used, and maintained under the immediate supervision of persons knowledgeable in the limitations and potential life-endangering characteristics of supplied-air suits.
(g) Employers shall advise employees of all areas and operations where exposure to acrylonitrile could occur.
(8) Common operations. Common operations in which exposure to acrylonitrile is likely to occur include the following: Manufacture of the acrylonitrile monomer; synthesis of acrylic fibers, ABS, SAN, and nitrile barrier plastics and resins, nitrile rubber, surface coatings, specialty chemicals; use as a chemical intermediate; use as a fumigant; and in the cyanoethylation of cotton.
[Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07338, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 88-11-021 (Order 88-04), § 296-62-07338, filed 5/11/88.]



296-62-07339
Appendix C—Medical surveillance guidelines for acrylonitrile.

(1) Route of entry.
(a) Inhalation;
(b) Skin absorption;
(c) Ingestion.
(2) Toxicology.
(a) Acrylonitrile vapor is an asphyxiant due to inhibitory action on metabolic enzyme systems. Animals exposed to 75 or 100 ppm for seven hours have shown signs of anoxia; in some animals which died at the higher level, cyanomethemoglobin was found in the blood. Two human fatalities from accidental poisoning have been reported; one was caused by inhalation of an unknown concentration of the vapor, and the other was thought to be caused by skin absorption or inhalation. Most cases of intoxication from industrial exposure have been mild, with rapid onset of eye irritation, headache, sneezing, and nausea. Weakness, lightheadedness, and vomiting may also occur. Exposure to high concentrations may produce profound weakness, asphyxia, and death. The vapor is a severe eye irritant. Prolonged skin contract [contact] with the liquid may result in absorption with systemic effects, and in the formation of large blisters after a latent period of several hours. Although there is usually little or no pain or inflammation, the affected skin resembles a second-degree thermal burn. Solutions spilled on exposed skin, or on areas covered only by a light layer of clothing, evaporate rapidly, leaving no irritation, or, at the most, mild transient redness. Repeated spills on exposed skin may result in dermatitis due to solvent effects.
(b) Results after one year of a planned two-year animal study on the effects of exposure to acrylonitrile have indicated that rats ingesting as little as 35 ppm in their drinking water develop tumors of the central nervous system. The interim results of this study have been supported by a similar study being conducted by the same laboratory, involving exposure of rats by inhalation of acrylonitrile vapor, which has shown similar types of tumors in animals exposed to 80 ppm.
(c) In addition, the preliminary results of an epidemiological study being performed by duPont on a cohort of workers in their Camden, S.C. acrylic fiber plant indicate a statistically significant increase in the incidence of colon and lung cancers among employees exposed to acrylonitrile.
(3) Signs and symptoms of acute overexposure. Asphyxia and death can occur from exposure to high concentrations of acrylonitrile. Symptoms of overexposure include eye irritation, headache, sneezing, nausea and vomiting, weakness, and light-headedness. Prolonged skin contact can cause blisters on the skin with appearance of a second-degree burn, but with little or no pain. Repeated skin contact may produce scaling dermatitis.
(4) Treatment of acute overexposure. Remove employee from exposure. Immediately flush eyes with water and wash skin with soap or mild detergent and water. If AN has been swallowed, and person is conscious, induce vomiting. Give artificial respiration if indicated. More severe cases, such as those associated with loss of consciousness, may be treated by the intravenous administration of sodium nitrite, followed by sodium thiosulfate, although this is not as effective for acrylonitrile poisoning as for inorganic cyanide poisoning.
(5) Surveillance and preventive considerations.
(a) As noted above, exposure to acrylonitrile has been linked to increased incidence of cancers of the colon and lung in employees of the duPont acrylic fiber plant in Camden, S.C. In addition, the animal testing of acrylonitrile has resulted in the development of cancers of the central nervous system in rats exposed by either inhalation or ingestion. The physician should be aware of the findings of these studies in evaluating the health of employees exposed to acrylonitrile.
(b) Most reported acute effects of occupational exposure to acrylonitrile are due to its ability to cause tissue anoxia and asphyxia. The effects are similar to those caused by hydrogen cyanide. Liquid acrylonitrile can be absorbed through the skin upon prolonged contact. The liquid readily penetrates leather, and will produce burns of the feet if footwear contaminated with acrylonitrile is not removed.
(c) It is important for the physician to become familiar with the operating conditions in which exposure to acrylonitrile may occur. Those employees with skin diseases may not tolerate the wearing of whatever protective clothing may be necessary to protect them from exposure. In addition, those with chronic respiratory disease may not tolerate the wearing of negative-pressure respirators.
(d) Surveillance and screening. Medical histories and laboratory examinations are required for each employee subject to exposure to acrylonitrile above the action level. The employer must screen employees for history of certain medical conditions which might place the employee at increased risk from exposure.
(i) Central nervous system dysfunction. Acute effects of exposure to acrylonitrile generally involve the central nervous system. Symptoms of acrylonitrile exposure include headache, nausea, dizziness, and general weakness. The animal studies cited above suggest possible carcinogenic effects of acrylonitrile on the central nervous system, since rats exposed by either inhalation or ingestion have developed similar CNS tumors.
(ii) Respiratory disease. The duPont data indicate an increased risk of lung cancer among employees exposed to acrylonitrile.
(iii) Gastrointestinal disease. The duPont data indicate an increased risk of cancer of the colon among employees exposed to acrylonitrile. In addition, the animal studies show possible tumor production in the stomachs of the rats in the ingestion study.
(iv) Skin disease. Acrylonitrile can cause skin burns when prolonged skin contact with the liquid occurs. In addition, repeated skin contact with the liquid can cause dermatitis.
(e) General. The purpose of the medical procedures outlined in the standard is to establish a baseline for future health monitoring. Persons unusually susceptible to the effects of anoxia or those with anemia would be expected to be at increased risk. In addition to emphasis on the CNS, respiratory and gastro-intestinal systems, the cardiovascular system, liver, and kidney function should also be stressed.
[Statutory Authority: Chapter 49.17 RCW. WSR 88-11-021 (Order 88-04), § 296-62-07339, filed 5/11/88.]



296-62-07340
Appendix D—Sampling and analytical methods for acrylonitrile.

(1) There are many methods available for monitoring employee exposures to acrylonitrile. Most of these involve the use of charcoal tubes and sampling pumps, with analysis by gas chromatograph. The essential differences between the charcoal tube methods include, among others, the use of different desorbing solvents, the use of different lots of charcoal, and the use of different equipment for analysis of the samples.
(2) Besides charcoal, considerable work has been performed on methods using porous polymer sampling tubes and passive dosimeters. In addition, there are several portable gas analyzers and monitoring units available on the open market.
(3) This appendix contains details for the methods which have been tested at OSHA Analytical Laboratory in Salt Lake City, and NIOSH in Cincinnati. Each is a variation on NIOSH Method S-156, which is also included for reference. This does not indicate that these methods are the only ones which will be satisfactory. There also may be workplace situations in which these methods are not adequate, due to such factors as high humidity. Copies of the other methods available to OSHA are available in the rulemaking record, and may be obtained from the OSHA docket office. These include, the Union Carbide, Monsanto, Dow Chemical and Dow Badische methods, as well as NIOSH Method P & CAM 127.
(4) Employers who note problems with sample breakthrough should try larger charcoal tubes. Tubes of larger capacity are available, and are often used for sampling vinyl chloride. In addition, lower flow rates and shorter sampling times should be beneficial in minimizing breakthrough problems.
(5) Whatever method the employer chooses, he must assure himself of the method's accuracy and precision under the unique conditions present in his workplace.
(6) NIOSH Method S-156 (unmodified)
Analyte: Acrylonitrile.
Matrix: Air.
Procedure: Absorption on charcoal, desorption with methanol, GC.
(a) Principle of the method. Reference (k)(i) of this subsection.
(i) A known volume of air is drawn through a charcoal tube to trap the organic vapors present.
(ii) The charcoal in the tube is transferred to a small, stoppered sample container, and the analyte is desorbed with methanol.
(iii) An aliquot of the desorbed sample is injected into a gas chromatograph.
(iv) The area of the resulting peak is determined and compared with areas obtained for standards.
(b) Range and sensitivity.
(i) This method was validated over the range of 17.5-70.0 mg/cu m at an atmospheric temperature and pressure of 22°C and 760 mm Hg, using a twenty-liter sample. Under the conditions of sample size (20 liters) the probable useful range of this method is 4.5-135 mg/cu m. The method is capable of measuring much smaller amounts if the desorption efficiency is adequate. Desorption efficiency must be determined over the range used.
(ii) The upper limit of the range of the method is dependent on the adsorptive capacity of the charcoal tube. This capacity varies with the concentrations of acrylonitrile and other substances in the air. The first section of the charcoal tube was found to hold at least 3.97 mg of acrylonitrile when a test atmosphere containing 92.0 mg/cu m of acrylonitrile in air was sampled 0.18 liter per minute for 240 minutes; at that time the concentration of acrylonitrile in the effluent was less than 5 percent of that in the influent. (The charcoal tube consists of two sections of activated charcoal separated by a section of urethane foam. See (f)(ii) of this subsection. If a particular atmosphere is suspected of containing a large amount of contaminant, a smaller sampling volume should be taken.
(c) Interference.
(i) When the amount of water in the air is so great that condensation actually occurs in the tube, organic vapors will not be trapped efficiently. Preliminary experiments using toluene indicate that high humidity severely decreases the breakthrough volume.
(ii) When interfering compounds are known or suspected to be present in the air, such information, including their suspected identities, should be transmitted with the sample.
(iii) It must be emphasized that any compound which has the same retention time as the analyte at the operating conditions described in this method is an interference. Retention time data on a single column cannot be considered proof of chemical identity.
(iv) If the possibility of interference exists, separation conditions (column packing, temperature, etc.) must be changed to circumvent the problem.
(d) Precision and accuracy.
(i) The coefficient of variation (CVt) for the total analytical and sampling method in the range of 17.5-70.0 mg/cu m was 0.073. This value corresponds to a 3.3 mg/cu m standard deviation at the (previous) OSHA standard level (20 ppm). Statistical information and details of the validation and experimental test procedures can be found in (k)(ii) of this subsection.
(ii) On the average the concentrations obtained at the 20 ppm level using the overall sampling and analytical method were 6.0 percent lower than the "true" concentrations for a limited number of laboratory experiments. Any difference between the "found" and "true" concentrations may not represent a bias in the sampling and analytical method, but rather a random variation from the experimentally determined "true" concentration. Therefore, no recovery correction should be applied to the final result in (j)(v) of this subsection.
(e) Advantages and disadvantages of the method.
(i) The sampling device is small, portable, and involves no liquids. Interferences are minimal, and most of those which do occur can be eliminated by altering chromatographic conditions. The tubes are analyzed by means of a quick, instrumental method.
(ii) The method can also be used for the simultaneous analysis of two or more substances suspected to be present in the same sample by simply changing gas chromatographic conditions.
(iii) One disadvantage of the method is that the amount of sample which can be taken is limited by the number of milligrams that the tube will hold before overloading. When the sample value obtained for the backup section of the charcoal tube exceeds 25 percent of that found on the front section, the possibility of sample loss exists.
(iv) Furthermore, the precision of the method is limited by the reproducibility of the pressure drop across the tubes. This drop will affect the flow rate and cause the volume to be imprecise, because the pump is usually calibrated for one tube only.
(f) Apparatus.
(i) A calibrated personal sampling pump whose flow can be determined within ±5 percent at the recommended flow rate. Reference (k)(iii) of this subsection.
(ii) Charcoal tubes: Glass tubes with both ends flame sealed, 7 cm long with a 6 mm O.D. and a 4 mm I.D., containing 2 sections of 20/40 mesh activated charcoal separated by a 2 mm portion of urethane foam. The activated charcoal is prepared from coconut shells and is fired at 600°C prior to packing. The adsorbing section contains 100 mg of charcoal, the backup section 50 mg. A 3 mm portion of urethane foam is placed between the outlet end of the tube and the backup section. A plug of silicated glass wool is placed in front of the adsorbing section. The pressure drop across the tube must be less than 1 inch of mercury at a flow rate of 1 liter per minute.
(iii) Gas chromatograph equipped with a flame ionization detector.
(iv) Column (4 ft × 1/4 in stainless steel) packed with 50/80 mesh Poropak, type Q.
(v) An electronic integrator or some other suitable method for measuring peak areas.
(vi) Two-milliliter sample containers with glass stoppers or Teflon-lined caps. If an automatic sample injector is used, the associated vials may be used.
(vii) Microliter syringes: Ten-microliter and other convenient sizes for making standards.
(viii) Pipets: 1.0 ml delivery pipets.
(ix) Volumetric flask: 10 ml or convenient sizes for making standard solutions.
(g) Reagents.
(i) Chromatographic quality methanol.
(ii) Acrylonitrile, reagent grade.
(iii) Hexane, reagent grade.
(iv) Purified nitrogen.
(v) Prepurified hydrogen.
(vi) Filtered compressed air.
(h) Procedure.
(i) Cleaning of equipment. All glassware used for the laboratory analysis should be detergent washed and thoroughly rinsed with tap water and distilled water.
(ii) Calibration of personal pumps. Each personal pump must be calibrated with a representative charcoal tube in the line. This will minimize errors associated with uncertainties in the sample volume collected.
(iii) Collection and shipping of samples.
(A) Immediately before sampling, break the ends of the tube to provide an opening at least one-half the internal diameter of the tube (2mm).
(B) The smaller section of charcoal is used as a backup and should be positioned nearest the sampling pump.
(C) The charcoal tube should be placed in a vertical direction during sampling to minimize channeling through the charcoal.
(D) Air being sampled should not be passed through any hose or tubing before entering the charcoal tube.
(E) A maximum sample size of 20 liters is recommended. Sample at a flow of 0.20 liter per minute or less. The flow rate should be known with an accuracy of at least ±5 percent.
(F) The temperature and pressure of the atmosphere being sampled should be recorded. If pressure reading is not available, record the elevation.
(G) The charcoal tubes should be capped with the supplied plastic caps immediately after sampling. Under no circumstances should rubber caps be used.
(H) With each batch of ten samples submit one tube from the same lot of tubes which was used for sample collection and which is subjected to exactly the same handling as the samples except that no air is drawn through it. Label this as a blank.
(I) Capped tubes should be packed tightly and padded before they are shipped to minimize tube breakage during shipping.
(J) A sample of the bulk material should be submitted to the laboratory in a glass container with a Teflon-lined cap. This sample should not be transported in the same container as the charcoal tubes.
(iv) Analysis of samples.
(A) Preparation of samples. In preparation for analysis, each charcoal tube is scored with a file in front of the first section of charcoal and broken open. The glass wool is removed and discarded. The charcoal in the first (larger) section is transferred to a 2 ml stoppered sample container. The separating section of foam is removed and discarded; the second section is transferred to another stoppered container. These two sections are analyzed separately.
(B) Desorption of samples. Prior to analysis, 1.0 ml of methanol is pipetted into each sample container. Desorption should be done for 30 minutes. Tests indicate that this is adequate if the sample is agitated occasionally during this period. If an automatic sample injector is used, the sample vials should be capped as soon as the solvent is added to minimize volatilization.
(C) GC conditions. The typical operating conditions for the gas chromatograph are:
(I) 50 ml/min (60 psig) nitrogen carrier gas flow.
(II) 65 ml/min (24 psig) hydrogen gas flow to detector.
(III) 500 ml/min (50 psig) air flow to detector.
(IV) 235°C injector temperature.
(V) 255°C manifold temperature (detector).
(VI) 155°C column temperature.
(D) Injection. The first step in the analysis is the injection of the sample into the gas chromatograph. To eliminate difficulties arising from blowback or distillation within the syringe needle, one should employ the solvent flush injection technique. The 10-microliter syringe is first flushed with solvent several times to wet the barrel and plunger. Three microliters of solvent are drawn into the syringe to increase the accuracy and reproducibility of the injected sample volume. The needle is removed from the solvent, and the plunger is pulled back about 0.2 microliter to separate the solvent flush from the sample with a pocket of air to be used as a marker. The needle is then immersed in the sample, and a five microliter aliquot is withdrawn, taking into consideration the volume of the needle, since the sample in the needle will be completely injected. After the needle is removed from the sample and prior to injection, the plunger is pulled back 1.2 microliters to minimize evaporation of the sample from the tip of the needle. Observe that the sample occupies 4.9-5.0 microliters in the barrel of the syringe. Duplicate injections of each sample and standard should be made. No more than a 3 percent difference in area is to be expected. An automatic sample injector can be used if it is shown to give reproducibility at least as good as the solvent flush method.
(E) Measurement of area. The area of the sample peak is measured by an electronic integrator or some other suitable form of area measurement, and preliminary results are read from a standard curve prepared as discussed below.
(v) Determination of desorption efficiency.
(A) Importance of determination. The desorption efficiency of a particular compound can vary from one laboratory to another and also from one batch of charcoal to another. Thus, it is necessary to determine at least once the percentage of the specific compound that is removed in the desorption process, provided the same batch of charcoal is used.
(B) Procedure for determining desorption efficiency.
(I) Activated charcoal equivalent to the amount in the first section of the sampling tube (100 mg) is measured into a 2.5 in., 4 mm I.D. glass tube, flame sealed at one end. This charcoal must be from the same batch as that used in obtaining the samples and can be obtained from unused charcoal tubes. The open end is capped with Parafilm. A known amount of hexane solution of acrylonitrile containing 0.239 g/ml is injected directly into the activated charcoal with a microliter syringe, and tube is capped with more Parafilm. When using an automatic sample injector, the sample injector vials, capped with Teflon-faced septa, may be used in place of the glass tube.
(II) The amount injected is equivalent to that present in a twenty-liter air sample at the selected level.
(III) Six tubes at each of three levels (0.5X, 1X, and 2X of the standard) are prepared in this manner and allowed to stand for at least overnight to assure complete adsorption of the analyte onto the charcoal. These tubes are referred to as the sample. A parallel blank tube should be treated in the same manner except that no sample is added to it. The sample and blank tubes are desorbed and analyzed in exactly the same manner as the sampling tube described in (h)(iv) of this subsection
(IV) Two or three standards are prepared by injecting the same volume of compound into 1.0 ml of methanol with the same syringe used in the preparation of the samples. These are analyzed with the samples.
(V) The desorption efficiency (D.E.) equals the average weight in mg recovered from the tube divided by the weight in mg added to the tube, or
D.E. =
Average weight recovered (mg)
———————————————
weight added (mg)
 
(VI) The desorption efficiency is dependent on the amount of analyte collected on the charcoal. Plot the desorption efficiency versus weight of analyte found. This curve is used in (j)(iv) of this subsection to correct for adsorption losses.
(i) Calibration and standards. It is convenient to express concentration of standards in terms of mg/1.0 ml methanol, because samples are desorbed in this amount of methanol. The density of the analyte is used to convert mg into microliters for easy measurement with a microliter syringe. A series of standards, varying in concentration over the range of interest, is prepared and analyzed under the same GC conditions and during the same time period as the unknown samples. Curves are established by plotting concentration in mg/1.0 ml versus peak area.
Note:
Since no internal standard is used in the method, standard solutions must be analyzed at the same time that the sample analysis is done. This will minimize the effect of known day-to-day variations and variations during the same day of the FID response.
(j) Calculations.
(i) Read the weight, in mg, corresponding to each peak area from the standard curve. No volume corrections are needed, because the standard curve is based on mg/1.0 ml methanol and the volume of sample injected is identical to the volume of the standards injected.
(ii) Corrections for the bank must be made for each sample.
mg = mg sample-mg blank
Where:
mg sample = mg found in front section of sample tube.
mg sample = mg found in front section of blank tube.
Note:
A similar procedure is followed for the backup sections.
(iii) Add the weights found in the front and backup sections to get the total weight in the sample.
(iv) Read the desorption efficiency from the curve (reference (h)(v)(B) of this subsection) for the amount found in the front section. Divide the total weight by this desorption efficiency to obtain the corrected mg/sample.
Corrected mg/sample =
Total
weight
————
D.E.
(v) The concentration of the analyte in the air sampled can be expressed in mg/cu m.
mg/cu m = Corrected mg (see (j)(iv)) x
1,000 (liter/cu m)
——————————————
air volume sampled (liter)
(vi) Another method of expressing concentration is ppm.
ppm = mg/cu m × 24.45/M.W. × 760/P × T + 273/298
Where:
P = Pressure (mm Hg) of air sampled.
T = Temperature (°C) of air sampled.
24.45 = Molar volume (liter/mole) at 25°C and 760 mm Hg.
M.W. = Molecular weight (g/mole) of analyte.
760 = Standard pressure (mm Hg).
298 = Standard temperature (°K).
(k) References.
(i) White, L. D. et al., "A Convenient Optimized Method for the Analysis of Selected Solvent Vapors in the Industrial Atmosphere," Amer. Ind. Hyg. Assoc. J., 31:225 (1970).
(ii) Documentation of NIOSH Validation Tests, NIOSH Contract No. CDC-99-74-45.
(iii) Final Report, NIOSH Contract HSM-99-71-31, "Personal Sampler Pump for Charcoal Tubes," September 15, 1972.
(7) NIOSH Modification of NIOSH Method S-156. The NIOSH recommended method for low levels for acrylonitrile is a modification of method S-156. It differs in the following respects:
(a) Samples are desorbed using 1 ml of 1 percent acetone in CS2 rather than methanol.
(b) The analytical column and conditions are:
(i) Column: 20 percent SP-1000 on 80/100 Supelcoport 10 feet × 1/8 inch S.S.
(ii) Conditions:
Injector temperature: 200°C.
Detector temperature: 100°C.
Column temperature: 85°C.
Helium flow: 25 ml/min.
Air flow: 450 ml/min.
Hydrogen flow: 55 ml/min.
(c) A 2 µl injection of the desorbed analyte is used.
(d) A sampling rate of 100 ml/min is recommended.
(8) OSHA Laboratory Modification of NIOSH Method S-156.
(a) Analyte: Acrylonitrile.
(b) Matrix: Air.
(c) Procedure: Adsorption on charcoal, desorption with methanol, GC.
(d) Principle of the method (subsection (1)(a) of this section).
(i) A known volume of air is drawn through a charcoal tube to trap the organic vapors present.
(ii) The charcoal in the tube is transferred to a small, stoppered sample vial, and the analyte is desorbed with methanol.
(iii) An aliquot of the desorbed sample is injected into a gas chromatograph.
(iv) The area of the resulting peak is determined and compared with areas obtained for standards.
(e) Advantages and disadvantages of the method.
(i) The sampling device is small, portable, and involves no liquids. Interferences are minimal, and most of those which do occur can be eliminated by altering chromatographic conditions. The tubes are analyzed by means of a quick, instrumental method.
(ii) This method may not be adequate for the simultaneous analysis of two or more substances.
(iii) The amount of sample which can be taken is limited by the number of milligrams that the tube will hold before overloading. When the sample value obtained for the backup section of the charcoal tube exceeds 25 percent of that found on the front section, the possibility of sample loss exists.
(iv) The precision of the method is limited by the reproducibility of the pressure drop across the tubes. This drop will affect the flow rate and cause the volume to be imprecise, because the pump is usually calibrated for one tube only.
(f) Apparatus.
(i) A calibrated personal sampling pump whose flow can be determined within ±5 percent at the recommended flow rate.
(ii) Charcoal tubes: Glass tube with both ends flame sealed, 7 cm long with a 6 mm O.D. and a 4 mm I.D., containing 2 sections of 20/40 mesh activated charcoal separated by a 2 mm portion of urethane foam. The activated charcoal is prepared from coconut shells and is fired at 600°C prior to packing. The absorbing section contains 100 mg of charcoal, the back-up section 50 mg. A 3 mm portion of urethane foam is placed between the outlet end of the tube and the back-up section. A plug of silicated glass wool is placed in front of the adsorbing section. The pressure drop across the tube must be less than one inch of mercury at a flow rate of 1 liter per minute.
(iii) Gas chromatograph equipped with a nitrogen phosphorus detector.
(iv) Column (10 ft × 1/8 in stainless steel) packed with 100/120 Supelcoport coated with 10 percent SP 1000.
(v) An electronic integrator or some other suitable method for measuring peak area.
(vi) Two-milliliter sample vials with Teflon-lined caps.
(vii) Microliter syringes: 10 microliter, and other convenient sizes for making standards.
(viii) Pipets: 1.0 ml delivery pipets.
(ix) Volumetric flasks: Convenient sizes for making standard solutions.
(g) Reagents.
(i) Chromatographic quality methanol.
(ii) Acrylonitrile, reagent grade.
(iii) Filtered compressed air.
(iv) Purified hydrogen.
(v) Purified helium.
(h) Procedure.
(i) Cleaning of equipment. All glassware used for the laboratory analysis should be properly cleaned and free of organics which could interfere in the analysis.
(ii) Calibration of personal pumps. Each pump must be calibrated with a representative charcoal tube in the line.
(iii) Collection and shipping of samples.
(A) Immediately before sampling, break the ends of the tube to provide an opening at least one-half the internal diameter of the tube (2 mm).
(B) The smaller section of the charcoal is used as the backup and should be placed nearest the sampling pump.
(C) The charcoal should be placed in a vertical position during sampling to minimize channeling through the charcoal.
(D) Air being sampled should not be passed through any hose or tubing before entering the charcoal tube.
(E) A sample size of 20 liters is recommended. Sample at a flow rate of approximately 0.2 liters per minute. The flow rate should be known with an accuracy of at least ±5 percent.
(F) The temperature and pressure of the atmosphere being sampled should be recorded.
(G) The charcoal tubes should be capped with the supplied plastic caps immediately after sampling. Rubber caps should not be used.
(H) Submit at least one blank tube (a charcoal tube subjected to the same handling procedures, without having any air drawn through it) with each set of samples.
(I) Take necessary shipping and packing precautions to minimize breakage of samples.
(iv) Analysis of samples.
(A) Preparation of samples. In preparation for analysis, each charcoal tube is scored with a file in front of the first section of charcoal and broken open. The glass wool is removed and discarded. The charcoal in the first (larger) section is transferred to a 2 ml vial. The separating section of foam is removed and discarded; the section is transferred to another capped vial. These two sections are analyzed separately.
(B) Desorption of samples. Prior to analysis, 1.0 ml of methanol is pipetted into each sample container. Desorption should be done for 30 minutes in an ultrasonic bath. The sample vials are recapped as soon as the solvent is added.
(C) GC conditions. The typical operating conditions for the gas chromatograph are:
(I) 30 ml/min (60 psig) helium carrier gas flow.
(II) 3.0 ml/min (30 psig) hydrogen gas flow to detector.
(III) 50 ml/min (60 psig) air flow to detector.
(IV) 200°C injector temperature.
(V) 200°C dejector temperature.
(VI) 100°C column temperature.
(D) Injection. Solvent flush technique or equivalent.
(E) Measurement of area. The area of the sample peak is measured by an electronic integator or some other suitable form of area measurement, and preliminary results are read from a standard curve prepared as discussed below.
(v) Determination of desorption efficiency.
(A) Importance of determination. The desorption efficiency of a particular compound can vary from one laboratory to another and also from one batch of charcoal to another. Thus, it is necessary to determine, at least once, the percentage of the specific compound that is removed in the desorption process, provided the same batch of charcoal is used.
(B) Procedure for determining desorption efficiency. The reference portion of the charcoal tube is removed. To the remaining portion, amounts representing 0.5X, 1X, and 2X (X represents TLV) based on a 20 l air sample are injected onto several tubes at each level. Dilutions of acrylonitrile with methanol are made to allow injection of measurable quantities. These tubes are then allowed to equilibrate at least overnight. Following equilibration they are analyzed following the same procedure as the samples. A curve of the desorption efficiency (amt recovered/amt added) is plotted versus amount of analyte found. This curve is used to correct for adsorption losses.
(i) Calibration and standards. A series of standards, varying in concentration over the range of interest, is prepared and analyzed under the same GC conditions and during the same time period as the unknown samples. Curves are prepared by plotting concentration versus peak area.
Note:
Since no internal standard is used in the method, standard solutions must be analyzed at the same time that the sample analysis is done. This will minimize the effect of known day-to-day variations and variations during the same day of the NPD response. Multiple injections are necessary.
(j) Calculations. Read the weight, corresponding to each peak area from the standard curve, correct for the blank, correct for the desorption efficiency, and make necessary air volume corrections.
(k) Reference. NIOSH Method S-156.
[Statutory Authority: Chapter 49.17 RCW. WSR 88-11-021 (Order 88-04), § 296-62-07340, filed 5/11/88.]



296-62-07342
1,2-Dibromo-3-chloropropane.

(1) Scope and application.
(a) This section applies to occupational exposure to 1,2-dibromo-3-chloropropane (DBCP).
(b) This section does not apply to:
(i) Exposure to DBCP which results solely from the application and use of DBCP as a pesticide; or
(ii) The storage, transportation, distribution or sale of DBCP in intact containers sealed in such a manner as to prevent exposure to DBCP vapors or liquids, except for the requirements of subsections (11), (16), and (17) of this section.
(2) Definitions applicable to this section:
(a) "Authorized person" - Any person specifically authorized by the employer and whose duties require the person to be present in areas where DBCP is present; and any person entering this area as a designated representative of employees exercising an opportunity to observe employee exposure monitoring.
(b) "DBCP" - 1,2-dibromo-3-chloropropane, Chemical Abstracts Service Registry Number 96-12-8, and includes all forms of DBCP.
(c) "Director" - The director of labor and industries, or his authorized representative.
(d) "Emergency" - Any occurrence such as, but not limited to equipment failure, rupture of containers, or failure of control equipment which may, or does, result in unexpected release of DBCP.
(3) Permissible exposure limits.
(a) Inhalation.
(i) Time-weighted average limit (TWA). The employer shall assure that no employee is exposed to an airborne concentration in excess of one part DBCP per billion part of air (ppb) as an eight-hour time-weighted average.
(ii) Ceiling limit. The employer shall assure that no employee is exposed to an airborne concentration in excess of five parts DBCP per billion parts of air (ppb) as averaged over any fifteen minutes during the working day.
(b) Dermal and eye exposure. The employer shall assure that no employee is exposed to eye or skin contact with DBCP.
(4) Notification of use. Within ten days of the effective date of this section or within ten days following the introduction of DBCP into the workplace, every employer who has a workplace where DBCP is present shall report the following information to the director for each such workplace:
(a) The address and location of each workplace in which DBCP is present;
(b) A brief description of each process or operation which may result in employee exposure to DBCP;
(c) The number of employees engaged in each process or operation who may be exposed to DBCP and an estimate of the frequency and degree of exposure that occurs;
(d) A brief description of the employer's safety and health program as it relates to limitation of employee exposure to DBCP.
(5) Regulated areas. The employer shall establish, within each place of employment, regulated areas wherever DBCP concentrations are in excess of the permissible exposure limit.
(a) The employer shall limit access to regulated areas to authorized persons.
(b) All employees entering or working in a regulated area shall wear respiratory protection in accordance with Table I.
(6) Exposure monitoring.
(a) General. Determinations of airborne exposure levels shall be made from air samples that are representative of each employee's exposure to DBCP over an eight-hour period. (For the purposes of this section, employee exposure is that exposure which would occur if the employee were not using a respirator.)
(b) Initial. Each employer who has a place of employment in which DBCP is present shall monitor each workplace and work operation to accurately determine the airborne concentrations of DBCP to which employees may be exposed.
(c) Frequency.
(i) If the monitoring required by this section reveals employee exposures to be below the permissible exposure limits, the employer shall repeat these determinations at least quarterly.
(ii) If the monitoring required by this section reveals employee exposure to be in excess of the permissible exposure limits, the employer shall repeat these determinations for each such employee at least monthly. The employer shall continue these monthly determinations until at least two consecutive measurements, taken at least seven days apart, are below the permissible exposure limit, thereafter the employer shall monitor at least quarterly.
(d) Additional. Whenever there has been a production process, control or personnel change which may result in any new or additional exposure to DBCP, or whenever the employer has any other reason to suspect a change which may result in new or additional exposure to DBCP, additional monitoring which complies with subsection (6) shall be conducted.
(e) Employee notification.
(i) Within five working days after the receipt of monitoring results, the employer shall notify each employee in writing of results which represent the employee's exposure.
(ii) Whenever the results indicate that employee exposure exceeds the permissible exposure limit, the employer shall include in the written notice a statement that the permissible exposure limit was exceeded and a description of the corrective action being taken to reduce exposure to or below the permissible exposure limits.
(f) Accuracy of measurement. The method of measurement shall be accurate, to a confidence level of ninety-five percent, to within plus or minus twenty-five percent for concentrations of DBCP at or above the permissible exposure limits.
(7) Methods of compliance.
(a) Priority of compliance methods. The employer shall institute engineering and work practice controls to reduce and maintain employee exposures to DBCP at or below the permissible exposure limit, except to the extent that the employer establishes that such controls are not feasible. Where feasible engineering and work practice controls are not sufficient to reduce employee exposures to within the permissible exposure limit, the employer shall nonetheless use them to reduce exposures to the lowest level achievable by these controls, and shall supplement them by use of respiratory protection.
(b) Compliance program.
(i) The employer shall establish and implement a written program to reduce employee exposure to DBCP to or below the permissible exposure limit solely by means of engineering and work practice controls as required by this section.
(ii) The written program shall include a detailed schedule for development and implementation of the engineering and work practice controls. These plans shall be revised at least every six months to reflect the current status of the program.
(iii) Written plans for these compliance programs shall be submitted upon request to the director, and shall be available at the worksite for examination and copying by the director, and any affected employee or designated representative of employees.
(iv) The employer shall institute and maintain at least the controls described in his most recent written compliance program.
(8) Respiratory protection.
(a) General. For employees who are required to use respirators under this section, the employer must provide each employee an appropriate respirator that complies with the requirements of this subsection. Respirators must be used during:
(i) Period necessary to install or implement feasible engineering and work-practice controls;
(ii) Maintenance and repair activities for which engineering and work-practice controls are not feasible;
(iii) Work operations for which feasible engineering and work-practice controls are not yet sufficient to reduce employee exposure to or below the permissible exposure limit;
(iv) Emergencies.
(b) The employer must establish, implement, and maintain a respiratory protection program as required by chapter 296-842 WAC, Respirators, which covers each employee required by this chapter to use a respirator.
(c) Respirator selection. The employer must:
(i) Select and provide to employees appropriate respirators according to this chapter and WAC 296-842-13005 in the respirator rule.
(ii) Provide employees with one of the following respirator options to use for entry into, or escape from, unknown DBCP concentrations:
(A) A combination respirator that includes a full-facepiece air-line respirator operated in a pressure-demand or other positive-pressure mode or continuous-flow mode and an auxiliary self-contained breathing apparatus (SCBA) operated in a pressure-demand or positive-pressure mode;
OR
(B) A full-facepiece SCBA operated in a pressure-demand or other positive-pressure mode.
(9) Reserved.
(10) Emergency situations.
(a) Written plans.
(i) A written plan for emergency situations shall be developed for each workplace in which DBCP is present.
(ii) Appropriate portions of the plan shall be implemented in the event of an emergency.
(b) Employees engaged in correcting conditions shall be equipped as required in subsection (11) of this section until the emergency is abated.
(c) Evacuation. Employees not engaged in correcting the emergency shall be removed and restricted from the area and normal operations in the affected area shall not be resumed until the emergency is abated.
(d) Alerting employees. Where there is a possibility of employee exposure to DBCP due to the occurrence of an emergency, a general alarm shall be installed and maintained to promptly alert employees of such occurrences.
(e) Medical surveillance. For any employee exposed to DBCP in an emergency situation, the employer shall provide medical surveillance in accordance with subsection (14) of this section.
(f) Exposure monitoring.
(i) Following an emergency, the employer shall conduct monitoring which complies with subsection (6) of this section.
(ii) In workplaces not normally subject to periodic monitoring, the employer may terminate monitoring when two consecutive measurements indicate exposures below the permissible exposure limit.
(11) Protective clothing and equipment.
(a) Provision and use. Where eye or skin contact with liquid or solid DBCP may occur, employers shall provide at no cost to the employee, and assure that employees wear impermeable protective clothing and equipment in accordance with WAC 296-800-160 to protect the area of the body which may come in contact with DBCP.
(b) Cleaning and replacement.
(i) The employer shall clean, launder, maintain, or replace protective clothing and equipment required by this subsection to maintain their effectiveness. In addition, the employer shall provide clean protective clothing and equipment at least daily to each affected employee.
(ii) Removal and storage.
(A) The employer shall assure that employees remove DBCP contaminated work clothing only in change rooms provided in accordance with subsection (13) of this section.
(B) The employer shall assure that employees promptly remove any protective clothing and equipment which becomes contaminated with DBCP-containing liquids and solids. This clothing shall not be reworn until the DBCP has been removed from the clothing or equipment.
(C) The employer shall assure that no employee takes DBCP contaminated protective devices and work clothing out of the change room, except those employees authorized to do so for the purpose of laundering, maintenance, or disposal.
(iii) The employer shall assure that DBCP-contaminated protective work clothing and equipment is placed and stored in closed containers which prevent dispersion of DBCP outside the container.
(iv) The employer shall inform any person who launders or cleans DBCP-contaminated protective clothing or equipment of the potentially harmful effects of exposure to DBCP.
(v) Containers of DBCP-contaminated protective devices or work clothing which are to be taken out of change rooms or the workplace for cleaning, maintenance or disposal shall bear labels with the following information: CONTAMINATED WITH 1,2-Dibromo-3-chloropropane (DBCP), MAY CAUSE CANCER.
(vi) The employer shall prohibit the removal of DBCP from protective clothing and equipment by blowing or shaking.
(12) Housekeeping.
(a) Surfaces.
(i) All surfaces shall be maintained free of accumulations of DBCP.
(ii) Dry sweeping and the use of air for the cleaning of floors and other surfaces where DBCP dust or liquids are found is prohibited.
(iii) Where vacuuming methods are selected, either portable units or a permanent system may be used.
(A) If a portable unit is selected, the exhaust shall be attached to the general workplace exhaust ventilation system or collected within the vacuum unit, equipped with high efficiency filters or other appropriate means of contaminant removal, so that DBCP is not reintroduced into the workplace air; and
(B) Portable vacuum units used to collect DBCP may not be used for other cleaning purposes and shall be labeled as prescribed by subsection (11)(b)(v) of this section.
(iv) Cleaning of floors and other contaminated surfaces may not be performed by washing down with a hose, unless a fine spray has first been laid down.
(b) Liquids. Where DBCP is present in a liquid form, or as a resultant vapor, all containers or vessels containing DBCP shall be enclosed to the maximum extent feasible and tightly covered when not in use.
(c) Waste disposal. DBCP waste, scrap, debris, bags, containers or equipment, shall be disposed in sealed bags or other closed containers which prevent dispersion of DBCP outside the container.
(13) Hygiene facilities and practices.
(a) Change rooms. The employer shall provide clean change rooms equipped with storage facilities for street clothes and separate storage facilities for protective clothing and equipment whenever employees are required to wear protective clothing and equipment in accordance with subsections (8), (9), and (11) of this section.
(b) Showers.
(i) The employer shall assure that employees working in the regulated area shower at the end of the work shift.
(ii) The employer shall assure that employees whose skin becomes contaminated with DBCP-containing liquids or solids immediately wash or shower to remove any DBCP from the skin.
(iii) The employer shall provide shower facilities in accordance with WAC 296-800-230.
(c) Lunchrooms. The employer shall provide lunchroom facilities which have a temperature controlled, positive pressure, filtered air supply, and which are readily accessible to employees working in regulated areas.
(d) Lavatories.
(i) The employer shall assure that employees working in the regulated area remove protective clothing and wash their hands and face prior to eating.
(ii) The employer shall provide a sufficient number of lavatory facilities which comply with WAC 296-800-230.
(e) Prohibition of activities in regulated areas. The employer shall assure that, in regulated areas, food or beverages are not present or consumed, smoking products and implements are not present or used, and cosmetics are not present or applied.
(14) Medical surveillance.
(a) General. The employer shall institute a program of medical surveillance for each employee who is or will be exposed, without regard to the use of respirators, to DBCP. The employer shall provide each such employee with an opportunity for medical examinations and tests in accordance with this subsection. All medical examinations and procedures shall be performed by or under the supervision of a licensed physician, and shall be provided without cost to the employee.
(b) Frequency and content. At the time of initial assignment, annually thereafter, and whenever exposure to DBCP occurs, the employer shall provide a medical examination for employees who work in regulated areas, which includes at least the following:
(i) A complete medical and occupational history with emphasis on reproductive history.
(ii) A complete physical examination with emphasis on the genito-urinary tract, testicle size, and body habitus including the following tests:
(A) Sperm count;
(B) Complete urinalysis (U/A);
(C) Complete blood count; and
(D) Thyroid profile.
(iii) A serum specimen shall be obtained and the following determinations made by radioimmunoassay techniques utilizing National Institutes of Health (NIH) specific antigen or one of equivalent sensitivity:
(A) Serum multiphasic analysis (SMA 12);
(B) Serum follicle stimulating hormone (FSH);
(C) Serum luteinizing hormone (LH); and
(D) Serum estrogen (females).
(iv) Any other tests deemed appropriate by the examining physician.
(c) Additional examinations. If the employee for any reason develops signs or symptoms commonly associated with exposure to DBCP, the employer shall provide the employee with a medical examination which shall include those elements considered appropriate by the examining physician.
(d) Information provided to the physician. The employer shall provide the following information to the examining physician:
(i) A copy of this standard and its appendices;
(ii) A description of the affected employee's duties as they relate to the employee's exposure;
(iii) The level of DBCP to which the employee is exposed; and
(iv) A description of any personal protective equipment used or to be used.
(e) Physician's written opinion.
(i) For each examination under this section, the employer shall obtain and provide the employee with a written opinion from the examining physician which shall include:
(A) The results of the medical tests performed;
(B) The physician's opinion as to whether the employee has any detected medical condition which would place the employee at an increased risk of material impairment of health from exposure to DBCP;
(C) Any recommended limitations upon the employee's exposure to DBCP or upon the use of protective clothing and equipment such as respirators; and
(D) A statement that the employee was informed by the physician of the results of the medical examination, and any medical conditions which require further examination or treatment.
(ii) The employer shall instruct the physician not to reveal in the written opinion specific findings or diagnoses unrelated to occupational exposure to DBCP.
(iii) The employer shall provide a copy of the written opinion to the affected employee.
(f) Emergency situations. If the employee is exposed to DBCP in an emergency situation, the employer shall provide the employee with a sperm count test as soon as practicable, or, if the employee is unable to produce a semen specimen, the hormone tests contained in (b) of this subsection. The employer shall provide these same tests three months later.
(15) Employee information and training.
(a) Training program.
(i) Within thirty days of the effective date of this standard, the employer shall institute a training program for all employees who may be exposed to DBCP and shall assure their participation in such training program.
(ii) The employer shall assure that each employee is informed of the following:
(A) The information contained in Appendices A, B and C;
(B) The quantity, location, manner of use, release or storage of DBCP and the specific nature of operations which could result in exposure to DBCP as well as any necessary protective steps;
(C) The purpose, proper use, limitations, and other training requirements covering respiratory protection as required in chapter 296-62 WAC, Part E;
(D) The purpose and description of the medical surveillance program required by subsection (14) of this section; and
(E) A review of this standard.
(b) Access to training materials.
(i) The employer shall make a copy of this standard and its appendices readily available to all affected employees.
(ii) The employer shall provide, upon request, all materials relating to the employee information and training program to the director.
(16) Communication of hazards.
(a) Hazard communication - General.
(i) Chemical manufacturers, importers, distributors and employers shall comply with all requirements of the Hazard Communication Standard (HCS), WAC 296-901-140 for DBCP.
(ii) In classifying the hazards of DBCP at least the following hazards are to be addressed: Cancer; reproductive effects; liver effects; kidney effects; central nervous system effects; skin, eye and respiratory tract irritation; and acute toxicity effects.
(iii) Employers shall include DBCP in the hazard communication program established to comply with the HCS, WAC 296-901-140. Employers shall ensure that each employee has access to labels on containers of DBCP and to safety data sheets, and is trained in accordance with the requirements of HCS and subsection (15) of this section.
(iv) The employer may use labels or signs required by other statutes, regulations, or ordinances in addition to or in combination with, signs and labels required by this subsection.
(v) The employer shall ensure that no statement appears on or near any sign or label required by this subsection which contradicts or detracts from the required sign or label.
(b) Signs.
(i) The employer shall post signs to clearly indicate all regulated areas. These signs shall bear the legend:
DANGER
1,2-Dibromo-3-chloropropane
MAY CAUSE CANCER
WEAR RESPIRATORY PROTECTION IN THIS AREA
AUTHORIZED PERSONNEL ONLY
(ii) Prior to June 1, 2016, employers may use the following legend in lieu of that specified in (b) of this subsection:
DANGER
1,2-Dibromo-3-chloropropane
(Insert appropriate trade or common names)
CANCER HAZARD
AUTHORIZED PERSONNEL ONLY
RESPIRATOR REQUIRED
(c) Labels.
(i) Where DBCP or products containing DBCP are sold, distributed or otherwise leave the employer's workplace bearing appropriate labels required by EPA under the regulations in 40 C.F.R. Part 162, the labels required by (c) of this subsection need not be affixed.
(ii) The employer shall ensure that the precautionary labels required by (c) of this subsection are readily visible and legible.
(iii) Prior to June 1, 2015, employers may include the following information on containers of DBCP or products containing DBCP, DBCP-contaminated protective devices or work clothing or DBCP-contaminated portable vacuums in lieu of the labeling requirements in (11)(b)(v), (12)(a)(iii)(B) and (a)(i) of this subsection:
DANGER
1,2-Dibromo-3-chloropropane
CANCER HAZARD
(17) Recordkeeping.
(a) Exposure monitoring.
(i) The employer shall establish and maintain an accurate record of all monitoring required by subsection (6) of this section.
(ii) This record shall include:
(A) The dates, number, duration and results of each of the samples taken, including a description of the sampling procedure used to determine representative employee exposure;
(B) A description of the sampling and analytical methods used;
(C) Type of respiratory worn, if any; and
(D) Name, Social Security number, and job classification of the employee monitored and of all other employees whose exposure the measurement is intended to represent.
(iii) The employer shall maintain this record for at least forty years or the duration of employment plus twenty years, whichever is longer.
(b) Medical surveillance.
(i) The employer shall establish and maintain an accurate record for each employee subject to medical surveillance required by subsection (14) of this section.
(ii) This record shall include:
(A) The name and Social Security number of the employee;
(B) A copy of the physician's written opinion;
(C) Any employee medical complaints related to exposure to DBCP;
(D) A copy of the information provided the physician as required by subsection (14)(c) of this section; and
(E) A copy of the employee's medical and work history.
(iii) The employer shall maintain this record for at least forty years or the duration of employment plus twenty years, whichever is longer.
(c) Availability.
(i) The employer shall assure that all records required to be maintained by this section be made available upon request to the director for examination and copying.
(ii) Employee exposure monitoring records and employee medical records required by this subsection shall be provided upon request to employees' designated representatives and the assistant director in accordance with chapter 296-802 WAC.
(d) Transfer of records.
(i) If the employer ceases to do business, the successor employer shall receive and retain all records required to be maintained by this section for the prescribed period.
(ii) The employer shall also comply with any additional requirements involving transfer of records set forth in WAC 296-802-60005.
(18) Observation of monitoring.
(a) Employee observation. The employer shall provide affected employees, or their designated representatives, an opportunity to observe any monitoring of employee exposure to DBCP conducted under subsection (6) of this section.
(b) Observation procedures.
(i) Whenever observation of the measuring or monitoring of employee exposure to DBCP requires entry into an area where the use of protective clothing or equipment is required, the employer shall provide the observer with personal protective clothing or equipment required to be worn by employees working in the area, assure the use of such clothing and equipment, and require the observer to comply with all other applicable safety and health procedures.
(ii) Without interfering with the monitoring or measurement, observers shall be entitled to:
(A) Receive an explanation of the measurement procedures;
(B) Observe all steps related to the measurement of airborne concentrations of DBCP performed at the place of exposure; and
(C) Record the results obtained.
(19) Appendices. The information contained in the appendices is not intended, by itself, to create any additional obligations not otherwise imposed or to detract from any existing obligation.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-62-07342, filed 3/18/14, effective 5/1/14. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and chapter 49.17 RCW. WSR 12-24-071, § 296-62-07342, filed 12/4/12, effective 1/4/13. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 09-15-145, § 296-62-07342, filed 7/21/09, effective 9/1/09; WSR 07-05-072, § 296-62-07342, filed 2/20/07, effective 4/1/07; WSR 05-03-093, § 296-62-07342, filed 1/18/05, effective 3/1/05; WSR 04-10-026, § 296-62-07342, filed 4/27/04, effective 8/1/04; WSR 03-18-090, § 296-62-07342, filed 9/2/03, effective 11/1/03. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07342, filed 5/9/01, effective 9/1/01; WSR 99-10-071, § 296-62-07342, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 96-09-030, § 296-62-07342, filed 4/10/96, effective 6/1/96; WSR 88-11-021 (Order 88-04), § 296-62-07342, filed 5/11/88.]



296-62-07343
Appendix A—Substance safety data sheet for DBCP.

(1) Substance identification.
(a) Synonyms and trades names: DBCP; Dibromochloropropane; Fumazone (Dow Chemical Company TM); Nemafume; Nemagon (Shell Chemical Co. TM); Nemaset; BBC 12; and OS 1879.
(b) Permissible exposure:
(i) Airborne. 1 part DBCP vapor per billion parts of air (1 ppb); time-weighted average (TWA) for an eight-hour workday.
(ii) Dermal. Eye contact and skin contact with DBCP are prohibited.
(c) Appearance and odor: Technical grade DBCP is a dense yellow or amber liquid with a pungent odor. It may also appear in granular form, or blended in varying concentrations with other liquids.
(d) Uses: DBCP is used to control nematodes, very small worm-like plant parasites, on crops including cotton, soybeans, fruits, nuts, vegetables and ornamentals.
(2) Health hazard data.
(a) Routes of entry: Employees may be exposed:
(i) Through inhalation (breathing);
(ii) Through ingestion (swallowing);
(iii) Skin contact; and
(iv) Eye contact.
(b) Effects of exposure:
(i) Acute exposure. DBCP may cause drowsiness, irritation of the eyes, nose, throat and skin, nausea and vomiting. In addition, overexposure may cause damage to the lungs, liver or kidneys.
(ii) Chronic exposure. Prolonged or repeated exposure to DBCP has been shown to cause sterility in humans. It also has been shown to produce cancer and sterility in laboratory animals and has been determined to constitute an increased risk of cancer in people.
(iii) Reporting signs and symptoms. If you develop any of the above signs or symptoms that you think are caused by exposure to DBCP, you should inform your employer.
(3) Emergency first-aid procedures.
(a) Eye exposure. If DBCP liquid or dust containing DBCP gets into your eyes, wash your eyes immediately with large amounts of water, lifting the lower and upper lids occasionally. Get medical attention immediately. Contact lenses should not be worn when working with DBCP.
(b) Skin exposure. If DBCP liquids or dusts containing DBCP get on your skin, immediately wash using soap or mild detergent and water. If DBCP liquids or dusts containing DBCP penetrate through your clothing, remove the clothing immediately and wash. If irritation is present after washing get medical attention.
(c) Breathing. If you or any person breathe in large amounts of DBCP, move the exposed person to fresh air at once. If breathing has stopped, perform artificial respiration. Do not use mouth-to-mouth. Keep the affected person warm and at rest. Get medical attention as soon as possible.
(d) Swallowing. When DBCP has been swallowed and the person is conscious, give the person large amounts of water immediately. After the water has been swallowed, try to get the person to vomit by having him touch the back of his throat with his finger. Do not make an unconscious person vomit. Get medical attention immediately.
(e) Rescue. Notify someone. Put into effect the established emergency rescue procedures. Know the locations of the emergency rescue equipment before the need arises.
(4) Respirators and protective clothing.
(a) Respirators. You may be required to wear a respirator in emergencies and while your employer is in the process of reducing DBCP exposures through engineering controls. If respirators are worn, they must have a label issued by the National Institute for Occupational Safety and Health (NIOSH) under the provisions of 42 C.F.R. part 84 stating that the respirators have been certified for use with organic vapors. For effective protection, a respirator must fit your face and head snugly. The respirator should not be loosened or removed in work situations where its use is required. Respirators must not be loosened or removed in work situations where their use is required.
(b) Protective clothing. When working with DBCP you must wear for your protection impermeable work clothing provided by your employer. (Standard rubber and neoprene protective clothing do not offer adequate protection). DBCP must never be allowed to remain on the skin. Clothing and shoes must not be allowed to become contaminated with DBCP, and if they do, they must be promptly removed and not worn again until completely free of DBCP. Turn in impermeable clothing that has developed leaks for repair or replacement.
(c) Eye protection. You must wear splashproof safety goggles where there is any possibility of DBCP liquid or dust contacting your eyes.
(5) Precautions for safe use, handling, and storage.
(a) DBCP must be stored in tightly closed containers in a cool, well-ventilated area.
(b) If your work clothing may have become contaminated with DBCP, or liquids or dusts containing DBCP, you must change into uncontaminated clothing before leaving the work premises.
(c) You must promptly remove any protective clothing that becomes contaminated with DBCP. This clothing must not be reworn until the DBCP is removed from the clothing.
(d) If your skin becomes contaminated with DBCP, you must immediately and thoroughly wash or shower with soap or mild detergent and water to remove any DBCP from your skin.
(e) You must not keep food, beverages, cosmetics, or smoking materials, nor eat or smoke, in regulated areas.
(f) If you work in a regulated area, you must wash your hands thoroughly with soap or mild detergent and water, before eating, smoking or using toilet facilities.
(g) If you work in a regulated area, you must remove any protective equipment or clothing before leaving the regulated area.
(h) Ask your supervisor where DBCP is used in your work area and for any additional safety and health rules.
(6) Access to information.
(a) Each year, your employer is required to inform you of the information contained in this substance safety data sheet for DBCP. In addition, your employer must instruct you in the safe use of DBCP, emergency procedures, and the correct use of protective equipment.
(b) Your employer is required to determine whether you are being exposed to DBCP. You or your representative have the right to observe employee exposure measurements and to record the result obtained. Your employer is required to inform you of your exposure. If your employer determines that you are being overexposed, they are required to inform you of the actions which are being taken to reduce your exposure.
(c) Your employer is required to keep records of your exposure and medical examinations. Your employer is required to keep exposure and medical data for at least forty years or the duration of your employment plus twenty years, whichever is longer.
(d) Your employer is required to release exposure and medical records to you, your physician, or other individual designated by you upon your written request.
[Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07343, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 94-15-096 (Order 94-07), § 296-62-07343, filed 7/20/94, effective 9/20/94; WSR 88-11-021 (Order 88-04), § 296-62-07343, filed 5/11/88.]



296-62-07344
Appendix B—Substance technical guidelines for DBCP.

(1) Physical and chemical data.
(a) Substance identification.
(i) Synonyms: 1,2-dibromo-3-chloropropane; DBCP, Fumazone; Nemafume; Nemagon; Nemaset; BBC 12; OS 1879. DBCP is also included in agricultural pesticides and fumigants which include the phrase "Nema____, in their name.
(ii) Formula: C3H5Br2 C1.
(iii) Molecular weight: 236.
(b) Physical data:
(i) Boiling point (760 mm HG): 195C (383F)
(ii) Specific gravity (water = 1): 2.093.
(iii) Vapor density (air = 1 at boiling point of DBCP): Data not available.
(iv) Melting point: 6C (43F).
(v) Vapor pressure at 20C (68F): 0.8 mm HG
(vi) Solubility in water: 1000 ppm.
(vii) Evaporation rate (Butyl Acetate = 1): Very much less than 1.
(c) Appearance and odor: Dense yellow or amber liquid with a pungent odor at high concentrations. Any detectable odor of DBCP indicates overexposure.
(2) Fire explosion and reactivity hazard data.
(a) Fire.
(i) Flash point: 170F (77C)
(ii) Autoignition temperature: Data not available.
(iii) Flammable limits in air, percent by volume: Data not available.
(iv) Extinguishing media: Carbon dioxide, dry chemical.
(v) Special fire-fighting procedures: Do not use a solid stream of water since a stream will scatter and spread the fire. Use water spray to cool containers exposed to a fire.
(vi) Unusual fire and explosion hazards: None known.
(vii) For purposes of complying with the requirements of WAC 296-24-330, liquid DBCP is classified as a Class III A combustible liquid.
(viii) For the purpose of complying with chapter 296-24 WAC Part L, the classification of hazardous locations as described in article 500 of the National Electrical Code for DBCP shall be Class I, Group D.
(ix) For the purpose of compliance with WAC 296-24-592, DBCP is classified as a Class B fire hazard.
(x) For the purpose of compliance with WAC 296-24-230, locations classified as hazardous locations due to the presence of DBCP shall be Class I, Group D.
(xi) Sources of ignition are prohibited where DBCP presents a fire or explosion hazard.
(b) Reactivity.
(i) Conditions contributing to instability: None known.
(ii) Incompatibilities: Reacts with chemically active metals, such as aluminum, magnesium and tin alloys.
(iii) Hazardous decomposition products: Toxic gases and vapors (such as HBr, HC1 and carbon monoxide) may be released in a fire involving DBCP.
(iv) Special precautions: DBCP will attack some rubber materials and coatings.
(3) Spill, leak and disposal procedures.
(a) If DBCP is spilled or leaked, the following steps should be taken:
(i) The area should be evacuated at once and reentered only after thorough ventilation.
(ii) Ventilate area of spill or leak.
(iii) If in liquid form, collect for reclamation or absorb in paper, vermiculite, dry sand, earth or similar material.
(iv) If in solid form, collect spilled material in the most convenient and safe manner for reclamation or for disposal.
(b) Persons not wearing protective equipment must be restricted from areas of spills or leaks until cleanup has been completed.
(c) Waste disposal methods:
(i) For small quantities of liquid DBCP, absorb on paper towels, remove to a safe place (such as a fume hood) and burn the paper. Large quantities can be reclaimed or collected and atomized in a suitable combustion chamber equipped with an appropriate effluent gas cleaning device. If liquid DBCP is absorbed in vermiculite, dry sand, earth or similar material and placed in sealed containers it may be disposed of in a state-approved sanitary landfill.
(ii) If in solid form, for small quantities, place on paper towels, remove to a safe place (such as a fume hood) and burn. Large quantities may be reclaimed. However, if this is not practical, dissolve in a flammable solvent (such as alcohol) and atomize in a suitable combustion chamber equipped with an appropriate effluent gas cleaning device. DBCP in solid form may also be disposed in a state-approved sanitary landfill.
(4) Monitoring and measurement procedures.
(a) Exposure above the permissible exposure limit.
(i) Eight hour exposure evaluation: Measurements taken for the purpose of determining employee exposure under this section are best taken so that the average eight-hour exposure may be determined from a single eight-hour sample or two four-hour samples. Air samples should be taken in the employee's breathing zone (air that would most nearly represent that inhaled by the employee).
(ii) Monitoring techniques: The sampling and analysis under this section may be performed by collecting the DBCP vapor on petroleum based charcoal absorption tubes with subsequent chemical analyses. The method of measurement chosen should determine the concentration of airborne DBCP at the permissible exposure limit to an accuracy of plus or minus twenty-five percent. If charcoal tubes are used, a total volume of ten liters should be collected at a flow rate of 50 cc per minute for each tube. Analyze the resultant samples as you would samples of halogenated solvent.
(b) Since many of the duties relating to employee protection are dependent on the results of monitoring and measuring procedures, employers should assure that the evaluation of employee exposures is performed by a competent industrial hygienist or other technically qualified person.
(5) Protective clothing. Employees should be required to wear appropriate protective clothing to prevent any possibility of skin contact with DBCP. Because DBCP is absorbed through the skin, it is important to prevent skin contact with both liquid and solid forms of DBCP. Protective clothing should include impermeable coveralls or similar fullbody work clothing, gloves, headcoverings, and workshoes or shoe coverings. Standard rubber and neoprene gloves do not offer adequate protection and should not be relied upon to keep DBCP off the skin. DBCP should never be allowed to remain on the skin. Clothing and shoes should not be allowed to become contaminated with the material; and if they do, they should be promptly removed and not worn again until completely free of the material. Any protective clothing which has developed leaks or is otherwise found to be defective should be repaired or replaced. Employees should also be required to wear splashproof safety goggles where there is any possibility of DBCP contacting the eyes.
(6) Housekeeping and hygiene facilities.
(a) The workplace must be kept clean, orderly and in a sanitary condition.
(b) Dry sweeping and the use of compressed air is unsafe for the cleaning of floors and other surfaces where DBCP dust or liquids are found. To minimize the contamination of air with dust, vacuuming with either portable or permanent systems must be used. If a portable unit is selected, the exhaust must be attached to the general workplace exhaust ventilation system, or collected within the vacuum unit equipped with high efficiency filters or other appropriate means of contamination removal and not used for other purposes. Units used to collect DBCP must be labeled.
(c) Adequate washing facilities with hot and cold water must be provided, and maintained in a sanitary condition. Suitable cleansing agents should also be provided to assure the effective removal of DBCP from the skin.
(d) Change or dressing rooms with individual clothes storage facilities must be provided to prevent the contamination of street clothes with DBCP. Because of the hazardous nature of DBCP, contaminated protective clothing must be stored in closed containers for cleaning or disposal.
(7) Miscellaneous precautions.
(a) Store DBCP in tightly closed containers in a cool, well ventilated area.
(b) Use of supplied-air suits or other impervious clothing (such as acid suits) may be necessary to prevent skin contact with DBCP. Supplied-air suits should be selected, used, and maintained under the supervision of persons knowledgeable in the limitations and potential life-endangering characteristics of supplied-air suits.
(c) The use of air-conditioned suits may be necessary in warmer climates.
(d) Advise employees of all areas and operations where exposure to DBCP could occur.
(8) Common operations. Common operations in which exposure to DBCP is likely to occur are: During its production; and during its formulation into pesticides and fumigants.
[Statutory Authority: Chapter 49.17 RCW. WSR 91-24-017 (Order 91-07), § 296-62-07344, filed 11/22/91, effective 12/24/91; WSR 88-11-021 (Order 88-04), § 296-62-07344, filed 5/11/88.]



296-62-07346
Appendix C—Medical surveillance guidelines for DBCP.

(1) Route of entry.
(a) Inhalation;
(b) Skin absorption.
(2) Toxicology. Recent data collected on workers involved in the manufacture and formulation of DBCP has shown that DBCP can cause sterility at very low levels of exposure. This finding is supported by studies showing that DBCP causes sterility in animals. Chronic exposure to DBCP resulted in pronounced necrotic action on the parenchymatous organs (i.e., liver, kidney, spleen) and on the testicles of rats at concentrations as low as 5 ppm. Rats that were chronically exposed to DBCP also showed changes in the composition of the blood, showing low RBC, hemoglobin, and WBC, and high reticulocyte levels as well as functional hepatic disturbance, manifesting itself in a long prothrombin time. Reznik et al., noted a single dose of 100 mg produced profound depression of the nervous system of rats. Their condition gradually improved. Acute exposure also resulted in the destruction of the sex gland activity of male rats as well as causing changes in the estrous cycle in female rats. Animal studies have also associated DBCP with an increased incidence of carcinoma. Olson, et al., orally administered DBCP to rats and mice five times per week at experimentally predetermined maximally tolerated doses and at half those doses. As early as ten weeks after initiation of treatment, DBCP induced a high incidence of squamous cell carcinomas of the stomach with metastases in both species. DBCP also induced mammary adenocarcinomas in the female rats at both dose levels.
(3) Signs and symptoms.
(a) Inhalation: Nausea, eye irritation, conjunctivitis, respiratory irritation, pulmonary congestion or edema, CNS depression with apathy, sluggishness, and ataxia.
(b) Dermal: Erythema or inflammation and dermatitis on repeated exposure.
(4) Special tests.
(a) Semen analysis: The following information excerpted from the document "Evaluation of Testicular Function," submitted by the Corporate Medical Department of the Shell Oil Company (exhibit 39-3), may be useful to physicians conducting the medical surveillance program. In performing semen analyses certain minimal but specific criteria should be met:
(i) It is recommended that a minimum of three valid semen analyses be obtained in order to make a determination of an individual's average sperm count.
(ii) A period of sexual abstinence is necessary prior to the collection of each masturbatory sample. It is recommended that intercourse or masturbation be performed 48 hours before the actual specimen collection. A period of 48 hours of abstinence would follow; then the masturbatory sample would be collected.
(iii) Each semen specimen should be collected in a clean, widemouthed, glass jar (not necessarily pre-sterilized) in a manner designated by the examining physician. Any part of the seminal fluid exam should be initialed only after liquifaction is complete, i.e., 30 to 45 minutes after collection.
(iv) Semen volume should be measured to the nearest 1/10 of a cubic centimeter.
(v) Sperm density should be determined using routine techniques involving the use of a white cell pipette and a hemocytometer chamber. The immobilizing fluid most effective and most easily obtained for this process is distilled water.
(vi) Thin, dry smears of the semen should be made for a morphologic classification of the sperm forms and should be stained with either hematoxalin or the more difficult, yet more precise, Papanicolaou technique. Also of importance to record is obvious sperm agglutination, pyospermia, delayed liquifaction (greater than 30 minutes), and hyperviscosity. In addition, pH, using nitrazine paper, should be determined.
(vii) A total morphology evaluation should include percentages of the following:
(A) Normal (oval) forms,
(B) Tapered forms,
(C) Amorphous forms (include large and small sperm shapes),
(D) Duplicated (either heads or tails) forms, and
(E) Immature forms.
(viii) Each sample should be evaluated for sperm viability (percent viable sperm moving at the time of examination) as well as sperm motility (subjective characterization of "purposeful forward sperm progression" of the majority of those viable sperm analyzed) within two hours after collection, ideally by the same or equally qualified examiner.
(b) Serum determinations: The following serum determinations should be performed by radiommuno-assay techniques using National Institutes of Health (NIH) specific antigen or antigen preparations of equivalent sensitivity:
(i) Serum follicle stimulating hormone (FSH),
(ii) Serum luteinizing hormone (LH), and
(iii) Serum total estrogen (females only).
(5) Treatment. Remove from exposure immediately, give oxygen or artificial resuscitation if indicated. Contaminated clothing and shoes should be removed immediately. Flush eyes and wash contaminated skin. If swallowed and the person is conscious, induce vomiting. Recovery from mild exposures is usually rapid and complete.
(6) Surveillance and preventive considerations.
(a) Other considerations. DBCP can cause both acute and chronic effects. It is important that the physician become familiar with the operating conditions in which exposure to DBCP occurs. Those with respiratory disorders may not tolerate the wearing of negative pressure respirators.
(b) Surveillance and screening. Medical histories and laboratory examinations are required for each employee subject to exposure to DBCP. The employer should screen employees for history of certain medical conditions (listed below) which might place the employee at increased risk from exposure:
(i) Liver disease. The primary site of biotransformation and detoxification of DBCP is the liver. Liver dysfunctions likely to inhibit the conjugation reactions will tend to promote the toxic actions of DBCP. These precautions should be considered before exposing persons with impaired liver function to DBCP.
(ii) Renal disease. Because DBCP has been associated with injury to the kidney it is important that special consideration be given to those with possible impairment of renal function.
(iii) Skin disease. DBCP can penetrate the skin and can cause erythema on prolonged exposure. Persons with preexisting skin disorders may be more susceptible to the effects of DBCP.
(iv) Blood dyscrasias. DBCP has been shown to decrease the content of erythrocytes, hemoglobin, and leukocytes in the blood, as well as increase the prothrombin time. Persons with existing blood disorders may be more susceptible to the effects of DBCP.
(v) Reproductive disorders. Animal studies have associated DBCP with various effects on the reproductive organs. Among these effects are atrophy of the testicles and changes in the estrous cycle. Persons with preexisting reproductive disorders may be at increased risk to these effects of DBCP.
(7) References.
(a) Reznik, Ya. B. and Sprinchan, G. K.: Experimental Data on the Gonadotoxic effect of Nemagon, Gig. Sanit., (6), 1975, pp. 101-102, (translated from Russian).
(b) Faydysh, E. V., Rakhmatullaev, N. N. and Varshavskii, V. A.: The Cytotoxic Action of Nemagon in a Subacute Experiment, Med. Zh. Uzbekistana, (No. 1), 1970, pp. 64-65, (translated from Russian).
(c) Rakhmatullaev, N. N.: Hygienic Characteristics of the Nematocide Nemagon in Relation to Water Pollution Control, Hyg. Sanit., 36(3), 1971, pp. 344-348, (translated from Russian).
(d) Olson, W. A. et al.: Induction of Stomach Cancer in Rats and Mice by Halogenated Aliphatic Fumigants, Journal of the National Cancer Institute, (51), 1973, pp. 1993-1995.
(e) Torkelson, T. R. et al.: Toxicologic Investigations of 1,2-Dibromo-3-chloropropane, Toxicology and Applied Pharmacology, 3, 1961 pp. 545-559.
[Statutory Authority: Chapter 49.17 RCW. WSR 88-11-021 (Order 88-04), § 296-62-07346, filed 5/11/88.]



296-62-07355
Ethylene oxide.

Scope and application.
Note:
The requirements in WAC 296-62-07355 through 296-62-07386 apply only to agriculture. The requirements for all other industries relating to ethylene oxide have been moved to chapter 296-855 WAC, Ethylene oxide.
(1) WAC 296-62-07355 through 296-62-07389 applies to all occupational exposures to ethylene oxide (EtO), Chemical Abstracts Service Registry No. 75-21-8, except as provided in subsection (2) of this section.
(2) WAC 296-62-07355 through 296-62-07389 does not apply to the processing, use, or handling of products containing EtO where objective data are reasonably relied upon that demonstrate that the product is not capable of releasing EtO in airborne concentrations at or above the action level, and may not reasonably be foreseen to release EtO in excess of the excursion limit, under the expected conditions of processing, use, or handling that will cause the greatest possible release.
(3) Where products containing EtO are exempted under subsection (2) of this section, the employer shall maintain records of the objective data supporting that exemption and the basis for the employer's reliance on the data, as provided in WAC 296-62-07375(1).
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 05-17-168, § 296-62-07355, filed 8/23/05, effective 1/1/06. Statutory Authority: Chapter 49.17 RCW. WSR 91-24-017 (Order 91-07), § 296-62-07355, filed 11/22/91, effective 12/24/91; WSR 88-23-054 (Order 88-25), § 296-62-07355, filed 11/14/88; WSR 87-24-051 (Order 87-24), § 296-62-07355, filed 11/30/87.]



296-62-07357
Definitions.

For the purpose of WAC 296-62-07355 through 296-62-07389, the following definitions shall apply:
(1) "Action level" means a concentration of airborne EtO of 0.5 ppm calculated as an eight-hour time-weighted average.
(2) "Authorized person" means any person specifically authorized by the employer whose duties require the person to enter a regulated area, or any person entering such an area as a designated representative of employees for the purpose of exercising the right to observe monitoring and measuring procedures under WAC 296-62-07377, or any other person authorized by chapter 49.17 RCW or regulations issued under chapter 49.17 RCW.
(3) "Director" means the director of the department of labor and industries, or designee.
(4) "Emergency" means any occurrence such as, but not limited to, equipment failure, rupture of containers, or failure of control equipment that is likely to or does result in an unexpected significant release of EtO.
(5) "Employee exposure" means exposure to airborne EtO which would occur if the employee were not using respiratory protective equipment.
(6) "Ethylene oxide" or "EtO" means the three-membered ring organic compound with chemical formula C2H4O.
[Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-07357, filed 11/30/87.]



296-62-07359
Permissible exposure limits (PEL).

(1) Eight-hour time-weighted average (TWA). The employer shall ensure that no employee is exposed to an airborne concentration of EtO in excess of one part EtO per million parts of air (1 ppm) as an eight-hour time-weighted average. (Eight-hour TWA.)
(2) Excursion limit. The employer shall ensure that no employee is exposed to an airborne concentration of EtO in excess of five parts of EtO per million parts of air (5 ppm) as averaged over a sampling period of fifteen minutes.
[Statutory Authority: Chapter 49.17 RCW. WSR 88-23-054 (Order 88-25), § 296-62-07359, filed 11/14/88; WSR 87-24-051 (Order 87-24), § 296-62-07359, filed 11/30/87.]



296-62-07361
Exposure monitoring.

(1) General.
(a) Determinations of employee exposure shall be made from breathing zone air samples that are representative of the eight-hour TWA and fifteen-minute short-term exposures of each employee.
(b) Representative eight-hour TWA employee exposure shall be determined on the basis of one or more samples representing full-shift exposure for each shift for each job classification in each work area. Representative fifteen-minute short-term employee exposures shall be determined on the basis of one or more samples representing fifteen-minute exposures associated with operations that are most likely to produce exposures above the excursion limit for each shift for each job classification in each work area.
(c) Where the employer can document that exposure levels are equivalent for similar operations in different work shifts, the employer need only determine representative employee exposure for that operation during one shift.
(2) Initial monitoring.
(a) Each employer who has a workplace or work operation covered by WAC 296-62-07355 through 296-62-07389, except as provided in WAC 296-62-07355 (2) or (b) of this subsection, shall perform initial monitoring to determine accurately the airborne concentrations of EtO to which employees may be exposed.
(b) Where the employer has monitored after June 15, 1983, and the monitoring satisfies all other requirements of WAC 296-62-07355 through 296-62-07389, the employer may rely on such earlier monitoring results to satisfy the requirements of (a) of this subsection.
(c) Where the employer has previously monitored for the excursion limit and the monitoring satisfies all other requirements of this section, the employer may rely on such earlier monitoring results to satisfy the requirements of (a) of this subsection.
(3) Monitoring frequency (periodic monitoring).
(a) If the monitoring required by subsection (2) of this section reveals employee exposure at or above the action level but at or below the eight-hour TWA, the employer shall repeat such monitoring for each such employee at least every six months.
(b) If the monitoring required by subsection (2)(a) of this section reveals employee exposure above the eight-hour TWA, the employer shall repeat such monitoring for each such employee at least every three months.
(c) The employer may alter the monitoring schedule from quarterly to semiannually for any employee for whom two consecutive measurements taken at least seven days apart indicate that the employee's exposure has decreased to or below the eight-hour TWA.
(d) If the monitoring required by subsection (2)(a) of this section reveals employee exposure above the fifteen-minute excursion limit, the employer shall repeat such monitoring for each such employee at least every three months, and more often as necessary to evaluate the employee's short-term exposures.
(4) Termination of monitoring.
(a) If the initial monitoring required by subsection (2)(a) of this section reveals employee exposure to be below the action level, the employer may discontinue TWA monitoring for those employees whose exposures are represented by the initial monitoring.
(b) If the periodic monitoring required by subsection (3) of this section reveals that employee exposures, as indicated by at least two consecutive measurements taken at least seven days apart, are below the action level, the employer may discontinue TWA monitoring for those employees whose exposures are represented by such monitoring.
(c) If the initial monitoring required by subsection (2)(a) of this section reveals the employee exposure to be at or below the excursion limit, the employer may discontinue excursion limit monitoring for those employees whose exposures are represented by the initial monitoring.
(d) If the periodic monitoring required by subsection (3) of this section reveals that employee exposures, as indicated by at least two consecutive measurements taken at least seven days apart, are at or below the excursion limit, the employer may discontinue excursion limit monitoring for those employees whose exposures are represented by such monitoring.
(5) Additional monitoring. Notwithstanding the provisions of subsection (4) of this section, the employer shall institute the exposure monitoring required under subsections (2)(a) and (3) of this section whenever there has been a change in the production, process, control equipment, personnel or work practices that may result in new or additional exposures to EtO or when the employer has any reason to suspect that a change may result in new or additional exposures.
(6) Accuracy of monitoring.
(a) Monitoring shall be accurate, to a confidence level of ninety-five percent, to within plus or minus twenty-five percent for airborne concentrations of EtO at the 1 ppm TWA and to within plus or minus thirty-five percent for airborne concentrations of EtO at the action level of 0.5 ppm.
(b) Monitoring shall be accurate, to a confidence level of ninety-five percent, to within plus or minus thirty-five percent for airborne concentrations of EtO at the excursion limit.
(7) Employee notification of monitoring results.
(a) The employer shall, within fifteen working days after the receipt of the results of any monitoring performed under WAC 296-62-07355 through 296-62-07389, notify the affected employee of these results in writing either individually or by posting of results in an appropriate location that is accessible to affected employees.
(b) The written notification required by (a) of this subsection shall contain the corrective action being taken by the employer to reduce employee exposure to or below the TWA and/or excursion limit, wherever monitoring results indicated that the TWA and/or excursion limit has been exceeded.
[Statutory Authority: Chapter 49.17 RCW. WSR 88-23-054 (Order 88-25), § 296-62-07361, filed 11/14/88; WSR 87-24-051 (Order 87-24), § 296-62-07361, filed 11/30/87.]



296-62-07363
Regulated areas.

(1) The employer shall establish a regulated area wherever occupational exposures to airborne concentrations of EtO may exceed the TWA or wherever the EtO concentration exceeds or can reasonably be expected to exceed the excursion limit.
(2) Access to regulated areas shall be limited to authorized persons.
(3) Regulated areas shall be demarcated in any manner that minimizes the number of employees within the regulated area.
[Statutory Authority: Chapter 49.17 RCW. WSR 88-23-054 (Order 88-25), § 296-62-07363, filed 11/14/88; WSR 87-24-051 (Order 87-24), § 296-62-07363, filed 11/30/87.]



296-62-07365
Methods of compliance.

(1) Engineering controls and work practices.
(a) The employer shall institute engineering controls and work practices to reduce and maintain employee exposure to or below the TWA and to or below the excursion limit, except to the extent that such controls are not feasible.
(b) Wherever the feasible engineering controls and work practices that can be instituted are not sufficient to reduce employee exposure to or below the TWA and to or below the excursion limit, the employer shall use them to reduce employee exposure to the lowest levels achievable by these controls and shall supplement them by the use of respiratory protection that complies with the requirements of WAC 296-62-07367.
(c) Engineering controls are generally infeasible for the following operations: Collection of quality assurance sampling from sterilized materials removal of biological indicators from sterilized materials: Loading and unloading of tank cars; changing of ethylene oxide tanks on sterilizers; and vessel cleaning. For these operations, engineering controls are required only where the director demonstrates that such controls are feasible.
(2) Compliance program.
(a) Where the TWA or excursion limit is exceeded, the employer shall establish and implement a written program to reduce employee exposure to or below the TWA and to or below the excursion limit by means of engineering and work practice controls, as required by subsection (1) of this section, and by the use of respiratory protection where required or permitted under WAC 296-62-07355 through 296-62-07389.
(b) The compliance program shall include a schedule for periodic leak detection surveys and a written plan for emergency situations, as specified in WAC 296-62-07369 (1)(a).
(c) Written plans for a program required in this subsection shall be developed and furnished upon request for examination and copying to the director, affected employees and designated employee representatives. Such plans shall be reviewed at least every twelve months, and shall be updated as necessary to reflect significant changes in the status of the employer's compliance program.
(d) The employer shall not implement a schedule of employee rotation as a means of compliance with the TWA or excursion limit.
[Statutory Authority: Chapter 49.17 RCW. WSR 88-23-054 (Order 88-25), § 296-62-07365, filed 11/14/88; WSR 87-24-051 (Order 87-24), § 296-62-07365, filed 11/30/87.]



296-62-07367
Respiratory protection and personal protective equipment.

(1) General. For employees who use respirators required by this section, the employer must provide respirators that comply with the requirements of WAC 296-62-07355 through 296-62-07389. Respirators must be used during:
(a) Periods necessary to install or implement feasible engineering and work-practice controls;
(b) Work operations, such as maintenance and repair activities, vessel cleaning, or other activities, for which engineering and work-practice controls are not feasible;
(c) Work operations for which feasible engineering and work-practice controls are not yet sufficient to reduce employee exposure to or below the TWA or excursion limit;
(d) Emergencies.
(2) Respirator program. The employer must establish, implement, and maintain a respiratory protection program as required in chapter 296-842 WAC, except WAC 296-842-13005 and 296-842-14005.
(3) Respirator selection. The employer must select the appropriate respirator from Table 1 of this section.
Table 1.—Minimum Requirements for Respiratory Protection for Airborne EtO
Condition of use or
concentration of
airborne EtO (ppm)
Minimum required respirator
Equal to or less
than 50
(a)
Full facepiece respirator with EtO approved canister, front- or back-mounted.
Equal to or less than 2,000
(a)
Positive-pressure supplied air respirator, equipped with full facepiece, hood or helmet, or
(b)
Continuous-flow supplied air respirator (positive pressure) equipped with hood, helmet or suit.
Concentration above 2,000 or unknown concentration (such as in emergencies)
(a)
Positive-pressure self-contained breathing apparatus (SCBA), equipped with full facepiece, or
(b)
Positive-pressure full facepiece supplied air respirator equipped with an auxiliary positive-pressure self-contained breathing apparatus.
Firefighting
(a)
Positive pressure self-contained breathing apparatus equipped with full facepiece.
Escape
(a)
Any respirator described above.
Note:
Respirators approved for use in higher concentrations are permitted to be used in lower concentrations.
(4) Protective clothing and equipment. Where employees could have eye or skin contact with EtO or EtO solutions, the employer must select and provide, at no cost to the employee, appropriate protective clothing or other equipment in accordance with WAC 296-800-160, and to protect any area of the body that may come in contact with liquid EtO or EtO in solution, and must ensure that the employee wears the protective clothing and equipment provided.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 05-03-093, § 296-62-07367, filed 1/18/05, effective 3/1/05. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07367, filed 5/9/01, effective 9/1/01; WSR 99-10-071, § 296-62-07367, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 94-20-057 (Order 94-16), § 296-62-07367, filed 9/30/94, effective 11/20/94; WSR 88-23-054 (Order 88-25), § 296-62-07367, filed 11/14/88; WSR 87-24-051 (Order 87-24), § 296-62-07367, filed 11/30/87.]



296-62-07369
Emergency situations.

(1) Written plan.
(a) A written plan for emergency situations shall be developed for each workplace where there is a possibility of an emergency. Appropriate portions of the plan shall be implemented in the event of an emergency.
(b) The plan shall specifically provide that employees engaged in correcting emergency conditions shall be equipped with respiratory protection as required by WAC 296-62-07367 until the emergency is abated.
(c) The plan shall include the elements prescribed in WAC 296-24-567, "Employee emergency plans and fire prevention plans."
(2) Alerting employees. Where there is the possibility of employee exposure to EtO due to an emergency, means shall be developed to alert potentially affected employees of such occurrences promptly. Affected employees shall be immediately evacuated from the area in the event that an emergency occurs.
[Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07369, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-07369, filed 11/30/87.]



296-62-07371
Medical surveillance.

(1) General.
(a) Employees covered.
(i) The employer shall institute a medical surveillance program for all employees who are or may be exposed to EtO at or above the action level, without regard to the use of respirators, for at least thirty days a year.
(ii) The employer shall make available medical examinations and consultations to all employees who have been exposed to EtO in an emergency situation.
(b) Examination by a physician. The employer shall ensure that all medical examinations and procedures are performed by or under the supervision of a licensed physician, and are provided without cost to the employee, without loss of pay, and at a reasonable time and place.
(2) Medical examinations and consultations.
(a) Frequency. The employer shall make available medical examinations and consultations to each employee covered under subsection (1)(a) of this section on the following schedules:
(i) Prior to assignment of the employee to an area where exposure may be at or above the action level for at least thirty days a year.
(ii) At least annually each employee exposed at or above the action level for at least thirty days in the past year.
(iii) At termination of employment or reassignment to an area where exposure to EtO is not at or above the action level for at least thirty days a year.
(iv) As medically appropriate for any employee exposed during an emergency.
(v) As soon as possible, upon notification by an employee either (A) that the employee has developed signs or symptoms indicating possible overexposure to EtO, or (B) that the employee desires medical advice concerning the effects of current or past exposure to EtO on the employee's ability to produce a healthy child.
(vi) If the examining physician determines that any of the examinations should be provided more frequently than specified, the employer shall provide such examinations to affected employees at the frequencies recommended by the physician.
(b) Content.
(i) Medical examinations made available pursuant to (a)(i) through (iv) of this subsection shall include:
(A) A medical and work history with special emphasis directed to symptoms related to the pulmonary, hematologic, neurologic, and reproductive systems and to the eyes and skin.
(B) A physical examination with particular emphasis given to the pulmonary, hematologic, neurologic, and reproductive systems and to the eyes and skin.
(C) A complete blood count to include at least a white cell count (including differential cell count), red cell count, hematocrit, and hemoglobin.
(D) Any laboratory or other test which the examining physician deems necessary by sound medical practice.
(ii) The content of medical examinations or consultation made available pursuant to (a)(i)(v) of this subsection shall be determined by the examining physician, and shall include pregnancy testing or laboratory evaluation of fertility, if requested by the employee and deemed appropriate by the physician.
(3) Information provided to the physician. The employer shall provide the following information to the examining physician:
(a) A copy of WAC 296-62-07355 through 296-62-07389.
(b) A description of the affected employee's duties as they relate to the employee's exposure.
(c) The employee's representative exposure level or anticipated exposure level.
(d) A description of any personal protective and respiratory equipment used or to be used.
(e) Information from previous medical examinations of the affected employee that is not otherwise available to the examining physician.
(4) Physician's written opinion.
(a) The employer shall obtain a written opinion from the examining physician. This written opinion shall contain the results of the medical examination and shall include:
(i) The physician's opinion as to whether the employee has any detected medical conditions that would place the employee at an increased risk of material health impairment from exposure to EtO;
(ii) Any recommended limitations on the employee or upon the use of personal protective equipment such as clothing or respirators; and
(iii) A statement that the employee has been informed by the physician of the results of the medical examination and of any medical conditions resulting from EtO exposure that require further explanation or treatment.
(b) The employer shall instruct the physician not to reveal in the written opinion given to the employer specific findings or diagnoses unrelated to occupational exposure to EtO.
(c) The employer shall provide a copy of the physician's written opinion to the affected employee within fifteen days from its receipt.
[Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-07371, filed 11/30/87.]



296-62-07373
Communication of EtO hazards.

(1) Hazard communication - General.
(a) Chemical manufacturers, importers, distributors and employers shall comply with all requirements of the Hazard Communication Standard (HCS), WAC 296-901-140 for EtO.
(b) In classifying the hazards of EtO at least the following hazards are to be addressed: Cancer; reproductive effects; mutagenicity; central nervous system; skin sensitization; skin, eye and respiratory tract irritation; acute toxicity effects; and flammability.
(c) Employers shall include EtO in the hazard communication program established to comply with the HCS, WAC 296-901-140. Employers shall ensure that each employee has access to labels on containers of EtO and to safety data sheets, and is trained in accordance with the requirements of HCS and WAC 296-855-20090.
(2) Signs and labels.
(a) Signs.
(i) The employer shall post and maintain legible signs demarcating regulated areas and entrances or accessways to regulated areas that bear the following legend:
DANGER
ETHYLENE OXIDE
MAY CAUSE CANCER
MAY DAMAGE FERTILITY OR THE UNBORN CHILD
RESPIRATORY PROTECTION AND PROTECTIVE CLOTHING MAY BE
REQUIRED IN THIS AREA
AUTHORIZED PERSONNEL ONLY
(ii) Prior to June 1, 2016, employers may use the following legend in lieu of that specified in (a)(i) of this subsection:
DANGER
ETHYLENE OXIDE
CANCER HAZARD AND REPRODUCTIVE HAZARD
AUTHORIZED PERSONNEL ONLY
RESPIRATORS AND PROTECTIVE CLOTHING MAY BE REQUIRED
TO BE WORN IN THIS AREA
(b) Labels.
(i) The employer shall ensure that labels are affixed to all containers of EtO whose contents are capable of causing employee exposure at or above the action level or whose contents may reasonably be foreseen to cause employee exposure above the excursion limit, and that the labels remain affixed when the containers of EtO leave the workplace. For the purpose of this subsection, reaction vessels, storage tanks, and pipes or piping systems are not considered to be containers.
(ii) Prior to June 1, 2015, employers may include the following information on containers of EtO in lieu of the labeling requirements in subsection (1)(a) of this section:
(A)
DANGER
CONTAINS ETHYLENE OXIDE
CANCER HAZARD AND REPRODUCTIVE HAZARD; and
(B) A warning statement against breathing airborne concentrations of EtO.
(c) The labeling requirements under WAC 296-62-07355 through 296-62-07389 do not apply where EtO is used as a pesticide, as such term is defined in the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. 136 et seq.), when it is labeled pursuant to that act and regulations issued under that act by the Environmental Protection Agency.
(d) The details of the hazard communication program developed by the employer, including an explanation of the labeling system and how employees can obtain and use the appropriate hazard information.
(3) Safety data sheets. Employers who are manufacturers or importers of EtO shall comply with the requirements regarding development of safety data sheets as specified in WAC 296-901-14014 of the Hazard Communication Standard.
(4) Information and training.
(a) The employer shall provide employees who are potentially exposed to EtO at or above the action level or above the excursion limit with information and training on EtO at the time of initial assignment and at least annually thereafter.
(b) Employees shall be informed of the following:
(i) The requirements of WAC 296-62-07353 through 296-62-07389 with an explanation of its contents, including Appendices A and B;
(ii) Any operations in their work area where EtO is present;
(iii) The location and availability of the written EtO final rule; and
(iv) The medical surveillance program required by WAC 296-62-07371 with an explanation of the information in Appendix C.
(c) Employee training shall include at least:
(i) Methods and observations that may be used to detect the presence or release of EtO in the work area (such as monitoring conducted by the employer, continuous monitoring devices, etc.);
(ii) The physical and health hazards of EtO;
(iii) The measures employees can take to protect themselves from hazards associated with EtO exposure, including specific procedures the employer has implemented to protect employees from exposure to EtO, such as work practices, emergency procedures, and personal protective equipment to be used; and
(iv) The details of the hazard communication program developed by the employer, including an explanation of the labeling system and how employees can obtain and use the appropriate hazard information.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-62-07373, filed 3/18/14, effective 5/1/14. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 07-03-163, § 296-62-07373, filed 1/24/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07373, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 88-23-054 (Order 88-25), § 296-62-07373, filed 11/14/88; WSR 87-24-051 (Order 87-24), § 296-62-07373, filed 11/30/87.]



296-62-07375
Recordkeeping.

(1) Objective data for exempted operations.
(a) Where the processing, use, or handling of products made from or containing EtO are exempted from other requirements of WAC 296-62-07355 through 296-62-07389 under WAC 296-62-07355, or where objective data have been relied on in lieu of initial monitoring under WAC 296-62-07361 (2)(b), the employer shall establish and maintain an accurate record of objective data reasonably relied upon in support of the exemption.
(b) This record shall include at least the following information:
(i) The product qualifying for exemption;
(ii) The source of the objective data;
(iii) The testing protocol, results of testing, and/or analysis of the material for the release of EtO;
(iv) A description of the operation exempted and how the data support the exemption; and
(v) Other data relevant to the operations, materials, processing, or employee exposures covered by the exemption.
(c) The employer shall maintain this record for the duration of the employer's reliance upon such objective data.
(2) Exposure measurements.
(a) The employer shall keep an accurate record of all measurements taken to monitor employee exposure to EtO as prescribed in WAC 296-62-07361.
(b) This record shall include at least the following information:
(i) The date of measurement;
(ii) The operation involving exposure to EtO which is being monitored;
(iii) Sampling and analytical methods used and evidence of their accuracy;
(iv) Number, duration, and results of samples taken;
(v) Type of protective devices worn, if any; and
(vi) Name, Social Security number and exposure of the employees whose exposures are represented.
(c) The employer shall maintain this record for at least thirty years, in accordance with chapter 296-802 WAC.
(3) Medical surveillance.
(a) The employer shall establish and maintain an accurate record for each employee subject to medical surveillance by WAC 296-62-07371 (1)(a), in accordance with chapter 296-802 WAC.
(b) The record shall include at least the following information:
(i) The name and Social Security number of the employee;
(ii) Physicians' written opinions;
(iii) Any employee medical complaints related to exposure to EtO; and
(iv) A copy of the information provided to the physician as required by WAC 296-62-07371(3).
(c) The employer shall ensure that this record is maintained for the duration of employment plus thirty years, in accordance with chapter 296-802 WAC.
(4) Availability.
(a) The employer, upon written request, shall make all records required to be maintained by WAC 296-62-07355 through 296-62-07389 available to the director for examination and copying.
(b) The employer, upon request, shall make any exemption and exposure records required by WAC 296-62-07377 (1) and (2) available for examination and copying to affected employees, former employees, designated representatives and the director, in accordance with chapter 296-802 WAC.
(c) The employer, upon request, shall make employee medical records required by subsection (3) of this section available for examination and copying to the subject employee, anyone having the specific written consent of the subject employee, and the director, in accordance with chapter 296-802 WAC.
(5) Transfer of records.
(a) The employer shall comply with the requirements concerning transfer of records set forth in chapter 296-802 WAC.
(b) Whenever the employer ceases to do business and there is no successor employer to receive and retain the records for the prescribed period, the employer shall notify the director at least ninety days prior to disposal and transmit them to the director.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-10-026, § 296-62-07375, filed 4/27/04, effective 8/1/04. Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-07375, filed 11/30/87.]



296-62-07377
Observation of monitoring.

(1) Employee observation. The employer shall provide affected employees or their designated representatives an opportunity to observe any monitoring of employee exposure to EtO conducted in accordance with WAC 296-62-07361.
(2) Observation procedures. When observation of the monitoring of employee exposure to EtO requires entry into an area where the use of protective clothing or equipment is required, the observer shall be provided with and be required to use such clothing and equipment and shall comply with all other applicable safety and health procedures.
[Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-07377, filed 11/30/87.]



296-62-07381
Appendices.

The information contained in the appendices is not intended by itself to create any additional obligations not otherwise imposed or to detract from any existing obligation.
[Statutory Authority: Chapter 49.17 RCW. WSR 87-24-051 (Order 87-24), § 296-62-07381, filed 11/30/87.]



296-62-07383
Appendix A—Substance safety data sheet for ethylene oxide (nonmandatory).

(1) Substance identification
(a) Substance: Ethylene oxide (C2H4O).
(b) Synonyms: Dihydrooxirene, dimethylene oxide, EO, 1,2-epoxyethane, EtO, ETO, oxacyclopropane, oxane, oxidoethane, alpha/beta-oxidoethane, oxiran, oxirane.
(c) Ethylene oxide can be found as a liquid or vapor.
(d) EtO is used in the manufacture of ethylene glycol, surfactants, ethanolamines, glycol ethers, and other organic chemicals. EtO is also used as a sterilant and fumigant.
(e) Appearance and odor: Colorless liquid below 10.7°C (51.3°F) or colorless gas with ether-like odor detected at approximately 700 parts EtO per million parts of air (700 ppm).
(f) Permissible exposure: Exposure may not exceed 1 part EtO per million parts of air averaged over the 8-hour work day.
(2) Health hazard data
(a) Ethylene oxide can cause bodily harm if you inhale the vapor, if it comes into contact with your eyes or skin, or if you swallow it.
(b) Effects of overexposure:
(i) Ethylene oxide in liquid form can cause eye irritation and injury to the cornea, frostbite, and severe irritation and blistering of the skin upon prolonged or confined contact. Ingestion of EtO can cause gastric irritation and liver injury. Acute effects from inhalation of EtO vapors include respiratory irritation and lung injury, headache, nausea, vomiting, diarrhea, shortness of breath, and cyanosis (blue or purple coloring of skin). Exposure has also been associated with the occurrence of cancer, reproductive effects, mutagenic changes, neurotoxicity, and sensitization.
(ii) EtO has been shown to cause cancer in laboratory animals and has been associated with higher incidences of cancer in humans. Adverse reproductive effects and chromosome damage may also occur from EtO exposure.
(c) Reporting signs and symptoms: You should inform your employer if you develop any signs or symptoms and suspect that they are caused by exposure to EtO.
(3) Emergency first-aid procedures
(a) Eye exposure: If EtO gets into your eyes, wash your eyes immediately with large amounts of water, lifting the lower and upper eyelids. Get medical attention immediately. Contact lenses should not be worn when working with this chemical.
(b) Skin exposure: If EtO gets on your skin, immediately wash the contaminated skin with water. If EtO soaks through your clothing, especially your shoes, remove the clothing immediately and wash the skin with water using an emergency deluge shower. Get medical attention immediately. Thoroughly wash contaminated clothing before reusing. Contaminated leather shoes or other leather articles should not be reused and should be discarded.
(c) Inhalation: If large amounts of EtO are inhaled, the exposed person must be moved to fresh air at once. If breathing has stopped, perform cardiopulmonary resuscitation. Keep the affected person warm and at rest. Get medical attention immediately.
(d) Swallowing: When EtO has been swallowed, give the person large quantities of water immediately. After the water has been swallowed, try to get the person to vomit by having him or her touch the back of the throat with his or her finger. Do not make an unconscious person vomit. Get medical attention immediately.
(e) Rescue: Move the affected person from the hazardous exposure. If the exposed person has been overcome, attempt rescue only after notifying at least one other person of the emergency and putting into effect established emergency procedures. Do not become a casualty yourself. Understand your emergency rescue procedures and know the location of the emergency equipment before the need arises.
(4) Respirators and protective clothing
(a) Respirators:
(i) You may be required to wear a respirator for nonroutine activities, in emergencies, while your employer is in the process of reducing EtO exposure through engineering controls, and in areas where engineering controls are not feasible. Only air supplied positive-pressure, full-facepiece respirators are approved for protection against EtO. If air-purifying respirators are worn in the future, they must have a label issued by the National Institute for Occupational Safety and Health (NIOSH) under the provisions of 42 C.F.R. part 84 stating that the respirators have been certified for use with ethylene oxide. For effective protection, respirators must fit your face and head snugly. Respirators must not be loosened or removed in work situations where their use is required.
(ii) EtO does not have a detectable odor except at levels well above the permissible exposure limits. If you can smell EtO while wearing a respirator, proceed immediately to fresh air. If you experience difficulty breathing while wearing a respirator, tell your employer.
(b) Protective clothing:
(i) You may be required to wear impermeable clothing, gloves, a face shield, or other appropriate protective clothing to prevent skin contact with liquid EtO or EtO-containing solutions. Where protective clothing is required, your employer must provide clean garments to you as necessary to assure that the clothing protects you adequately.
(ii) Replace or repair protective clothing that has become torn or otherwise damaged.
(iii) EtO must never be allowed to remain on the skin. Clothing and shoes which are not impermeable to EtO should not be allowed to become contaminated with EtO, and if they do, the clothing should be promptly removed and decontaminated. Contaminated leather shoes should be discarded. Once EtO penetrates shoes or other leather articles, they should not be worn again.
(c) Eye protection: You must wear splashproof safety goggles in areas where liquid EtO or EtO-containing solutions may contact your eyes. In addition, contact lenses should not be worn in areas where eye contact with EtO can occur.
(5) Precautions for safe use, handling, and storage
(a) EtO is a flammable liquid, and its vapors can easily form explosive mixtures in air.
(b) EtO must be stored in tightly closed containers in a cool, well-ventilated area, away from heat, sparks, flames, strong oxidizers, alkalines, and acids, strong bases, acetylide forming metals such as copper, silver, mercury and their alloys.
(c) Sources of ignition such as smoking material, open flames and some electrical devices are prohibited wherever EtO is handled, used, or stored in a manner that could create a potential fire or explosion hazard.
(d) You should use nonsparking tools when opening or closing metal containers of EtO, and containers must be bonded and grounded in the rare instances in which liquid EtO is poured or transferred.
(e) Impermeable clothing wet with liquid EtO or EtO-containing solutions may be easily ignited. If you are wearing impermeable clothing and are splashed with liquid EtO or EtO-containing solution, you should immediately remove the clothing while under an emergency deluge shower.
(f) If your skin comes into contact with liquid EtO or EtO-containing solutions, you should immediately remove the EtO using an emergency deluge shower.
(g) You should not keep food, beverages, or smoking materials in regulated areas where employee exposures are above the permissible exposure limits.
(h) Fire extinguishers and emergency deluge showers for quick drenching should be readily available, and you should know where they are and how to operate them.
(i) Ask your supervisor where EtO is used in your work area and for any additional plant safety and health rules.
(6) Access to information
(a) Each year, your employer is required to inform you of the information contained in this standard and appendices for EtO. In addition, your employer must instruct you in the proper work practices for using EtO emergency procedures, and the correct use of protective equipment.
(b) Your employer is required to determine whether you are being exposed to EtO. You or your representative has the right to observe employee measurements and to record the results obtained. Your employer is required to inform you of your exposure. If your employer determines that you are being overexposed, he or she is required to inform you of the actions which are being taken to reduce your exposure to within permissible exposure limits.
(c) Your employer is required to keep records of your exposures and medical examinations. These exposure records must be kept by the employer for at least thirty years. Medical records must be kept for the period of your employment plus thirty years.
(d) Your employer is required to release your exposure and medical records to your physician or designated representative upon your written request.
(7) Sterilant use of EtO in hospitals and health care facilities.
(a) This section of Appendix A, for informational purposes, sets forth EPA's recommendations for modifications in workplace design and practice in hospitals and health care facilities for which the Environmental Protection Agency has registered EtO for uses as a sterilant or fumigant under the Federal Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. 136 et seq. These new recommendations, published in the Federal Register by EPA at 49 FR 15268, as modified in today's Register, are intended to help reduce the exposure of hospital and health care workers to EtO to 1 ppm. EPA's recommended workplace design and workplace practice are as follows:
(i) Workplace design
(A) Installation of gas line hand valves. Hand valves must be installed on the gas supply line at the connection to the supply cylinders to minimize leakage during cylinder change.
(B) Installation of capture boxes. Sterilizer operations result in a gas/water discharge at the completion of the process. This discharge is routinely piped to a floor drain which is generally located in an equipment or an adjacent room. When the floor drain is not in the same room as the sterilizer and workers are not normally present, all that is necessary is that the room be well ventilated.
(C) The installation of a "capture box" will be required for those work place layouts where the floor drain is located in the same room as the sterilizer or in a room where workers are normally present. A "capture box" is a piece of equipment that totally encloses the floor drain where the discharge from the sterilizer is pumped. The "capture box" is to be vented directly to a nonrecirculating or dedicated ventilation system. Sufficient air intake should be allowed at the bottom of the box to handle the volume of air that is ventilated from the top of the box. The "capture box" can be made of metal, plastic, wood or other equivalent material. The box is intended to reduce levels of EtO discharged into the work room atmosphere. The use of a "capture box" is not required if: (I) The vacuum pump discharge floor drain is located in a well ventilated equipment or other room where workers are not normally present or (II) the water sealed vacuum pump discharges directly to a closed sealed sewer line (check local plumbing codes).
(D) If it is impractical to install a vented "capture box" and a well ventilated equipment or other room is not feasible, a box that can be sealed over the floor drain may be used if: (I) The floor drain is located in a room where workers are not normally present and EtO cannot leak into an occupied area, and (II) the sterilizer in use is less than 12 cubic feet in capacity (check local plumbing codes).
(ii) Ventilation of aeration units.
(A) Existing aeration units. Existing units must be vented to a nonrecirculating or dedicated system or vented to an equipment or other room where workers are not normally present and which is well ventilated. Aerator units must be positioned as close as possible to the sterilizer to minimize the exposure from the off-gassing of sterilized items.
(B) Installation of new aerator units (where none exist). New aerator units must be vented as described above for existing aerators. Aerators must be in place by July 1, 1986.
(iii) Ventilation during cylinder change. Workers may be exposed to short but relatively high levels of EtO during the change of gas cylinders. To reduce exposure from this route, users must select one of three alternatives designed to draw off gas that may be released when the line from the sterilizer to the cylinder is disconnected:
(A) Location of cylinders in a well ventilated equipment room or other room where workers are not normally present.
(B) Installation of a flexible hose (at least four inches in diameter) to a nonrecirculating or dedicated ventilation system and located in the area of cylinder change in such a way that the hose can be positioned at the point where the sterilizer gas line is disconnected from the cylinder.
(C) Installation of a hood that is part of a nonrecirculating or dedicated system and positioned no more than one foot above the point where the change of cylinders takes place.
(iv) Ventilation of sterilizer door area. One of the major sources of exposure to EtO occurs when the sterilizer door is opened following the completion of the sterilization process. In order to reduce this avenue of exposure, a hood or metal canopy closed on each end must be installed over the sterilizer door. The hood or metal canopy must be connected to a nonrecirculating or dedicated ventilation system or one that exhausts gases to a well ventilated equipment or other room where workers are not normally present. A hood or canopy over the sterilizer door is required for use even with those sterilizers that have a purge cycle and must be in place by July 1, 1986.
(v) Ventilation of sterilizer relief valve. Sterilizers are typically equipped with a safety relief device to release gas in case of increased pressure in the sterilizer. Generally, such relief devices are used on pressure vessels. Although these pressure relief devices are rarely opened for hospital and health care sterilizers, it is suggested that they be designed to exhaust vapor from the sterilizer by one of the following methods:
(A) Through a pipe connected to the outlet of the relief valve ventilated directly outdoors at a point high enough to be away from passers by, and not near any windows that open, or near any air conditioning or ventilation air intakes.
(B) Through a connection to an existing or new nonrecirculating or dedicated ventilation system.
(C) Through a connection to a well ventilated equipment or other room where workers are not normally present.
(vi) Ventilation systems. Each hospital and health care facility affected by this notice that uses EtO for the sterilization of equipment and supplies must have a ventilation system which enables compliance with the requirements of (a)(i)(B) through (v) of this subsection in the manner described in these sections and within the time frames allowed. Thus, each affected hospital and health care facility must have or install a nonrecirculating or dedicated ventilation equipment or other room where workers are not normally present in which to vent EtO.
(vii) Installation of alarm systems. An audible and visual indicator alarm system must be installed to alert personnel of ventilation system failures, i.e., when the ventilation fan motor is not working.
(b) Workplace practices
(i) All the workplace practices discussed in this unit must be permanently posted near the door of each sterilizer prior to use by any operator.
(ii) Changing of supply line filters.
Filters in the sterilizer liquid line must be changed when necessary, by the following procedure:
(A) Close the cylinder valve and the hose valve.
(B) Disconnect the cylinder hose (piping) from the cylinder.
(C) Open the hose valve and bleed slowly into a proper ventilating system at or near the in-use supply cylinders.
(D) Vacate the area until the line is empty.
(E) Change the filter.
(F) Reconnect the lines and reverse the valve position.
(G) Check hoses, filters, and valves for leaks with a fluorocarbon leak detector (for those sterilizers using the eighty-eight percent chlorofluorocarbon, twelve percent ethylene oxide mixture (12/88)).
(iii) Restricted access area.
(A) Areas involving use of EtO must be designated as restricted access areas. They must be identified with signs or floor marks near the sterilizer door, aerator, vacuum pump floor drain discharge, and in-use cylinder storage.
(B) All personnel must be excluded from the restricted area when certain operations are in progress, such as discharging a vacuum pump, emptying a sterilizer liquid line, or venting a nonpurge sterilizer with the door ajar or other operations where EtO might be released directly into the face of workers.
(iv) Door opening procedures.
(A) Sterilizers with purge cycles. A load treated in a sterilizer equipped with a purge cycle should be removed immediately upon completion of the cycle (provided no time is lost opening the door after cycle is completed). If this is not done, the purge cycle should be repeated before opening door.
(B) Sterilizers without purge cycles. For a load treated in a sterilizer not equipped with a purge cycle, the sterilizer door must be ajar six inches for fifteen minutes, and then fully opened for at least another fifteen minutes before removing the treated load. The length of time of the second period should be established by peak monitoring for one hour after the two fifteen-minute periods suggested. If the level is above 10 ppm time-weighted average for eight hours, more time should be added to the second waiting period (door wide open). However, in no case may the second period be shortened to less than fifteen minutes.
(v) Chamber unloading procedures.
(A) Procedures for unloading the chamber must include the use of baskets or rolling carts, or baskets and rolling tables to transfer treated loads quickly, thus avoiding excessive contact with treated articles, and reducing the duration of exposures.
(B) If rolling carts are used, they should be pulled not pushed by the sterilizer operators to avoid offgassing exposure.
(vi) Maintenance. A written log should be instituted and maintained documenting the date of each leak detection and any maintenance procedures undertaken. This is a suggested use practice and is not required.
(vii) Leak detection. Sterilizer door gaskets, cylinder and vacuum piping, hoses, filters, and valves must be checked for leaks under full pressure with a Fluorocarbon leak detector (for 12/88 systems only) every two weeks by maintenance personnel. Also, the cylinder piping connections must be checked after changing cylinders. Particular attention in leak detection should be given to the automatic solenoid valves that control the flow of EtO to the sterilizer. Specifically, a check should be made at the EtO gasline entrance port to the sterilizer, while the sterilizer door is open and the solenoid valves are in a closed position.
(viii) Maintenance procedures. Sterilizer/aerator door gaskets, valves, and fittings must be replaced when necessary as determined by maintenance personnel in their biweekly checks; in addition, visual inspection of the door gaskets for cracks, debris, and other foreign substances should be conducted daily by the operator.
[Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07383, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 88-14-108 (Order 88-11), § 296-62-07383, filed 7/6/88; WSR 87-24-051 (Order 87-24), § 296-62-07383, filed 11/30/87.]



296-62-07385
Appendix B—Substance technical guidelines for ethylene oxide (nonmandatory).

(1) Physical and chemical data:
(a) Substance identification:
(i) Synonyms: Dihydrooxirene, dimethylene oxide, EO, 1,2-epoxyethane, EtO, ETO, oxacyclopropane, oxane, oxidoethane, alpha/beta-oxidoethane, oxiran, oxirane.
(ii) Formula: (C2H4O).
(iii) Molecular weight: 44.06.
(b) Physical data:
(i) Boiling point (760 mm Hg): 10.70°C (51.3°F);
(ii) Specific gravity (water = 1): 0.87 (at 20°C or 68°F);
(iii) Vapor density (air = 1): 1.49;
(iv) Vapor pressure (at 20°C): 1,095 mm Hg;
(v) Solubility in water: Complete;
(vi) Appearance and odor: Colorless liquid; gas at temperature above 10.7°F or 51.3°C with ether-like odor above 700 ppm.
(2) Fire, explosion, and reactivity hazard data:
(a) Fire:
(i) Flash point; Less than 0°F (open cup);
(ii) Stability: Decomposes violently at temperatures above 800°F;
(iii) Flammable limits in air, percent by volume: Lower: 3, Upper: 100;
(iv) Extinguishing media: Carbon dioxide for small fires, polymer or alcohol foams for large fires;
(v) Special firefighting procedures: Dilution of ethylene oxide with 23 volumes of water renders it nonflammable;
(vi) Unusual fire and explosion hazards: Vapors of EtO will burn without the presence of air or other oxidizers. EtO vapors are heavier than air and may travel along the ground and be ignited by open flames or sparks at locations remote from the site at which EtO is being used.
(vii) For purposes of compliance with the requirements of WAC 296-24-330, EtO is classified as a flammable gas. For example, 7,500 ppm, approximately one-fourth of the lower flammable limit, would be considered to pose a potential fire and explosion hazard.
(viii) For purposes of compliance with WAC 296-24-585, EtO is classified as a Class B fire hazard.
(ix) For purpose of compliance with chapter 296-24 WAC Part L, and WAC 296-800-280, locations classified as hazardous due to the presence of EtO shall be Class I.
(b) Reactivity:
(i) Conditions contributing to instability: EtO will polymerize violently if contaminated with aqueous alkalies, amines, mineral acids, metal chlorides, or metal oxides. Violent decomposition will also occur at temperatures above 800°F;
(ii) Incompatibilities: Alkalines and acids;
(iii) Hazardous decomposition products: Carbon monoxide and carbon dioxide.
(3) Spill, leak, and disposal procedures:
(a) If EtO is spilled or leaked, the following steps should be taken:
(i) Remove all ignition sources.
(ii) The area should be evacuated at once and reentered only after the area has been thoroughly ventilated and washed down with water.
(b) Persons not wearing appropriate protective equipment should be restricted from areas of spills or leaks until cleanup has been completed.
(c) Waste disposal method: Waste material should be disposed of in a manner that is not hazardous to employees or to the general population. In selecting the method of waste disposal, applicable local, state, and federal regulations should be consulted.
(4) Monitoring and measurement procedures:
(a) Exposure above the permissible exposure limit:
(i) Eight-hour exposure evaluation: Measurements taken for the purpose of determining employee exposure under this section are best taken with consecutive samples covering the full shift. Air samples should be taken in the employee's breathing zone (air that would most nearly represent that inhaled by the employee.)
(ii) Monitoring techniques: The sampling and analysis under this section may be performed by collection of the EtO vapor on charcoal adsorption tubes or other composition adsorption tubes, with subsequent chemical analysis. Sampling and analysis may also be performed by instruments such as real time continuous monitoring systems, portable direct reading instruments, or passive dosimeters as long as measurements taken using these methods accurately evaluate the concentration of EtO in employees' breathing zones.
(iii) Appendix D describes the validated method of sampling and analysis which has been tested by OSHA for use with EtO. Other available methods are also described in Appendix D. The employer has the obligation of selecting a monitoring method which meets the accuracy and precision requirements of the standard under his/her unique field conditions. The standard requires that the method of monitoring should be accurate, to a ninety-five percent confidence level, to plus or minus twenty-five percent for concentrations of EtO at 1 ppm, and to plus or minus thirty-five percent for concentrations at 0.5 ppm. In addition to the method described in Appendix D, there are numerous other methods available for monitoring for EtO in the workplace. Details on these other methods have been submitted by various companies to the rulemaking record, and are available at the OSHA Docket Office.
(b) Since many of the duties relating to employee exposure are dependent on the results of measurement procedures, employers should assure that the evaluation of employee exposures is performed by a technically qualified person.
(5) Protective clothing and equipment:
(a) Employees should be provided with and be required to wear appropriate protective clothing wherever there is significant potential for skin contact with liquid EtO or EtO-containing solutions. Protective clothing shall include impermeable coveralls or similar full-body work clothing, gloves, and head coverings, as appropriate to protect areas of the body which may come in contact with liquid EtO or EtO-containing solutions.
(b) Employers should ascertain that the protective garments are impermeable to EtO. Permeable clothing, including items made of rubber, and leather shoes should not be allowed to become contaminated with liquid EtO. If permeable clothing does become contaminated, it should be immediately removed, while the employer is under an emergency deluge shower. If leather footwear or other leather garments become wet from EtO they should be discarded and not be worn again, because leather absorbs EtO and holds it against the skin.
(c) Any protective clothing that has been damaged or is otherwise found to be defective should be repaired or replaced. Clean protective clothing should be provided to the employee as necessary to assure employee protection. Whenever impermeable clothing becomes wet with liquid EtO, it should be washed down with water before being removed by the employee. Employees are also required to wear splashproof safety goggles where there is any possibility of EtO contacting the eyes.
(6) Miscellaneous precautions:
(a) Store EtO in tightly closed containers in a cool, well-ventilated area and take all necessary precautions to avoid any explosion hazard.
(b) Nonsparking tools must be used to open and close metal containers. These containers must be effectively grounded and bonded.
(c) Do not incinerate EtO cartridges, tanks or other containers.
(d) Employers should advise employees of all areas and operations where exposure to EtO occurs.
(7) Common operations:
Common operations in which exposure to EtO is likely to occur include the following: (a) Manufacture of EtO, (b) surfactants, (c) ethanolamines, (d) glycol ethers, (e) specialty chemicals, and (f) use as a sterilant in the hospital, health product and spice industries.
[Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07385, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 91-24-017 (Order 91-07), § 296-62-07385, filed 11/22/91, effective 12/24/91; WSR 88-14-108 (Order 88-11), § 296-62-07385, filed 7/6/88; WSR 87-24-051 (Order 87-24), § 296-62-07385, filed 11/30/87.]



296-62-07387
Appendix C—Medical surveillance guidelines for ethylene oxide (nonmandatory).

(1) Route of entry: Inhalation.
(2) Toxicology:
(a) Clinical evidence of adverse effects associated with the exposure to EtO is present in the form of increased incidence of cancer in laboratory animals (leukemia, stomach, brain), mutation in offspring in animals, and resorptions and spontaneous abortions in animals and human populations respectively. Findings in humans and experimental animals exposed to airborne concentrations of EtO also indicate damage to the genetic material (DNA). These include hemoglobin alkylation, unscheduled DNA synthesis, sister chromatid exchange chromosomal aberration, and functional sperm abnormalities.
(b) Ethylene oxide in liquid form can cause eye irritation and injury to the cornea, frostbite, severe irritation, and blistering of the skin upon prolonged or confined contact. Ingestion of EtO can cause gastric irritation and liver injury. Other effects from inhalation of EtO vapors include respiratory irritation and lung injury, headache, nausea, vomiting, diarrhea, dyspnea and cyanosis.
(3) Signs and symptoms of acute overexposure:
(a) The early effects of acute overexposure to EtO are nausea and vomiting, headache, and irritation of the eyes and respiratory passages. The patient may notice a "peculiar taste" in the mouth. Delayed effects can include pulmonary edema, drowsiness, weakness, and incoordination. Studies suggest that blood cell changes, an increase in chromosomal aberrations, and spontaneous abortion may also be casually related to acute overexposure to EtO.
(b) Skin contact with liquid or gaseous EtO causes characteristic burns and possible even an allergic-type sensitization. The edema and erythema occurring from skin contact with EtO progress to vesiculation with a tendency to coalesce into blebs with desquamation. Healing occurs within three weeks, but there may be a residual brown pigmentation. A 40-80% solution is extremely dangerous, causing extensive blistering after only brief contact. Pure liquid EtO causes frostbite because of rapid evaporation. In contrast, the eye is relatively insensitive to EtO, but there may be some irritation of the cornea.
(c) Most reported acute effects of occupational exposure to EtO are due to contact with EtO in liquid phase. The liquid readily penetrates rubber and leather, and will produce blistering if clothing or footwear contaminated with EtO are not removed.
(4) Surveillance and preventive considerations:
(a) As noted above, exposure to EtO has been linked to an increased risk of cancer and reproductive effects including decreased male fertility, fetotoxicity, and spontaneous abortion. EtO workers are more likely to have chromosomal damage than similar groups not exposed to EtO. At the present, limited studies of chronic effects in humans resulting from exposure to EtO suggest a causal association with leukemia. Animal studies indicate leukemia and cancers at other sites (brain, stomach) as well. The physician should be aware of the findings of these studies in evaluating the health of employees exposed to EtO.
(b) Adequate screening tests to determine an employee's potential for developing serious chronic diseases, such as cancer, from exposure to EtO do not presently exist. Laboratory tests may, however, give evidence to suggest that an employee is potentially overexposed to EtO. It is important for the physician to become familiar with the operating conditions in which exposure to EtO is likely to occur. The physician also must become familiar with the signs and symptoms that indicate a worker is receiving otherwise unrecognized and unacceptable exposure to EtO. These elements are especially important in evaluating the medical and work histories and in conducting the physical exam. When an unacceptable exposure in an active employee is identified by the physician, measures taken by the employer to lower exposure should also lower the risk of serious long-term consequences.
(c) The employer is required to institute a medical surveillance program for all employees who are or will be exposed to EtO at or above the action level (0.5 ppm) for at least thirty days per year, without regard to respirator use. All examinations and procedures must be performed by or under the supervision of a licensed physician at a reasonable time and place for the employee and at no cost to the employee.
(d) Although broad latitude in prescribing specific tests to be included in the medical surveillance program is extended to the examining physician, WISHA requires inclusion of the following elements in the routine examination:
(i) Medical and work histories with special emphasis directed to symptoms related to the pulmonary, hematologic, neurologic, and reproductive systems and to the eyes and skin.
(ii) Physical examination with particular emphasis given to the pulmonary, hematologic, neurologic, and reproductive systems and to the eyes and skin.
(iii) Complete blood count to include at least a white cell count (including differential cell count), red cell count, hematocrit, and hemoglobin.
(iv) Any laboratory or other test which the examining physician deems necessary by sound medical practice.
(e) If requested by the employee, the medical examinations shall include pregnancy testing or laboratory evaluation of fertility as deemed appropriate by the physician.
(f) In certain cases, to provide sound medical advice to the employer and the employee, the physician must evaluate situations not directly related to EtO. For example, employees with skin diseases may be unable to tolerate wearing protective clothing. In addition those with chronic respiratory diseases may not tolerate the wearing of negative pressure (air purifying) respirators. Additional tests and procedures that will help the physician determine which employees are medically unable to wear such respirators should include: An evaluation of cardiovascular function, a baseline chest X-ray to be repeated at five year intervals, and a pulmonary function test to be repeated every three years. The pulmonary function test should include measurement of the employee's forced vital capacity (FVC), forced expiratory volume at one second (FEV1), as well as calculation of the ratios of FEV1 to FVC, and measured FVC and measured FEV1 to expected values corrected for variation due to age, sex, race, and height.
(g) The employer is required to make the prescribed tests available at least annually to employees who are or will be exposed at or above the action level, for thirty or more days per year; more often than specified if recommended by the examining physician; and upon the employee's termination of employment or reassignment to another work area. While little is known about the long-term consequences of high short-term exposures, it appears prudent to monitor such affected employees closely in light of existing health data. The employer shall provide physician recommended examinations to any employee exposed to EtO in emergency conditions. Likewise, the employer shall make available medical consultations including physician recommended exams to employees who believe they are suffering signs or symptoms of exposure to EtO.
(h) The employer is required to provide the physician with the following information: A copy of this standard and its appendices; a description of the affected employee's duties as they relate to the employee exposure level; and information from the employee's previous medical examinations which is not readily available to the examining physician. Making this information available to the physician will aid in the evaluation of the employee's health in relation to assigned duties and fitness to wear personal protective equipment, when required.
(i) The employer is required to obtain a written opinion from the examining physician containing the results of the medical examinations; the physician's opinion as to whether the employee has any detected medical conditions which would place the employee at increased risk of material impairment of his or her health from exposure to EtO; any recommended restrictions upon the employee's exposure to EtO, or upon the use of protective clothing or equipment such as respirators; and a statement that the employee has been informed by the physician of the results of the medical examination and of any medical conditions which require further explanation or treatment. This written opinion must not reveal specific findings or diagnoses unrelated to occupational exposure to EtO, and a copy of the opinion must be provided to the affected employee.
(j) The purpose in requiring the examining physician to supply the employer with a written opinion is to provide the employer with a medical basis to aid in the determination of initial placement of employees and to assess the employee's ability to use protective clothing and equipment.
[Statutory Authority: Chapter 49.17 RCW. WSR 88-14-108 (Order 88-11), § 296-62-07387, filed 7/6/88; WSR 87-24-051 (Order 87-24), § 296-62-07387, filed 11/30/87.]



296-62-07389
Appendix D—Sampling and analytical methods for ethylene oxide (nonmandatory).

(1) A number of methods are available for monitoring employee exposures to EtO. Most of these involve the use of charcoal tubes and sampling pumps, followed by analysis of the samples by gas chromatograph. The essential differences between the charcoal tube methods include, among others, the use of different desorbing solvents, the use of different lots of charcoal, and the use of different equipment for analysis of the samples. Besides charcoal, methods using passive dosimeters, gas sampling bags, impingers, and detector tubes have been utilized for determination of EtO exposure. In addition, there are several commercially available portable gas analyzers and monitoring units. This appendix contains details for the method which has been tested at the OSHA Analytical Laboratory in Salt Lake City. Inclusion of this method in the appendix does not mean that this method is the only one which will be satisfactory. Copies of descriptions of other methods available are available in the rulemaking record, and may be obtained from the OSHA Docket Office. These include the Union Carbide, Dow Chemical, 3M, and DuPont methods, as well as NIOSH Method S-286. These methods are briefly described at the end of this appendix.
(2) Employers who note problems with sample breakthrough using the OSHA or other charcoal methods should try larger charcoal tubes. Tubes of larger capacity are available. In addition, lower flow rates and shorter sampling times should be beneficial in minimizing breakthrough problems. Whatever method the employer chooses, he/she must assure himself/herself of the method's accuracy and precision under the unique conditions present in his workplace.
(3) Ethylene oxide:
(a) Method No.: 30.
(b) Matrix: Air.
(i) Target concentration: 1.0 ppm (1.8 mg/m3)
(ii) Procedure: Samples are collected on two charcoal tubes in series and desorbed with 1% CS2 in benzene. The samples are derivatized with HBr and treated with sodium carbonate. Analysis is done by gas chromatography with an electron capture detector.
(iii) Recommended air volume and sampling rate: 1 liter and 0.05 Lpm.
(iv) Detection limit of the overall procedure: 13.3 ppb (0.024 mg/m3) (based on 1.0 liter air sample).
(v) Reliable quantitation limit: 52.2 ppb (0.094 mg/m3) (based on 1.0 liter air sample).
(vi) Standard error of estimate: 6.59% (see backup section 4.6).
(vii) Special requirements: Samples must be analyzed within fifteen days of sampling date.
(viii) Status of method: The sampling and analytical method has been subject to the established evaluation procedures of the Organic Method Evaluations Branch.
(c) Date: August 1981.
(d) Chemist: Wayne D. Potter
(e) Organic Solvents Branch, OSHA Analytical Laboratory, Salt Lake City, Utah
(f) General discussion:
(i) Background.
(A) History of procedure.
(I) Ethylene oxide samples analyzed at the OSHA laboratory have normally been collected on activated charcoal and desorbed with carbon disulfide. The analysis is performed with a gas chromatograph equipped with a FID (flame ionization detector) as described in NIOSH Method S286 (Ref. (3)(j)(i)). This method is based on a PEL of 50 ppm and has a detection limit of about 1 ppm.
(II) Recent studies have prompted the need for a method to analyze and detect ethylene oxide at very low concentrations.
(III) Several attempts were made to form an ultraviolet (UV) sensitive derivative with ethylene oxide for analysis with HPLC. Among those tested that gave no detectable product were: p-anisidine, methylimidazole, aniline, and 2,3,6-trichlorobenzoic acid. Each was tested with catalysts such as triethylamine, aluminum chloride, methylene chloride and sulfuric acid but no detectable derivative was produced.
(IV) The next derivatization attempt was to react ethylene oxide with HBr to form 2-bromoethanol. This reaction was successful. An ECD (electron capture detector) gave a very good response for 2-bromoethanol due to the presence of bromine. The use of carbon disulfide as the desorbing solvent gave too large a response and masked the 2-bromoethanol. Several other solvents were tested for both their response on the ECD and their ability to desorb ethylene oxide from the charcoal. Among those tested were toluene, xylene, ethyl benzene, hexane, cyclohexane and benzene. Benzene was the only solvent tested that gave a suitable response on the ECD and a high desorption. It was found that the desorption efficiency was improved by using 1% CS2 with the benzene. The carbon disulfide did not significantly improve the recovery with the other solvents. SKC Lot 120 was used in all tests done with activated charcoal.
(B) Physical properties (Ref. (3)(j)(ii) - (iv)):
(I) Synonyms: Oxirane; dimethylene oxide; 1,2-epoxy-ethane; oxane; C2H4O; ETO;
(II) Molecular weight: 44.06;
(III) Boiling point: 10.7°C (51.3°);
(IV) Melting point: --111°C;
(V) Description: Colorless, flammable gas;
(VI) Vapor pressure: 1095 mm. at 20°C;
(VII) Odor: Ether-like odor;
(VIII) Lower explosive limits: 3.0% (by volume);
(IX) Flash point (TOC): Below 0°F;
(X) Molecular structure: CH2--CH2;
(ii) Limit defining parameters:
(A) Detection limit of the analytical procedure. The detection limit of the analytical procedure is 12.0 picograms of ethylene oxide per injection. This is the amount of analyte which will give a peak whose height is five times the height of the baseline noise. (See backup data section (3)(i)(i).)
(B) Detection limit of the overall procedure.
(I) The detection limit of the overall procedure is 24.0 ng of ethylene oxide per sample.
(II) This is the amount of analyte spiked on the sampling device which allows recovery of an amount of analyte equivalent to the detection limit of the analytical procedure. (See backup data section (3)(i)(ii).)
(C) Reliable quantitation limit.
(I) The reliable quantitation limit is 94.0 nanograms of ethylene oxide per sample. This is the smallest amount of analyte which can be quantitated within the requirements of 75% recovery and 95% confidence limits. (See backup data section (3)(i)(ii).)
(II) It must be recognized that the reliable quantitation limit and detection limits reported in the method are based upon optimization of the instrument for the smallest possible amount of analyte. When the target concentration of an analyte is exceptionally higher than these limits, they may not be attainable at the routine operating parameters. In this case, the limits reported on analysis reports will be based on the operating parameters used during the analysis of the samples.
(D) Sensitivity.
(I) The sensitivity of the analytical procedure over a concentration range representing 0.5 to 2 times the target concentration based on the recommended air volume is 34105 area units per ug/mL. The sensitivity is determined by the slope of the calibration curve (see backup data section (3)(i)(iii)).
(II) The sensitivity will vary somewhat with the particular instrument used in the analysis.
(E) Recovery. The recovery of analyte from the collection medium must be 75% or greater. The average recovery from spiked samples over the range of 0.5 to 2 times the target concentration is 88.0% (see backup section (3)(i)(iv)). At lower concentrations the recovery appears to be nonlinear.
(F) Precision (analytical method only). The pooled coefficient of variation obtained from replicate determination of analytical standards at 0.5X, 1X and 2X the target concentration is 0.036 (see backup data section (3)(i)(v)).
(G) Precision (overall procedure).
(I) The overall procedure must provide results at the target concentration that are 25% or better at the 95% confidence level. The precision at the 95% confidence level for the fifteen day storage test is plus or minus 12.9% (see backup data section (3)(i)(vi)).
(II) This includes an additional plus or minus 5% for sampling error.
(iii) Advantages.
(A) The sampling procedure is convenient.
(B) The analytical procedure is very sensitive and reproducible.
(C) Reanalysis of samples is possible.
(D) Samples are stable for at least fifteen days at room temperature.
(E) Interferences are reduced by the longer GC retention time of the new derivative.
(iv) Disadvantages.
(A) Two tubes in series must be used because of possible breakthrough and migration.
(B) The precision of the sampling rate may be limited by the reproducibility of the pressure drop across the tubes. The pumps are usually calibrated for one tube only.
(C) The use of benzene as the desorption solvent increases the hazards of analysis because of the potential carcinogenic effects of benzene.
(D) After repeated injections there can be a buildup of residue formed on the electron capture detector which decreases sensitivity.
(E) Recovery from the charcoal tubes appears to be nonlinear at low concentrations.
(g) Sampling procedure.
(i) Apparatus.
(A) A calibrated personal sampling pump whose flow can be determined within plus or minus 5% of the recommended flow.
(B) SKC Lot 120 Charcoal tubes: Glass tube with both ends flame sealed, 7 cm long with a 6 mm O.D. and a 4-mm I.D., containing 2 sections of coconut shell charcoal separated by a 2-mm portion of urethane foam. The adsorbing section contains 100 mg of charcoal, the backup section 50 mg. A 3-mm portion of urethane foam is placed between the outlet end of the tube and the backup section. A plug of silylated glass wool is placed in front of the adsorbing section.
(ii) Reagents.
None required.
(iii) Sampling technique.
(A) Immediately before sampling, break the ends of the charcoal tubes. All tubes must be from the same lot.
(B) Connect two tubes in series to the sampling pump with a short section of flexible tubing. A minimum amount of tubing is used to connect the two sampling tubes together. The tube closer to the pump is used as a backup. This tube should be identified as the backup tube.
(C) The tubes should be placed in a vertical position during sampling to minimize channeling.
(D) Air being sampled should not pass through any hose or tubing before entering the charcoal tubes.
(E) Seal the charcoal tubes with plastic caps immediately after sampling. Also, seal each sample with OSHA seals lengthwise.
(F) With each batch of samples, submit at least one blank tube from the same lot used for samples. This tube should be subjected to exactly the same handling as the samples (break, seal, transport) except that no air is drawn through it.
(G) Transport the samples (and corresponding paperwork) to the lab for analysis.
(H) If bulk samples are submitted for analysis, they should be transported in glass containers with Teflon-lined caps. These samples must be mailed separately from the container used for the charcoal tubes.
(iv) Breakthrough.
The breakthrough (5% breakthrough) volume for a 3.0 mg/m3 ethylene oxide sample stream at approximately 85% relative humidity, 22°C and 633 mm is 2.6 liters sampled at 0.05 liters per minute. This is equivalent to 7.8 µg of ethylene oxide. Upon saturation of the tube it appeared that the water may be displacing ethylene oxide during sampling.
(v) Desorption efficiency.
(A) The desorption efficiency, from liquid injection onto charcoal tubes, averaged 88.0% from 0.5 to 2.0 x the target concentration for a 1.0 liter air sample. At lower ranges it appears that the desorption efficiency is nonlinear (see backup data section (3)(i)(ii)).
(B) The desorption efficiency may vary from one laboratory to another and also from one lot of charcoal to another. Thus, it is necessary to determine the desorption efficiency for a particular lot of charcoal.
(vi) Recommended air volume and sampling rate.
(A) The recommended air volume is 1.0 liter.
(B) The recommended maximum sampling rate is 0.05 Lpm.
(vii) Interferences.
(A) Ethylene glycol and Freon 12 at target concentration levels did not interfere with the collection of ethylene oxide.
(B) Suspected interferences should be listed on the sample data sheets.
(C) The relative humidity may affect the sampling procedure.
(viii) Safety precautions.
(A) Attach the sampling equipment to the employee so that it does not interfere with work performance.
(B) Wear safety glasses when breaking the ends of the sampling tubes.
(C) If possible, place the sampling tubes in a holder so the sharp end is not exposed while sampling.
(h) Analytical method.
(i) Apparatus.
(A) Gas chromatograph equipped with a linearized electron capture detector.
(B) GC column capable of separating the derivative of ethylene oxide (2-bromoethanol) from any interferences and the 1% CS2 in benzene solvent. The column used for validation studies was: 10 ft x 1/8 inch stainless steel 20% SP-2100, .1% Carbowax 1500 on 100/120 Supelcoport.
(C) An electronic integrator or some other suitable method of measuring peak areas.
(D) Two milliliter vials with Teflon-lined caps.
(E) Gas tight syringe—500 µL or other convenient sizes for preparing standards.
(F) Microliter syringes—10 µL or other convenient sizes for diluting standards and 1 µL for sample injections.
(G) Pipets for dispensing the 1% CS2 in benzene solvent. The Glenco 1 mL dispenser is adequate and convenient.
(H) Volumetric flasks—5 mL and other convenient sizes for preparing standards.
(I) Disposable Pasteur pipets.
(ii) Reagents.
(A) Benzene, reagent grade.
(B) Carbon disulfide, reagent grade.
(C) Ethylene oxide, 99.7% pure.
(D) Hydrobromic acid, 48% reagent grade.
(E) Sodium carbonate, anhydrous, reagent grade.
(F) Desorbing reagent, 99% Benzene/1% CS2.
(iii) Sample preparation.
(A) The front and back sections of each sample are transferred to separate 2-mL vials.
(B) Each sample is desorbed with 1.0 mL of desorbing reagent.
(C) The vials are sealed immediately and allowed to desorb for one hour with occasional shaking.
(D) Desorbing reagent is drawn off the charcoal with a disposable pipet and put into clean 2-mL vials.
(E) One drop of HBr is added to each vial. Vials are resealed and HBr is mixed well with the desorbing reagent.
(F) About 0.15 gram of sodium carbonate is carefully added to each vial. Vials are again resealed and mixed well.
(iv) Standard preparation.
(A) Standards are prepared by injecting the pure ethylene oxide gas into the desorbing reagent.
(B) A range of standards are prepared to make a calibration curve. A concentration of 1.0 µL of ethylene oxide gas per 1 mL desorbing reagent is equivalent to 1.0 ppm air concentration (all gas volumes at 25°C and 760 mm) for the recommended 1 liter air sample. This amount is uncorrected for desorption efficiency (see backup data section (3)(i)(ii), for desorption efficiency corrections).
(C) One drop of HBr per mL of standard is added and mixed well.
(D) About 0.15 grams of sodium carbonate is carefully added for each drop of HBr (a small reaction will occur).
(v) Analysis.
(A) GC conditions.
Nitrogen flow rate—10mL/min.
Injector temperature—250°C
Detector temperature—300°C
Column temperature—100°C
Injection size—0.8 µL
Elution time—3.9 minutes
(B) Peak areas are measured by an integrator or other suitable means.
(C) The integrator results are in area units and a calibration curve is set up with concentration vs. area units.
(vi) Interferences.
(A) Any compound having the same retention time of 2-bromoethanol is a potential interference. Possible interferences should be listed on the sample data sheets.
(B) GC parameters may be changed to circumvent interferences.
(C) There are usually trace contaminants in benzene.
These contaminants, however, posed no problem of interference.
(D) Retention time date on a single column is not considered proof of chemical identity. Samples over the 1.0 ppm target level should be confirmed by GC/Mass Spec or other suitable means.
(vii) Calculations.
(A) The concentration in µg/mL for a sample is determined by comparing the area of a particular sample to the calibration curve, which has been prepared from analytical standards.
(B) The amount of analyte in each sample is corrected for desorption efficiency by use of a desorption curve.
(C) Analytical results, A, from the two tubes that compose a particular air sample are added together.
(D) The concentration for a sample is calculated by the following equation:
ETO, mg/m3
=
AXB
 
C
where:
A
=
µg/mL
B
=
desorption volume in milliliters
C
=
air volume in liters.
(E) To convert mg/m3 to parts per million (ppm) the following relationship is used:
ETO, ppm
=
mg/m3 x 24.45
 
44.05
where:
mg/m3
=
results from 3.7.4
24.45
=
molar volume at 25°C and 760 mm Hg
44.05
=
air volume in liters.
(viii) Safety precaution
(A) Ethylene oxide and benzene are potential carcinogens and care must be exercised when working with these compounds.
(B) All work done with the solvents (preparation of standards, desorption of samples, etc.) should be done in a hood.
(C) Avoid any skin contact with all of the solvents.
(D) Wear safety glasses at all times.
(E) Avoid skin contact with HBr because it is highly toxic and a strong irritant to eyes and skin.
(i) Backup data.
(i) Detection limit data.
The detection limit was determined by injecting 0.8 µL of a 0.015 µg/mL standard of ethylene oxide into 1% CS2 in benzene. The detection limit of the analytical procedure is taken to be 1.20 x 10-5 µg per injection. This is equivalent to 8.3 ppb (0.015 mg/m3) for the recommended air volume.
(ii) Desorption efficiency. Ethylene oxide was spiked into charcoal tubes and the following recovery data was obtained:
Amount
spiked (µg)
Amount
recovered (µg)
Percent
recovery
4.5
4.32
96.0
3.0
2.61
87.0
2.25
2.025
90.0
1.5
1.365
91.0
1.5
1.38
92.0
.75
6525
87.0
.375
.315
84.0
.375
.312
83.2
.1875
.151
80.5
.094
.070
74.5
Note:
At lower amounts the recovery appears to be nonlinear.
(iii) Sensitivity data. The following data was used to determine the calibration curve:
Injection
0.5 x .75
µg/mL
1 x 1.5
µg/mL
2 x 3.0
µg/mL
1 . . . . . . . . . .
30904
59567
111778
2 . . . . . . . . . .
30987
62914
106016
3 . . . . . . . . . .
32555
58578
106122
4 . . . . . . . . . .
32242
57173
109716
X . . . . . . . . . .
31672
59558
108408
Slope = 34.105.
(iv) Recovery. The recovery was determined by spiking ethylene oxide onto lot 120 charcoal tubes and desorbing with 1% CS2 in Benzene. Recoveries were done at 0.5, 1.0, and 2.0 X the target concentration (1 ppm) for the recommended air volume.
Percent Recovery
Sample
0.5x
1.0x
2.0x
1 . . . . . . . . . .
88.7
95.0
91.7
2 . . . . . . . . . .
83.8
95.0
87.3
3 . . . . . . . . . .
84.2
91.0
86.0
4 . . . . . . . . . .
88.0
91.0
83.0
5 . . . . . . . . . .
88.0
86.0
85.0
X . . . . . . . . . .
86.5
90.5
87.0
Weighted average = 88.2
(v) Precision of the analytical procedure. The following data was used to determine the precision of the analytical method:
Concentration
0.5 x .75
µg/mL
1 x 1.5
µg/mL
2 x 3.0
µg/mL
Injection
.7421
.7441
.7831
.7753
.7612
1.4899
1.5826
1.4628
1.4244
1.4899
3.1184
3.0447
2.9149
2.9185
2.9991
Average
Standard
Deviation
.0211
.0674
.0998
CV . . . . . . . .
.0277
.0452
.0333
CV
=
3(.0277) + 3 (.0452)2 + 3 (.0333)2
3 + 3 + 3
   CV  +   0.036
(vi) Storage data. Samples were generated at 1.5 mg/m3 ethylene oxide at 85% relative humidity, 22°C and 633 mm. All samples were taken for twenty minutes at 0.05 Lpm. Six samples were analyzed as soon as possible and fifteen samples were stored at refrigerated temperature (5°C) and fifteen samples were stored at ambient temperature (23°C). These stored samples were analyzed over a period of nineteen days.
Percent Recovery
Day analyzed
Refrigerated
Ambient
1 . . . . . . . . . . . .
87.0
87.0
1 . . . . . . . . . . . .
93.0
93.0
1 . . . . . . . . . . . .
94.0
94.0
1 . . . . . . . . . . . .
92.0
92.0
4 . . . . . . . . . . . .
92.0
91.0
4 . . . . . . . . . . . .
93.0
88.0
4 . . . . . . . . . . . .
91.0
89.0
6 . . . . . . . . . . . .
92.0
 
. . . .
 
6 . . . . . . . . . . . .
92.0
. . . .
 
8 . . . . . . . . . . . .
. . . .
 
92.0
8 . . . . . . . . . . . .
. . . .
 
86.0
10 . . . . . . . . . . .
91.7
. . . .
 
10 . . . . . . . . . . .
95.5
. . . .
 
10 . . . . . . . . . . .
95.7
. . . .
 
11 . . . . . . . . . . .
. . . .
 
90.0
11 . . . . . . . . . . .
. . . .
 
82.0
13 . . . . . . . . . . .
78.0
. . . .
 
13 . . . . . . . . . . .
81.4
. . . .
 
13 . . . . . . . . . . .
82.4
. . . .
 
14 . . . . . . . . . . .
. . . .
 
78.5
14 . . . . . . . . . . .
. . . .
 
72.1
18 . . . . . . . . . . .
66.0
. . . .
 
18 . . . . . . . . . . .
68.0
. . . .
 
19 . . . . . . . . . . .
. . . .
 
64.0
19 . . . . . . . . . . .
. . . .
 
77.0
(vii) Breakthrough data.
(A) Breakthrough studies were done at 2 ppm (3.6 mg/m3) at approximately 85% relative humidity at 22°C (ambient temperature). Two charcoal tubes were used in series. The backup tube was changed every ten minutes and analyzed for breakthrough. The flow rate was 0.050 Lpm.
Tube No.
Time
(Minutes)
Percent
breakthrough
1 . . . . . . . . . . . . . . . .
10
(1)
2 . . . . . . . . . . . . . . . .
20
(1)
3 . . . . . . . . . . . . . . . .
30
(1)
4 . . . . . . . . . . . . . . . .
40
1.23
5 . . . . . . . . . . . . . . . .
50
3.46
6 . . . . . . . . . . . . . . . .
60
18.71
7 . . . . . . . . . . . . . . . .
70
39.2
8 . . . . . . . . . . . . . . . .
80
53.3
9 . . . . . . . . . . . . . . . .
90
72.0
10 . . . . . . . . . . . . . . .
100
96.0
11 . . . . . . . . . . . . . . .
110
113.0
12 . . . . . . . . . . . . . . .
120
133.9
1
None.
(B) The 5% breakthrough volume was reached when 2.6 liters of test atmosphere were drawn through the charcoal tubes.
(j) References.
(i) "NIOSH Manual of Analytical Methods," 2nd ed. NIOSH: Cincinnati, 1977; Method S 286.
(ii) "IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man." International Agency for Research on Cancer: Lyon, 1976; Vol. II, p. 157.
(iii) Sax., N.I. "Dangerous Properties of Industrial Materials," 4th ed.; Van Nostrand Reinhold Company, New York, 1975; p. 741.
(iv) "The Condensed Chemical Dictionary," 9th ed.; Hawley, G.G., ed.; Van Nostrand Reinhold Company, New York, 1977; p. 361.
(4) Summary of other sampling procedures. OSHA believes that several other types of monitoring equipment and techniques exist for monitoring time-weighted averages. Considerable research and method development is currently being performed, which will lead to improvements and a wider variety of monitoring techniques. A combination of monitoring procedures can be used. There probably is no one best method for monitoring personal exposure to ethylene oxide in all cases. There are advantages, disadvantages, and limitations to each method. The method of choice will depend on the need and requirements. Some commonly used methods include the use of charcoal tubes, passive dosimeters, Tedler gas sampling bags, detector tubes, photoionization detection units, infrared detection units and gas chromatographs. A number of these methods are described below.
(a) Charcoal tube sampling procedures.
(i) Qazi-Ketcham method (Ex-11-133)—This method consists of collecting EtO on Columbia JXC activated carbon, desorbing the EtO with carbon disulfide and analyzing by gas chromatography with flame ionization detection. Union Carbide has recently updated and revalidated this monitoring procedure. This method is capable of determining both eight-hour time-weighted average exposures and short-term exposures. The method was validated to 0.5 ppm. Like other charcoal collecting procedures, the method requires considerable analytical expertise.
(ii) ASTM-proposed method—The Ethylene Oxide Industry Council (EOIC) has contracted with Clayton Environmental Consultants, Inc. to conduct a collaborative study for the proposed method. The ASTM-Proposed method is similar to the method published by Qazi and Ketcham in the November 1977 American Industrial Hygiene Association Journal, and to the method of Pilney and Coyne, presented at the 1979 American Industrial Hygiene Conference. After the air to be sampled is drawn through an activated charcoal tube, the ethylene oxide is desorbed from the tube using carbon disulfide and is quantitated by gas chromatography utilizing a flame ionization detector. The ASTM-proposed method specifies a large two-section charcoal tube, shipment in dry ice, storage at less than -5°C, and analysis within three weeks to prevent migration and sample loss. Two types of charcoal tubes are being tested—Pittsburgh Coconut-Based (PCB) and columbia JXC charcoal. This collaborative study will give an indication of the inter- and intralaboratory precision and accuracy of the ASTM/proposed method. Several laboratories have considerable expertise using the Qazi-Ketcham and Dow methods.
(b) Passive monitors—Ethylene oxide diffuses into the monitor and is collected in the sampling media. The DuPont Pro-Tek badge collects EtO in an absorbing solution, which is analyzed colorimetrically to determine the amount of EtO present. The 3M 350 badge collects the EtO on chemically treated charcoal. Other passive monitors are currently being developed and tested. Both 3M and DuPont have submitted data indicating their dosimeters meet the precision and accuracy requirements of the proposed ethylene oxide standard. Both presented laboratory validation data to 0.2 ppm (Exs. 11-65, 4-20, 108, 109, 130).
(c) Tedlar gas sampling bags-samples are collected by drawing a known volume of air into a Tedlar gas sampling bag. The ethylene oxide concentration is often determined on-site using a portable gas chromatograph or portable infrared spectometer.
(d) Detector tubes—A known volume of air is drawn through a detector tube using a small hand pump. The concentration of EtO is related to the length of stain developed in the tube. Detector tubes are economical, easy to use, and give an immediate readout. Unfortunately, partly because they are nonspecific, their accuracy is often questionable. Since the sample is taken over a short period of time, they may be useful for determining the source of leaks.
(e) Direct reading instruments:
(i) There are numerous types of direct reading instruments, each having its own strengths and weaknesses (Exs. 135B, 135C, 107, 11-78, 11-153). Many are relatively new, offering greater sensitivity and specificity. Popular ethylene oxide direct reading instruments include infrared detection units, photoionization detection units, and gas chromatographs.
(ii) Portable infrared analyzers provide an immediate, continuous indication of a concentration value; making them particularly useful for locating high concentration pockets, in leak detection and in ambient air monitoring. In infrared detection units, the amount of infrared light absorbed by the gas being analyzed at selected infrared wavelengths is related to the concentration of a particular component. Various models have either fixed or variable infrared filters, differing cell pathlengths, and microcomputer controls for greater sensitivity, automation, and interference elimination.
(iii) A fairly recent detection system is photoionization detection. The molecules are ionized by high energy ultraviolet light. The resulting current is measured. Since different substances have different ionization potentials, other organic compounds may be ionized. The lower the lamp energy, the better the selectivity. As a continuous monitor, photoionization detection can be useful for locating high concentration pockets, in leak detection, and continuous ambient air monitoring. Both portable and stationary gas chromatographs are available with various types of detectors, including photoionization detectors. A gas chromatograph with a photoionization detector retains the photoionization sensitivity, but minimizes or eliminates interferences. For several GC/PID units, the sensitivity is in the 0.1-0.2 ppm EtO range. The GC/PID with microprocessors can sample up to twenty sample points sequentially, calculate and record data, and activate alarms or ventilation systems. Many are quite flexible and can be configured to meet the specific analysis needs for the workplace.
(iv) DuPont presented their laboratory validation data of the accuracy of the Qazi-Ketcham charcoal tube, the PCB charcoal tube, Miran 103 IR analyzer, 3M #3550 monitor and the DuPont C-70 badge. Quoting Elbert V. Kring:
(v) We also believe that OSHA's proposed accuracy in this standard is appropriate. At plus or minus twenty-five percent at one part per million, and plus or minus thirty-five percent below that. And, our data indicates there's only one monitoring method, right now, that we've tested thoroughly, that meets that accuracy requirements. That is the DuPont Pro-Tek badge***. We also believe that this kind of data should be confirmed by another independent laboratory, using the same type dynamic chamber testing (Tr. 1470).
Additional data by an independent laboratory following their exact protocol was not submitted. However, information was submitted on comparisons and precision and accuracy of those monitoring procedures which indicate far better precision and accuracy of those monitoring procedures than that obtained by DuPont (Ex. 4-20, 130, 11-68, 11-133, 130, 135A)
(vi) The accuracy of any method depends to a large degree upon the skills and experience of those who not only collect the samples but also those who analyze the samples. Even for methods that are collaboratively tested, some laboratories are closer to the true values than others. Some laboratories may meet the precision and accuracy requirements of the method; others may consistently far exceed them for the same method.
[Statutory Authority: Chapter 49.17 RCW. WSR 88-14-108 (Order 88-11), § 296-62-07389, filed 7/6/88; WSR 87-24-051 (Order 87-24), § 296-62-07389, filed 11/30/87.]



296-62-074
Cadmium.

[Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-074, filed 3/13/93, effective 4/27/93.]



296-62-07401
Scope.

This standard applies to all occupational exposures to cadmium and cadmium compounds, in all forms, and in all industries covered by the Washington Industrial Safety and Health Act, except the construction-related industries, which are covered under WAC 296-155-174.
[Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07401, filed 3/13/93, effective 4/27/93.]



296-62-07403
Definitions.

(1) Action level (AL) is defined as an airborne concentration of cadmium of 2.5 micrograms per cubic meter of air (2.5 µg/m3), calculated as an 8-hour time-weighted average (TWA).
(2) Authorized person means any person authorized by the employer and required by work duties to be present in regulated areas or any person authorized by the WISH Act or regulations issued under it to be in regulated areas.
(3) Director means the director of the department of labor and industries, or authorized representatives.
(4) Employee exposure and similar language referring to the air cadmium level to which an employee is exposed means the exposure to airborne cadmium that would occur if the employee were not using respiratory protective equipment.
(5) Final medical determination is the written medical opinion of the employee's health status by the examining physician under WAC 296-62-07423 (3) through (12) or, if multiple physician review under WAC 296-62-07423(13) or the alternative physician determination under WAC 296-62-07423(14) is invoked, it is the final, written medical finding, recommendation or determination that emerges from that process.
(6) High-efficiency particulate air (HEPA) filter means a filter capable of trapping and retaining at least 99.97 percent of mono-dispersed particles of 0.3 micrometers in diameter.
(7) Regulated area means an area demarcated by the employer where an employee's exposure to airborne concentrations of cadmium exceeds, or can reasonably be expected to exceed the permissible exposure limit (PEL).
[Statutory Authority: Chapter 49.17 RCW. WSR 93-21-075 (Order 93-06), § 296-62-07403, filed 10/20/93, effective 12/1/93; WSR 93-07-044 (Order 93-01), § 296-62-07403, filed 3/13/93, effective 4/27/93.]



296-62-07405
Permissible exposure limit (PEL).

The employer shall assure that no employee is exposed to an airborne concentration of cadmium in excess of five micrograms per cubic meter of air (5 µg/m3), calculated as an 8-hour time-weighted average exposure (TWA).
[Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07405, filed 3/13/93, effective 4/27/93.]



296-62-07407
Exposure monitoring.

(1) General.
(a) Each employer who has a workplace or work operation covered by this section shall determine if any employee may be exposed to cadmium at or above the action level.
(b) Determinations of employee exposure shall be made from breathing zone air samples that reflect the monitored employee's regular, daily 8-hour TWA exposure to cadmium.
(c) 8-hour TWA exposures shall be determined for each employee on the basis of one or more personal breathing zone air samples reflecting full shift exposure on each shift, for each job classification, in each work area. Where several employees perform the same job tasks, in the same job classification, on the same shift, in the same work area, and the length, duration, and level of cadmium exposures are similar, an employer may sample a representative fraction of the employees instead of all employees in order to meet this requirement. In representative sampling, the employer shall sample the employee(s) expected to have the highest cadmium exposures.
(2) Specific.
(a) Initial monitoring. Except as provided for in (b) and (c) of this subsection, the employer shall monitor employee exposures and shall base initial determinations on the monitoring results.
(b) Where the employer has monitored after September 14, 1991, under conditions that in all important aspects closely resemble those currently prevailing and where that monitoring satisfies all other requirements of this section, including the accuracy and confidence levels of subsection (6) of this section, the employer may rely on such earlier monitoring results to satisfy the requirements of WAC 296-62-07427 (2)(a).
(c) Where the employer has objective data, as defined in WAC 296-62-07427(2), demonstrating that employee exposure to cadmium will not exceed the action level under the expected conditions of processing, use, or handling, the employer may rely upon such data instead of implementing initial monitoring.
(3) Monitoring frequency (periodic monitoring).
(a) If the initial monitoring or periodic monitoring reveals employee exposures to be at or above the action level, the employer shall monitor at a frequency and pattern needed to represent the levels of exposure of employees and where exposures are above the PEL to assure the adequacy of respiratory selection and the effectiveness of engineering and work practice controls. However, such exposure monitoring shall be performed at least every six months. The employer, at a minimum, shall continue these semiannual measurements unless and until the conditions set out in (b) of this subsection are met.
(b) If the initial monitoring or the periodic monitoring indicates that employee exposures are below the action level and that result is confirmed by the results of another monitoring taken at least seven days later, the employer may discontinue the monitoring for those employees whose exposures are represented by such monitoring.
(4) Additional monitoring. The employer also shall institute the exposure monitoring required under (2)(a) and (3) of this section whenever there has been a change in the raw materials, equipment, personnel, work practices, or finished products that may result in additional employees being exposed to cadmium at or above the action level or in employees already exposed to cadmium at or above the action level being exposed above the PEL, or whenever the employer has any reason to suspect that any other change might result in such further exposure.
(5) Employee notification of monitoring results.
(a) Within fifteen working days after the receipt of the results of any monitoring performed under this section, the employer shall notify each affected employee individually in writing of the results. In addition, within the same time period the employer shall post the results of the exposure monitoring in an appropriate location that is accessible to all affected employees.
(b) Wherever monitoring results indicate that employee exposure exceeds the PEL, the employer shall include in the written notice a statement that the PEL has been exceeded and a description of the corrective action being taken by the employer to reduce employee exposure to or below the PEL.
(6) Accuracy of measurement. The employer shall use a method of monitoring and analysis that has an accuracy of not less than plus or minus twenty-five percent, with a confidence level of ninety-five percent, for airborne concentrations of cadmium at or above the action level, the permissible exposure limit (PEL), and the separate engineering control air limit (SECAL).
[Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07407, filed 3/13/93, effective 4/27/93.]



296-62-07409
Regulated areas.

(1) Establishment. The employer shall establish a regulated area wherever an employee's exposure to airborne concentrations of cadmium is, or can reasonably be expected to be in excess of the permissible exposure limit (PEL).
(2) Demarcation. Regulated areas shall be demarcated from the rest of the workplace in any manner that adequately establishes and alerts employees of the boundaries of the regulated area.
(3) Access. Access to regulated areas shall be limited to authorized persons.
(4) Provision of respirators. Each person entering a regulated area shall be supplied with and required to use a respirator, selected in accordance with WAC 296-62-07413(2).
(5) Prohibited activities. The employer shall assure that employees do not eat, drink, smoke, chew tobacco or gum, or apply cosmetics in regulated areas, carry the products associated with these activities into regulated areas, or store such products in those areas.
[Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07409, filed 3/13/93, effective 4/27/93.]



296-62-07411
Methods of compliance.

(1) Compliance hierarchy.
(a) Except as specified in (b), (c), and (d) of this subsection, the employer shall implement engineering and work practice controls to reduce and maintain employee exposure to cadmium at or below the PEL, except to the extent that the employer can demonstrate that such controls are not feasible.
(b) Except as specified in (c) and (d) of this subsection, in industries where a separate engineering control air limit (SECAL) has been specified for particular processes (Table 1 of this subsection), the employer shall implement engineering and work practice controls to reduce and maintain employee exposure at or below the SECAL, except to the extent that the employer can demonstrate that such controls are not feasible.
Table I.—Separate Engineering
Control Airborne Limits(SECALs) for Processes in Selected Industries
 
SECAL
Industry
Process
(µg/m3)
Nickel cadmium battery
Plate making, plate
preparation
50
All other processes
15
Zinc/Cadmium refining*
Cadmium refining, casting, melting, oxide production, sinter plant
50
Pigment manufacture
Calcine, crushing, milling, blending
50
All other processes
15
Stabilizers*
Cadmium oxide charging, crushing, drying, blending
50
Lead smelting*
Sinter plant, blast furnace, baghouse, yard area
50
Plating*
Mechanical plating
15
*
Processes in these industries that are not specified in this table must achieve the PEL using engineering controls and work practices as required in (a) of this subsection.
(c) The requirement to implement engineering and work practice controls to achieve the PEL or, where applicable, the SECAL does not apply where the employer demonstrates the following:
(i) The employee is only intermittently exposed; and
(ii) The employee is not exposed above the PEL on thirty or more days per year (twelve consecutive months).
(d) Wherever engineering and work practice controls are required and are not sufficient to reduce employee exposure to or below the PEL or, where applicable, the SECAL, the employer nonetheless shall implement such controls to reduce exposures to the lowest levels achievable. The employer shall supplement such controls with respiratory protection that complies with the requirements of WAC 296-62-07413 and the PEL.
(e) The employer shall not use employee rotation as a method of compliance.
(2) Compliance program.
(a) Where the PEL is exceeded, the employer shall establish and implement a written compliance program to reduce employee exposure to or below the PEL by means of engineering and work practice controls, as required by subsection (1) of this section. To the extent that engineering and work practice controls cannot reduce exposures to or below the PEL, the employer shall include in the written compliance program the use of appropriate respiratory protection to achieve compliance with the PEL.
(b) Written compliance programs shall include at least the following:
(i) A description of each operation in which cadmium is emitted; e.g., machinery used, material processed, controls in place, crew size, employee job responsibilities, operating procedures, and maintenance practices;
(ii) A description of the specific means that will be employed to achieve compliance, including engineering plans and studies used to determine methods selected for controlling exposure to cadmium, as well as, where necessary, the use of appropriate respiratory protection to achieve the PEL;
(iii) A report of the technology considered in meeting the PEL;
(iv) Air monitoring data that document the sources of cadmium emissions;
(v) A detailed schedule for implementation of the program, including documentation such as copies of purchase orders for equipment, construction contracts, etc.;
(vi) A work practice program that includes items required under WAC 296-62-07415, 296-62-07417, and 296-62-07419;
(vii) A written plan for emergency situations, as specified in WAC 296-62-07415; and
(viii) Other relevant information.
(c) The written compliance programs shall be reviewed and updated at least annually, or more often if necessary, to reflect significant changes in the employer's compliance status.
(d) Written compliance programs shall be provided upon request for examination and copying to affected employees, designated employee representatives, and the director.
(3) Mechanical ventilation.
(a) When ventilation is used to control exposure, measurements that demonstrate the effectiveness of the system in controlling exposure, such as capture velocity, duct velocity, or static pressure shall be made as necessary to maintain its effectiveness.
(b) Measurements of the system's effectiveness in controlling exposure shall be made as necessary within five working days of any change in production, process, or control that might result in a significant increase in employee exposure to cadmium.
(c) Recirculation of air. If air from exhaust ventilation is recirculated into the workplace, the system shall have a high efficiency filter and be monitored to assure effectiveness.
(d) Procedures shall be developed and implemented to minimize employee exposure to cadmium when maintenance of ventilation systems and changing of filters is being conducted.
[Statutory Authority: Chapter 49.17 RCW. WSR 93-21-075 (Order 93-06), § 296-62-07411, filed 10/20/93, effective 12/1/93; WSR 93-07-044 (Order 93-01), § 296-62-07411, filed 3/13/93, effective 4/27/93.]



296-62-07413
Respirator protection.

(1) General. For employees who use respirators required by this section, the employer must provide each employee an appropriate respirator that complies with the requirements of this subsection. Respirators must be used during:
(a) Periods necessary to install or implement feasible engineering and work-practice controls when employee exposure levels exceed the PEL;
(b) Maintenance and repair activities, and brief or intermittent operations, where employee exposures exceed the PEL and engineering and work-practice controls are not feasible or are not required;
(c) Activities in regulated areas as specified in WAC 296-62-07409;
(d) Work operations for which the employer has implemented all feasible engineering and work-practice controls and such controls are not sufficient to reduce employee exposures to or below the PEL;
(e) Work operations for which an employee who is exposed to cadmium at or above the action level, and the employee requests a respirator;
(f) Work operations for which an employee is exposed above the PEL and engineering controls are not required by WAC 296-62-07411 (1)(b); and
(g) Emergencies.
(2) Respirator program.
(a) The employer must develop, implement and maintain a respiratory protection program as required by chapter 296-842 WAC, Respirators, which covers each employee required by this chapter to use a respirator.
(b) No employees must use a respirator if, based on their recent medical examination, the examining physician determines that they will be unable to continue to function normally while using a respirator. If the physician determines that the employee must be limited in, or removed from, their current job because of their inability to use a respirator, the limitation or removal must be in accordance with WAC 296-62-07423 (11) and (12).
(c) If an employee has breathing difficulty during fit testing or respirator use, the employer must provide the employee with a medical examination as required by WAC 296-62-07423 (6)(b) to determine if the employee can use a respirator while performing the required duties.
(3) Respirator selection. The employer must:
(a) Select and provide the appropriate respirator as specified in this section and WAC 296-842-13005, found in the respirator rule.
(i) Provide employees with full-facepiece respirators when they experience eye irritation.
(ii) Make sure high-efficiency particulate air (HEPA) filters or N-, R-, or P-100 series filters are provided for powered air-purifying respirators (PAPRs) and negative-pressure air-purifying respirators.
(b) Provide an employee with a powered, air-purifying respirator (PAPR) instead of a negative-pressure respirator when an employee who is entitled to a respirator chooses to use this type of respirator and such a respirator provides adequate protection to the employee.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 09-15-145, § 296-62-07413, filed 7/21/09, effective 9/1/09; WSR 07-05-072, § 296-62-07413, filed 2/20/07, effective 4/1/07; WSR 05-03-093, § 296-62-07413, filed 1/18/05, effective 3/1/05. Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-10-071, § 296-62-07413, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 93-21-075 (Order 93-06), § 296-62-07413, filed 10/20/93, effective 12/1/93; WSR 93-07-044 (Order 93-01), § 296-62-07413, filed 3/13/93, effective 4/27/93.]



296-62-07415
Emergency situations.

The employer shall develop and implement a written plan for dealing with emergency situations involving substantial releases of airborne cadmium. The plan shall include provisions for the use of appropriate respirators and personal protective equipment. In addition, employees not essential to correcting the emergency situation shall be restricted from the area and normal operations halted in that area until the emergency is abated.
[Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07415, filed 3/13/93, effective 4/27/93.]



296-62-07417
Protective work clothing and equipment.

(1) Provision and use. If an employee is exposed to airborne cadmium above the PEL or where skin or eye irritation is associated with cadmium exposure at any level, the employer shall provide at no cost to the employee, and assure that the employee uses, appropriate protective work clothing and equipment that prevents contamination of the employee and the employee's garments. Protective work clothing and equipment includes, but is not limited to:
(a) Coveralls or similar full-body work clothing;
(b) Gloves, head coverings, and boots or foot coverings; and
(c) Face shields, vented goggles, or other appropriate protective equipment that complies with WAC 296-800-160.
(2) Removal and storage.
(a) The employer shall assure that employees remove all protective clothing and equipment contaminated with cadmium at the completion of the work shift and do so only in change rooms provided in accordance with WAC 296-62-07419(1).
(b) The employer shall assure that no employee takes cadmium-contaminated protective clothing or equipment from the workplace, except for employees authorized to do so for purposes of laundering, cleaning, maintaining, or disposing of cadmium contaminated protective clothing and equipment at an appropriate location or facility away from the workplace.
(c) The employer shall assure that contaminated protective clothing and equipment, when removed for laundering, cleaning, maintenance, or disposal, is placed and stored in sealed, impermeable bags or other closed, impermeable containers that are designed to prevent dispersion of cadmium dust.
(d) The employer shall assure that bags or containers of contaminated protective clothing and equipment that are to be taken out of the change rooms or the workplace for laundering, cleaning, maintenance, or disposal shall bear labels in accordance with WAC 296-62-07425(3).
(3) Cleaning, replacement, and disposal.
(a) The employer shall provide the protective clothing and equipment required by subsection (1) of this section in a clean and dry condition as often as necessary to maintain its effectiveness, but in any event at least weekly. The employer is responsible for cleaning and laundering the protective clothing and equipment required by this paragraph to maintain its effectiveness and is also responsible for disposing of such clothing and equipment.
(b) The employer also is responsible for repairing or replacing required protective clothing and equipment as needed to maintain its effectiveness. When rips or tears are detected while an employee is working they shall be immediately mended, or the worksuit shall be immediately replaced.
(c) The employer shall prohibit the removal of cadmium from protective clothing and equipment by blowing, shaking, or any other means that disperses cadmium into the air.
(d) The employer shall assure that any laundering of contaminated clothing or cleaning of contaminated equipment in the workplace is done in a manner that prevents the release of airborne cadmium in excess of the permissible exposure limit prescribed in WAC 296-62-07405.
(e) The employer shall inform any person who launders or cleans protective clothing or equipment contaminated with cadmium of the potentially harmful effects of exposure to cadmium and that the clothing and equipment should be laundered or cleaned in a manner to effectively prevent the release of airborne cadmium in excess of the PEL.
[Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07417, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 94-20-057 (Order 94-16), § 296-62-07417, filed 9/30/94, effective 11/20/94; WSR 93-21-075 (Order 93-06), § 296-62-07417, filed 10/20/93, effective 12/1/93; WSR 93-07-044 (Order 93-01), § 296-62-07417, filed 3/13/93, effective 4/27/93.]



296-62-07419
Hygiene areas and practices.

(1) General. For employees whose airborne exposure to cadmium is above the PEL, the employer shall provide clean change rooms, handwashing facilities, showers, and lunchroom facilities that comply with WAC 296-800-230.
(2) Change rooms. The employer shall assure that change rooms are equipped with separate storage facilities for street clothes and for protective clothing and equipment, which are designed to prevent dispersion of cadmium and contamination of the employee's street clothes.
(3) Showers and handwashing facilities.
(a) The employer shall assure that employees who are exposed to cadmium above the PEL shower during the end of the work shift.
(b) The employer shall assure that employees whose airborne exposure to cadmium is above the PEL wash their hands and faces prior to eating, drinking, smoking, chewing tobacco or gum, or applying cosmetics.
(4) Lunchroom facilities.
(a) The employer shall assure that the lunchroom facilities are readily accessible to employees, that tables for eating are maintained free of cadmium, and that no employee in a lunchroom facility is exposed at any time to cadmium at or above a concentration of 2.5 µg/m3.
(b) The employer shall assure that employees do not enter lunchroom facilities with protective work clothing or equipment unless surface cadmium has been removed from the clothing and equipment by HEPA vacuuming or some other method that removes cadmium dust without dispersing it.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 03-18-090, § 296-62-07419, filed 9/2/03, effective 11/1/03. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07419, filed 5/9/01, effective 9/1/01. Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07419, filed 3/13/93, effective 4/27/93.]



296-62-07421
Housekeeping.

(1) All surfaces shall be maintained as free as practicable of accumulations of cadmium.
(2) All spills and sudden releases of material containing cadmium shall be cleaned up as soon as possible.
(3) Surfaces contaminated with cadmium shall, wherever possible, be cleaned by vacuuming or other methods that minimize the likelihood of cadmium becoming airborne.
(4) HEPA-filtered vacuuming equipment or equally effective filtration methods shall be used for vacuuming. The equipment shall be used and emptied in a manner that minimizes the reentry of cadmium into the workplace.
(5) Shoveling, dry or wet sweeping, and brushing may be used only where vacuuming or other methods that minimize the likelihood of cadmium becoming airborne have been tried and found not to be effective.
(6) Compressed air shall not be used to remove cadmium from any surface unless the compressed air is used in conjunction with a ventilation system designed to capture the dust cloud created by the compressed air.
(7) Waste, scrap, debris, bags, containers, personal protective equipment, and clothing contaminated with cadmium and consigned for disposal must be collected and disposed of in sealed impermeable bags or other closed, impermeable containers. These bags and containers must be labeled in accordance with WAC 296-62-07425(3).
[Statutory Authority: RCW 49.17.010, [49.17].040, [49.17].050. WSR 02-12-098, § 296-62-07421, filed 6/5/02, effective 8/1/02. Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07421, filed 3/13/93, effective 4/27/93.]



296-62-07423
Medical surveillance.

(1) General.
(a) Scope.
(i) Currently exposed. The employer shall institute a medical surveillance program for all employees who are or may be exposed to cadmium at or above the action level unless the employer demonstrates that the employee is not, and will not be, exposed at or above the action level on thirty or more days per year (twelve consecutive months); and
(ii) Previously exposed. The employer shall also institute a medical surveillance program for all employees who prior to the effective date of this section might previously have been exposed to cadmium at or above the action level by the employer, unless the employer demonstrates that the employee did not prior to the effective date of this section work for the employer in jobs with exposure to cadmium for an aggregated total of more than sixty months.
(b) To determine an employee's fitness for using a respirator, the employer shall provide the limited medical examination specified in subsection (6) of this section.
(c) The employer shall assure that all medical examinations and procedures required by this standard are performed by or under the supervision of a licensed physician, who has read and is familiar with the health effects WAC 296-62-07441, Appendix A, the regulatory text of this section, the protocol for sample handling and laboratory selection in WAC 296-62-07451, Appendix F and the questionnaire of WAC 296-62-07447, Appendix D. These examinations and procedures shall be provided without cost to the employee and at a time and place that is reasonable and convenient to employees.
(d) The employer shall assure that the collecting and handling of biological samples of cadmium in urine (CdU), cadmium in blood (CdB), and beta-2 microglobulin in urine (β2-M) taken from employees under this section is done in a manner that assures their reliability and that analysis of biological samples of cadmium in urine (CdU), cadmium in blood (CdB), and beta-2 microglobulin in urine (β2-M) taken from employees under this section is performed in laboratories with demonstrated proficiency for that particular analyte. (See WAC 296-62-07451, Appendix F.)
(2) Initial examination.
(a) The employer shall provide an initial (preplacement) examination to all employees covered by the medical surveillance program required in subsection (1)(a) of this section. The examination shall be provided to those employees within thirty days after initial assignment to a job with exposure to cadmium or no later than ninety days after the effective date of this section, whichever date is later.
(b) The initial (preplacement) medical examination shall include:
(i) A detailed medical and work history, with emphasis on: Past, present, and anticipated future exposure to cadmium; any history of renal, cardiovascular, respiratory, hematopoietic, reproductive, and/or musculo-skeletal system dysfunction; current usage of medication with potential nephrotoxic side-effects; and smoking history and current status; and
(ii) Biological monitoring that includes the following tests:
(A) Cadmium in urine (CdU), standardized to grams of creatinine (g/Cr);
(B) Beta-2 microglobulin in urine (β2-M), standardized to grams of creatinine (g/Cr), with pH specified, as described in WAC 296-62-07451, Appendix F; and
(C) Cadmium in blood (CdB), standardized to liters of whole blood (lwb).
(c) Recent examination: An initial examination is not required to be provided if adequate records show that the employee has been examined in accordance with the requirements of (b) of this subsection within the past twelve months. In that case, such records shall be maintained as part of the employee's medical record and the prior exam shall be treated as if it were an initial examination for the purposes of subsections (3) and (4) of this section.
(3) Actions triggered by initial biological monitoring:
(a) If the results of the initial biological monitoring tests show the employee's CdU level to be at or below 3 µg/g Cr, β2-M level to be at or below 300 µg/g Cr and CdB level to be at or below 5 µg/lwb, then:
(i) For currently exposed employees, who are subject to medical surveillance under subsection (1)(a)(i) of this section, the employer shall provide the minimum level of periodic medical surveillance in accordance with the requirements in subsection (4)(a) of this section; and
(ii) For previously exposed employees, who are subject to medical surveillance under subsection (1)(a)(ii) of this section, the employer shall provide biological monitoring for CdU, β2-M, and CdB one year after the initial biological monitoring and then the employer shall comply with the requirements of subsection (4)(e) of this section.
(b) For all employees who are subject to medical surveillance under subsection (1)(a) of this section, if the results of the initial biological monitoring tests show the level of CdU to exceed 3 µg/g Cr, the level of β2-M to exceed 300 µg/g Cr, or the level of CdB to exceed 5 µg/lwb, the employer shall:
(i) Within two weeks after receipt of biological monitoring results, reassess the employee's occupational exposure to cadmium as follows:
(A) Reassess the employee's work practices and personal hygiene;
(B) Reevaluate the employee's respirator use, if any, and the respirator program;
(C) Review the hygiene facilities;
(D) Reevaluate the maintenance and effectiveness of the relevant engineering controls;
(E) Assess the employee's smoking history and status;
(ii) Within thirty days after the exposure reassessment, specified in (b)(i) of this subsection, take reasonable steps to correct any deficiencies found in the reassessment that may be responsible for the employee's excess exposure to cadmium; and,
(iii) Within ninety days after receipt of biological monitoring results, provide a full medical examination to the employee in accordance with the requirements of WAC 296-62-07423 (4)(b). After completing the medical examination, the examining physician shall determine in a written medical opinion whether to medically remove the employee. If the physician determines that medical removal is not necessary, then until the employee's CdU level falls to or below 3 µg/g Cr, µ2-M level falls to or below 300 µg/g Cr and CdB level falls to or below 5 µg/lwb, the employer shall:
(A) Provide biological monitoring in accordance with subsection (2)(b)(ii) of this section on a semiannual basis; and
(B) Provide annual medical examinations in accordance with subsection (4)(b) of this section.
(c) For all employees who are subject to medical surveillance under subsection (1)(a) of this section, if the results of the initial biological monitoring tests show the level of CdU to be in excess of 15 µg/g Cr, or the level of CdB to be in excess of 15 µg/lwb, or the level of β2-M to be in excess of 1,500 µg/g Cr, the employer shall comply with the requirements of (b)(i) and (ii) of this subsection. Within ninety days after receipt of biological monitoring results, the employer shall provide a full medical examination to the employee in accordance with the requirements of subsection (4)(b) of this section. After completing the medical examination, the examining physician shall determine in a written medical opinion whether to medically remove the employee. However, if the initial biological monitoring results and the biological monitoring results obtained during the medical examination both show that: CdU exceeds 15 µg/g Cr; or CdB exceeds 15 µg/lwb; or β2-M exceeds 1500 µg/g Cr, and in addition CdU exceeds 3 µg/g Cr or CdB exceeds 5 µg/liter of whole blood, then the physician shall medically remove the employee from exposure to cadmium at or above the action level. If the second set of biological monitoring results obtained during the medical examination does not show that a mandatory removal trigger level has been exceeded, then the employee is not required to be removed by the mandatory provisions of this section. If the employee is not required to be removed by the mandatory provisions of this section or by the physician's determination, then until the employee's CdU level falls to or below 3 µg/g Cr, β2-M level falls to or below 300 µg/g Cr and CdB level falls to or below 5 µg/lwb, the employer shall:
(i) Periodically reassess the employee's occupational exposure to cadmium;
(ii) Provide biological monitoring in accordance with subsection (2)(b)(ii) of this section on a quarterly basis; and
(iii) Provide semiannual medical examinations in accordance with subsection (4)(b) of this section.
(d) For all employees to whom medical surveillance is provided, beginning on January 1, 1999, and in lieu of (a) through (c) of this subsection:
(i) If the results of the initial biological monitoring tests show the employee's CdU level to be at or below 3 µg/g Cr, β2-M level to be at or below 300 µg/g Cr and CdB level to be at or below 5 µg/lwb, then for currently exposed employees, the employer shall comply with the requirements of (a)(i) of this subsection and for previously exposed employees, the employer shall comply with the requirements of (a)(ii) of this subsection;
(ii) If the results of the initial biological monitoring tests show the level of CdU to exceed 3 µg/g Cr, the level of β2-M to exceed 300 µg/g Cr, or the level of CdB to exceed 5 µg/lwb, the employer shall comply with the requirements of (b)(i) through (iii) of this subsection; and
(iii) If the results of the initial biological monitoring tests show the level of CdU to be in excess of 7 µg/g Cr, or the level of CdB to be in excess of 10 µg/lwb, or the level of β2-M to be in excess of 750 µg/g Cr, the employer shall: Comply with the requirements of (b)(i) through (ii) of this subsection; and, within ninety days after receipt of biological monitoring results, provide a full medical examination to the employee in accordance with the requirements of subsection (4)(b) of this section. After completing the medical examination, the examining physician shall determine in a written medical opinion whether to medically remove the employee. However, if the initial biological monitoring results and the biological monitoring results obtained during the medical examination both show that: CdU exceeds 7 µg/g Cr; or CdB exceeds 10 µg/lwb; or β2-M exceeds 750 µg/g Cr, and in addition CdU exceeds 3 µg/g Cr or CdB exceeds 5 µg/liter of whole blood, then the physician shall medically remove the employee from exposure to cadmium at or above the action level. If the second set of biological monitoring results obtained during the medical examination does not show that a mandatory removal trigger level has been exceeded, then the employee is not required to be removed by the mandatory provisions of this section. If the employee is not required to be removed by the mandatory provisions of this section or by the physician's determination, then until the employee's CdU level falls to or below 3 µg/g Cr, β2-M level falls to or below 300 µg/g Cr and CdB level falls to or below 5 µg/lwb, the employer shall: periodically reassess the employee's occupational exposure to cadmium; provide biological monitoring in accordance with subsection (2)(b)(ii) of this section on a quarterly basis; and provide semiannual medical examinations in accordance with subsection (4)(b) of this section.
(4) Periodic medical surveillance.
(a) For each employee who is covered under subsection (1)(a)(i) of this section, the employer shall provide at least the minimum level of periodic medical surveillance, which consists of periodic medical examinations and periodic biological monitoring. A periodic medical examination shall be provided within one year after the initial examination required by subsection (2) of this section and thereafter at least biennially. Biological sampling shall be provided at least annually, either as part of a periodic medical examination or separately as periodic biological monitoring.
(b) The periodic medical examination shall include:
(i) A detailed medical and work history, or update thereof, with emphasis on: Past, present and anticipated future exposure to cadmium; smoking history and current status; reproductive history; current use of medications with potential nephrotoxic side-effects; any history of renal, cardiovascular, respiratory, hematopoietic, and/or musculo-skeletal system dysfunction; and as part of the medical and work history, for employees who wear respirators, questions 3-11 and 25-32 in WAC 296-62-07447, Appendix D;
(ii) A complete physical examination with emphasis on: Blood pressure, the respiratory system, and the urinary system;
(iii) A 14 inch by 17 inch, or a reasonably standard sized posterior-anterior chest X-ray (after the initial X-ray, the frequency of chest X-rays is to be determined by the examining physician);
(iv) Pulmonary function tests, including forced vital capacity (FVC) and forced expiratory volume at 1 second (FEV1);
(v) Biological monitoring, as required in subsection (2)(b)(ii) of this section;
(vi) Blood analysis, in addition to the analysis required under this section, including blood urea nitrogen, complete blood count, and serum creatinine;
(vii) Urinalysis, in addition to the analysis required under subsection (2)(b)(ii) of this section, including the determination of albumin, glucose, and total and low molecular weight proteins;
(viii) For males over forty years old, prostate palpation, or other at least as effective diagnostic test(s); and
(ix) Any additional tests deemed appropriate by the examining physician.
(c) Periodic biological monitoring shall be provided in accordance with subsection (2)(b)(ii) of this section.
(d) If the results of periodic biological monitoring or the results of biological monitoring performed as part of the periodic medical examination show the level of the employee's CdU, β2-M, or CdB to be in excess of the levels specified in subsection (3)(b) or (c) of this section; or, beginning on January 1, 1999, in excess of the levels specified in subsection (3)(b) or (d) of this section, the employer shall take the appropriate actions specified in subsection (3)(b) through (d) of this section.
(e) For previously exposed employees under subsection (1)(a)(ii) of this section:
(i) If the employee's levels of CdU did not exceed 3 µg/g Cr, CdB did not exceed 5 µg/lwb, and β2-M did not exceed 300 µg/g Cr in the initial biological monitoring tests, and if the results of the followup biological monitoring required by subsection (3)(a)(ii) of this section one year after the initial examination confirm the previous results, the employer may discontinue all periodic medical surveillance for that employee.
(ii) If the initial biological monitoring results for CdU, CdB, or β2-M were in excess of the levels specified in subsection (3)(a) of this section, but subsequent biological monitoring results required by subsection (3)(b) through (e) of this section show that the employee's CdU levels no longer exceed 3 µg/g Cr, CdB levels no longer exceed 5 µg/lwb, and β2-M levels no longer exceed 300 µg/g Cr, the employer shall provide biological monitoring for CdU, CdB, and β2-M one year after these most recent biological monitoring results. If the results of the followup biological monitoring, specified in this section, confirm the previous results, the employer may discontinue all periodic medical surveillance for that employee.
(iii) However, if the results of the follow-up tests specified in (e)(i) or (ii) of this subsection indicate that the level of the employee's CdU, β2-M, or CdB exceeds these same levels, the employer is required to provide annual medical examinations in accordance with the provisions of (b) of this subsection until the results of biological monitoring are consistently below these levels or the examining physician determines in a written medical opinion that further medical surveillance is not required to protect the employee's health.
(f) A routine, biennial medical examination is not required to be provided in accordance with subsections (3)(a) and (4) of this section if adequate medical records show that the employee has been examined in accordance with the requirements of (b) of this subsection within the past twelve months. In that case, such records shall be maintained by the employer as part of the employee's medical record, and the next routine, periodic medical examination shall be made available to the employee within two years of the previous examination.
(5) Actions triggered by medical examinations.
If the results of a medical examination carried out in accordance with this section indicate any laboratory or clinical finding consistent with cadmium toxicity that does not require employer action under subsections (2), (3), or (4) of this section, the employer, within thirty days, shall reassess the employee's occupational exposure to cadmium and take the following corrective action until the physician determines they are no longer necessary:
(a) Periodically reassess: The employee's work practices and personal hygiene; the employee's respirator use, if any; the employee's smoking history and status; the respiratory protection program; the hygiene facilities; and the maintenance and effectiveness of the relevant engineering controls;
(b) Within thirty days after the reassessment, take all reasonable steps to correct the deficiencies found in the reassessment that may be responsible for the employee's excess exposure to cadmium;
(c) Provide semiannual medical reexaminations to evaluate the abnormal clinical sign(s) of cadmium toxicity until the results are normal or the employee is medically removed; and
(d) Where the results of tests for total proteins in urine are abnormal, provide a more detailed medical evaluation of the toxic effects of cadmium on the employee's renal system.
(6) Examination for respirator use.
(a) To determine an employee's fitness for respirator use, the employer shall provide a medical examination that includes the elements specified in (a)(i) through (iv) of this subsection. This examination shall be provided prior to the employee's being assigned to a job that requires the use of a respirator or no later than ninety days after this section goes into effect, whichever date is later, to any employee without a medical examination within the preceding twelve months that satisfies the requirements of this paragraph.
(i) A detailed medical and work history, or update thereof, with emphasis on: Past exposure to cadmium; smoking history and current status; any history of renal, cardiovascular, respiratory, hematopoietic, and/or musculoskeletal system dysfunction; a description of the job for which the respirator is required; and questions 3 through 11 and 25 through 32 in WAC 296-62-07447, Appendix D;
(ii) A blood pressure test;
(iii) Biological monitoring of the employee's levels of CdU, CdB and β2-M in accordance with the requirements of subsection (2)(b)(ii) of this section, unless such results already have been obtained within the previous twelve months; and
(iv) Any other test or procedure that the examining physician deems appropriate.
(b) After reviewing all the information obtained from the medical examination required in (a) of this subsection, the physician shall determine whether the employee is fit to wear a respirator.
(c) Whenever an employee has exhibited difficulty in breathing during a respirator fit test or during use of a respirator, the employer, as soon as possible, shall provide the employee with a periodic medical examination in accordance with subsection (4)(b) of this section to determine the employee's fitness to wear a respirator.
(d) Where the results of the examination required under (a), (b), or (c) of this subsection are abnormal, medical limitation or prohibition of respirator use shall be considered. If the employee is allowed to wear a respirator, the employee's ability to continue to do so shall be periodically evaluated by a physician.
(7) Emergency examinations.
(a) In addition to the medical surveillance required in subsections (2) through (6) of this section, the employer shall provide a medical examination as soon as possible to any employee who may have been acutely exposed to cadmium because of an emergency.
(b) The examination shall include the requirements of subsection (4)(b) of this section, with emphasis on the respiratory system, other organ systems considered appropriate by the examining physician, and symptoms of acute overexposure, as identified in WAC 296-62-07441 (2)(b)(i) through (ii) and (4), Appendix A.
(8) Termination of employment examination.
(a) At termination of employment, the employer shall provide a medical examination in accordance with subsection (4)(b) of this section, including a chest X-ray, to any employee to whom at any prior time the employer was required to provide medical surveillance under subsection (1)(a) or (7) of this section. However, if the last examination satisfied the requirements of subsection (4)(b) of this section and was less than six months prior to the date of termination, no further examination is required unless otherwise specified in subsection (3) or (5) of this section;
(b) However, for employees covered by subsection (1)(a)(ii) of this section, if the employer has discontinued all periodic medical surveillance under subsection (4)(e) of this section, no termination of employment medical examination is required.
(9) Information provided to the physician. The employer shall provide the following information to the examining physician:
(a) A copy of this standard and appendices;
(b) A description of the affected employee's former, current, and anticipated duties as they relate to the employee's occupational exposure to cadmium;
(c) The employee's former, current, and anticipated future levels of occupational exposure to cadmium;
(d) A description of any personal protective equipment, including respirators, used or to be used by the employee, including when and for how long the employee has used that equipment; and
(e) Relevant results of previous biological monitoring and medical examinations.
(10) Physician's written medical opinion.
(a) The employer shall promptly obtain a written, signed medical opinion from the examining physician for each medical examination performed on each employee. This written opinion shall contain:
(i) The physician's diagnosis for the employee;
(ii) The physician's opinion as to whether the employee has any detected medical condition(s) that would place the employee at increased risk of material impairment to health from further exposure to cadmium, including any indications of potential cadmium toxicity;
(iii) The results of any biological or other testing or related evaluations that directly assess the employee's absorption of cadmium;
(iv) Any recommended removal from, or limitation on the activities or duties of the employee or on the employee's use of personal protective equipment, such as respirators;
(v) A statement that the physician has clearly and carefully explained to the employee the results of the medical examination, including all biological monitoring results and any medical conditions related to cadmium exposure that require further evaluation or treatment, and any limitation on the employee's diet or use of medications.
(b) The employer promptly shall obtain a copy of the results of any biological monitoring provided by an employer to an employee independently of a medical examination under subsections (2) and (4) of this section, and, in lieu of a written medical opinion, an explanation sheet explaining those results.
(c) The employer shall instruct the physician not to reveal orally or in the written medical opinion given to the employer specific findings or diagnoses unrelated to occupational exposure to cadmium.
(11) Medical removal protection (MRP).
(a) General.
(i) The employer shall temporarily remove an employee from work where there is excess exposure to cadmium on each occasion that medical removal is required under subsection (3), (4), or (6) of this section and on each occasion that a physician determines in a written medical opinion that the employee should be removed from such exposure. The physician's determination may be based on biological monitoring results, inability to wear a respirator, evidence of illness, other signs or symptoms of cadmium-related dysfunction or disease, or any other reason deemed medically sufficient by the physician.
(ii) The employer shall medically remove an employee in accordance with this subsection regardless of whether at the time of removal a job is available into which the removed employee may be transferred.
(iii) Whenever an employee is medically removed under this subsection, the employer shall transfer the removed employee to a job where the exposure to cadmium is within the permissible levels specified in that subsection as soon as one becomes available.
(iv) For any employee who is medically removed under the provisions of (a) of this subsection, the employer shall provide follow-up biological monitoring in accordance with subsection (2)(b)(ii) of this section at least every three months and follow-up medical examinations semiannually at least every six months until in a written medical opinion the examining physician determines that either the employee may be returned to his/her former job status as specified under (d) through (e) of this subsection or the employee must be permanently removed from excess cadmium exposure.
(v) The employer may not return an employee who has been medically removed for any reason to his/her former job status until a physician determines in a written medical opinion that continued medical removal is no longer necessary to protect the employee's health.
(b) Where an employee is found unfit to wear a respirator under subsection (6)(b) of this section, the employer shall remove the employee from work where exposure to cadmium is above the PEL.
(c) Where removal is based on any reason other than the employee's inability to wear a respirator, the employer shall remove the employee from work where exposure to cadmium is at or above the action level.
(d) Except as specified in (e) of this subsection, no employee who was removed because his/her level of CdU, CdB and/or β2-M exceeded the medical removal trigger levels in subsection (3) or (4) of this section may be returned to work with exposure to cadmium at or above the action level until the employee's levels of CdU fall to or below 3 µg/g Cr, CdB falls to or below 5 µg/lwb, and β2-M falls to or below 300 µg/g Cr.
(e) However, when in the examining physician's opinion continued exposure to cadmium will not pose an increased risk to the employee's health and there are special circumstances that make continued medical removal an inappropriate remedy, the physician shall fully discuss these matters with the employee, and then in a written determination may return a worker to his/her former job status despite what would otherwise be unacceptably high biological monitoring results. Thereafter, the returned employee shall continue to be provided with medical surveillance as if he/she were still on medical removal until the employee's levels of CdU fall to or below 3 µg/g Cr, CdB falls to or below 5 µg/lwb, and β2-M falls to or below 300 µg/g Cr.
(f) Where an employer, although not required by (a) through (c) of this subsection to do so, removes an employee from exposure to cadmium or otherwise places limitations on an employee due to the effects of cadmium exposure on the employee's medical condition, the employer shall provide the same medical removal protection benefits to that employee under subsection (12) of this section as would have been provided had the removal been required under (a) through (c) of this subsection.
(12) Medical removal protection benefits (MRPB).
(a) The employer shall provide MRPB for up to a maximum of eighteen months to an employee each time and while the employee is temporarily medically removed under subsection (11) of this section.
(b) For purposes of this section, the requirement that the employer provide MRPB means that the employer shall maintain the total normal earnings, seniority, and all other employee rights and benefits of the removed employee, including the employee's right to his/her former job status, as if the employee had not been removed from the employee's job or otherwise medically limited.
(c) Where, after eighteen months on medical removal because of elevated biological monitoring results, the employee's monitoring results have not declined to a low enough level to permit the employee to be returned to his/her former job status:
(i) The employer shall make available to the employee a medical examination pursuant in order to obtain a final medical determination as to whether the employee may be returned to his/her former job status or must be permanently removed from excess cadmium exposure; and
(ii) The employer shall assure that the final medical determination indicates whether the employee may be returned to his/her former job status and what steps, if any, should be taken to protect the employee's health.
(d) The employer may condition the provision of MRPB upon the employee's participation in medical surveillance provided in accordance with this section.
(13) Multiple physician review.
(a) If the employer selects the initial physician to conduct any medical examination or consultation provided to an employee under this section, the employee may designate a second physician to:
(i) Review any findings, determinations, or recommendations of the initial physician; and
(ii) Conduct such examinations, consultations, and laboratory tests as the second physician deems necessary to facilitate this review.
(b) The employer shall promptly notify an employee of the right to seek a second medical opinion after each occasion that an initial physician provided by the employer conducts a medical examination or consultation pursuant to this section. The employer may condition its participation in, and payment for, multiple physician review upon the employee doing the following within fifteen days after receipt of this notice, or receipt of the initial physician's written opinion, whichever is later:
(i) Informing the employer that he or she intends to seek a medical opinion; and
(ii) Initiating steps to make an appointment with a second physician.
(c) If the findings, determinations, or recommendations of the second physician differ from those of the initial physician, then the employer and the employee shall assure that efforts are made for the two physicians to resolve any disagreement.
(d) If the two physicians have been unable to quickly resolve their disagreement, then the employer and the employee, through their respective physicians, shall designate a third physician to:
(i) Review any findings, determinations, or recommendations of the other two physicians; and
(ii) Conduct such examinations, consultations, laboratory tests, and discussions with the other two physicians as the third physician deems necessary to resolve the disagreement among them.
(e) The employer shall act consistently with the findings, determinations, and recommendations of the third physician, unless the employer and the employee reach an agreement that is consistent with the recommendations of at least one of the other two physicians.
(14) Alternate physician determination. The employer and an employee or designated employee representative may agree upon the use of any alternate form of physician determination in lieu of the multiple physician review provided by subsection (13) of this section, so long as the alternative is expeditious and at least as protective of the employee.
(15) Information the employer must provide the employee.
(a) The employer shall provide a copy of the physician's written medical opinion to the examined employee within two weeks after receipt thereof.
(b) The employer shall provide the employee with a copy of the employee's biological monitoring results and an explanation sheet explaining the results within two weeks after receipt thereof.
(c) Within thirty days after a request by an employee, the employer shall provide the employee with the information the employer is required to provide the examining physician under subsection (9) of this section.
(16) Reporting. In addition to other medical events that are required to be reported on the OSHA Form No. 200, the employer shall report any abnormal condition or disorder caused by occupational exposure to cadmium associated with employment as specified in WAC 296-27-060.
[Statutory Authority: Chapter 49.17 RCW. WSR 93-21-075 (Order 93-06), § 296-62-07423, filed 10/20/93, effective 12/1/93; WSR 93-07-044 (Order 93-01), § 296-62-07423, filed 3/13/93, effective 4/27/93.]



296-62-07425
Communication of cadmium hazards.

(1) General. Chemical manufacturers, importers, distributors and employers shall comply with all requirements of WAC 296-901-140, Hazard communication.
(2) In classifying the hazards of cadmium at least the following hazards are to be addressed: Cancer; lung effects; kidney effects; and acute toxicity effects.
(3) Employers shall include cadmium in the hazard communication program established to comply with WAC 296-901-140, Hazard communication. Employers shall ensure that each employee has access to labels on containers of cadmium and to safety data sheets (SDSs), and is trained in accordance with the requirements of WAC 296-901-140, Hazard communication and subsection (m)(4) of this section.
(4) Warning signs.
(a) Warning signs shall be provided and displayed in regulated areas. In addition, warning signs shall be posted at all approaches to regulated areas so that an employee may read the signs and take necessary protective steps before entering the area.
(b) Prior to June 1, 2016, employers may use the following legend in lieu of that specified in (d) of this subsection:
DANGER CADMIUM CANCER HAZARD CAN CAUSE LUNG
AND KIDNEY DISEASE AUTHORIZED PERSONNEL ONLY
RESPIRATORS REQUIRED IN THIS AREA
(c) The employer shall ensure that signs required by this subsection are illuminated, cleaned, and maintained as necessary so that the legend is readily visible.
(d) Warning signs required by (a) of this subsection shall bear the following legend:
DANGER CADMIUM MAY CAUSE CANCER
CAUSES DAMAGE TO LUNGS AND KIDNEYS
WEAR RESPIRATORY PROTECTION IN THIS AREA
AUTHORIZED PERSONNEL ONLY
(5) Warning labels.
(a) Shipping and storage containers containing cadmium, cadmium compounds, or cadmium contaminated clothing, equipment, waste, scrap, or debris shall bear appropriate warning labels, as specified in subsection (1) of this section.
(b) Prior to June 1, 2015, employers may include the following information on warning labels in lieu of the labeling requirements specified in subsection (1) of this section and (c) of this subsection:
DANGER CONTAINS CADMIUM CANCER HAZARD AVOID
CREATING DUST CAN CAUSE LUNG AND KIDNEY DISEASE
(c) The warning labels for containers of contaminated protective clothing, equipment, waste, scrap, or debris shall include at least the following information:
DANGER CONTAINS CADMIUM MAY CAUSE CANCER
CAUSES DAMAGE TO LUNGS AND KIDNEYS
AVOID CREATING DUST
(d) Where feasible, installed cadmium products shall have a visible label or other indication that cadmium is present.
(6) Employee information and training.
(a) The employer shall train each employee who is potentially exposed to cadmium in accordance with the requirements of this chapter. The employer shall institute a training program, ensure employee participation in the program, and maintain a record of the contents of such program.
(b) Training shall be provided prior to or at the time of initial assignment to a job involving potential exposure to cadmium and at least annually thereafter.
(c) The employer shall make the training program understandable to the employee and shall assure that each employee is informed of the following:
(i) The health hazards associated with cadmium exposure, with special attention to the information incorporated in WAC 296-62-07441, Appendix A;
(ii) The quantity, location, manner of use, release, and storage of cadmium in the workplace and the specific nature of operations that could result in exposure to cadmium, especially exposures above the PEL;
(iii) The engineering controls and work practices associated with the employee's job assignment;
(iv) The measures employees can take to protect themselves from exposure to cadmium, including modification of such habits as smoking and personal hygiene, and specific procedures the employer has implemented to protect employees from exposure to cadmium such as appropriate work practices, emergency procedures, and the provision of personal protective equipment;
(v) The purpose, proper selection, fitting, proper use, and limitations of protective clothing;
(vi) The purpose and a description of the medical surveillance program required by WAC 296-62-07423;
(vii) The contents of this section and its appendices;
(viii) The employee's rights of access to records under WAC 296-901-140 and chapter 296-802 WAC; and
(ix) The purpose, proper use, limitations, and other training requirements for respiratory protection as required in chapter 296-62 WAC, Part E.
(d) Additional access to information and training program and materials.
(i) The employer shall make a copy of this section and its appendices readily available without cost to all affected employees and shall provide a copy if requested.
(ii) The employer shall provide to the director, upon request, all materials relating to the employee information and the training program.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060 and 29 C.F.R. 1910 Subpart Z. WSR 14-07-086, § 296-62-07425, filed 3/18/14, effective 5/1/14. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, 49.17.060. WSR 09-15-145, § 296-62-07425, filed 7/21/09, effective 9/1/09; WSR 07-03-163, § 296-62-07425, filed 1/24/07, effective 4/1/07. Statutory Authority: RCW 49.17.010, [49.17].040, and [49.17].050. WSR 01-11-038, § 296-62-07425, filed 5/9/01, effective 9/1/01; WSR 99-10-071, § 296-62-07425, filed 5/4/99, effective 9/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 93-21-075 (Order 93-06), § 296-62-07425, filed 10/20/93, effective 12/1/93; WSR 93-07-044 (Order 93-01), § 296-62-07425, filed 3/13/93, effective 4/27/93.]



296-62-07427
Recordkeeping.

(1) Exposure monitoring.
(a) The employer shall establish and keep an accurate record of all air monitoring for cadmium in the workplace.
(b) This record shall include at least the following information:
(i) The monitoring date, duration, and results in terms of an 8-hour TWA of each sample taken;
(ii) The name, Social Security number, and job classification of the employees monitored and of all other employees whose exposures the monitoring is intended to represent;
(iii) A description of the sampling and analytical methods used and evidence of their accuracy;
(iv) The type of respiratory protective device, if any, worn by the monitored employee;
(v) A notation of any other conditions that might have affected the monitoring results.
(c) The employer shall maintain this record for at least thirty years, in accordance with chapter 296-802 WAC.
(2) Objective data for exemption from requirement for initial monitoring.
(a) For purposes of this section, objective data are information demonstrating that a particular product or material containing cadmium or a specific process, operation, or activity involving cadmium cannot release dust or fumes in concentrations at or above the action level even under the worst-case release conditions. Objective data can be obtained from an industry-wide study or from laboratory product test results from manufacturers of cadmium-containing products or materials. The data the employer uses from an industry-wide survey must be obtained under workplace conditions closely resembling the processes, types of material, control methods, work practices and environmental conditions in the employer's current operations.
(b) The employer shall establish and maintain a record of the objective data for at least thirty years.
(3) Medical surveillance.
(a) The employer shall establish and maintain an accurate record for each employee covered by medical surveillance under WAC 296-62-07423 (1)(a).
(b) The record shall include at least the following information about the employee:
(i) Name, Social Security number, and description of the duties;
(ii) A copy of the physician's written opinions and an explanation sheet for biological monitoring results;
(iii) A copy of the medical history, and the results of any physical examination and all test results that are required to be provided by this section, including biological tests, X-rays, pulmonary function tests, etc., or that have been obtained to further evaluate any condition that might be related to cadmium exposure;
(iv) The employee's medical symptoms that might be related to exposure to cadmium; and
(v) A copy of the information provided to the physician as required by WAC 296-62-07423 (9)(b) through (e).
(c) The employer shall assure that this record is maintained for the duration of employment plus thirty years, in accordance with chapter 296-802 WAC.
(4) Training. The employer shall certify that employees have been trained by preparing a certification record which includes the identity of the person trained, the signature of the employer or the person who conducted the training, and the date the training was completed. The certification records shall be prepared at the completion of training and shall be maintained on file for one year beyond the date of training of that employee.
(5) Availability.
(a) Except as otherwise provided for in this section, access to all records required to be maintained by subsections (1) through (4) of this section shall be in accordance with the provisions of chapter 296-802 WAC.
(b) Within fifteen days after a request, the employer shall make an employee's medical records required to be kept by subsection (3) of this section available for examination and copying to the subject employee, to designated representatives, to anyone having the specific written consent of the subject employee, and after the employee's death or incapacitation, to the employee's family members.
(6) Transfer of records. Whenever an employer ceases to do business and there is no successor employer to receive and retain records for the prescribed period or the employer intends to dispose of any records required to be preserved for at least thirty years, the employer shall comply with the requirements concerning transfer of records set forth in chapter 296-802 WAC.
[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-10-026, § 296-62-07427, filed 4/27/04, effective 8/1/04. Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07427, filed 3/13/93, effective 4/27/93.]



296-62-07429
Observation of monitoring.

(1) Employee observation. The employer shall provide affected employees or their designated representatives an opportunity to observe any monitoring of employee exposure to cadmium.
(2) Observation procedures. When observation of monitoring requires entry into an area where the use of protective clothing or equipment is required, the employer shall provide the observer with that clothing and equipment and shall assure that the observer uses such clothing and equipment and complies with all other applicable safety and health procedures.
[Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07429, filed 3/13/93, effective 4/27/93.]



296-62-07433
Appendices.

WAC 296-62-07441, Appendix A; WAC 296-62-07443, Appendix B; WAC 296-62-07447, Appendix D; WAC 296-62-07449, Appendix E; and WAC 296-62-07451, Appendix F are nonmandatory appendices and are not intended to create any additional obligations.
[Statutory Authority: RCW 49.17.010, [49.17].040 and [49.17].050. WSR 99-17-094, § 296-62-07433, filed 8/17/99, effective 12/1/99. Statutory Authority: Chapter 49.17 RCW. WSR 93-07-044 (Order 93-01), § 296-62-07433, filed 3/13/93, effective 4/27/93.]



296-62-07441
Appendix A, substance safety data sheet—Cadmium.

(1) Substance identification.
(a) Substance: Cadmium.
(b) 8-Hour, time-weighted-average, permissible exposure limit (TWA PEL):
(c) TWA PEL: Five micrograms of cadmium per cubic meter of air 5 µg/m3, time-weighted average (TWA) for an 8-hour workday.
(d) Appearance: Cadmium metal—soft, blue-white, malleable, lustrous metal or grayish-white powder. Some cadmium compounds may also appear as a brown, yellow, or red powdery substance.
(2) Health hazard data.
(a) Routes of exposure. Cadmium can cause local skin or eye irritation. Cadmium can affect your health if you inhale it or if you swallow it.
(b) Effects of overexposure.
(i) Short-term (acute) exposure: Cadmium is much more dangerous by inhalation than by ingestion. High exposures to cadmium that may be immediately dangerous to life or health occur in jobs where workers handle large quantities of cadmium dust or fume; heat cadmium-containing compounds or cadmium-coated surfaces; weld with cadmium solders or cut cadmium-containing materials such as bolts.
(ii) Severe exposure may occur before symptoms appear. Early symptoms may include mild irritation of the upper respiratory tract, a sensation of constriction of the throat, a metallic taste and/or a cough. A period of one to ten hours may precede the onset of rapidly progressing shortness of breath, chest pain, and flu-like symptoms with weakness, fever, headache, chills, sweating, and muscular pain. Acute pulmonary edema usually develops within twenty-four hours and reaches a maximum by three days. If death from asphyxia does not occur, symptoms may resolve within a week.
(iii) Long-term (chronic) exposure. Repeated or long-term exposure to cadmium, even at relatively low concentrations, may result in kidney damage and an increased risk of cancer of the lung and of the prostate.
(c) Emergency first-aid procedures.
(i) Eye exposure: Direct contact may cause redness or pain. Wash eyes immediately with large amounts of water, lifting the upper and lower eyelids. Get medical attention immediately.
(ii) Skin exposure: Direct contact may result in irritation. Remove contaminated clothing and shoes immediately. Wash affected area with soap or mild detergent and large amounts of water. Get medical attention immediately.
(iii) Ingestion: Ingestion may result in vomiting, abdominal pain, nausea, diarrhea, headache, and sore throat. Treatment for symptoms must be administered by medical personnel. Under no circumstances should the employer allow any person whom he/she retains, employs, supervises, or controls to engage in therapeutic chelation. Such treatment is likely to translocate cadmium from pulmonary or other tissue to renal tissue. Get medical attention immediately.
(iv) Inhalation: If large amounts of cadmium are inhaled, the exposed person must be moved to fresh air at once. If breathing has stopped, perform cardiopulmonary resuscitation. Administer oxygen if available. Keep the affected person warm and at rest. Get medical attention immediately.
(v) Rescue: Move the affected person from the hazardous exposure. If the exposed person has been overcome, attempt rescue only after notifying at least one other person of the emergency and putting into effect established emergency procedures. Do not become a casualty yourself. Understand your emergency rescue procedures and know the location of the emergency equipment before the need arises.
(3) Employee information.
(a) Protective clothing and equipment.
(i) Respirators: You may be required to wear a respirator for nonroutine activities; in emergencies; while your employer is in the process of reducing cadmium exposures through engineering controls; and where engineering controls are not feasible. If air-purifying respirators are worn, they must have a label issued by the National Institute for Occupational Safety and Health (NIOSH) under the provisions of 42 C.F.R. part 84 stating that the respirators have been certified for use with cadmium. Cadmium does not have a detectable odor except at levels well above the permissible exposure limits. If you can smell cadmium while wearing a respirator, proceed immediately to fresh air. If you experience difficulty breathing while wearing a respirator, tell your employer.
(ii) Protective clothing: You may be required to wear impermeable clothing, gloves, foot gear, a face shield, or other appropriate protective clothing to prevent skin contact with cadmium. Where protective clothing is required, your employer must provide clean garments to you as necessary to assure that the clothing protects you adequately. The employer must replace or repair protective clothing that has become torn or otherwise damaged.
(iii) Eye protection: You may be required to wear splash-proof or dust resistant goggles to prevent eye contact with cadmium.
(b) Employer requirements.
(i) Medical: If you are exposed to cadmium at or above the action level, your employer is required to provide a medical examination, laboratory tests and a medical history according to the medical surveillance provisions under WAC 296-62-07423. (See summary chart and tables in this section, appendix A.) These tests shall be provided without cost to you. In addition, if you are accidentally exposed to cadmium under conditions known or suspected to constitute toxic exposure to cadmium, your employer is required to make special tests available to you.
(ii) Access to records: All medical records are kept strictly confidential. You or your representative are entitled to see the records of measurements of your exposure to cadmium. Your medical examination records can be furnished to your personal physician or designated representative upon request by you to your employer.
(iii) Observation of monitoring: Your employer is required to perform measurements that are representative of your exposure to cadmium and you or your designated representative are entitled to observe the monitoring procedure. You are entitled to observe the steps taken in the measurement procedure, and to record the results obtained. When the monitoring procedure is taking place in an area where respirators or personal protective clothing and equipment are required to be worn, you or your representative must also be provided with, and must wear the protective clothing and equipment.
(c) Employee requirements. You will not be able to smoke, eat, drink, chew gum or tobacco, or apply cosmetics while working with cadmium in regulated areas. You will also not be able to carry or store tobacco products, gum, food, drinks, or cosmetics in regulated areas because these products easily become contaminated with cadmium from the workplace and can therefore create another source of unnecessary cadmium exposure. Some workers will have to change out of work clothes and shower at the end of the day, as part of their workday, in order to wash cadmium from skin and hair. Handwashing and cadmium-free eating facilities shall be provided by the employer and proper hygiene should always be performed before eating. It is also recommended that you do not smoke or use tobacco products, because among other things, they naturally contain cadmium. For further information, read the labeling on such products.
(4) Physician information.
(a) Introduction. The medical surveillance provisions of WAC 296-62-07423 generally are aimed at accomplishing three main interrelated purposes: First, identifying employees at higher risk of adverse health effects from excess, chronic exposure to cadmium; second, preventing cadmium-induced disease; and third, detecting and minimizing existing cadmium-induced disease. The core of medical surveillance in this standard is the early and periodic monitoring of the employee's biological indicators of:
(i) Recent exposure to cadmium;
(ii) Cadmium body burden; and
(iii) Potential and actual kidney damage associated with exposure to cadmium. The main adverse health effects associated with cadmium overexposure are lung cancer and kidney dysfunction. It is not yet known how to adequately biologically monitor human beings to specifically prevent cadmium-induced lung cancer. By contrast, the kidney can be monitored to provide prevention and early detection of cadmium-induced kidney damage. Since, for noncarcinogenic effects, the kidney is considered the primary target organ of chronic exposure to cadmium, the medical surveillance provisions of this standard effectively focus on cadmium-induced kidney disease. Within that focus, the aim, where possible, is to prevent the onset of such disease and, where necessary, to minimize such disease as may already exist. The by-products of successful prevention of kidney disease are anticipated to be the reduction and prevention of other cadmium-induced diseases.
(b) Health effects. The major health effects associated with cadmium overexposure are described below.
(i) Kidney: The most prevalent nonmalignant disease observed among workers chronically exposed to cadmium is kidney dysfunction. Initially, such dysfunction is manifested as proteinuria. The proteinuria associated with cadmium exposure is most commonly characterized by excretion of low-molecular weight proteins (15,000 to 40,000 MW) accompanied by loss of electrolytes, uric acid, calcium, amino acids, and phosphate. The compounds commonly excreted include: Beta-2-microglobulin (β2-M), retinol binding protein (RBP), immunoglobulin light chains, and lysozyme. Excretion of low molecular weight proteins are characteristic of damage to the proximal tubules of the kidney (Iwao et al., 1980). It has also been observed that exposure to cadmium may lead to urinary excretion of high-molecular weight proteins such as albumin, immunoglobulin G, and glycoproteins (Ex. 29). Excretion of high-molecular weight proteins is typically indicative of damage to the glomeruli of the kidney. Bernard et al., (1979) suggest that damage to the glomeruli and damage to the proximal tubules of the kidney may both be linked to cadmium exposure but they may occur independently of each other. Several studies indicate that the onset of low-molecular weight proteinuria is a sign of irreversible kidney damage (Friberg et al., 1974; Roels et al., 1982; Piscator 1984; Elinder et al., 1985; Smith et al., 1986). Above specific levels of β2-M associated with cadmium exposure it is unlikely that β2-M levels return to normal even when cadmium exposure is eliminated by removal of the individual from the cadmium work environment (Friberg, Ex. 29, 1990). Some studies indicate that such proteinuria may be progressive; levels of β2-M observed in the urine increase with time even after cadmium exposure has ceased. See, for example, Elinder et al., 1985. Such observations, however, are not universal, and it has been suggested that studies in which proteinuria has not been observed to progress may not have tracked patients for a sufficiently long time interval (Jarup, Ex. 8-661). When cadmium exposure continues after the onset of proteinuria, chronic nephrotoxicity may occur (Friberg, Ex. 29). Uremia results from the inability of the glomerulus to adequately filter blood. This leads to severe disturbance of electrolyte concentrations and may lead to various clinical complications including kidney stones (L-140-50). After prolonged exposure to cadmium, glomerular proteinuria, glucosuria, aminoaciduria, phosphaturia, and hypercalciuria may develop (Exs. 8-86, 4-28, 14-18). Phosphate, calcium, glucose, and amino acids are essential to life, and under normal conditions, their excretion should be regulated by the kidney. Once low molecular weight proteinuria has developed, these elements dissipate from the human body. Loss of glomerular function may also occur, manifested by decreased glomerular filtration rate and increased serum creatinine. Severe cadmium-induced renal damage may eventually develop into chronic renal failure and uremia (Ex. 55). Studies in which animals are chronically exposed to cadmium confirm the renal effects observed in humans (Friberg et al., 1986). Animal studies also confirm problems with calcium metabolism and related skeletal effects which have been observed among humans exposed to cadmium in addition to the renal effects. Other effects commonly reported in chronic animal studies include anemia, changes in liver morphology, immunosuppression and hypertension. Some of these effects may be associated with co-factors. Hypertension, for example, appears to be associated with diet as well as cadmium exposure. Animals injected with cadmium have also shown testicular necrosis (Ex. 8-86B).
(ii) Biological markers. It is universally recognized that the best measures of cadmium exposures and its effects are measurements of cadmium in biological fluids, especially urine and blood. Of the two, CdU is conventionally used to determine body burden of cadmium in workers without kidney disease. CdB is conventionally used to monitor for recent exposure to cadmium. In addition, levels of CdU and CdB historically have been used to predict the percent of the population likely to develop kidney disease (Thun et al., Ex. L-140-50; WHO, Ex. 8-674; ACGIH, Exs. 8-667, 140-50). The third biological parameter upon which WISHA relies for medical surveillance is beta-2-microglobulin in urine (β2-M), a low molecular weight protein. Excess β2-M has been widely accepted by physicians and scientists as a reliable indicator of functional damage to the proximal tubule of the kidney (Exs. 8-447, 144-3-C, 4-47, L-140-45, 19-43-A). Excess β2-M is found when the proximal tubules can no longer reabsorb this protein in a normal manner. This failure of the proximal tubules is an early stage of a kind of kidney disease that commonly occurs among workers with excessive cadmium exposure. Used in conjunction with biological test results indicating abnormal levels of CdU and CdB, the finding of excess β2-M can establish for an examining physician that any existing kidney disease is probably cadmium-related (Trs. 6/6/90, pp. 82-86, 122, 134). The upper limits of normal levels for cadmium in urine and cadmium in blood are 3 µg Cd/gram creatinine in urine and 5 µgCd/liter whole blood, respectively. These levels were derived from broad-based population studies. Three issues confront the physicians in the use of β2-M as a marker of kidney dysfunction and material impairment. First, there are a few other causes of elevated levels of β2-M not related to cadmium exposures, some of which may be rather common diseases and some of which are serious diseases (e.g., myeloma or transient flu, Exs. 29 and 8-086). These can be medically evaluated as alternative causes (Friberg, Ex. 29). Also, there are other factors that can cause β2-M to degrade so that low levels would result in workers with tubular dysfunction. For example, regarding the degradation of β2-M, workers with acidic urine (pH<6) might have β2-M levels that are within the "normal" range when in fact kidney dysfunction has occurred (Ex. L-140-1) and the low molecular weight proteins are degraded in acid urine. Thus, it is very important that the pH of urine be measured, that urine samples be buffered as necessary (See WAC 296-62-07451, appendix F.), and that urine samples be handled correctly, i.e., measure the pH of freshly voided urine samples, then if necessary, buffer to Ph˃6 (or above for shipping purposes), measure Ph again and then, perhaps, freeze the sample for storage and shipping. (See also WAC 296-62-07451, appendix F.) Second, there is debate over the pathological significance of proteinuria, however, most world experts believe that β2-M levels greater than 300 µg/g Cr are abnormal (Elinder, Ex. 55, Friberg, Ex. 29). Such levels signify kidney dysfunction that constitutes material impairment of health. Finally, detection of β2-M at low levels has often been considered difficult, however, many laboratories have the capability of detecting excess β2-M using simple kits, such as the Phadebas Delphia test, that are accurate to levels of 100 µg β2-M/g Cr U (Ex. L-140-1). Specific recommendations for ways to measure β2-M and proper handling of urine samples to prevent degradation of β2-M have been addressed by WISHA in WAC 296-62-07451, appendix F, in the section on laboratory standardization. All biological samples must be analyzed in a laboratory that is proficient in the analysis of that particular analyte, under WAC 296-62-07423 (1)(d). (See WAC 296-62-07451, appendix F). Specifically, under WAC 296-62-07423 (1)(d), the employer is to assure that the collecting and handling of biological samples of cadmium in urine (CdU), cadmium in blood (CdB), and beta-2 microglobulin in urine (β2-M) taken from employees is collected in a manner that assures reliability. The employer must also assure that analysis of biological samples of cadmium in urine (CdU), cadmium in blood (CdB), and beta-2 microglobulin in urine (β2-M) taken from employees is performed in laboratories with demonstrated proficiency for that particular analyte. (See WAC 296-62-07451, appendix F).
(iii) Lung and prostate cancer. The primary sites for cadmium-associated cancer appear to be the lung and the prostate (L-140-50). Evidence for an association between cancer and cadmium exposure derives from both epidemiological studies and animal experiments. Mortality from prostate cancer associated with cadmium is slightly elevated in several industrial cohorts, but the number of cases is small and there is not clear dose-response relationship. More substantive evidence exists for lung cancer. The major epidemiological study of lung cancer was conducted by Thun et al., (Ex. 4-68). Adequate data on cadmium exposures were available to allow evaluation of dose-response relationships between cadmium exposure and lung cancer. A statistically significant excess of lung cancer attributed to cadmium exposure was observed in this study even when confounding variables such as co-exposure to arsenic and smoking habits were taken into consideration (Ex. L-140-50). The primary evidence for quantifying a link between lung cancer and cadmium exposure from animal studies derives from two rat bioassay studies; one by Takenaka et al., (1983), which is a study of cadmium chloride and a second study by Oldiges and Glaser (1990) of four cadmium compounds. Based on the above cited studies, the U.S. Environmental Protection Agency (EPA) classified cadmium as "B1," a probable human carcinogen, in 1985 (Ex. 4-4). The International Agency for Research on Cancer (IARC) in 1987 also recommended that cadmium be listed as "2A," a probable human carcinogen (Ex. 4-15). The American Conference of Governmental Industrial Hygienists (ACGIH) has recently recommended that cadmium be labeled as a carcinogen. Since 1984, NIOSH has concluded that cadmium is possibly a human carcinogen and has recommended that exposures be controlled to the lowest level feasible.
(iv) Noncarcinogenic effects. Acute pneumonitis occurs 10 to 24 hours after initial acute inhalation of high levels of cadmium fumes with symptoms such as fever and chest pain (Exs. 30, 8-86B). In extreme exposure cases pulmonary edema may develop and cause death several days after exposure. Little actual exposure measurement data is available on the level of airborne cadmium exposure that causes such immediate adverse lung effects, nonetheless, it is reasonable to believe a cadmium concentration of approximately 1 mg/m3 over an eight hour period is "immediately dangerous" (55 FR 4052, ANSI; Ex. 8-86B). In addition to acute lung effects and chronic renal effects, long term exposure to cadmium may cause other severe effects on the respiratory system. Reduced pulmonary function and chronic lung disease indicative of emphysema have been observed in workers who have had prolonged exposure to cadmium dust or fumes (Exs. 4-29, 4-22, 4-42, 4-50, 4-63). In a study of workers conducted by Kazantzis et al., a statistically significant excess of worker deaths due to chronic bronchitis was found, which in his opinion was directly related to high cadmium exposures of 1 mg/m3 or more (Tr. 6/8/90, pp. 156-157). Cadmium need not be respirable to constitute a hazard. Inspirable cadmium particles that are too large to be respirable but small enough to enter the tracheobronchial region of the lung can lead to bronchoconstriction, chronic pulmonary disease, and cancer of that portion of the lung. All of these diseases have been associated with occupational exposure to cadmium (Ex. 8-86B). Particles that are constrained by their size to the extra-thoracic regions of the respiratory system such as the nose and maxillary sinuses can be swallowed through mucocillary clearance and be absorbed into the body (ACGIH, Ex. 8-692). The impaction of these particles in the upper airways can lead to anosmia, or loss of sense of smell, which is an early indication of overexposure among workers exposed to heavy metals. This condition is commonly reported among cadmium-exposed workers (Ex. 8-86-B).
(c) Medical surveillance. In general, the main provisions of the medical surveillance section of the standard, under WAC 296-62-07423 (1) through (16), are as follows:
(i) Workers exposed above the action level are covered;
(ii) Workers with intermittent exposures are not covered;
(iii) Past workers who are covered receive biological monitoring for at least one year;
(iv) Initial examinations include a medical questionnaire and biological monitoring of cadmium in blood (CdB), cadmium in urine (CdU), and Beta-2-microglobulin in urine (β2-M);
(v) Biological monitoring of these three analytes is performed at least annually; full medical examinations are performed biennially;
(vi) Until five years from the effective date of the standard, medical removal is required when CdU is greater than 15 µg/gram creatinine (g Cr), or CdB is greater than 15 µg/liter whole blood (lwb), or β2-M is greater than 1500 µg/g Cr, and CdB is greater than 5 µg/lwb or CdU is greater than 3 µg/g Cr;
(vii) Beginning five years after the standard is in effect, medical removal triggers will be reduced;
(viii) Medical removal protection benefits are to be provided for up to eighteen months;
(ix) Limited initial medical examinations are required for respirator usage;
(x) Major provisions are fully described under WAC 296-62-07423; they are outlined here as follows:
(A) Eligibility.
(B) Biological monitoring.
(C) Actions triggered by levels of CdU, CdB, and β2-M (See Summary Charts and Tables in WAC 296-62-07441(5).)
(D) Periodic medical surveillance.
(E) Actions triggered by periodic medical surveillance (See appendix A Summary Chart and Tables in WAC 296-62-07441(5).)
(F) Respirator usage.
(G) Emergency medical examinations.
(H) Termination examination.
(I) Information to physician.
(J) Physician's medical opinion.
(K) Medical removal protection.
(L) Medical removal protection benefits.
(M) Multiple physician review.
(N) Alternate physician review.
(O) Information employer gives to employee.
(P) Recordkeeping.
(Q) Reporting on OSHA form 200.
(xi) The above mentioned summary of the medical surveillance provisions, the summary chart, and tables for the actions triggered at different levels of CdU, CdB and β2-M (in subsection (5) of this section, Attachment 1) are included only for the purpose of facilitating understanding of the provisions of WAC 296-62-07423(3) of the final cadmium standard. The summary of the provisions, the summary chart, and the tables do not add to or reduce the requirements in WAC 296-62-07423(3).
(d) Recommendations to physicians.
(i) It is strongly recommended that patients with tubular proteinuria are counseled on: The hazards of smoking; avoidance of nephrotoxins and certain prescriptions and over-the-counter medications that may exacerbate kidney symptoms; how to control diabetes and/or blood pressure; proper hydration, diet, and exercise (Ex. 19-2). A list of prominent or common nephrotoxins is attached. (See subsection (6) of this section, Attachment 2.)
(ii) do not chelate; know which drugs are nephrotoxins or are associated with nephritis.
(iii) The gravity of cadmium-induced renal damage is compounded by the fact there is no medical treatment to prevent or reduce the accumulation of cadmium in the kidney (Ex. 8-619). Dr. Friberg, a leading world expert on cadmium toxicity, indicated in 1992, that there is no form of chelating agent that could be used without substantial risk. He stated that tubular proteinuria has to be treated in the same way as other kidney disorders (Ex. 29).
(iv) After the results of a workers' biological monitoring or medical examination are received the employer is required to provide an information sheet to the patient, briefly explaining the significance of the results. (See subsection (7) of this section.)
(v) For additional information the physician is referred to the following additional resources:
(A) The physician can always obtain a copy of the OSHA final rule preamble, with its full discussion of the health effects, from OSHA's Computerized Information System (OCIS).
(B) The OSHA Docket Officer maintains a record of the OSHA rulemaking. The Cadmium Docket (H-057A), is located at 200 Constitution Ave. NW., Room N-2625, Washington, DC 20210; telephone: (202) 219-7894.
(C) The following articles and exhibits in particular from that docket (H-057A):
Exhibit number
Author and paper title
 
8-447
Lauwerys et. al., Guide for physicians, "Health Maintenance of Workers Exposed to Cadmium," published by the Cadmium Council.
 
4-67
Takenaka, S., H. Oldiges, H. Konig, D. Hochrainer, G. Oberdorster. "Carcinogenicity of Cadmium Chloride Aerosols in Wistar Rats." JNCI 70:367-373, 1983. (32)
 
4-68
Thun, M.J., T.M. Schnoor, A.B. Smith, W.E. Halperin, R.A. Lemen. "Mortality Among a Cohort of U.S. Cadmium Production Workers—An Update." JNCI 74(2):325-33, 1985. (8)
 
4-25
Elinder, C.G., Kjellstrom, T., Hogstedt, C., et al., "Cancer Mortality of Cadmium Workers." Brit. J. Ind. Med. 42:651-655, 1985. (14)
 
4-26
Ellis, K.J. et al., "Critical Concentrations of Cadmium in Human Renal Cortex: Dose Effect Studies to Cadmium Smelter Workers." J. Toxicol. Environ. Health 7:691-703, 1981. (76)
 
4-27
Ellis, K.J., S.H. Cohn and T.J. Smith. "Cadmium Inhalation Exposure Estimates: Their Significance with Respect to Kidney and Liver Cadmium Burden." J. Toxicol. Environ. Health 15:173-187, 1985.
 
4-28
Falck, F.Y., Jr., Fine, L.J., Smith, R.G., McClatchey, K.D., Annesley, T., England, B., and Schork, A.M. "Occupational Cadmium Exposure and Renal Status." Am. J. Ind. Med. 4:541, 1983. (64)
 
8-86A
Friberg, L., C.G. Elinder, et al., "Cadmium and Health a Toxicological and Epidemiological Appraisal, Volume I, Exposure, Dose, and Metabolism." CRC Press, Inc., Boca Raton, FL, 1986. (Available from the OSHA Technical Data Center)
 
8-86B
Friberg, L., C.G. Elinder, et al., "Cadmium and Health: A Toxicological and Epidemiological Appraisal, Volume II, Effects and Response." CRC Press, Inc., Boca Raton, FL, 1986. (Available from the OSHA Technical Data Center)
 
L-140-45
Elinder, C.G., "Cancer Mortality of Cadmium Workers," Brit. J. Ind. Med., 42, 651-655, 1985.
 
L-140-50
Thun, M., Elinder, C.G., Friberg, L, "Scientific Basis for an Occupational Standard for Cadmium, Am. J. Ind. Med., 20; 629-642, 1991.
(5) Information sheet. The information sheet (subsection (8) of this section, Attachment 3) or an equally explanatory one should be provided to you after any biological monitoring results are reviewed by the physician, or where applicable, after any medical examination.
(6) Attachment 1—Appendix A, summary chart and Tables A and B of actions triggered by biological monitoring.
(a) Summary chart: WAC 296-62-07423(3) Medical surveillance—Categorizing biological monitoring results.
(i) Biological monitoring results categories are set forth in Table A for the periods ending December 31, 1998, and for the period beginning January 1, 1999.
(ii) The results of the biological monitoring for the initial medical exam and the subsequent exams shall determine an employee's biological monitoring result category.
(b) Actions triggered by biological monitoring.
(i) The actions triggered by biological monitoring for an employee are set forth in Table B.
(ii) The biological monitoring results for each employee under WAC 296-62-07423(3) shall determine the actions required for that employee. That is, for any employee in biological monitoring category C, the employer will perform all of the actions for which there is an X in column C of Table B.
(iii) An employee is assigned the alphabetical category ("A" being the lowest) depending upon the test results of the three biological markers.
(iv) An employee is assigned category A if monitoring results for all three biological markers fall at or below the levels indicated in the table listed for category A.
(v) An employee is assigned category B if any monitoring result for any of the three biological markers fall within the range of levels indicated in the table listed for category B, providing no result exceeds the levels listed for category B.
(vi) An employee is assigned category C if any monitoring result for any of the three biological markers are above the levels listed for category C.
(c) The user of Tables A and B should know that these tables are provided only to facilitate understanding of the relevant provisions of WAC 296-62-07423. Tables A and B are not meant to add to or subtract from the requirements of those provisions.
Table A
Categorization of Biological Monitoring Results
Applicable Through 1998 Only
 
Monitoring result categories
Biological marker
A
B
C
Cadmium in urine (CdU)
(µg/g creatinine)
≤=3
˃3 and ≤=15